Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" AAGAB "FLJ11506, p34" ENSG00000103591 "Alpha and gamma adaptin binding protein" Q6PD74 15 67201033-67255195 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039371, HPA040174" Supported Supported "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA039371: AB_10805476, HPA040174: AB_10805605" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (8.25e-2)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (2.84e-2)" "unprognostic (4.52e-2)" "unprognostic (9.10e-2)" "unprognostic (5.28e-2)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "prognostic favourable (1.36e-4)" "unprognostic (9.88e-2)" "unprognostic (3.05e-1)" "prognostic unfavourable (9.48e-4)" "unprognostic (1.53e-1)" 19.3 23.6 17.0 15.6 22.5 15.6 20.3 13.3 29.8 16.7 23.6 14.7 24.1 13.3 18.1 24.7 22.3 14.6 16.1 14.8 15.9 22.5 29.5 22.2 15.2 15.4 17.7 20.2 14.4 18.0 29.9 39.1 16.0 31.5 16.9 29.7 14.9 19.3 19.0 33.4 14.3 21.9 18.4 13.8 18.2 20.1 23.8 13.4 25.9 28.8 18.1 21.4 19.8 14.1 16.1 23.9 28.4 24.7 27.7 26.8 20.1 18.0 32.7 23.6 24.2 23.5 19.1 11.8 19.0 28.1 23.0 26.6 24.2 19.6 17.4 19.5 19.9 36.5 49.1 22.2 24.2 24.2 23.2 16.5 24.6 9.9 25.4 28.0 19.4 18.6 30.6 17.1 36.8 18.2 34.1 24.7 22.4 22.0 17.0 12.0 20.2 11.9 19.1 30.3 21.0 21.2 42.6 33.8 21.6 22.8 16.5 26.9 26.9 21.5 18.9 21.1 25.4 18.7 26.4 12.8 43.1 26.1 19.9 26.2 20.9 28.4 18.9 18.5 23.5 24.6 26.8 16.1 20.8 22.1 23.9 12.5 17.7 19.4 10.1 27.7 24.7 17.7 25.1 20.1 17.0 22.5 13.3 29.8 15.9 22.5 17.7 20.2 31.5 13.4 AC023055.1 ENSG00000257390 12 55757275-55827546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "blood: 6.4;testis: 12.9" "Cell line enhanced" "Detected in many" "SK-MEL-30: 6.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA017653, HPA030902, HPA030903" Uncertain Approved "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles" "Cytoplasmic bodies" "HPA017653: AB_1847799, HPA030902: AB_10669872, HPA030903: AB_10964180" "unprognostic (8.84e-4)" "unprognostic (2.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.55e-3)" "unprognostic (1.86e-1)" "unprognostic (6.30e-2)" "unprognostic (3.79e-2)" "unprognostic (3.05e-2)" "unprognostic (2.16e-2)" "unprognostic (1.16e-5)" "unprognostic (6.36e-2)" "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (4.37e-3)" 0.3 0.1 0.1 0.0 0.1 0.6 0.0 0.3 0.4 0.0 0.1 0.3 0.0 0.6 0.2 0.1 0.7 0.2 0.2 0.1 0.1 0.3 0.1 0.5 0.2 0.0 0.1 0.4 0.1 0.0 0.3 0.7 0.0 0.0 0.4 0.2 0.7 0.0 0.1 0.1 0.2 12.9 0.0 0.3 0.4 0.0 6.4 4.1 5.3 5.9 5.7 5.8 4.7 0.3 0.0 2.8 4.0 3.0 0.0 3.2 1.7 1.4 0.3 1.2 1.1 0.8 3.1 0.6 2.0 1.5 2.4 3.0 1.3 0.0 2.7 2.2 0.6 0.3 1.2 2.6 2.8 0.7 0.0 1.4 0.6 0.4 1.3 0.0 0.6 0.0 1.6 2.4 4.5 0.0 2.8 3.2 1.8 1.6 0.8 4.2 1.3 0.9 4.4 6.4 1.0 1.1 0.0 0.0 0.3 0.6 0.9 0.0 2.2 1.8 0.8 0.3 0.5 2.8 2.6 5.3 5.6 3.2 3.5 6.4 4.9 4.5 4.1 3.5 3.9 5.8 1.5 5.7 5.9 2.7 5.2 4.7 AC091959.3 ENSG00000275740 5 146203550-146339251 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 21.6" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA035944, HPA036422" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA035944: AB_10670672, HPA036422: AB_10669987" "unprognostic (6.42e-2)" "unprognostic (7.72e-4)" "unprognostic (2.05e-2)" "unprognostic (4.95e-2)" "unprognostic (1.51e-2)" "unprognostic (1.13e-2)" "unprognostic (3.24e-2)" "unprognostic (8.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.61e-2)" "unprognostic (1.17e-1)" "unprognostic (3.77e-3)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (1.56e-2)" "unprognostic (2.12e-2)" 3.6 2.8 4.0 5.7 5.4 8.0 3.4 6.5 5.4 4.6 5.1 2.9 3.5 6.0 4.8 2.3 4.9 4.4 2.8 3.6 3.7 3.1 4.1 3.3 5.0 3.6 4.1 5.9 3.3 5.5 4.3 4.1 4.0 4.3 3.4 3.0 3.5 3.4 7.3 2.2 4.6 5.8 3.7 4.3 4.2 21.6 3.8 8.4 5.8 4.0 4.7 5.6 3.9 16.1 12.5 17.6 13.3 11.8 15.0 8.4 5.9 9.8 4.8 4.6 1.5 1.5 4.4 7.7 4.6 9.1 9.5 10.5 4.8 7.0 4.6 4.1 4.6 7.1 6.7 7.7 13.4 3.9 8.0 4.8 1.1 1.1 9.6 8.1 2.2 0.9 8.6 5.3 2.7 10.8 4.7 2.7 2.7 7.8 0.0 4.4 6.4 7.9 9.1 3.9 0.7 7.8 4.7 3.4 11.1 2.5 3.8 7.9 1.4 5.4 4.9 5.9 6.0 7.5 5.5 12.2 11.4 5.6 5.8 5.4 17.6 8.8 16.6 13.6 8.7 15.0 12.9 12.5 10.4 9.0 16.1 13.3 12.9 12.8 11.8 13.3 12.5 10.8 8.4 AC105001.2 ENSG00000258724 8 10725399-10839847 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 6.0;HBEC3-KT: 2.4;SiHa: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 13 "NK-cells: 1.5" "Low region specificity" "Detected in some" HPA009065 Uncertain Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (2.57e-1)" "unprognostic (6.34e-2)" 6.7 2.7 1.9 3.7 3.1 1.7 2.7 2.9 3.9 9.8 3.1 2.6 0.9 3.3 3.6 1.7 4.0 2.1 3.1 3.2 2.0 1.9 2.2 4.8 4.7 2.2 2.8 2.1 3.8 4.1 1.7 2.3 3.3 4.2 2.7 1.8 3.6 3.4 2.0 8.7 4.6 3.0 2.1 2.5 3.3 3.2 6.3 1.7 4.6 2.6 4.3 3.8 2.2 15.2 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.2 0.0 0.1 0.2 0.4 0.0 0.1 0.0 6.0 0.4 2.4 0.0 0.1 0.1 0.0 0.0 0.2 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.3 0.3 0.1 1.1 0.0 0.0 0.3 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.3 0.2 0.0 0.1 0.9 0.1 0.1 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 3.1 2.9 3.9 2.0 1.9 2.8 2.1 4.2 1.7 ALOX12 12S-LOX ENSG00000108839 "Arachidonate 12-lipoxygenase, 12S type" P18054 17 6996065-7010736 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Hydrolase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7" "Group enriched" "Detected in some" 5 "A-431: 17.1;HEL: 27.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 5 "olfactory region: 5.4" "HPA010691, CAB019287, HPA064819" Enhanced Supported "Nuclear speckles,Cytosol" 5800000 Cytosol "Nuclear speckles" "CAB019287: , HPA010691: AB_1844756, HPA064819: " "unprognostic (3.61e-3)" "unprognostic (6.93e-2)" "unprognostic (7.17e-5)" "unprognostic (9.43e-2)" "unprognostic (6.06e-2)" "unprognostic (2.25e-3)" "unprognostic (2.45e-1)" "unprognostic (3.16e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-2)" "unprognostic (3.96e-5)" "unprognostic (4.01e-3)" "unprognostic (2.25e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (5.90e-2)" "unprognostic (3.47e-2)" 0.3 0.6 0.3 1.5 0.4 2.0 0.3 0.3 1.0 28.6 0.4 0.3 0.3 0.7 3.4 0.5 28.4 0.4 1.6 0.8 0.3 0.1 0.3 0.3 0.5 1.9 0.5 0.3 0.4 0.8 0.0 0.3 0.7 0.4 0.3 0.0 0.4 8.1 0.3 0.5 12.8 0.8 0.3 0.3 1.5 0.3 0.6 0.3 0.3 0.8 22.7 9.5 1.2 42.7 1.1 1.3 4.8 0.9 0.7 0.8 14.3 17.1 2.9 1.3 1.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 2.5 0.6 0.8 0.6 0.0 2.2 0.0 0.1 0.0 1.8 2.2 27.4 3.8 1.8 0.1 0.2 4.5 0.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 0.2 0.3 0.6 0.9 0.6 0.9 0.5 0.4 0.0 2.2 0.1 0.6 0.5 0.5 0.2 1.0 0.7 3.2 1.5 0.8 1.4 0.7 0.5 0.2 0.5 0.8 2.0 0.7 1.8 0.9 1.7 0.7 0.5 0.5 1.1 0.5 0.8 0.7 0.7 0.2 0.4 4.8 0.7 0.4 1.3 0.3 14.3 0.3 0.4 0.3 0.6 0.3 0.1 0.5 0.3 0.4 0.3 ANKRD44 PP6-ARS-B ENSG00000065413 "Ankyrin repeat domain 44" Q8N8A2 2 196967017-197311173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 34.7;lymphoid tissue: 38.2" "Cell line enhanced" "Detected in many" "HDLM-2: 26.1;HMC-1: 20.3;Karpas-707: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030122, HPA056549" Approved Approved "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "HPA030122: AB_10600980, HPA056549: " "unprognostic (3.64e-1)" "unprognostic (1.70e-2)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (2.63e-1)" "unprognostic (7.04e-5)" "unprognostic (1.97e-2)" "unprognostic (1.58e-3)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" "unprognostic (3.67e-2)" 6.0 6.0 4.9 29.4 8.8 12.5 4.3 3.7 5.1 8.6 6.7 10.8 3.9 3.2 6.5 3.9 4.3 4.9 7.6 6.4 6.4 4.7 5.6 4.5 15.4 36.7 9.4 4.7 5.1 3.5 6.0 6.1 6.4 6.4 5.0 4.8 7.4 8.0 4.7 2.9 3.0 12.6 9.6 8.0 17.8 5.6 7.1 8.9 38.2 5.1 3.0 27.0 9.0 9.8 15.7 9.4 34.7 11.4 12.0 13.4 6.3 1.0 0.6 1.6 1.7 3.8 1.5 0.3 2.4 1.1 1.3 1.2 0.4 0.5 8.8 1.1 2.0 0.1 0.5 0.5 1.0 26.1 2.2 0.3 3.1 0.1 0.2 6.4 20.3 0.8 0.3 1.3 0.1 1.7 1.4 14.7 1.9 1.5 3.1 5.2 0.2 1.6 5.6 1.8 12.0 3.1 0.8 1.6 7.2 0.8 0.6 6.9 0.9 6.3 9.1 4.5 2.5 1.3 1.8 3.7 4.3 11.2 3.1 8.0 2.6 21.8 9.5 21.0 13.1 9.8 12.4 11.6 9.8 11.1 9.4 15.7 11.3 13.4 34.7 12.0 11.4 6.2 9.3 6.3 4.9 8.8 3.7 5.1 6.4 4.7 9.4 4.7 6.4 8.9 ANKRD55 FLJ11795 ENSG00000164512 "Ankyrin repeat domain 55" Q3KP44 5 56099678-56233359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7" "Group enriched" "Detected in some" 6 "HEL: 23.9;HMC-1: 12.4;NB-4: 15.7" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3" "Group enriched" "Detected in many" 67 "granulocytes: 13.1;T-cells: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051049, HPA061649" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" "Nucleoplasm, Nuclear speckles" Cytosol "HPA051049: , HPA061649: " "unprognostic (1.00e-4)" "unprognostic (1.58e-4)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (7.78e-4)" "unprognostic (1.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.33e-1)" "unprognostic (1.40e-1)" "unprognostic (7.19e-6)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (1.01e-1)" 0.9 0.5 3.3 1.3 20.0 1.4 0.5 0.5 6.7 0.3 0.5 1.5 0.0 0.5 0.3 0.2 0.6 0.6 0.8 0.4 4.3 7.8 1.1 5.7 0.6 6.1 2.3 3.5 0.5 0.3 0.2 0.5 1.4 9.9 0.3 0.7 0.7 2.1 0.3 0.3 0.9 2.4 0.5 4.1 3.0 0.7 16.7 1.8 0.0 0.4 0.0 3.8 1.0 0.3 0.0 0.0 13.1 0.2 0.0 14.3 2.1 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.1 0.9 0.0 1.1 12.4 0.0 0.0 0.0 0.0 3.0 1.9 0.8 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.3 12.6 0.2 13.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 14.3 0.5 1.2 0.0 0.0 0.0 0.6 2.1 3.3 20.0 0.5 6.7 4.3 7.8 2.3 3.5 9.9 1.8 ANXA9 ANX31 ENSG00000143412 "Annexin A9" O76027 1 150982017-150995634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 62.0;seminal vesicle: 78.1" "Cell line enhanced" "Detected in many" "CACO-2: 12.0;CAPAN-2: 14.4;Hep G2: 14.5;MCF7: 19.3;T-47d: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028404, HPA028698" Enhanced Approved "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA028404: AB_10599190, HPA028698: AB_10600227" "unprognostic (4.06e-1)" "unprognostic (1.55e-2)" "unprognostic (3.15e-3)" "unprognostic (2.08e-3)" "unprognostic (2.93e-2)" "unprognostic (4.49e-2)" "unprognostic (1.84e-2)" "unprognostic (3.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "unprognostic (2.97e-1)" "prognostic favourable (8.74e-6)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (8.99e-2)" "unprognostic (1.72e-2)" 2.4 1.1 1.2 0.9 1.2 0.3 2.6 1.3 2.5 2.3 0.9 0.6 62.0 1.4 6.0 11.6 10.7 2.3 12.5 1.9 1.4 1.0 12.1 15.8 1.2 0.5 1.8 0.8 1.8 32.0 9.9 1.2 0.7 1.3 4.1 0.0 1.2 2.5 78.1 0.9 18.9 1.2 0.9 3.2 1.0 1.3 3.6 0.6 1.3 10.4 9.1 21.1 4.5 4.4 0.5 3.8 2.5 3.1 0.1 0.8 0.8 3.9 0.9 1.4 1.4 0.0 0.0 4.1 0.3 0.2 0.0 0.0 12.0 14.4 0.1 0.8 0.0 2.4 0.0 0.2 0.0 1.2 1.4 2.0 1.4 14.5 0.0 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.9 4.4 0.0 19.3 0.1 1.0 0.3 0.2 0.9 0.2 4.7 0.0 5.6 2.1 1.2 0.8 9.9 0.5 48.0 1.2 1.5 0.3 0.4 0.2 0.2 1.3 4.0 6.2 2.1 1.3 1.1 0.0 3.1 1.8 0.1 1.8 0.8 0.5 0.3 0.5 3.8 0.1 0.8 0.2 2.5 0.1 0.4 0.0 0.0 0.8 1.2 1.2 1.3 0.9 1.4 1.0 1.8 0.8 1.3 0.6 AP001273.2 ENSG00000284057 11 93741664-93812378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA040511, HPA046619" Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA040511: AB_10795369, HPA046619: " 2.4 3.0 1.8 4.2 3.4 0.6 2.7 2.8 2.4 3.6 6.1 3.5 3.6 8.2 2.6 3.0 2.9 2.5 3.3 4.0 2.0 16.9 17.6 3.6 1.7 3.9 1.9 4.8 5.4 5.3 5.9 2.8 3.2 4.5 2.7 4.2 3.8 2.8 4.2 3.7 11.1 2.9 4.5 1.9 3.7 2.6 3.6 4.2 5.7 2.0 1.8 3.0 1.0 2.7 2.9 4.4 2.9 3.0 3.8 2.0 0.2 0.0 4.7 0.9 3.5 0.0 0.6 0.0 1.5 1.0 2.0 1.5 1.2 0.3 4.2 2.5 1.8 5.2 0.7 0.0 1.4 0.0 0.0 1.5 0.0 0.9 0.0 1.0 0.0 0.7 0.0 0.6 0.0 1.0 0.5 5.4 0.0 2.2 3.7 2.0 0.0 1.0 2.7 1.7 5.1 0.0 0.3 0.4 0.0 1.3 3.7 2.1 1.0 2.3 0.0 0.8 0.7 1.9 0.9 0.9 3.9 0.4 1.1 1.7 2.9 2.9 4.4 3.2 2.1 3.0 2.7 2.6 2.6 2.9 1.0 2.9 3.6 4.4 3.0 2.3 1.5 3.8 2.0 ARHGAP18 "bA307O14.2, MacGAP" ENSG00000146376 "Rho GTPase activating protein 18" Q8N392 6 129576132-129710225 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 91.0;LHCN-M2: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031595 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" 840000 "Plasma membrane, Cytosol" "Nuclear speckles" "HPA031595: AB_10959905" "unprognostic (6.39e-2)" "unprognostic (1.60e-1)" "unprognostic (5.45e-2)" "unprognostic (5.49e-2)" "unprognostic (3.05e-1)" "unprognostic (3.17e-1)" "unprognostic (9.32e-3)" "unprognostic (1.25e-2)" "unprognostic (2.98e-2)" "unprognostic (3.12e-2)" "prognostic unfavourable (2.54e-4)" "unprognostic (4.08e-1)" "unprognostic (2.29e-3)" "unprognostic (2.22e-1)" "unprognostic (3.05e-2)" "unprognostic (5.52e-2)" "unprognostic (1.08e-1)" 23.8 32.2 4.1 14.1 4.0 1.7 19.7 2.5 2.4 9.6 19.5 2.9 12.0 13.3 7.8 25.8 5.8 15.7 11.8 16.9 4.4 6.8 33.2 4.5 38.8 15.5 4.1 1.4 8.0 38.2 10.6 22.0 16.7 12.2 9.6 8.2 10.4 16.7 24.2 12.1 5.4 40.6 6.5 9.0 15.8 15.1 10.9 3.8 5.1 12.7 12.1 6.4 10.3 5.8 2.9 11.8 13.0 5.9 2.5 5.8 6.0 1.8 4.2 0.4 0.5 4.1 5.9 3.4 14.3 11.0 6.3 4.3 2.2 3.1 1.5 7.0 9.6 2.4 3.0 4.7 11.9 1.5 1.3 10.2 3.3 12.5 5.9 1.5 91.0 3.7 0.7 11.5 10.3 18.0 5.4 3.9 25.6 0.5 0.0 1.4 0.4 1.0 0.0 1.9 2.9 19.3 1.0 0.0 0.0 1.1 2.0 7.0 2.2 1.8 13.7 6.6 0.9 0.5 11.4 1.8 1.3 1.0 2.2 2.8 9.2 8.9 5.2 13.0 5.3 5.9 3.3 2.9 2.8 5.8 4.8 1.7 0.5 2.9 4.0 2.5 3.1 11.8 2.7 6.0 4.1 4.0 2.5 2.4 4.4 6.8 4.1 1.4 12.2 3.8 ARHGAP42 "AD031, FLJ32810, GRAF3, TMEM133" ENSG00000165895 "Rho GTPase activating protein 42" "A6NI28, Q9H2Q1" 11 100687653-100993941 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 38.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 22.8;RH-30: 15.8;RT4: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039924, HPA060528" Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA039924: AB_10674428, HPA060528: " "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.21e-3)" "unprognostic (2.74e-1)" "unprognostic (1.50e-2)" "unprognostic (4.17e-2)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.30e-2)" "unprognostic (2.36e-1)" "prognostic unfavourable (9.29e-4)" "unprognostic (1.32e-1)" "unprognostic (1.75e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" 11.1 4.9 6.8 8.9 5.8 0.9 10.4 3.0 7.0 9.8 8.3 4.1 2.3 9.9 11.4 7.7 4.3 5.6 9.5 6.5 8.8 3.8 11.9 12.7 13.7 5.1 6.3 5.3 4.8 2.6 9.1 6.0 38.0 5.9 4.8 8.4 25.5 5.1 3.8 9.0 7.2 12.1 5.8 8.7 8.2 11.7 4.1 6.7 12.7 10.9 7.4 3.8 5.5 7.9 1.5 2.5 0.0 0.0 0.7 0.4 0.3 0.5 3.5 4.6 0.1 2.5 3.4 3.1 0.5 0.9 1.1 2.1 4.4 22.8 0.7 6.4 1.7 7.7 2.3 1.7 1.1 0.0 1.9 11.0 8.9 1.4 4.5 0.1 0.0 3.3 2.1 4.2 0.7 1.7 0.4 0.0 3.4 0.6 1.2 0.0 5.5 5.6 3.4 15.8 0.4 5.3 14.8 2.5 1.6 7.6 0.2 6.0 0.8 1.4 3.0 3.0 3.7 3.5 1.7 3.3 0.0 4.4 3.5 2.7 12.9 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.3 6.8 5.8 3.0 7.0 8.8 3.8 6.3 5.3 5.9 6.7 ARMCX5 "FLJ12969, GASP5" ENSG00000125962 "Armadillo repeat containing, X-linked 5" Q6P1M9 X 102599168-102604159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000996 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Nuclear speckles, Cytosol" "Plasma membrane" "HPA000996: AB_1078212" "unprognostic (7.71e-2)" "unprognostic (2.43e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (1.54e-1)" "unprognostic (5.05e-2)" "unprognostic (4.07e-2)" "prognostic favourable (6.58e-5)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (2.83e-1)" "unprognostic (3.28e-3)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (2.83e-1)" "unprognostic (5.24e-2)" 8.6 13.2 11.4 7.0 17.3 6.4 13.8 24.3 19.8 11.2 9.5 8.7 13.1 7.9 13.3 12.5 10.1 11.9 7.5 7.8 11.1 6.3 10.0 15.5 8.3 6.9 8.1 12.9 16.5 25.3 14.5 26.4 6.1 12.8 16.6 11.9 9.2 13.4 11.0 6.1 9.9 10.4 10.8 7.0 10.2 11.7 6.1 8.4 9.5 15.3 7.0 9.6 10.4 9.8 9.7 9.3 2.5 9.8 7.1 15.9 8.5 8.0 7.3 17.2 9.1 7.7 8.7 9.7 7.9 6.1 9.3 16.6 8.6 10.0 0.0 9.7 7.9 7.0 15.3 7.5 10.6 0.0 6.1 8.1 9.2 7.1 10.0 14.7 9.5 10.8 9.8 8.0 9.7 9.4 7.8 0.0 12.3 7.1 10.4 1.7 7.7 13.8 10.3 42.2 0.0 6.9 11.2 8.2 7.3 14.2 7.4 11.3 5.1 7.1 9.5 6.9 6.2 7.8 5.6 0.0 5.7 0.0 5.4 15.1 17.7 0.0 9.5 2.5 12.0 9.8 11.5 9.7 11.3 9.4 9.3 6.0 15.9 12.3 0.8 7.1 6.0 8.1 7.7 8.5 11.4 17.3 24.3 19.8 11.1 6.3 8.1 12.9 12.8 8.4 ATXN7L3 DKFZp761G2113 ENSG00000087152 "Ataxin 7 like 3" Q14CW9 17 44191805-44200113 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064316 Supported Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA064316: " "unprognostic (2.37e-2)" "unprognostic (8.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.74e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (4.03e-4)" "unprognostic (2.86e-3)" "unprognostic (6.74e-3)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.00e-1)" "prognostic unfavourable (2.87e-4)" "unprognostic (1.21e-3)" "unprognostic (9.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.40e-1)" 14.0 12.9 36.7 18.9 25.1 23.8 11.9 23.0 53.1 13.2 16.1 11.3 16.7 19.1 14.3 16.9 22.3 14.2 14.9 12.4 30.7 24.8 12.4 12.6 14.3 20.8 22.7 32.1 13.2 13.7 16.3 17.1 18.8 23.6 13.0 15.3 7.9 16.9 18.5 11.3 19.0 16.5 16.1 15.1 17.6 15.5 17.0 14.1 13.9 14.3 11.3 21.3 16.7 22.4 5.1 4.4 6.7 3.2 1.3 4.8 2.6 17.5 29.8 32.9 21.3 23.0 22.9 17.9 21.6 24.2 27.7 26.3 22.7 20.0 30.9 17.4 24.3 19.4 25.6 20.3 23.3 36.0 25.4 20.9 24.5 25.1 22.7 32.6 42.6 25.8 31.0 23.2 24.6 26.7 27.9 19.4 18.2 13.2 39.1 24.9 24.7 23.4 27.0 31.9 23.1 22.3 25.3 21.0 26.6 12.8 11.3 22.1 27.7 29.1 22.9 28.0 29.4 14.5 20.1 23.5 30.5 37.4 18.4 14.2 16.3 1.4 3.2 3.7 4.8 2.2 2.9 3.6 3.8 3.0 2.7 5.1 2.9 3.6 6.7 1.3 2.3 4.4 2.0 2.6 36.7 25.1 23.0 53.1 30.7 24.8 22.7 32.1 23.6 14.1 BEND5 "C1orf165, FLJ11588" ENSG00000162373 "BEN domain containing 5" Q7L4P6 1 48727523-48776969 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 4.2;HDLM-2: 13.5;MOLT-4: 5.5;NTERA-2: 3.2;REH: 7.7;SH-SY5Y: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 7.1;naive B-cell: 10.1" "Lineage enriched" "Detected in many" 5 "B-cells: 10.1" "Low region specificity" "Detected in many" "HPA054347, HPA058007" Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA054347: , HPA058007: " "prognostic favourable (2.50e-5)" "unprognostic (1.36e-2)" "unprognostic (7.19e-3)" "unprognostic (1.16e-1)" "unprognostic (1.11e-1)" "unprognostic (1.65e-2)" "unprognostic (4.42e-2)" "prognostic favourable (1.29e-4)" "unprognostic (1.41e-1)" "unprognostic (6.02e-2)" "prognostic favourable (1.29e-4)" "unprognostic (1.32e-2)" "unprognostic (4.28e-2)" "unprognostic (2.37e-3)" "unprognostic (3.35e-2)" "unprognostic (9.68e-2)" "prognostic favourable (8.30e-6)" 2.7 5.4 6.5 5.6 7.7 3.0 3.1 2.1 15.5 4.8 5.0 2.8 3.5 1.6 5.0 4.9 2.3 4.3 6.0 4.0 6.0 5.1 6.5 0.8 3.0 5.9 5.4 9.7 12.8 2.8 1.9 5.9 1.4 14.7 3.9 1.6 3.3 2.5 4.3 6.6 1.9 2.6 2.6 3.2 6.4 2.9 2.6 1.9 11.3 4.3 0.5 4.1 4.4 2.9 10.1 1.9 0.2 0.0 1.1 2.0 0.6 0.0 0.0 4.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 0.2 3.2 0.0 7.7 1.4 0.0 0.1 1.5 1.4 3.8 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.1 0.2 1.9 10.1 2.0 1.2 0.2 1.1 0.0 1.9 0.0 0.6 6.5 7.7 2.1 15.5 6.0 5.1 5.4 9.7 14.7 1.9 BORCS7 "C10orf32, FLJ40752" ENSG00000166275 "BLOC-1 related complex subunit 7" Q96B45 10 102854223-102864961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA037648 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA037648: AB_10673634" "unprognostic (2.16e-1)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (2.05e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (1.35e-2)" "unprognostic (7.46e-3)" "unprognostic (3.16e-2)" "unprognostic (1.77e-1)" "prognostic favourable (9.08e-8)" "unprognostic (9.85e-2)" "unprognostic (1.77e-1)" "unprognostic (1.06e-1)" "unprognostic (1.67e-3)" 16.0 40.4 22.7 8.1 26.5 13.2 20.2 14.3 22.1 15.6 11.9 16.4 15.2 15.2 15.2 19.4 9.7 20.2 17.7 15.1 19.7 20.9 26.0 42.7 15.7 10.4 18.0 22.5 15.4 15.2 32.8 23.2 21.2 20.1 18.7 10.3 15.0 11.2 12.6 17.2 9.1 17.7 11.8 17.8 18.1 13.7 18.0 17.3 8.9 36.9 14.2 7.9 11.3 10.9 16.2 29.7 16.8 21.6 16.4 13.5 8.6 7.6 10.4 12.8 11.0 14.1 19.4 10.5 11.4 23.4 8.8 8.4 6.9 8.7 4.9 6.0 18.1 6.4 4.2 5.8 6.5 6.1 8.9 11.2 7.1 14.3 16.2 20.2 19.4 24.2 16.1 5.9 9.5 15.3 6.5 5.1 14.0 5.6 5.5 8.3 4.2 9.9 10.2 16.9 7.0 7.3 8.5 3.6 13.9 4.2 7.6 17.4 14.4 11.6 11.4 7.4 7.9 7.5 8.0 13.5 20.5 5.8 15.7 11.8 2.6 16.8 19.5 13.6 11.8 21.6 12.9 16.2 12.1 11.9 13.8 14.4 13.5 12.4 6.0 16.4 19.3 29.7 11.8 8.6 22.7 26.5 14.3 22.1 19.7 20.9 18.0 22.5 20.1 17.3 BPNT1 ENSG00000162813 "3'(2'), 5'-bisphosphate nucleotidase 1" O95861 1 220057482-220090462 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048461 Approved Approved "Nuclear speckles" 170000 "Nuclear speckles" "HPA048461: " "unprognostic (6.42e-2)" "unprognostic (4.69e-2)" "unprognostic (2.78e-2)" "unprognostic (1.02e-1)" "unprognostic (5.19e-3)" "unprognostic (7.65e-2)" "unprognostic (2.07e-2)" "unprognostic (3.00e-1)" "unprognostic (2.44e-1)" "unprognostic (1.66e-1)" "unprognostic (6.69e-2)" "unprognostic (2.87e-1)" "prognostic favourable (6.38e-4)" "unprognostic (1.82e-2)" "unprognostic (6.58e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-1)" 11.1 24.1 12.7 22.2 17.2 2.9 13.4 13.7 16.5 12.9 27.9 15.9 14.4 30.5 10.6 8.0 14.9 11.5 16.1 11.6 11.3 10.8 31.0 17.0 11.5 21.5 14.0 10.6 13.5 8.6 14.1 20.2 12.7 11.9 9.6 22.5 11.8 22.2 12.2 7.6 10.6 49.0 12.3 17.6 12.0 12.9 10.4 13.3 15.6 13.8 12.6 28.8 13.5 10.4 18.9 10.9 11.6 8.5 12.1 13.8 7.6 11.7 9.7 7.3 5.8 13.0 10.4 10.9 15.8 7.7 13.6 12.6 12.7 23.8 59.4 20.8 10.2 8.5 14.7 13.2 11.0 21.3 17.1 10.7 12.5 15.6 7.6 28.4 10.1 9.8 6.3 20.1 7.5 10.6 18.5 5.9 13.0 6.6 16.3 7.8 6.2 11.9 11.7 21.0 16.8 16.9 16.1 13.5 11.1 19.9 24.0 13.0 18.8 9.8 17.7 8.5 6.6 11.8 19.5 10.4 25.2 28.1 7.6 10.6 19.2 11.6 7.8 5.0 11.0 8.5 8.7 18.9 11.3 11.0 9.0 14.1 13.8 10.2 1.1 12.1 7.8 10.9 11.5 7.6 12.7 17.2 13.7 16.5 11.3 10.8 14.0 10.6 11.9 13.3 BRK1 "C3orf10, HSPC300, MDS027" ENSG00000254999 "BRICK1, SCAR/WAVE actin nucleating complex subunit" Q8WUW1 3 10115592-10127190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060391 Approved "Nuclear speckles,Cell Junctions" 130000 "Nuclear speckles" "Cell Junctions" "HPA060391: " "unprognostic (4.99e-2)" "unprognostic (3.48e-2)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (2.91e-1)" "unprognostic (9.60e-2)" "prognostic unfavourable (5.76e-5)" "unprognostic (2.49e-2)" "unprognostic (2.89e-1)" "unprognostic (1.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.37e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-1)" "unprognostic (9.40e-2)" "unprognostic (4.35e-2)" "unprognostic (7.75e-3)" 67.1 47.6 53.4 40.4 57.1 52.4 62.9 33.4 69.5 52.8 58.6 36.1 47.3 37.9 63.2 68.3 73.0 59.4 70.8 54.4 42.6 45.3 66.8 57.3 49.3 53.2 43.3 53.6 62.7 57.8 38.8 39.2 44.4 40.7 60.8 51.8 41.5 84.2 53.1 62.7 57.0 46.5 74.3 37.2 47.0 57.2 65.2 34.2 50.2 83.3 62.4 64.8 63.0 61.0 67.4 89.7 76.1 75.4 47.2 61.0 89.1 30.1 36.2 38.6 20.0 64.6 70.6 91.4 44.9 44.8 42.2 42.0 24.8 35.5 34.8 21.4 51.6 15.8 27.7 45.5 46.3 38.3 38.4 48.0 41.8 36.9 36.8 45.6 36.4 46.3 44.1 47.2 34.4 58.8 31.1 40.8 63.6 66.3 29.5 36.5 44.4 45.9 28.6 39.7 37.8 55.5 50.1 15.0 26.1 36.1 31.5 36.3 51.2 40.0 53.1 42.5 32.6 49.7 40.0 23.5 63.0 78.5 61.5 62.7 34.9 54.1 75.4 75.9 56.5 72.4 50.3 67.4 55.0 53.1 84.3 67.4 50.1 54.4 76.1 47.2 70.9 89.7 61.0 89.1 53.4 57.1 33.4 69.5 42.6 45.3 43.3 53.6 40.7 34.2 C10orf67 "bA215C7.4, C10orf115, LINC01552, MGC46732" ENSG00000179133 "Chromosome 10 open reading frame 67" Q8IYJ2 10 23201916-23344845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8" "Cell line enhanced" "Detected in some" "HaCaT: 5.2;SiHa: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 4.2" "Low lineage specificity" "Detected in many" "HPA038130, HPA038131" Approved Approved "Nucleoplasm,Nucleoli,Nuclear speckles" Nucleoplasm "Nucleoli, Nuclear speckles" "HPA038130: , HPA038131: AB_10670658" "unprognostic (4.76e-4)" "unprognostic (2.38e-1)" "unprognostic (3.75e-2)" "unprognostic (2.92e-2)" "unprognostic (9.67e-3)" "unprognostic (1.91e-1)" "unprognostic (1.54e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (2.46e-3)" "unprognostic (3.98e-1)" "unprognostic (3.59e-2)" "unprognostic (3.84e-3)" "unprognostic (9.58e-2)" 0.1 0.1 1.3 1.7 2.6 0.2 0.0 0.1 1.9 0.3 0.5 0.4 1.3 0.5 0.2 4.6 0.1 7.3 0.2 3.2 1.6 1.4 5.0 0.5 4.0 0.3 0.9 0.5 1.8 0.3 0.4 9.0 0.1 1.2 0.1 0.0 0.2 0.1 0.1 0.6 1.9 0.4 0.0 0.7 0.2 0.1 13.8 0.6 0.0 0.6 0.7 0.1 0.1 0.1 1.1 1.1 1.0 0.5 1.1 4.2 0.0 1.5 0.1 1.9 0.2 0.0 0.5 0.4 0.2 0.1 2.0 1.6 0.1 2.4 0.2 0.2 1.5 5.2 0.2 0.7 1.6 0.5 0.4 0.1 0.7 0.3 1.0 0.1 0.0 0.6 1.7 0.6 1.0 0.0 0.2 0.7 0.0 0.3 0.1 0.5 0.9 0.1 0.1 0.2 0.4 1.7 0.3 0.9 0.4 8.4 0.3 0.1 0.3 0.3 0.2 0.4 1.5 0.4 0.1 1.0 0.2 0.1 2.5 0.2 0.1 1.0 0.5 0.6 0.7 0.3 0.6 1.1 1.5 0.8 0.1 1.0 1.1 1.0 0.8 1.1 0.3 1.1 4.2 0.0 1.3 2.6 0.1 1.9 1.6 1.4 0.9 0.5 1.2 0.6 C11orf49 "FLJ22210, MGC4707" ENSG00000149179 "Chromosome 11 open reading frame 49" Q9H6J7 11 46936689-47164385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040051, HPA040280" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA040051: AB_10795412, HPA040280: AB_10795363" "unprognostic (3.11e-2)" "unprognostic (3.01e-1)" "unprognostic (2.15e-1)" "unprognostic (1.06e-2)" "unprognostic (6.65e-2)" "unprognostic (7.76e-2)" "prognostic unfavourable (2.18e-5)" "unprognostic (1.27e-1)" "unprognostic (2.76e-1)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.55e-1)" "unprognostic (1.54e-2)" "unprognostic (1.36e-1)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.34e-3)" 5.2 9.4 20.9 6.0 27.6 2.9 10.0 18.3 36.3 15.8 11.5 16.5 7.2 11.3 12.7 14.5 7.6 33.1 9.7 10.3 21.0 26.0 13.1 3.5 11.2 5.9 18.7 20.3 15.2 12.4 21.6 21.0 7.2 23.0 11.0 11.7 12.2 8.9 13.9 4.2 23.9 10.6 12.9 12.7 5.6 14.5 19.0 11.4 11.3 15.1 5.1 7.5 8.2 7.1 15.8 16.4 7.6 8.8 15.6 16.2 11.8 5.7 15.7 20.0 16.1 10.6 16.3 5.5 6.2 14.6 14.6 17.1 3.8 9.8 5.1 7.1 13.8 8.1 10.6 15.8 12.0 9.7 14.8 7.4 18.9 6.1 17.5 8.4 9.5 9.7 11.0 6.9 9.5 15.8 5.6 6.5 10.4 12.1 12.6 7.3 8.4 8.0 4.5 6.0 5.3 23.0 5.8 14.5 20.3 8.5 8.3 7.7 14.6 4.6 3.9 7.9 6.3 13.8 9.9 5.9 4.9 4.3 20.1 1.8 10.0 7.6 7.0 5.8 13.6 8.8 16.2 15.8 12.9 15.9 16.4 11.3 13.8 14.5 0.1 15.6 5.9 15.3 12.5 11.8 20.9 27.6 18.3 36.3 21.0 26.0 18.7 20.3 23.0 11.4 C16orf70 "C16orf6, FLJ12076, lin-10, LIN10" ENSG00000125149 "Chromosome 16 open reading frame 70" Q9BSU1 16 67109958-67148539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041131, HPA041214" Approved Approved "Nucleoli fibrillar center,Nuclear speckles,Cytosol" "Nuclear speckles" "Nucleoli fibrillar center, Cytosol" "HPA041131: AB_10795487, HPA041214: AB_10794267" "unprognostic (1.30e-2)" "unprognostic (2.58e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (3.23e-2)" "unprognostic (1.32e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (2.25e-1)" "unprognostic (3.74e-3)" "unprognostic (1.81e-2)" "unprognostic (6.29e-2)" "unprognostic (1.07e-1)" "unprognostic (4.38e-2)" "unprognostic (1.68e-1)" "unprognostic (2.15e-2)" 8.0 7.7 11.3 6.7 14.6 14.2 10.5 14.0 22.4 8.4 7.9 24.2 8.6 6.7 8.9 8.8 12.5 10.1 8.2 8.0 12.6 8.9 11.8 43.2 7.9 7.6 18.2 13.1 10.1 6.2 19.5 8.3 10.6 15.5 12.9 9.4 7.7 8.9 8.4 20.1 22.0 7.1 10.0 18.0 11.2 6.9 10.6 16.0 7.0 7.1 5.8 10.3 8.4 10.3 7.2 14.1 6.3 15.9 5.2 8.3 7.3 6.7 10.1 9.7 10.1 12.3 7.4 22.9 7.7 8.4 15.7 17.3 11.2 6.0 6.8 6.8 9.1 9.1 12.0 7.6 20.4 3.6 11.0 5.4 6.4 23.4 7.6 5.2 30.0 7.3 10.6 15.3 7.2 8.8 8.7 2.9 9.6 6.8 10.2 8.2 10.7 16.5 14.3 16.8 10.7 6.9 4.1 12.6 6.8 23.9 5.5 5.8 11.0 4.5 6.7 11.2 9.5 7.9 6.6 4.5 8.1 20.4 10.1 5.5 8.8 2.9 15.9 5.4 4.7 11.8 6.2 7.2 7.0 8.3 14.1 4.9 7.1 6.6 6.3 5.2 11.8 4.6 6.7 7.3 11.3 14.6 14.0 22.4 12.6 8.9 18.2 13.1 15.5 16.0 C19orf24 FLJ20640 ENSG00000228300 "Chromosome 19 open reading frame 24" Q9BVV8 19 1275438-1279249 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043279, HPA047026" Uncertain Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA043279: AB_10794656, HPA047026: AB_2679906" "unprognostic (1.10e-1)" "unprognostic (3.39e-1)" "unprognostic (1.12e-1)" "unprognostic (1.65e-3)" "unprognostic (7.05e-2)" "unprognostic (4.90e-1)" "unprognostic (4.23e-3)" "unprognostic (3.12e-2)" "unprognostic (1.18e-1)" "unprognostic (3.59e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (2.54e-3)" "unprognostic (2.16e-1)" "unprognostic (1.10e-1)" "unprognostic (2.25e-2)" 20.2 25.3 13.4 20.9 14.9 17.1 65.7 11.3 15.8 11.7 15.6 9.1 17.5 21.8 13.8 22.0 18.7 13.0 26.5 14.3 13.3 10.9 22.6 48.6 17.0 55.0 13.4 7.0 16.6 41.6 5.9 16.9 18.4 9.7 17.6 6.0 11.1 29.6 22.5 6.9 16.6 19.6 10.5 10.9 22.8 16.6 16.8 10.0 23.1 25.7 19.0 15.8 15.5 21.9 40.9 44.8 9.5 27.5 19.0 33.8 21.3 25.6 24.5 2.3 20.2 3.9 9.3 9.4 12.5 6.7 13.3 11.7 28.0 14.4 7.4 17.5 4.4 13.7 4.1 13.2 1.5 27.0 21.1 8.0 21.9 16.2 16.6 16.9 17.8 11.1 17.1 10.1 4.4 9.7 15.2 42.9 5.3 25.7 20.3 25.1 11.9 24.8 15.1 4.7 46.1 7.4 13.7 16.6 10.8 7.9 19.4 28.9 14.1 28.6 6.1 24.5 7.8 29.8 29.6 28.2 36.6 9.2 26.5 21.2 21.9 9.5 26.8 9.2 31.2 27.5 30.9 40.9 33.8 32.9 26.7 36.0 31.9 32.3 4.7 19.0 23.1 44.8 31.9 21.3 13.4 14.9 11.3 15.8 13.3 10.9 13.4 7.0 9.7 10.0 C1orf35 "MGC4174, MMTAG2" ENSG00000143793 "Chromosome 1 open reading frame 35" Q9BU76 1 228100726-228105411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046175 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Nuclear speckles, Plasma membrane" Cytosol "HPA046175: AB_10959459" "unprognostic (1.12e-1)" "unprognostic (2.91e-1)" "prognostic unfavourable (7.71e-4)" "unprognostic (6.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.64e-2)" "unprognostic (5.44e-3)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "prognostic favourable (7.38e-4)" "unprognostic (6.12e-2)" "unprognostic (1.39e-1)" "prognostic unfavourable (1.79e-6)" "unprognostic (2.70e-1)" "unprognostic (8.58e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" 10.1 12.7 14.3 15.6 17.0 12.7 12.0 23.9 15.7 12.5 11.2 11.6 16.1 12.5 13.7 10.6 17.3 14.9 8.1 8.0 13.8 10.0 10.6 10.2 11.0 12.5 17.7 13.6 19.0 21.0 12.5 10.0 12.4 15.0 13.2 6.4 10.4 19.1 16.1 14.0 24.1 11.3 13.3 9.2 12.6 13.2 8.8 13.2 14.6 12.4 6.9 12.0 12.8 13.9 20.2 26.7 21.9 18.4 17.6 21.5 10.3 9.5 10.7 6.8 4.1 3.7 3.8 16.0 7.4 3.4 6.6 4.8 9.6 9.1 9.3 16.0 2.5 10.7 6.4 7.1 2.4 10.6 34.1 5.8 7.4 9.4 6.2 12.9 7.3 3.3 8.5 6.3 6.1 7.2 14.7 5.2 4.9 11.3 17.2 16.5 13.4 24.8 12.2 10.8 15.4 5.7 7.2 12.0 11.3 6.9 11.1 9.5 13.2 12.1 6.3 5.2 7.7 13.7 15.6 9.6 4.9 8.7 6.3 7.6 8.1 6.3 16.3 21.9 16.2 18.4 20.9 20.2 18.1 17.7 20.4 16.7 21.5 18.1 2.2 17.6 17.5 26.7 18.0 10.3 14.3 17.0 23.9 15.7 13.8 10.0 17.7 13.6 15.0 13.2 C3orf62 FLJ43654 ENSG00000188315 "Chromosome 3 open reading frame 62" Q6ZUJ4 3 49268602-49277909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "blood: 25.0;testis: 76.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 25.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 25.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043328 Approved "Nuclear speckles" "Nuclear speckles" "HPA043328: AB_10795613" "prognostic favourable (3.93e-4)" "unprognostic (4.87e-3)" "unprognostic (3.70e-3)" "unprognostic (2.35e-2)" "unprognostic (9.51e-2)" "prognostic favourable (9.72e-4)" "prognostic unfavourable (5.20e-4)" "prognostic favourable (8.88e-4)" "unprognostic (1.28e-1)" "unprognostic (9.40e-3)" "prognostic favourable (8.15e-4)" "unprognostic (7.23e-2)" "unprognostic (3.27e-2)" "prognostic favourable (3.29e-5)" "unprognostic (2.46e-1)" "unprognostic (4.79e-1)" "prognostic favourable (1.62e-5)" 4.2 5.5 3.2 4.4 4.0 7.4 2.7 6.6 4.8 3.8 3.6 2.8 4.4 3.1 3.5 4.9 3.7 4.1 5.0 3.5 3.7 4.3 2.7 2.8 3.9 4.5 3.3 4.0 8.0 4.7 2.4 4.5 2.6 3.6 4.1 2.3 5.7 4.4 2.2 3.7 3.5 2.7 3.6 3.6 7.0 2.6 76.9 3.3 2.2 3.7 2.2 3.3 4.8 7.5 1.2 1.6 25.0 3.2 0.6 1.0 0.7 4.7 2.8 6.8 8.5 5.6 5.1 3.8 2.9 4.8 2.5 3.8 4.0 3.7 9.4 4.5 4.3 3.7 3.4 3.1 3.0 8.3 3.9 6.2 5.9 4.5 1.9 8.7 11.6 3.9 9.3 3.7 7.0 3.0 7.0 7.2 2.1 2.9 6.4 6.3 4.8 4.1 4.9 3.5 4.9 4.2 11.0 5.2 7.0 7.9 6.0 10.2 3.0 9.7 3.5 3.6 8.6 6.0 5.1 6.5 10.7 8.1 2.7 8.4 4.8 1.5 3.2 3.4 0.8 1.2 0.9 1.2 0.9 0.8 0.7 0.9 0.9 0.8 25.0 0.6 1.4 1.6 1.0 0.7 3.2 4.0 6.6 4.8 3.7 4.3 3.3 4.0 3.6 3.3 C5orf46 "MGC23985, SSSP1" ENSG00000178776 "Chromosome 5 open reading frame 46" Q6UWT4 5 147880726-147906538 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "salivary gland: 107.9;skin 1: 42.7" "Cell line enhanced" "Detected in some" "PC-3: 40.1;SiHa: 9.0;U-2 OS: 26.2;U-251 MG: 10.2" "Cancer enhanced" "Detected in many" "renal cancer: 8.3" "Region enriched" "Detected in single" 5 "cerebellum: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058999 Approved "Nuclear speckles,Mitochondria" "Secreted in other tissues" "Nuclear speckles" Mitochondria "HPA058999: " "unprognostic (1.72e-1)" "prognostic unfavourable (3.98e-4)" "unprognostic (1.26e-4)" "unprognostic (9.75e-3)" "unprognostic (2.95e-3)" "unprognostic (1.69e-3)" "unprognostic (1.99e-2)" "unprognostic (3.08e-2)" "unprognostic (2.22e-1)" "unprognostic (4.96e-2)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "prognostic unfavourable (1.75e-9)" "unprognostic (6.48e-3)" "unprognostic (3.47e-2)" "unprognostic (6.01e-2)" "unprognostic (2.79e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 5.2 2.0 0.1 0.6 0.1 0.1 0.1 0.0 0.3 0.6 0.2 0.0 0.2 3.0 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 0.6 0.0 0.1 4.3 0.4 0.4 0.0 0.2 107.9 0.4 0.6 42.7 0.1 1.0 0.1 0.1 0.0 6.5 0.2 0.2 0.1 1.1 0.6 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.0 0.1 0.1 0.0 0.0 0.0 4.7 26.2 0.3 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.1 0.1 0.0 0.1 0.1 0.4 0.2 C6orf106 "dJ391O22.4, FLJ22195" ENSG00000196821 "Chromosome 6 open reading frame 106" Q9H6K1 6 34587288-34696859 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034489, HPA034490" Approved Approved "Nuclear speckles,Centrosome" "Nuclear speckles" Centrosome "HPA034489: AB_10669991, HPA034490: AB_2674186" "unprognostic (3.76e-2)" "unprognostic (2.51e-1)" "unprognostic (7.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.41e-1)" "unprognostic (1.32e-1)" "unprognostic (8.40e-2)" "unprognostic (9.94e-2)" "unprognostic (7.57e-2)" "unprognostic (5.68e-2)" "unprognostic (3.55e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (1.05e-1)" "unprognostic (1.53e-1)" 16.5 10.7 12.5 13.7 12.7 7.5 15.2 22.5 18.7 9.5 22.4 6.3 6.7 9.1 9.0 15.5 13.7 8.6 15.9 60.4 11.2 10.0 23.9 35.2 16.9 10.1 14.4 6.8 11.6 12.0 14.1 7.3 11.1 9.0 9.0 9.5 10.3 12.6 16.1 66.3 10.4 14.9 12.3 7.8 9.1 10.0 20.7 8.2 5.8 15.7 26.6 13.3 13.4 11.4 8.6 4.1 18.2 7.3 5.7 9.2 4.7 29.5 13.4 13.5 19.6 32.1 17.7 15.8 20.1 23.6 24.0 30.1 26.3 13.9 33.8 15.2 19.9 29.4 38.9 16.9 30.6 47.6 15.2 28.3 15.7 25.1 31.4 23.7 31.6 11.9 35.4 24.1 22.0 18.9 31.8 14.4 13.5 17.6 16.6 16.4 12.3 12.1 13.1 17.1 18.0 18.8 29.6 16.0 12.5 30.0 14.7 29.5 18.6 20.0 19.1 19.9 15.3 20.7 19.9 20.6 46.7 26.3 7.1 21.1 23.1 18.2 3.5 7.3 9.1 6.3 4.8 6.7 6.6 7.2 4.1 8.6 3.6 5.7 4.5 5.7 7.3 2.2 9.2 4.7 12.5 12.7 22.5 18.7 11.2 10.0 14.4 6.8 9.0 8.2 C6orf226 LOC441150 ENSG00000221821 "Chromosome 6 open reading frame 226" Q5I0X4 6 42890265-42890816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA045350 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA045350: AB_10964640" "prognostic favourable (1.93e-5)" "unprognostic (2.21e-3)" "unprognostic (2.91e-1)" "unprognostic (2.77e-3)" "unprognostic (1.71e-1)" "unprognostic (4.17e-2)" "unprognostic (5.40e-2)" "unprognostic (2.00e-3)" "unprognostic (8.82e-2)" "unprognostic (3.50e-3)" "prognostic favourable (5.13e-4)" "unprognostic (2.24e-2)" "prognostic favourable (3.35e-4)" "unprognostic (4.63e-1)" "unprognostic (3.97e-2)" "unprognostic (6.13e-2)" "unprognostic (5.82e-3)" 16.5 21.7 14.4 11.5 15.2 22.6 23.3 11.0 17.0 9.0 11.1 8.2 11.3 16.3 11.7 21.9 11.1 9.6 9.9 15.1 13.3 15.5 12.4 16.2 11.0 25.8 13.1 11.7 10.5 15.5 8.7 16.4 5.8 14.5 13.1 4.1 12.2 11.9 16.4 22.1 17.5 12.3 16.3 13.8 13.8 12.1 12.9 8.2 14.0 9.4 12.6 7.4 11.4 7.2 13.6 20.9 17.3 18.8 18.7 19.5 12.2 6.4 5.1 4.6 9.2 5.0 4.5 5.6 4.0 2.2 5.0 6.4 1.9 2.2 1.3 8.4 1.9 5.2 1.2 2.6 1.4 6.1 9.4 5.1 4.6 12.8 5.2 1.4 3.8 5.0 3.4 2.4 1.1 3.8 0.3 7.6 3.0 13.0 10.3 8.8 1.6 4.3 4.6 3.3 6.7 2.7 5.1 9.0 10.9 7.7 3.4 10.0 8.2 4.0 5.0 3.9 11.7 7.3 3.8 18.5 13.9 21.3 2.4 2.8 2.7 6.1 18.7 17.3 15.6 14.2 11.6 13.3 19.5 15.8 20.9 13.6 15.4 18.8 8.3 18.7 18.8 19.7 15.7 12.2 14.4 15.2 11.0 14.4 13.3 15.5 13.1 11.7 14.5 8.2 C6orf52 ENSG00000137434 "Chromosome 6 open reading frame 52" Q5T4I8 6 10671418-10694797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 17.7" "Cell line enhanced" "Detected in many" "MCF7: 8.5;NB-4: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 6.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051142 Uncertain Approved "Nuclear speckles,Intermediate filaments" "Nuclear speckles" "Intermediate filaments" "HPA051142: " "unprognostic (1.14e-2)" "unprognostic (2.21e-2)" "unprognostic (1.63e-1)" "prognostic favourable (6.50e-5)" "unprognostic (9.12e-2)" "unprognostic (2.96e-1)" "unprognostic (1.11e-3)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-2)" "unprognostic (3.92e-2)" "unprognostic (9.31e-3)" "unprognostic (7.65e-2)" 1.6 2.4 5.6 1.4 4.8 0.9 3.0 2.7 4.3 1.2 1.5 4.4 5.5 7.7 1.4 9.0 0.9 8.0 1.2 0.7 4.9 5.3 3.8 1.4 1.7 1.1 4.5 3.2 1.9 7.7 1.5 2.9 1.5 4.4 3.1 1.0 0.7 1.8 1.7 1.2 2.5 2.1 0.9 4.0 1.0 1.6 17.7 2.6 1.6 2.1 1.0 1.6 1.0 2.0 0.7 1.0 4.7 1.0 1.4 6.2 0.6 1.1 2.7 2.5 2.1 0.9 0.0 4.3 0.2 0.1 0.3 0.6 2.9 2.3 0.1 3.9 0.0 0.2 2.4 0.0 1.0 1.3 4.1 0.6 0.5 0.4 0.0 0.8 0.4 0.5 3.8 1.0 1.5 0.0 4.6 0.3 1.0 8.5 1.8 7.5 2.3 3.0 1.5 0.2 1.0 1.2 0.6 4.9 3.0 0.9 0.6 4.8 0.2 1.5 0.4 2.0 0.6 1.5 1.7 3.5 7.4 1.5 3.4 1.0 1.9 0.0 0.5 4.7 1.2 1.0 0.4 0.5 1.5 1.3 1.0 0.7 0.7 0.6 0.6 1.4 0.7 0.8 6.2 0.6 5.6 4.8 2.7 4.3 4.9 5.3 4.5 3.2 4.4 2.6 C8orf46 MGC33510 ENSG00000169085 "Chromosome 8 open reading frame 46" Q8TAG6 8 66460003-66518524 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 51.7" "Cell line enhanced" "Detected in some" "A-431: 3.2;CAPAN-2: 3.2;fHDF/TERT166: 3.2;LHCN-M2: 4.2;SK-MEL-30: 4.6;T-47d: 5.9;WM-115: 5.8" "Cancer enriched" "Detected in many" 6 "glioma: 16.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "amygdala: 164.2;basal ganglia: 80.3;cerebral cortex: 305.1;hippocampal formation: 240.3" "Low region specificity" "Detected in all" HPA075134 Approved "Nuclear speckles" "Nuclear speckles" "HPA075134: " "unprognostic (6.87e-2)" "unprognostic (7.85e-2)" "unprognostic (2.01e-1)" "unprognostic (8.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (7.53e-4)" "unprognostic (7.87e-3)" "unprognostic (1.45e-1)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "unprognostic (1.82e-1)" "unprognostic (6.36e-3)" "unprognostic (3.53e-4)" "unprognostic (1.86e-1)" "unprognostic (4.98e-2)" "unprognostic (2.91e-2)" 1.2 1.4 14.9 1.2 16.6 1.2 1.2 1.8 51.7 1.6 1.2 16.3 0.0 1.0 1.6 1.3 1.5 1.2 1.7 2.2 39.1 8.3 1.3 1.2 1.4 1.4 13.8 19.4 1.1 1.8 1.1 0.2 1.1 10.9 2.2 1.3 0.0 1.7 5.3 3.1 1.4 1.4 2.0 17.9 1.2 1.1 1.4 10.0 0.0 1.3 0.0 1.1 1.5 0.2 0.0 0.7 0.0 0.0 0.0 0.7 0.1 3.2 0.2 0.5 2.1 0.0 0.1 0.0 0.3 0.4 0.5 0.1 0.0 3.2 0.0 0.3 3.2 0.1 0.0 0.0 2.3 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.2 4.2 0.5 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.3 0.1 0.5 0.0 0.0 0.0 4.6 5.9 0.0 0.0 0.4 0.7 0.2 2.8 0.1 1.2 0.0 1.2 0.1 5.8 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.9 16.6 1.8 26.7 39.1 8.3 13.8 19.4 10.9 10.0 CBFA2T2 "MTGR1, ZMYND3" ENSG00000078699 "CBFA2/RUNX1 translocation partner 2" O43439 20 33490075-33650036 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060523, HPA072433" Supported Approved "Nuclear speckles" "Nuclear speckles" "HPA060523: , HPA072433: " "unprognostic (6.51e-3)" "unprognostic (3.29e-1)" "unprognostic (2.16e-2)" "unprognostic (1.91e-3)" "unprognostic (1.21e-1)" "unprognostic (8.37e-3)" "unprognostic (2.85e-3)" "unprognostic (3.90e-2)" "unprognostic (3.08e-1)" "unprognostic (3.89e-2)" "prognostic favourable (6.93e-6)" "unprognostic (7.83e-2)" "unprognostic (1.39e-3)" "unprognostic (9.40e-2)" "unprognostic (1.21e-1)" "unprognostic (2.24e-2)" "unprognostic (3.12e-2)" 8.7 8.5 19.2 15.6 20.8 10.2 11.6 19.2 20.3 12.3 14.7 24.6 8.1 14.8 12.8 10.0 12.7 12.8 10.1 10.5 16.4 13.2 10.9 10.1 11.3 11.6 21.2 17.0 21.0 11.0 19.5 15.9 9.7 17.5 27.9 17.3 15.2 13.9 12.7 16.2 21.7 16.9 13.4 15.9 13.3 13.7 15.4 21.2 15.8 15.6 3.9 14.2 13.4 14.9 5.6 3.1 5.9 2.4 2.7 7.3 1.4 5.1 5.2 6.3 5.0 5.9 4.6 8.1 3.1 3.3 4.5 3.6 11.2 4.5 5.7 7.1 3.9 6.5 4.3 4.8 3.7 2.4 3.2 7.9 4.4 7.2 3.8 3.1 6.2 3.9 5.7 4.9 5.6 3.4 5.2 3.7 3.1 4.4 7.3 4.5 2.2 6.0 5.7 7.9 6.0 4.0 7.4 21.9 31.2 15.9 5.4 4.5 5.5 4.2 3.8 10.6 4.6 6.4 3.8 7.8 8.9 3.5 5.3 2.7 2.9 5.9 2.4 2.8 5.3 2.3 5.0 5.3 5.2 7.3 1.0 5.6 2.9 3.9 4.8 2.7 1.4 3.1 4.2 1.4 19.2 20.8 19.2 20.3 16.4 13.2 21.2 17.0 17.5 21.2 CCDC181 "C1orf114, FLJ25846" ENSG00000117477 "Coiled-coil domain containing 181" Q5TID7 1 169394870-169460669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 22.3;testis: 29.2" "Cell line enhanced" "Detected in some" "AF22: 7.2;NTERA-2: 13.9;SCLC-21H: 8.5;SH-SY5Y: 10.1;U-251 MG: 6.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "basophil: 3.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027189, HPA027275, HPA027281, HPA027312" Enhanced Approved "Nuclear speckles" "Nuclear speckles" "HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349" "unprognostic (2.45e-1)" "unprognostic (2.20e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-3)" "unprognostic (3.00e-1)" "unprognostic (5.97e-2)" "unprognostic (6.87e-2)" "unprognostic (2.15e-3)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (4.89e-4)" "unprognostic (4.03e-2)" "unprognostic (3.06e-2)" "unprognostic (1.18e-2)" "unprognostic (8.41e-2)" 0.8 3.3 6.3 1.0 8.3 0.9 0.9 5.9 8.4 2.6 0.7 1.6 0.4 0.7 4.6 2.7 0.9 14.5 4.6 2.3 6.6 9.9 7.5 0.6 2.4 0.6 5.2 5.0 8.0 3.0 17.3 22.3 0.5 8.7 2.9 0.7 5.3 0.8 2.9 0.7 1.1 0.9 2.7 4.9 0.5 1.2 29.2 4.1 0.0 1.1 0.0 0.5 1.4 0.8 0.1 0.0 3.2 0.1 0.0 0.2 0.0 0.2 0.3 7.2 0.1 0.2 0.2 0.2 0.1 0.0 1.8 3.8 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.0 0.3 0.2 1.6 1.7 0.1 0.0 0.0 1.9 0.1 0.7 0.0 0.4 0.0 0.1 0.1 0.1 1.3 0.1 4.3 0.0 13.9 0.0 0.0 6.0 0.1 1.1 0.0 8.5 10.1 0.0 0.3 0.5 0.0 0.0 0.5 1.5 4.5 0.2 6.2 2.1 1.9 0.0 2.9 0.1 5.5 3.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 6.3 8.3 5.9 8.4 6.6 9.9 5.2 5.0 8.7 4.1 CCDC32 "C15orf57, MGC20481" ENSG00000128891 "Coiled-coil domain containing 32" Q9BV29 15 40528683-40565057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041688 Uncertain Approved "Nuclear speckles,Vesicles" "Nuclear speckles" Vesicles "HPA041688: AB_10796779" "unprognostic (7.10e-2)" "unprognostic (1.04e-1)" "unprognostic (9.86e-3)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (4.25e-5)" "unprognostic (4.03e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.70e-2)" "unprognostic (2.34e-1)" "unprognostic (1.23e-2)" "unprognostic (5.77e-2)" "unprognostic (3.72e-1)" "unprognostic (1.18e-1)" "unprognostic (2.20e-1)" "unprognostic (6.47e-2)" 22.7 23.5 17.9 17.2 24.3 19.0 17.9 17.6 24.0 17.1 18.4 17.6 17.4 18.4 24.5 20.0 12.6 20.3 19.4 21.4 20.7 21.9 25.9 15.3 16.6 27.8 17.6 21.0 28.2 32.6 15.8 26.5 22.6 20.8 16.5 22.0 20.5 20.7 17.4 22.4 11.5 18.5 18.5 16.7 25.2 18.9 9.2 16.1 16.2 24.4 9.4 26.8 26.9 22.2 50.6 16.3 12.7 9.6 7.7 13.8 11.6 7.8 5.7 7.5 12.1 15.3 16.1 4.5 6.3 9.4 11.2 11.8 8.5 11.1 2.9 17.7 9.3 14.8 7.4 7.1 8.1 17.8 8.5 32.2 9.6 10.6 10.4 12.1 17.0 13.9 7.6 8.8 5.9 14.1 17.6 19.6 8.5 6.8 5.5 10.5 3.0 7.3 9.7 9.5 9.7 20.7 19.1 8.3 8.5 9.4 9.8 4.6 10.4 22.4 15.5 10.5 9.2 18.4 9.0 10.7 10.5 9.4 11.1 19.1 14.7 12.7 9.4 9.3 9.8 9.6 7.9 40.9 11.0 10.6 12.2 50.6 11.2 9.5 9.9 7.7 9.4 16.3 13.8 11.6 17.9 24.3 17.6 24.0 20.7 21.9 17.6 21.0 20.8 16.1 CCDC85C ENSG00000205476 "Coiled-coil domain containing 85C" A6NKD9 14 99500180-99604026 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058346 Uncertain Approved "Nuclear speckles,Cell Junctions" "Nuclear speckles, Cell Junctions" "HPA058346: " "unprognostic (7.17e-2)" "unprognostic (2.23e-2)" "unprognostic (3.64e-1)" "prognostic unfavourable (1.44e-4)" "unprognostic (5.70e-2)" "unprognostic (2.61e-1)" "unprognostic (1.68e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-2)" "unprognostic (8.75e-2)" "unprognostic (3.30e-1)" "unprognostic (1.68e-3)" "prognostic favourable (2.60e-5)" "unprognostic (4.14e-2)" "unprognostic (1.95e-1)" "unprognostic (8.74e-3)" "unprognostic (9.81e-3)" 3.5 12.0 13.9 3.3 15.5 7.2 6.1 45.2 11.8 11.3 15.3 11.7 16.6 15.4 8.7 12.6 24.0 10.0 13.9 11.4 11.6 7.6 7.8 32.3 6.7 1.9 10.3 5.9 6.9 15.3 10.4 10.0 7.1 9.1 15.8 9.5 19.9 20.8 14.8 15.2 13.6 27.0 15.4 8.4 3.0 10.5 8.1 8.1 2.7 9.5 9.3 8.7 13.7 17.9 0.3 0.1 0.7 0.0 0.4 2.0 0.6 17.3 15.9 19.8 11.8 0.2 0.0 18.4 5.9 6.0 11.9 6.9 19.3 18.4 0.1 23.4 6.6 23.4 14.6 14.1 7.4 28.5 8.6 0.9 15.8 13.0 1.6 0.2 1.8 0.0 7.5 3.4 9.8 3.7 4.2 2.6 1.4 29.0 7.7 2.3 7.2 16.6 11.6 8.3 3.9 8.4 6.9 9.8 12.3 15.0 8.0 3.6 17.5 3.5 8.3 2.3 19.8 8.4 5.8 4.2 5.5 0.1 0.4 1.5 1.6 0.7 0.0 0.0 0.6 0.0 0.8 0.2 1.9 1.3 0.0 0.3 2.0 1.1 0.6 0.4 0.0 0.1 2.0 0.6 13.9 15.5 45.2 11.8 11.6 7.6 10.3 5.9 9.1 8.1 CCNJL FLJ14166 ENSG00000135083 "Cyclin J like" Q8IV13 5 160249106-160345396 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 48.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 26.3;WM-115: 19.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 19 "cerebellum: 48.9" "Group enriched" "Detected in some" 19 "neutrophil: 13.5;NK-cell: 4.1" "Group enriched" "Detected in many" 35 "granulocytes: 13.5;NK-cells: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049970 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA049970: " "unprognostic (1.09e-2)" "unprognostic (2.36e-2)" "prognostic favourable (7.31e-4)" "unprognostic (1.50e-3)" "unprognostic (1.79e-1)" "unprognostic (4.31e-2)" "unprognostic (1.60e-4)" "unprognostic (1.26e-2)" "unprognostic (6.92e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-1)" "unprognostic (1.75e-2)" "unprognostic (6.27e-3)" "unprognostic (6.63e-3)" "unprognostic (2.62e-1)" "prognostic favourable (7.10e-4)" "prognostic favourable (8.02e-4)" 1.0 3.0 0.9 3.4 1.2 1.3 2.1 48.9 1.5 2.1 9.0 0.9 1.5 1.8 1.1 1.5 0.8 1.0 1.0 4.4 2.5 0.8 2.7 1.2 9.0 2.5 1.5 1.1 5.3 0.2 0.0 17.0 1.7 2.1 2.0 7.9 3.9 7.6 2.0 0.6 0.4 2.7 1.0 0.9 5.8 4.4 10.7 1.2 4.8 8.4 1.7 2.6 4.0 5.4 0.1 0.2 13.5 0.0 4.1 0.0 0.2 3.0 11.0 9.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.4 4.8 8.7 0.0 8.6 0.1 3.7 1.2 26.3 0.7 0.0 0.2 4.7 3.9 3.5 0.1 0.0 1.0 0.0 2.3 1.5 6.6 6.7 0.0 0.0 2.9 1.5 0.0 7.7 8.4 6.2 1.7 3.0 1.0 7.0 14.0 3.0 8.2 1.4 2.2 10.0 5.0 0.5 8.1 1.6 10.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 19.9 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 13.5 4.1 0.0 0.2 0.0 0.2 0.9 1.2 48.9 1.5 2.5 0.8 1.5 1.1 2.1 1.2 CDK11B "CDC2L1, CDK11-p110, CDK11-p46, CDK11-p58" ENSG00000248333 "Cyclin dependent kinase 11B" 1 1635227-1659012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA025061, HPA073626" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA025061: AB_1846407, HPA073626: " "unprognostic (7.52e-3)" "unprognostic (4.85e-2)" "unprognostic (1.14e-1)" "unprognostic (2.02e-2)" "unprognostic (3.75e-2)" "prognostic favourable (1.14e-4)" "unprognostic (9.75e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (1.48e-1)" "unprognostic (2.18e-1)" "unprognostic (1.14e-2)" "unprognostic (6.04e-2)" "unprognostic (8.45e-2)" "unprognostic (1.27e-1)" "unprognostic (7.19e-2)" "unprognostic (6.52e-3)" 10.5 9.8 10.4 11.7 15.1 24.3 8.6 15.0 14.1 9.0 13.3 11.6 6.7 17.4 11.0 6.1 8.6 7.3 7.5 11.2 12.2 9.3 7.9 8.3 12.8 13.1 11.4 9.7 10.3 11.8 9.1 9.6 8.3 11.0 8.9 7.1 7.0 14.0 9.5 33.7 14.0 18.0 14.0 14.8 12.9 9.6 15.8 13.1 12.2 9.5 8.3 10.3 11.6 11.8 5.2 6.2 16.4 4.2 5.1 8.0 2.1 20.6 16.8 12.8 10.2 12.2 8.1 14.3 20.2 11.2 15.8 13.7 18.7 23.4 19.3 20.1 10.0 18.9 11.8 11.9 9.3 17.5 20.5 20.3 31.2 16.8 14.3 23.1 24.5 10.1 8.1 14.8 11.8 12.9 24.6 13.8 8.2 14.5 22.7 22.4 19.3 20.7 23.4 21.1 15.4 8.5 8.2 14.6 17.8 19.4 20.0 21.3 14.9 17.1 17.9 15.5 16.5 10.5 19.4 28.5 25.2 39.0 18.0 28.0 10.7 8.2 4.2 6.3 8.0 3.6 4.1 4.2 5.1 5.4 3.1 5.2 5.9 4.4 16.4 5.1 3.8 6.2 4.1 2.1 10.4 15.1 15.0 14.1 12.2 9.3 11.4 9.7 11.0 13.1 CDK5RAP1 "C20orf34, C42, CGI-05, HSPC167" ENSG00000101391 "CDK5 regulatory subunit associated protein 1" Q96SZ6 20 33358839-33401561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066301 Approved "Nuclear speckles,Mitochondria" "Nuclear speckles" Mitochondria "HPA066301: " "unprognostic (2.86e-1)" "unprognostic (7.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.66e-3)" "unprognostic (2.25e-1)" "unprognostic (6.49e-2)" "unprognostic (7.68e-3)" "unprognostic (2.18e-2)" "unprognostic (5.10e-1)" "unprognostic (2.36e-1)" "unprognostic (5.90e-3)" "prognostic unfavourable (8.07e-4)" "unprognostic (3.51e-2)" "unprognostic (8.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-1)" 13.9 12.8 15.1 13.0 23.0 20.8 14.8 29.2 22.4 11.1 12.2 18.3 12.3 11.3 15.4 15.4 13.2 12.8 8.3 15.0 11.2 9.5 11.8 14.6 12.5 14.7 12.2 16.2 14.0 12.4 16.6 17.9 13.1 15.5 11.5 16.2 15.5 19.7 12.0 29.2 19.0 14.5 14.1 10.1 15.8 13.0 14.8 15.9 14.4 15.8 11.2 18.7 13.4 12.5 16.0 14.2 8.5 16.3 15.6 17.4 10.8 10.9 11.3 7.9 7.1 7.4 5.8 17.4 6.6 9.5 19.2 20.2 47.8 9.8 19.3 8.9 7.1 16.2 13.4 18.8 14.9 3.5 7.1 23.3 11.7 18.1 8.9 14.7 7.4 7.6 8.1 12.8 15.4 10.6 14.7 8.1 8.3 10.9 15.0 11.1 5.8 16.7 11.1 18.0 14.8 10.5 9.6 10.8 6.0 21.0 10.1 13.9 14.6 7.1 7.8 14.2 11.6 9.6 11.0 7.0 7.9 14.2 8.5 15.9 6.7 3.3 12.7 8.5 14.7 16.3 17.4 16.0 14.5 14.0 14.2 9.8 13.1 11.3 0.7 15.6 13.0 9.9 12.4 10.8 15.1 23.0 29.2 22.4 11.2 9.5 12.2 16.2 15.5 15.9 CHIC1 BRX ENSG00000204116 "Cysteine rich hydrophobic domain 1" Q5VXU3 X 73563200-73687102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA052062" Uncertain Approved "Nuclear speckles,Vesicles,Cytosol" "Nuclear speckles, Vesicles" Cytosol "HPA026782: AB_1846654, HPA052062: " "unprognostic (9.85e-3)" "unprognostic (3.91e-2)" "unprognostic (3.10e-2)" "unprognostic (9.95e-2)" "unprognostic (6.22e-2)" "unprognostic (1.91e-1)" "unprognostic (1.57e-1)" "unprognostic (1.36e-2)" "unprognostic (2.43e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-3)" "unprognostic (2.65e-1)" "prognostic favourable (2.75e-4)" "unprognostic (1.37e-2)" "unprognostic (2.19e-1)" "unprognostic (3.51e-1)" "unprognostic (2.76e-2)" 5.6 13.9 11.0 7.1 16.3 1.5 7.5 14.7 17.6 14.6 8.2 8.5 7.7 4.7 11.1 7.9 5.1 8.7 9.2 10.3 11.7 13.2 12.4 3.4 5.6 7.2 11.2 13.8 11.8 4.1 13.3 18.2 4.4 16.8 9.9 8.6 6.8 5.1 13.0 4.6 6.0 5.9 10.7 15.4 7.7 4.9 3.3 12.5 3.7 12.8 2.6 6.8 7.4 10.1 1.1 0.2 1.0 0.3 1.2 3.0 0.6 4.0 4.1 2.1 2.7 6.0 8.2 0.0 4.5 6.1 3.7 4.5 2.7 5.1 1.9 6.3 4.0 1.2 3.0 2.2 8.3 4.6 3.7 2.7 3.4 0.0 3.9 0.0 5.5 5.6 2.7 7.0 3.8 5.3 0.7 18.3 7.2 0.6 1.6 0.0 6.6 4.1 1.6 5.3 1.2 4.7 2.0 1.2 1.7 5.1 2.4 5.4 2.0 1.1 6.1 4.3 4.2 8.5 2.7 5.2 12.9 0.0 6.3 3.0 3.3 1.0 0.1 0.0 1.9 0.1 3.0 1.1 1.5 1.9 0.0 1.1 1.5 2.0 0.0 1.2 0.3 0.2 1.2 0.6 11.0 16.3 14.7 17.6 11.7 13.2 11.2 13.8 16.8 12.5 CLIC5 DFNB102 ENSG00000112782 "Chloride intracellular channel 5" Q9NZA1 6 45880827-46080348 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Hearing, Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel, Voltage-gated channel" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9" "Group enriched" "Detected in some" 8 "CAPAN-2: 13.3;EFO-21: 9.4;HDLM-2: 4.9;REH: 11.4;U-266/70: 12.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 8.8" "Lineage enriched" "Detected in single" 23 "T-cells: 8.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA074371 Supported "Nuclear speckles,Plasma membrane" 1000000 "Plasma membrane" "Nuclear speckles" "HPA074371: " "unprognostic (4.95e-2)" "unprognostic (1.59e-2)" "unprognostic (8.84e-2)" "unprognostic (5.05e-2)" "unprognostic (2.44e-1)" "unprognostic (6.73e-2)" "unprognostic (3.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (6.46e-2)" "unprognostic (5.50e-2)" "unprognostic (3.65e-1)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.99e-1)" "unprognostic (8.26e-2)" "unprognostic (1.01e-1)" 7.4 0.6 0.8 3.2 1.5 0.0 2.3 0.6 1.1 6.0 10.2 0.3 0.4 5.6 0.8 2.5 2.2 1.2 2.1 65.6 0.9 1.2 17.5 0.5 32.8 0.4 1.1 1.4 0.7 0.7 0.4 1.3 22.0 0.8 0.9 7.5 7.8 2.0 0.4 99.9 0.7 46.2 1.4 0.9 16.1 0.9 1.0 0.0 0.2 4.8 18.8 1.5 1.0 4.3 0.3 0.0 0.0 0.0 0.3 8.8 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 13.3 0.0 9.4 0.0 0.3 0.0 0.1 0.0 4.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.3 0.0 11.4 0.3 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 12.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 8.8 0.3 3.6 2.2 0.0 0.0 0.6 0.5 0.0 0.3 0.0 0.0 1.6 0.8 0.8 1.5 0.6 1.1 0.9 1.2 1.1 1.4 0.8 0.0 CMTR2 "AFT, FLJ11171, FTSJD1, MTr2" ENSG00000180917 "Cap methyltransferase 2" Q8IYT2 16 71281389-71289715 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041700, HPA048265" Uncertain Approved "Nuclear speckles,Cell Junctions" "Cell Junctions" "Nuclear speckles" "HPA041700: , HPA048265: " "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (2.94e-3)" "unprognostic (1.43e-1)" "unprognostic (6.30e-2)" "unprognostic (3.82e-2)" "unprognostic (1.93e-3)" "unprognostic (2.86e-2)" "unprognostic (7.93e-2)" "unprognostic (3.41e-1)" "unprognostic (1.85e-2)" "unprognostic (7.39e-2)" "prognostic favourable (4.97e-5)" "unprognostic (9.55e-2)" "unprognostic (5.99e-2)" "unprognostic (1.54e-1)" "unprognostic (5.34e-2)" 10.4 14.9 7.1 11.7 9.0 5.4 15.9 5.3 9.1 10.6 13.4 11.5 15.6 14.1 12.5 16.4 20.4 8.8 11.0 9.0 8.5 6.9 13.5 18.2 10.7 14.7 12.4 3.4 16.2 12.2 12.7 24.3 17.4 9.0 11.9 10.5 10.6 13.6 14.1 8.4 9.9 16.1 9.4 9.5 17.5 8.9 16.0 9.3 20.9 14.3 7.6 15.4 9.6 14.2 11.2 10.3 11.0 8.0 13.1 11.2 8.6 11.3 7.9 11.4 11.3 12.9 11.2 6.4 9.3 9.1 10.5 10.1 4.7 15.8 6.1 11.2 7.3 11.2 7.0 8.3 12.9 6.3 4.7 17.0 4.6 5.9 16.1 10.0 23.3 8.1 15.9 7.7 10.4 11.9 7.3 4.6 17.4 10.1 12.1 16.9 7.1 4.7 16.4 7.3 13.2 12.9 7.7 7.5 8.5 10.5 9.2 10.2 13.7 7.3 11.4 11.9 11.0 12.1 7.2 8.6 8.9 10.9 8.9 10.2 10.2 11.0 7.2 7.1 9.8 8.0 11.2 11.2 9.2 10.3 10.3 10.2 10.5 10.3 0.4 13.1 5.2 3.6 8.0 8.6 7.1 9.0 5.3 9.1 8.5 6.9 12.4 3.4 9.0 9.3 COG6 "COD2, KIAA1134" ENSG00000133103 "Component of oligomeric golgi complex 6" Q9Y2V7 13 39655627-39791665 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040410, HPA040441" Uncertain Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles, Golgi apparatus" "HPA040410: AB_10793964, HPA040441: AB_10794030" "unprognostic (2.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.85e-2)" "unprognostic (1.05e-2)" "unprognostic (4.81e-2)" "unprognostic (4.99e-2)" "unprognostic (6.81e-2)" "unprognostic (9.59e-2)" "unprognostic (3.66e-2)" "unprognostic (1.14e-1)" "unprognostic (9.07e-2)" "unprognostic (1.62e-1)" "unprognostic (6.60e-3)" "prognostic favourable (2.81e-4)" "unprognostic (4.87e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" 11.7 16.1 16.3 9.5 18.8 2.6 13.6 23.8 18.7 17.1 12.0 11.4 9.6 13.1 12.6 8.5 13.8 13.2 13.8 19.6 13.3 12.9 13.7 11.8 8.9 9.9 13.3 17.9 19.1 23.4 18.6 37.7 19.4 17.9 17.6 11.4 8.8 16.4 15.7 10.2 13.0 13.3 14.6 15.4 9.9 15.4 24.0 14.1 10.3 18.5 7.9 10.1 14.2 11.5 7.6 6.4 5.6 7.2 10.0 10.3 5.6 7.1 4.7 8.1 5.5 15.5 19.5 14.4 11.4 16.7 10.1 12.5 5.7 11.8 12.3 6.7 17.6 9.7 8.6 9.0 11.4 14.1 10.9 11.8 5.1 8.7 9.1 11.8 12.8 8.2 11.1 6.4 7.5 9.9 4.9 4.7 16.8 7.2 8.5 11.4 7.4 6.2 8.5 20.5 6.0 7.6 9.2 4.4 5.8 10.5 9.0 9.0 10.4 7.5 14.1 5.5 6.6 12.1 5.8 3.8 3.6 9.1 16.6 6.6 16.4 4.4 4.7 5.6 6.1 7.2 10.3 7.6 7.8 8.2 6.4 6.6 6.6 8.5 1.1 10.0 4.2 3.6 8.9 5.6 16.3 18.8 23.8 18.7 13.3 12.9 13.3 17.9 17.9 14.1 CPD GP180 ENSG00000108582 "Carboxypeptidase D" O75976 17 30378905-30469989 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HSkMC: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052796, HPA055465" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear speckles" 930000 "Nucleoplasm, Nuclear speckles" "Nuclear membrane" "HPA052796: , HPA055465: " "unprognostic (1.05e-1)" "unprognostic (1.31e-1)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (6.13e-2)" "unprognostic (1.65e-1)" "unprognostic (7.97e-3)" "unprognostic (4.45e-2)" "unprognostic (2.07e-2)" "unprognostic (2.96e-1)" "unprognostic (1.62e-1)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.25e-2)" "unprognostic (3.36e-1)" "unprognostic (1.08e-1)" 16.4 8.0 9.8 12.3 12.4 18.1 17.9 9.1 13.3 28.6 16.2 18.5 10.1 12.9 12.6 10.1 10.0 15.2 33.6 10.5 12.8 10.4 13.4 26.8 20.0 14.2 22.1 11.4 7.8 14.7 21.2 14.9 22.3 13.9 11.4 13.3 7.5 59.7 7.9 10.0 7.8 22.0 15.1 25.9 7.9 24.6 25.0 13.5 5.8 37.2 7.7 10.0 11.5 11.6 0.4 3.4 19.3 5.5 2.1 3.8 2.5 12.1 18.5 16.1 16.5 16.8 32.0 5.8 16.8 24.6 11.7 14.4 21.7 7.9 1.5 21.4 19.2 8.7 10.4 21.2 19.7 5.7 14.9 3.4 11.4 13.4 20.4 22.6 9.1 57.0 9.5 14.9 14.5 23.6 6.7 18.0 9.3 2.3 7.2 6.2 4.5 4.2 7.0 18.7 4.7 21.8 13.9 4.0 10.2 20.0 17.3 8.7 16.4 15.7 28.1 11.7 7.7 18.1 16.0 7.2 15.1 5.1 14.9 14.8 9.8 2.8 5.5 6.4 3.4 2.8 3.8 0.2 1.7 2.8 3.4 0.4 1.4 1.7 19.3 2.1 2.3 0.4 1.1 2.5 9.8 12.4 9.1 13.3 12.8 10.4 22.1 11.4 13.9 13.5 CRIP1 CRIP ENSG00000213145 "Cysteine rich protein 1" P50238 14 105486317-105488947 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 129.0;CAPAN-2: 71.9;HaCaT: 77.9;HDLM-2: 55.1;HeLa: 63.2;T-47d: 101.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042462 Approved Approved "Nuclear speckles,Plasma membrane,Centrosome,Cytosol" "Nuclear speckles, Cytosol" "Plasma membrane, Centrosome" "HPA042462: AB_10794277" "unprognostic (2.97e-3)" "unprognostic (1.27e-3)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.39e-1)" "unprognostic (2.93e-3)" "unprognostic (4.33e-1)" "unprognostic (3.33e-1)" "unprognostic (3.20e-2)" "unprognostic (2.60e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (3.26e-3)" "unprognostic (5.10e-2)" "unprognostic (2.66e-1)" "unprognostic (7.51e-3)" "unprognostic (2.14e-1)" 44.3 3.3 3.8 37.5 4.9 5.5 97.2 3.2 4.0 37.7 44.0 4.5 65.3 25.7 20.0 83.0 28.4 23.7 33.8 45.5 4.5 4.7 20.4 2.6 56.7 53.0 4.7 4.5 11.2 4.2 1.1 7.3 38.5 4.8 11.7 13.2 9.9 21.8 71.0 12.9 48.8 106.3 25.9 5.1 16.6 20.3 7.5 1.9 24.2 32.0 83.4 58.3 18.4 18.9 111.4 79.3 56.3 49.4 56.9 121.1 75.8 0.0 129.0 0.8 0.1 2.3 1.6 12.0 0.2 0.0 1.7 0.0 4.0 71.9 38.9 0.7 34.4 77.9 0.0 0.0 0.1 55.1 0.0 3.0 63.2 21.7 0.4 0.0 0.0 0.7 0.0 4.2 0.0 0.1 0.1 0.1 0.0 1.0 1.9 0.3 1.2 6.7 30.5 0.0 8.1 0.0 0.0 3.4 0.2 0.4 0.2 0.0 101.1 18.5 0.2 0.0 0.1 0.9 0.0 0.0 0.0 3.2 0.0 0.0 0.1 19.4 43.3 56.3 47.7 38.5 32.7 111.4 92.1 51.4 79.3 43.6 21.9 25.7 2.9 56.9 49.4 62.1 121.1 75.8 3.8 4.9 3.2 4.0 4.5 4.7 4.7 4.5 4.8 1.9 CRIP3 "bA480N24.2, TLP, TLP-A" ENSG00000146215 "Cysteine rich protein 3" Q6Q6R5 6 43299710-43308797 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 25.5;heart muscle: 24.8;liver: 29.0" "Cell line enhanced" "Detected in some" "HAP1: 4.0;HEK 293: 4.8;HeLa: 5.0;Hep G2: 9.0;NTERA-2: 8.2;RPMI-8226: 6.7;THP-1: 3.6" "Cancer enhanced" "Detected in some" "liver cancer: 3.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 14 "myeloid DC: 25.5" "Lineage enriched" "Detected in many" 14 "dendritic cells: 25.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036198 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA036198: AB_10670791" "unprognostic (8.35e-3)" "unprognostic (4.14e-3)" "unprognostic (6.37e-2)" "unprognostic (5.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.07e-2)" "unprognostic (1.18e-1)" "unprognostic (2.30e-2)" "unprognostic (4.34e-2)" "unprognostic (1.46e-2)" "unprognostic (8.49e-4)" "unprognostic (1.86e-2)" "unprognostic (7.30e-3)" "unprognostic (5.02e-2)" "unprognostic (4.89e-2)" "unprognostic (4.46e-2)" "unprognostic (2.80e-4)" 0.4 0.5 4.2 5.6 5.8 2.5 2.1 9.4 3.0 0.8 0.8 0.6 3.1 2.2 0.8 2.7 0.9 1.0 4.6 24.8 3.5 3.5 10.4 29.0 0.6 5.3 2.3 2.2 1.0 2.4 0.8 1.1 0.7 2.1 4.1 0.5 1.0 0.7 9.5 0.5 1.8 4.5 1.0 1.7 4.4 0.3 13.5 0.4 0.6 1.1 0.4 6.1 1.8 0.5 1.7 25.5 0.5 1.5 0.2 0.0 0.9 0.0 1.1 0.3 0.1 0.4 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.4 0.0 0.9 4.0 0.1 0.0 0.0 4.8 0.0 5.0 9.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.2 0.0 0.0 0.0 6.7 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.9 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 1.5 0.5 0.0 1.0 0.0 1.4 0.0 0.0 25.5 1.7 0.0 0.0 0.4 0.2 1.3 0.2 0.0 0.9 4.2 5.8 9.4 3.0 3.5 3.5 2.3 2.2 2.1 0.4 CSRNP2 "C12ORF2, C12orf22, FAM130A1, PPP1R72, TAIP-12" ENSG00000110925 "Cysteine and serine rich nuclear protein 2" Q9H175 12 51061205-51083664 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018503, HPA019914" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA018503: AB_1845535, HPA019914: " "unprognostic (8.67e-3)" "unprognostic (1.00e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-1)" "unprognostic (1.83e-1)" "unprognostic (9.07e-2)" "prognostic unfavourable (1.08e-4)" "unprognostic (1.38e-1)" "unprognostic (1.20e-1)" "unprognostic (2.41e-2)" "unprognostic (1.14e-1)" "unprognostic (5.10e-2)" "prognostic unfavourable (6.51e-4)" "unprognostic (1.10e-1)" "unprognostic (8.98e-2)" "unprognostic (1.74e-2)" "prognostic favourable (2.78e-4)" 13.7 12.3 14.7 8.0 16.5 3.5 22.2 23.3 26.4 13.3 9.2 11.4 6.0 7.6 16.1 14.2 9.0 9.6 13.3 11.8 14.0 16.2 10.4 7.9 9.7 9.3 12.7 13.5 14.7 10.4 11.2 15.7 12.8 13.3 11.3 8.2 11.7 8.6 12.8 15.8 8.9 7.1 16.7 11.4 9.6 8.3 32.1 12.8 12.1 13.0 8.3 7.7 11.2 9.0 1.2 0.9 2.6 0.9 5.9 2.7 0.4 5.7 6.4 19.4 17.3 14.9 10.6 20.6 11.2 12.6 15.4 10.6 12.2 4.1 4.7 11.0 11.7 6.9 9.4 6.0 12.2 10.2 7.1 5.6 7.2 3.7 16.3 3.7 8.5 12.9 17.0 17.7 10.2 15.0 7.8 8.4 17.6 9.6 13.1 5.3 16.0 10.0 8.0 12.6 3.7 8.7 7.3 13.7 16.3 16.3 12.8 16.2 8.1 10.6 13.6 15.3 8.2 10.2 7.6 9.1 10.1 4.4 9.4 5.1 4.9 0.0 0.9 2.3 1.9 0.1 0.7 1.2 2.0 1.1 0.9 0.7 2.0 2.7 2.6 5.9 0.6 0.4 1.3 0.4 14.7 16.5 23.3 23.2 14.0 16.2 12.7 13.5 13.3 12.8 CWC15 "AD002, C11orf5, Cwf15, HSPC148" ENSG00000150316 "CWC15 spliceosome associated protein homolog" Q9P013 11 94962622-94973612 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039878 Supported Approved "Nuclear speckles,Mitochondria" "Nuclear speckles, Mitochondria" "HPA039878: " "unprognostic (1.97e-1)" "unprognostic (5.51e-2)" "unprognostic (1.66e-2)" "unprognostic (8.64e-2)" "unprognostic (3.81e-1)" "unprognostic (6.85e-2)" "unprognostic (1.29e-1)" "unprognostic (1.52e-1)" "unprognostic (4.84e-3)" "prognostic favourable (9.75e-4)" "unprognostic (4.69e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (1.91e-5)" "unprognostic (1.44e-1)" "unprognostic (1.34e-1)" "prognostic favourable (7.17e-4)" "unprognostic (5.23e-2)" 9.5 9.6 9.9 7.9 12.0 10.6 13.5 12.4 11.9 10.1 9.2 7.2 7.7 5.8 8.6 14.9 10.0 9.2 5.5 14.1 9.8 9.6 14.0 15.6 8.8 8.7 10.3 10.1 11.8 8.6 7.5 12.1 11.1 12.6 9.5 8.1 6.4 10.2 9.1 24.4 9.0 10.1 7.3 11.7 10.7 9.5 17.2 12.4 11.2 11.2 14.7 9.6 9.8 10.6 31.8 31.3 36.8 33.0 26.1 35.8 25.7 10.7 8.7 26.0 12.4 24.7 22.6 13.6 16.1 22.7 27.1 22.4 38.8 24.5 16.6 32.8 22.8 11.3 15.7 20.4 29.1 21.0 13.8 20.8 10.4 17.5 21.2 26.0 13.0 22.4 23.4 18.1 24.2 26.3 24.5 14.4 24.3 14.2 25.0 35.2 12.5 21.9 17.0 15.8 17.5 26.9 12.9 14.8 11.5 17.8 17.5 13.9 28.3 21.0 14.4 17.8 14.2 24.7 16.0 6.9 17.4 22.9 10.0 30.1 17.3 36.8 25.1 34.5 26.8 27.3 35.8 31.8 34.6 32.8 31.3 27.6 34.4 34.7 29.5 26.1 33.0 29.7 35.4 25.7 9.9 12.0 12.4 11.9 9.8 9.6 10.3 10.1 12.6 12.4 CWF19L2 FLJ32343 ENSG00000152404 "CWF19 like 2, cell cycle control (S. pombe)" Q2TBE0 11 107326345-107457844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038166 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA038166: AB_10669518" "unprognostic (1.38e-1)" "unprognostic (9.41e-2)" "unprognostic (1.37e-1)" "unprognostic (7.35e-2)" "unprognostic (7.17e-2)" "unprognostic (6.42e-2)" "unprognostic (8.78e-2)" "unprognostic (1.63e-1)" "unprognostic (4.19e-2)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (4.48e-2)" "unprognostic (1.26e-1)" "unprognostic (4.74e-2)" "unprognostic (1.76e-2)" 16.5 9.9 19.0 18.2 24.4 11.5 18.4 43.7 25.1 23.0 13.6 5.6 14.9 8.0 17.7 13.9 11.5 13.2 9.8 11.3 16.2 10.7 18.2 13.3 11.4 14.8 16.3 16.9 23.8 9.6 17.7 27.9 13.2 17.9 16.6 10.3 5.1 11.4 14.6 29.1 13.0 11.3 14.9 23.5 18.0 11.1 9.0 21.7 15.8 15.8 9.2 16.8 21.0 47.4 19.4 12.5 22.2 6.8 11.2 13.9 2.8 6.1 5.0 10.9 5.2 9.0 10.2 8.1 8.0 7.6 6.4 8.5 11.6 14.5 10.7 15.5 5.6 15.0 12.0 6.2 11.1 11.9 6.7 11.9 5.7 7.6 5.9 13.9 10.0 5.2 10.9 7.3 11.1 8.6 17.9 6.2 9.2 4.5 10.7 12.7 10.2 7.2 9.4 10.3 14.3 7.5 7.6 6.3 5.2 11.8 8.8 4.5 11.9 6.7 7.7 10.6 8.5 5.5 7.2 3.3 6.1 10.5 3.1 13.7 9.7 22.2 6.8 11.8 9.8 6.0 10.8 17.6 11.4 9.7 2.9 19.4 13.9 10.6 13.0 11.2 6.3 12.5 9.7 2.8 19.0 24.4 43.7 25.1 16.2 10.7 16.3 16.9 17.9 21.7 CYP4V2 CYP4AH1 ENSG00000145476 "Cytochrome P450 family 4 subfamily V member 2" Q6ZWL3 4 186191520-186213456 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sensory transduction, Vision" "Monooxygenase, Oxidoreductase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.7" "Cell line enhanced" "Detected in many" "Karpas-707: 12.9;SK-MEL-30: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029122 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA029122: AB_10601806" "unprognostic (1.65e-1)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "prognostic favourable (5.86e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "prognostic favourable (1.85e-4)" "unprognostic (6.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.05e-1)" "unprognostic (6.49e-2)" "unprognostic (9.89e-2)" "prognostic favourable (1.49e-7)" "unprognostic (3.25e-2)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" 6.6 16.6 7.8 5.0 12.4 1.6 5.5 8.9 7.5 6.7 8.0 8.9 4.9 11.4 5.7 4.2 5.2 6.2 13.7 7.4 7.7 4.6 21.6 64.7 7.3 4.1 7.7 9.0 6.3 12.1 30.8 16.1 3.0 6.7 5.6 8.2 19.1 6.2 9.1 3.3 2.8 14.7 6.4 7.0 7.5 5.2 3.2 7.4 4.4 11.9 2.1 3.8 8.0 5.1 2.3 2.5 0.0 6.2 1.3 4.0 1.5 2.6 1.8 0.6 0.0 11.1 4.6 0.1 3.7 7.9 1.4 1.9 0.0 10.7 1.0 0.5 2.4 1.3 1.3 1.1 0.4 6.4 1.3 4.0 0.4 0.5 3.3 2.2 2.0 4.1 0.5 1.4 0.6 0.1 1.6 12.9 4.6 2.2 2.4 0.6 1.4 0.0 2.1 0.5 1.1 4.5 5.1 2.8 4.0 0.9 0.0 19.0 1.9 3.5 4.2 2.9 0.7 3.3 1.6 0.0 0.0 0.5 8.8 8.2 3.5 0.0 1.2 0.0 4.0 4.1 2.5 1.0 2.5 3.4 1.5 2.3 2.7 2.3 0.0 1.3 6.2 2.5 2.1 1.5 7.8 12.4 8.9 7.5 7.7 4.6 7.7 9.0 6.7 7.4 CYSRT1 "C9orf169, MGC59937" ENSG00000197191 "Cysteine rich tail 1" 9 137224635-137226311 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "esophagus: 33.4" "Cell line enhanced" "Detected in many" "A-431: 9.8;CAPAN-2: 12.4;HaCaT: 13.8;HeLa: 12.2;MCF7: 19.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 23.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021883, HPA021886" Approved Approved "Nuclear speckles,Vesicles,Midbody" "Nuclear speckles" "Vesicles, Midbody" "HPA021883: AB_1853190, HPA021886: AB_1853192" "unprognostic (1.35e-1)" "unprognostic (2.53e-2)" "unprognostic (8.31e-3)" "unprognostic (6.87e-3)" "unprognostic (2.14e-1)" "unprognostic (2.66e-2)" "unprognostic (8.11e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (6.24e-3)" "unprognostic (7.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 0.7 0.4 1.0 0.7 0.9 0.2 0.8 0.7 1.7 1.4 0.7 0.7 0.7 0.3 0.7 0.7 33.4 1.0 0.7 0.7 1.4 1.3 1.4 0.7 0.7 0.7 0.8 0.7 0.7 0.7 0.3 3.5 0.7 0.7 1.1 0.0 0.7 2.2 0.7 0.7 8.1 0.7 0.7 0.7 0.7 0.8 2.2 0.7 0.7 1.3 0.7 5.3 0.7 2.1 0.9 0.6 0.9 3.0 0.9 0.3 0.1 9.8 1.2 1.0 2.1 0.0 0.0 2.7 0.3 0.3 0.3 0.1 0.7 12.4 0.7 0.7 0.2 13.8 0.3 3.1 0.0 1.3 1.0 0.2 12.2 6.5 0.7 0.1 0.6 0.3 1.5 0.4 0.1 0.1 0.4 2.1 0.8 19.1 0.4 0.7 0.5 1.5 1.5 1.3 1.7 0.4 0.7 0.3 1.0 2.0 1.8 0.5 3.9 0.2 0.5 0.8 0.5 1.8 0.3 1.2 0.9 0.7 0.7 0.5 0.8 0.9 0.2 0.2 0.3 1.7 0.1 0.9 0.3 0.2 0.6 0.8 0.2 0.3 0.7 0.9 3.0 0.4 0.2 0.1 1.0 0.9 0.7 1.7 1.4 1.3 0.8 0.7 0.7 0.7 DBNDD1 "FLJ12582, MGC3101" ENSG00000003249 "Dysbindin domain containing 1" Q9H9R9 16 90004865-90020128 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.6;skeletal muscle: 39.7" "Cell line enhanced" "Detected in many" "MCF7: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 14.4" "Lineage enriched" "Detected in many" 6 "B-cells: 14.4" HPA043018 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA043018: AB_10794921" "unprognostic (1.07e-1)" "unprognostic (8.40e-2)" "unprognostic (8.70e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-2)" "unprognostic (4.18e-2)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.07e-2)" "unprognostic (9.52e-2)" "unprognostic (1.54e-1)" "unprognostic (2.86e-2)" "prognostic favourable (2.75e-7)" "unprognostic (1.03e-1)" "unprognostic (5.67e-1)" "unprognostic (2.44e-2)" "unprognostic (2.00e-2)" 2.1 6.9 21.5 2.3 13.7 0.8 4.7 16.1 31.6 2.6 2.0 6.5 1.9 1.9 1.4 9.6 13.9 3.9 3.9 3.4 15.7 14.6 6.9 6.2 3.0 3.9 17.6 9.4 3.1 14.1 6.3 3.0 0.6 19.2 3.7 1.8 3.9 11.9 3.8 39.7 3.9 1.2 1.6 6.8 1.6 4.3 1.1 4.5 0.0 3.6 2.3 4.7 2.0 2.3 14.4 0.1 0.6 0.0 0.0 2.5 0.8 7.7 11.8 1.1 14.2 0.3 0.1 8.4 1.7 2.1 3.5 1.7 11.4 6.3 0.0 0.9 0.3 8.0 12.4 0.3 3.3 0.0 22.7 0.0 1.6 18.7 0.5 0.1 1.3 0.3 1.0 5.9 0.0 14.9 2.2 0.1 1.2 46.7 0.0 9.7 19.8 5.0 4.7 10.8 0.2 19.4 1.4 17.1 18.3 1.9 1.7 14.6 11.0 1.3 12.0 2.7 5.3 0.1 7.7 0.0 0.1 0.0 1.1 0.9 6.8 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.6 0.4 0.0 14.4 2.5 0.4 0.0 0.0 0.0 0.1 0.0 0.8 21.5 13.7 16.1 31.6 15.7 14.6 17.6 9.4 19.2 4.5 DDX39A "BAT1L, DDX39, DDXL, URH49" ENSG00000123136 "DExD-box helicase 39A" O00148 19 14408819-14419383 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055334 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA055334: " "unprognostic (1.31e-1)" "prognostic favourable (6.86e-4)" "unprognostic (2.41e-1)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (5.20e-2)" "unprognostic (2.55e-3)" "unprognostic (1.92e-1)" "unprognostic (1.87e-1)" "unprognostic (8.81e-2)" "unprognostic (1.64e-1)" "unprognostic (3.09e-2)" "prognostic unfavourable (1.50e-10)" "unprognostic (1.55e-3)" "unprognostic (8.57e-2)" "unprognostic (3.92e-1)" "unprognostic (7.38e-3)" 10.9 8.5 7.2 20.6 11.4 41.4 10.5 9.1 7.9 8.2 10.9 11.0 4.4 13.0 9.4 7.2 15.9 7.0 8.1 7.8 6.6 6.1 9.7 12.1 10.3 31.2 12.6 5.0 7.4 8.8 3.0 7.4 10.5 10.0 7.3 8.9 5.2 7.9 4.4 7.9 10.6 12.8 6.8 9.4 23.4 10.4 60.7 10.3 39.9 8.4 16.3 26.1 10.3 8.8 36.7 36.6 7.7 28.5 21.5 39.7 33.6 32.6 26.8 13.8 26.6 5.7 4.1 13.5 14.5 8.1 30.3 18.7 27.2 17.7 63.2 15.5 12.0 20.2 33.9 23.6 12.4 22.0 17.7 67.8 31.3 19.5 10.0 36.8 30.3 5.7 5.3 19.7 8.0 15.8 41.6 27.8 16.8 39.5 63.1 54.7 26.3 41.1 43.8 24.4 36.9 10.8 26.9 32.1 17.7 10.8 22.6 16.3 24.9 36.0 14.8 26.8 16.7 44.1 32.5 28.9 50.7 65.0 30.1 40.3 26.8 6.8 25.9 7.7 35.6 28.5 30.5 36.7 28.4 28.2 36.6 33.2 24.9 26.7 7.7 21.5 23.4 22.6 39.7 33.6 7.2 11.4 9.1 7.9 6.6 6.1 12.6 5.0 10.0 10.3 DENND1B "C1orf218, FAM31B, FLJ20054, MGC27044" ENSG00000213047 "DENN domain containing 1B" Q6P3S1 1 197504748-197775696 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042586 Uncertain Supported "Nuclear speckles,Cytosol" Cytosol "Nuclear speckles" "HPA042586: " "unprognostic (8.79e-2)" "unprognostic (1.58e-1)" "unprognostic (4.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.39e-1)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (9.54e-2)" "unprognostic (7.79e-3)" "unprognostic (3.99e-2)" "unprognostic (3.13e-2)" "unprognostic (5.36e-2)" "unprognostic (6.11e-2)" "unprognostic (5.61e-3)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-2)" 5.9 3.9 6.2 12.7 8.3 6.4 8.7 3.9 5.6 5.7 13.0 1.4 8.8 7.5 3.6 6.4 9.0 3.1 5.4 7.3 4.9 4.9 7.9 6.6 7.3 7.8 4.0 2.7 5.6 8.7 9.9 15.9 3.6 3.7 7.5 7.8 6.4 9.9 15.8 6.5 3.8 21.6 4.1 3.5 7.7 6.1 4.4 2.6 17.9 8.2 6.5 11.7 6.9 6.8 2.3 2.0 5.0 0.6 5.8 3.6 0.7 5.9 1.5 1.7 2.9 0.8 4.4 2.7 4.6 3.2 2.8 1.7 1.6 3.8 10.9 2.4 7.0 3.1 2.7 3.3 2.5 8.2 2.9 3.9 3.0 0.7 2.4 12.8 4.9 1.5 4.5 1.1 3.2 1.2 3.0 16.9 2.8 1.1 6.8 6.6 0.6 1.5 4.2 1.5 8.5 7.0 5.6 2.9 4.6 7.1 4.8 1.2 2.0 11.2 3.4 0.3 2.8 0.1 2.7 8.6 0.0 5.5 3.0 5.2 5.3 5.0 0.3 2.3 2.1 0.6 1.1 2.3 1.4 3.3 1.5 0.7 0.8 1.5 1.0 5.8 0.6 2.0 3.6 0.7 6.2 8.3 3.9 5.6 4.9 4.9 4.0 2.7 3.7 2.6 DEXI MYLE ENSG00000182108 "Dexi homolog" O95424 16 10928891-10942460 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041511 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA041511: AB_10796675" "unprognostic (4.14e-1)" "unprognostic (8.52e-2)" "unprognostic (1.29e-1)" "unprognostic (9.70e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (1.19e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "unprognostic (1.47e-2)" "prognostic favourable (4.23e-4)" "unprognostic (5.21e-2)" "unprognostic (1.33e-3)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.75e-2)" "unprognostic (1.83e-2)" 15.0 25.2 15.7 8.0 20.8 4.1 10.7 14.0 27.5 12.2 13.9 9.8 12.7 11.1 11.7 18.5 12.9 14.5 11.6 32.2 13.1 13.6 13.3 26.3 9.5 9.9 18.8 12.3 15.9 18.0 22.1 12.9 13.3 21.3 13.6 6.6 13.7 15.4 16.6 81.6 10.3 11.1 12.1 9.4 12.7 10.6 8.9 11.9 13.7 18.4 10.6 8.1 10.9 10.5 4.0 2.4 8.2 0.7 3.9 7.0 1.2 9.3 13.7 7.4 13.0 30.2 16.6 6.8 14.5 15.1 9.5 9.1 6.4 9.9 11.2 21.9 16.4 12.2 8.7 15.6 8.2 26.2 19.5 5.5 9.0 27.1 17.3 9.5 10.5 16.9 18.0 9.3 10.8 13.7 12.6 11.2 10.5 16.5 11.8 10.3 10.3 14.3 11.0 9.8 17.1 11.8 7.0 15.3 13.5 13.8 15.3 11.5 12.1 16.5 14.9 9.6 10.4 22.7 9.4 14.9 11.4 3.2 8.4 20.4 10.8 1.7 0.6 8.2 6.0 0.7 5.6 0.6 5.2 7.0 0.4 4.0 6.4 6.0 0.7 3.9 0.3 2.4 3.9 1.2 15.7 20.8 14.0 27.5 13.1 13.6 18.8 12.3 21.3 11.9 DLX2 TES-1 ENSG00000115844 "Distal-less homeobox 2" Q07687 2 172099439-172102900 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.9" "Group enriched" "Detected in some" 8 "AN3-CA: 38.7;HEK 293: 24.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 13.8;olfactory region: 36.1" "Region enriched" "Detected in many" 5 "olfactory region: 43.5" HPA056965 Approved "Nuclear speckles" "Nuclear speckles" "HPA056965: " "unprognostic (8.12e-2)" "unprognostic (3.56e-1)" "unprognostic (2.48e-2)" "unprognostic (1.28e-2)" "unprognostic (4.07e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (3.03e-2)" "unprognostic (2.41e-1)" "unprognostic (8.74e-2)" "unprognostic (3.53e-2)" "unprognostic (3.01e-1)" "unprognostic (6.69e-10)" "unprognostic (9.38e-2)" "unprognostic (2.47e-1)" "unprognostic (2.41e-1)" "unprognostic (7.95e-3)" 0.7 3.2 4.5 0.7 5.4 1.2 1.2 0.1 10.9 0.4 0.7 1.1 0.0 0.6 0.5 0.4 0.4 0.5 0.7 0.7 4.3 7.5 0.5 0.6 0.5 0.4 0.4 4.1 0.4 0.4 0.4 0.2 0.6 0.0 1.0 0.6 0.0 1.7 0.7 0.4 1.9 1.2 0.5 0.1 0.4 0.5 2.5 3.4 1.4 1.5 1.5 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 38.7 0.2 0.1 1.1 2.0 0.4 0.3 0.1 0.2 0.0 0.0 1.2 0.9 2.0 1.2 0.1 0.1 0.0 24.6 0.6 4.0 0.9 0.1 0.2 0.1 0.0 1.8 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.6 2.3 0.3 0.1 0.1 2.7 0.0 1.5 0.2 0.0 0.0 0.2 2.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 5.4 0.1 10.9 4.3 7.5 0.4 4.1 0.0 3.4 DNAAF1 "CILD13, FLJ25330, LRRC50, ODA7, swt" ENSG00000154099 "Dynein axonemal assembly factor 1" Q8NEP3 16 84145287-84178767 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.3;testis: 49.6" "Cell line enhanced" "Detected in some" "Hep G2: 3.4;Karpas-707: 8.6;PC-3: 2.6;SK-BR-3: 2.4;U-266/70: 7.2;U-266/84: 4.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.1" "Group enriched" "Detected in many" 5 "amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1" "Cell type enhanced" "Detected in some" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA041166, HPA074239" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nuclear speckles" "HPA041166: AB_10794190, HPA074239: " "unprognostic (5.25e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-2)" "prognostic favourable (2.14e-4)" "unprognostic (1.42e-1)" "unprognostic (9.99e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (7.71e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-5)" "unprognostic (2.70e-2)" "unprognostic (4.61e-3)" "unprognostic (1.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-4)" "unprognostic (7.51e-4)" 0.8 1.2 3.5 0.6 9.4 1.5 0.5 0.1 1.5 2.1 0.6 5.3 1.5 0.4 1.0 13.3 0.9 21.3 0.5 0.4 4.6 6.5 0.7 2.0 3.7 0.9 0.5 1.5 4.2 0.4 0.7 6.1 1.5 11.1 0.4 0.4 0.9 0.5 0.6 0.6 0.5 0.6 0.4 1.0 7.2 0.5 49.6 1.2 0.0 1.2 0.0 0.4 0.8 0.0 0.5 1.0 5.5 0.8 0.9 2.1 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 3.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.1 1.3 0.2 0.0 0.0 2.4 0.1 0.9 0.0 0.0 0.4 0.0 0.0 0.0 7.2 4.7 0.7 0.2 0.4 0.0 3.6 0.8 0.4 0.4 0.6 0.1 0.0 0.2 0.1 0.4 0.5 0.8 0.8 5.5 0.9 0.4 1.0 2.1 0.9 3.5 9.4 0.1 1.5 4.6 6.5 0.5 1.5 11.1 1.2 DNMT3L MGC1090 ENSG00000142182 "DNA methyltransferase 3 like" Q9UJW3 21 44246339-44262216 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "kidney: 7.8;liver: 20.5" "Cell line enriched" "Detected in some" 7 "BEWO: 30.6" "Cancer enriched" "Detected in some" 90 "testis cancer: 46.3" "Region enriched" "Detected in single" 13 "cerebellum: 2.5" "Group enriched" "Detected in some" 16 "memory B-cell: 3.2;naive B-cell: 1.1;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 19 "B-cells: 3.2;dendritic cells: 1.1" "HPA055234, HPA066780" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA055234: , HPA066780: " "unprognostic (1.05e-4)" "unprognostic (1.91e-1)" "unprognostic (2.73e-9)" "unprognostic (2.77e-1)" "unprognostic (5.28e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 2.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 7.8 20.5 0.1 1.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.6 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.2 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 2.5 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.1 2.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 DPCD "DKFZP566F084, RP11-529I10.4" ENSG00000166171 "Deleted in primary ciliary dyskinesia homolog (mouse)" Q9BVM2 10 101570560-101609668 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 56.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 11.9;intermediate monocyte: 13.2;myeloid DC: 17.4;non-classical monocyte: 5.3" "Group enriched" "Detected in many" 13 "dendritic cells: 17.4;monocytes: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036603, HPA036604" Enhanced Approved "Nuclear speckles" "Nuclear speckles" "HPA036603: , HPA036604: AB_10673503" "unprognostic (1.22e-2)" "unprognostic (1.73e-3)" "unprognostic (4.66e-1)" "prognostic favourable (6.57e-4)" "unprognostic (1.90e-1)" "unprognostic (9.13e-2)" "unprognostic (4.00e-3)" "unprognostic (1.71e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (1.64e-1)" "unprognostic (4.55e-2)" "unprognostic (2.70e-1)" "unprognostic (5.04e-2)" "unprognostic (3.83e-2)" "unprognostic (7.54e-2)" 4.6 8.1 21.9 4.0 19.9 4.4 9.3 3.4 14.0 10.7 7.1 6.0 4.6 3.1 8.4 20.6 8.3 35.0 7.2 13.0 15.6 16.6 14.7 4.9 6.7 3.8 16.1 18.6 10.8 9.0 17.9 23.6 4.8 16.0 7.9 6.5 9.6 10.0 10.2 9.5 5.8 2.8 8.5 8.1 1.7 6.1 56.2 7.5 1.1 15.5 5.1 3.6 5.2 5.5 0.8 17.4 0.6 13.2 0.9 1.2 4.6 30.9 17.3 12.6 25.7 11.8 19.8 5.4 14.8 16.7 18.7 17.8 12.3 16.9 2.8 24.8 13.2 17.7 17.3 20.5 19.9 7.2 17.1 3.6 16.9 18.2 6.3 18.9 2.7 14.1 17.7 22.8 18.3 16.0 9.7 4.0 14.1 38.7 0.0 14.9 9.3 13.2 0.0 17.2 6.6 30.1 8.4 12.4 21.4 11.9 7.9 9.8 23.9 7.6 11.5 9.1 8.6 18.6 19.5 11.6 13.3 5.3 32.2 4.3 3.9 0.0 11.9 0.5 1.1 13.2 1.0 0.8 0.9 0.9 17.4 0.5 1.0 1.2 0.6 0.9 5.3 2.4 0.3 4.6 21.9 19.9 3.4 14.0 15.6 16.6 16.1 18.6 16.0 7.5 DRP2 ENSG00000102385 "Dystrophin related protein 2" Q13474 X 101219769-101264497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.3" "Cell line enhanced" "Detected in some" "RH-30: 11.0;TIME: 18.5;U-87 MG: 4.5" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002949 Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles, Plasma membrane" "HPA002949: AB_1078706" "unprognostic (8.47e-4)" "unprognostic (3.56e-3)" "unprognostic (1.01e-2)" "unprognostic (5.58e-4)" "unprognostic (1.74e-2)" "unprognostic (2.47e-2)" "unprognostic (7.93e-3)" "unprognostic (2.94e-3)" "unprognostic (1.27e-2)" "unprognostic (5.46e-3)" "unprognostic (1.42e-1)" "unprognostic (4.61e-2)" "unprognostic (4.44e-16)" "unprognostic (3.71e-4)" "unprognostic (4.22e-1)" "unprognostic (9.03e-2)" "unprognostic (1.25e-1)" 1.1 1.5 9.3 1.2 17.2 1.1 0.8 0.4 20.3 1.7 2.8 1.2 0.0 1.1 2.5 2.7 1.3 1.0 1.3 0.9 5.8 4.2 0.7 0.6 0.8 0.8 4.6 10.1 4.4 0.6 0.6 2.4 0.7 2.6 4.1 1.8 0.5 0.7 3.1 0.7 0.8 1.2 2.2 3.1 0.7 0.7 1.6 2.2 0.9 0.6 0.0 0.8 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 2.3 0.1 0.1 0.2 0.1 0.4 0.1 0.3 1.0 0.0 0.4 0.3 0.3 0.1 0.0 0.3 0.0 0.7 0.1 0.2 0.2 0.5 0.0 0.2 0.1 0.4 1.5 0.0 0.7 0.0 1.4 0.0 0.9 1.6 0.0 1.3 0.5 0.1 0.1 0.3 11.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.1 18.5 0.2 0.7 0.2 0.4 0.0 0.1 0.0 4.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 9.3 17.2 0.4 20.3 5.8 4.2 4.6 10.1 2.6 2.2 EEPD1 KIAA1706 ENSG00000122547 "Endonuclease/exonuclease/phosphatase family domain containing 1" Q7L9B9 7 36153149-36301543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 13.3;HDLM-2: 14.0;PC-3: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.2;neutrophil: 21.9" "Group enriched" "Detected in many" 6 "granulocytes: 23.2;T-cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053668 Approved "Nuclear speckles,Vesicles,Plasma membrane" "Nuclear speckles" "Vesicles, Plasma membrane" "HPA053668: " "unprognostic (1.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.54e-3)" "unprognostic (5.21e-3)" "unprognostic (1.14e-1)" "unprognostic (4.76e-1)" "unprognostic (1.19e-2)" "unprognostic (3.75e-2)" "unprognostic (7.89e-2)" "unprognostic (8.77e-2)" "unprognostic (7.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (4.59e-2)" 20.3 5.1 4.9 6.4 8.6 8.1 22.5 3.3 19.3 9.6 15.2 11.8 6.5 11.0 12.5 5.6 6.5 5.4 18.4 6.2 6.4 5.4 3.7 15.2 8.7 4.6 13.3 3.5 6.9 8.1 2.4 3.3 4.6 5.6 8.2 4.5 5.7 3.8 4.3 39.7 10.2 23.6 9.1 10.2 7.5 10.5 3.4 7.7 11.5 2.2 4.4 3.6 6.1 10.9 0.1 1.5 23.2 2.8 1.7 11.5 2.0 1.6 4.6 1.4 4.5 13.3 2.9 0.1 1.1 5.7 0.9 1.6 0.9 3.5 4.5 1.5 1.7 1.9 1.9 2.2 0.8 14.0 3.2 0.6 0.4 8.4 1.2 0.7 4.4 5.9 1.4 0.5 0.4 0.1 5.5 0.5 1.0 1.8 4.6 11.2 6.5 17.8 1.2 1.6 1.0 2.8 3.7 3.5 2.5 0.4 0.6 1.7 1.4 5.4 0.4 1.8 5.3 1.2 1.3 3.5 3.8 0.0 4.4 3.0 1.1 10.0 2.8 23.2 1.5 1.7 2.6 0.1 11.5 3.3 1.5 0.0 2.6 0.7 21.9 1.7 0.7 1.3 5.1 2.0 4.9 8.6 3.3 7.5 6.4 5.4 13.3 3.5 5.6 7.7 EFCAB13 "C17orf57, FLJ40342" ENSG00000178852 "EF-hand calcium binding domain 13" Q8IY85 17 47323290-47441312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 29.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "CAB002501, HPA021633, HPA023249, HPA026561" Uncertain Enhanced "Nucleoplasm,Nuclear speckles,Cytosol" "Nucleoplasm, Cytosol" "Nuclear speckles" "CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596" "unprognostic (1.66e-1)" "unprognostic (3.48e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.40e-1)" "unprognostic (7.43e-2)" "unprognostic (8.79e-3)" "unprognostic (8.75e-2)" "unprognostic (1.75e-2)" "unprognostic (1.46e-5)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (8.10e-2)" "unprognostic (1.90e-3)" 4.1 2.8 2.9 12.2 3.4 3.4 6.5 2.8 3.8 6.5 4.7 2.3 3.5 4.8 8.9 4.4 2.4 4.2 4.1 3.5 2.3 1.5 7.5 4.0 3.1 4.3 3.6 0.4 5.5 2.8 8.4 7.6 5.4 3.2 9.3 3.4 2.6 5.4 2.0 1.3 2.2 6.3 9.9 3.5 4.6 3.5 20.0 2.7 2.4 14.9 0.7 4.3 5.5 29.9 5.6 1.0 5.3 2.1 0.8 2.6 0.8 0.9 3.9 1.7 0.2 2.1 7.2 3.0 2.2 0.5 0.6 1.1 1.7 5.6 0.3 6.5 0.8 1.0 0.0 0.4 3.9 0.2 0.6 5.1 3.2 0.5 2.0 3.9 0.6 1.3 1.9 2.7 0.0 4.4 1.5 9.7 2.4 0.1 1.7 2.2 0.9 3.1 4.6 1.2 1.8 9.1 3.2 1.2 0.6 1.2 0.1 2.6 6.5 4.7 1.6 0.2 1.3 0.4 1.0 10.0 6.9 0.9 6.2 7.7 4.2 5.3 2.1 0.6 1.1 1.2 0.9 4.3 0.9 0.6 1.0 5.6 2.6 1.2 0.0 0.8 0.7 0.4 0.1 0.8 2.9 3.4 2.8 3.8 2.3 1.5 3.6 0.4 3.2 2.7 EGFL8 "C6orf8, NG3" ENSG00000241404 "EGF like domain multiple 8" Q99944 6 32164583-32168281 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061173 Uncertain Approved "Nuclear speckles,Vesicles" "Secreted - unknown location" Vesicles "Nuclear speckles" "HPA061173: " "unprognostic (7.13e-2)" "unprognostic (1.86e-1)" "unprognostic (6.79e-3)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (7.60e-4)" "unprognostic (3.42e-2)" "unprognostic (2.49e-1)" "unprognostic (6.42e-3)" "unprognostic (1.97e-1)" "unprognostic (7.60e-3)" "unprognostic (8.11e-3)" "unprognostic (1.07e-4)" "unprognostic (1.11e-1)" "unprognostic (6.79e-2)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" 4.5 6.3 7.3 2.6 7.6 4.5 5.0 6.3 9.4 7.1 6.7 8.4 8.7 4.7 6.4 5.5 4.3 4.8 8.4 4.8 8.2 4.4 4.3 1.8 4.3 2.0 25.7 3.9 14.4 2.9 1.3 2.9 9.2 14.1 6.0 2.7 14.7 3.9 5.3 3.8 12.9 5.8 3.0 11.9 3.5 3.9 2.3 7.0 0.2 3.1 8.3 2.0 5.2 6.8 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.3 1.3 3.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.2 0.0 2.0 1.3 0.4 0.0 0.0 1.9 0.0 0.9 3.6 1.1 0.0 0.7 0.0 0.3 0.3 0.0 0.7 0.3 0.0 0.0 1.7 0.9 3.0 0.0 0.0 1.1 0.1 0.0 0.2 0.6 0.5 1.2 0.0 0.1 3.7 1.4 2.2 0.0 0.8 1.7 0.0 0.1 0.0 0.1 0.1 0.1 1.1 1.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.3 7.6 6.3 9.4 8.2 4.4 25.7 3.9 14.1 7.0 EPC2 DKFZP566F2124 ENSG00000135999 "Enhancer of polycomb homolog 2" Q52LR7 2 148644440-148787568 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036759 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA036759: AB_10672365" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "unprognostic (2.83e-3)" "unprognostic (2.59e-2)" "unprognostic (1.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.47e-2)" "unprognostic (3.86e-2)" "unprognostic (2.29e-1)" "unprognostic (6.21e-2)" "unprognostic (5.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.54e-2)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" 19.5 16.3 16.1 16.2 15.6 41.0 18.6 32.9 18.3 23.9 17.2 13.6 19.3 9.7 26.0 15.2 13.2 17.1 15.8 16.2 14.1 14.0 13.6 12.8 14.7 16.4 14.5 16.6 33.4 12.0 15.4 30.6 22.7 13.7 20.1 14.6 13.1 14.8 19.0 19.1 14.6 16.5 19.8 14.8 18.1 12.0 13.8 15.8 27.7 20.0 12.9 15.6 18.8 22.7 1.9 2.0 8.6 3.7 0.8 3.3 1.0 5.9 4.7 16.3 10.1 10.9 13.8 12.2 10.6 14.5 17.3 14.7 9.3 8.2 13.1 5.3 12.4 8.1 14.0 8.5 21.4 11.3 10.4 25.3 7.4 13.0 11.2 19.0 15.6 14.4 15.3 17.6 17.4 10.7 13.3 22.5 10.8 9.7 13.0 13.0 16.4 9.2 13.5 15.0 11.8 8.7 17.1 22.5 16.2 13.1 8.2 19.6 5.3 17.1 12.8 13.9 12.2 9.3 8.8 13.7 10.7 16.7 10.9 11.5 14.8 0.3 1.9 2.2 2.1 1.4 2.7 1.9 3.0 1.8 1.8 1.9 3.3 2.3 8.6 0.8 3.7 2.0 2.6 1.0 16.1 15.6 32.9 18.3 14.1 14.0 14.5 16.6 13.7 15.8 EPG5 "hEPG5, KIAA1632" ENSG00000152223 "Ectopic P-granules autophagy protein 5 homolog" Q9HCE0 18 45847609-45967274 "Disease related genes, Predicted intracellular proteins" Autophagy "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031689 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA031689: AB_10609997" "unprognostic (3.43e-1)" "unprognostic (1.20e-1)" "unprognostic (8.11e-2)" "unprognostic (6.84e-2)" "unprognostic (2.20e-2)" "unprognostic (4.59e-2)" "unprognostic (5.58e-2)" "unprognostic (1.02e-1)" "unprognostic (4.66e-1)" "unprognostic (4.87e-1)" "unprognostic (1.15e-2)" "unprognostic (7.50e-2)" "prognostic favourable (4.04e-5)" "unprognostic (5.71e-2)" "unprognostic (1.35e-1)" "unprognostic (4.05e-1)" "unprognostic (1.18e-1)" 11.1 12.5 15.4 11.3 16.1 26.8 16.3 20.1 21.1 10.3 9.3 11.2 11.6 7.8 13.1 14.5 12.2 10.4 8.1 14.5 14.1 10.1 13.5 10.0 14.7 14.0 11.5 12.3 16.7 11.1 18.6 18.1 14.8 12.7 10.4 10.1 13.0 10.7 10.1 23.8 22.7 10.2 10.2 15.6 16.9 9.5 8.6 12.4 20.2 17.0 8.7 13.8 9.1 14.4 1.7 1.9 2.4 2.2 1.1 4.8 0.9 2.8 2.2 2.2 1.6 7.8 9.5 2.3 18.0 7.5 10.4 10.9 0.6 2.1 2.9 1.1 13.5 2.7 3.0 3.6 13.4 2.3 1.3 2.2 2.5 2.2 7.5 3.8 5.8 6.3 3.3 11.5 7.9 5.2 1.9 1.6 30.6 2.0 1.6 3.6 1.1 1.3 1.6 2.8 2.0 4.8 4.0 2.4 1.9 3.2 1.3 3.7 1.8 2.7 12.4 13.0 2.7 1.8 4.9 3.2 2.2 1.6 5.5 3.3 4.2 1.2 2.2 2.0 4.8 2.1 4.6 1.2 2.9 2.8 1.6 1.7 2.6 3.1 2.4 1.1 2.0 1.9 1.6 0.9 15.4 16.1 20.1 21.1 14.1 10.1 11.5 12.3 12.7 12.4 EPHA2 ECK ENSG00000142627 "EPH receptor A2" P29317 1 16124337-16156087 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 51.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 41.9;EFO-21: 40.4;PC-3: 48.0;U-251 MG: 49.2;WM-115: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 115 "dendritic cells: 11.4" "Low region specificity" "Detected in all" CAB010464 Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "Nuclear speckles, Golgi apparatus" "CAB010464: AB_631436" "unprognostic (9.41e-2)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.67e-2)" "unprognostic (6.22e-2)" "unprognostic (9.12e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-3)" "unprognostic (2.52e-2)" "unprognostic (7.05e-3)" "unprognostic (1.52e-3)" "unprognostic (2.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (4.77e-3)" "unprognostic (4.40e-2)" 6.7 3.4 1.3 3.1 2.6 0.0 5.2 0.5 2.1 12.1 4.9 1.6 1.9 4.3 7.8 3.8 51.2 4.6 16.7 6.4 1.1 0.8 5.7 8.2 6.6 4.7 2.7 1.3 4.5 10.2 2.2 2.8 8.9 3.4 5.8 2.6 5.4 31.0 2.8 3.4 12.7 13.1 2.7 3.0 2.8 6.8 2.4 1.2 1.2 5.7 21.8 25.5 15.2 18.5 0.0 11.4 0.0 0.0 0.0 0.0 0.0 15.4 31.3 8.7 4.2 0.6 0.7 5.1 9.3 13.3 17.0 10.8 13.0 41.9 0.0 40.4 5.3 6.3 2.0 21.6 5.9 0.0 1.4 0.0 9.1 8.3 11.1 0.0 0.0 1.0 8.1 9.2 20.5 18.1 0.0 0.0 10.7 4.9 0.0 0.0 4.2 48.0 0.0 7.9 0.0 18.0 8.0 0.0 1.3 18.2 4.4 1.2 0.6 0.1 22.3 6.1 16.3 0.4 49.2 0.0 0.1 0.1 4.7 0.0 53.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 1.3 2.6 0.5 2.1 1.1 0.8 2.7 1.3 3.4 1.2 EPHB6 HEP ENSG00000106123 "EPH receptor B6" 7 142855061-142871094 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1" "Group enriched" "Detected in some" 6 "MOLT-4: 17.8;RT4: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035784 Approved "Nuclear speckles" "Intracellular and membrane" "Nuclear speckles" "HPA035784: " "unprognostic (1.90e-2)" "prognostic favourable (1.80e-4)" "unprognostic (7.08e-3)" "unprognostic (2.95e-2)" "prognostic unfavourable (4.10e-4)" "unprognostic (2.53e-3)" "unprognostic (3.15e-2)" "unprognostic (4.39e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.06e-3)" "unprognostic (3.18e-1)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.16e-1)" "prognostic favourable (4.68e-5)" 3.3 1.7 7.4 3.0 30.1 3.3 2.6 3.1 29.3 9.0 1.5 0.8 3.4 0.9 3.0 4.5 7.5 6.4 2.8 1.4 5.4 4.2 1.7 1.3 2.4 3.6 3.3 14.4 3.9 7.8 0.8 1.1 2.9 1.7 6.8 0.9 1.5 4.7 8.1 1.8 32.1 1.6 2.0 1.4 2.6 3.3 3.8 3.6 26.7 6.6 2.5 3.3 5.1 6.5 4.1 0.9 1.0 1.3 0.0 3.1 1.4 0.1 0.0 0.0 0.4 1.9 1.0 0.0 0.2 0.4 0.1 0.0 0.5 1.3 0.0 0.0 0.1 4.4 0.2 0.0 0.0 1.0 0.1 0.3 0.0 0.2 0.6 4.2 0.1 0.3 0.0 1.1 0.0 0.2 0.6 0.0 0.0 0.0 17.8 3.2 3.0 1.3 0.4 0.0 0.0 0.0 33.8 0.0 0.0 1.2 0.8 0.0 2.8 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 1.3 0.5 0.1 1.0 0.6 4.1 2.5 1.4 0.9 1.0 3.1 1.5 1.0 0.0 0.4 0.1 1.9 1.4 7.4 30.1 3.1 29.3 5.4 4.2 3.3 14.4 1.7 3.6 ERCC8 "CKN1, CSA" ENSG00000049167 "ERCC excision repair 8, CSA ubiquitin ligase complex subunit" Q13216 5 60873831-60945073 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Cockayne syndrome, Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029328 Approved "Nuclear speckles" "Nuclear speckles" "HPA029328: " "unprognostic (5.45e-2)" "unprognostic (1.90e-1)" "unprognostic (2.56e-2)" "unprognostic (6.59e-2)" "unprognostic (1.68e-2)" "unprognostic (4.96e-2)" "unprognostic (2.10e-3)" "unprognostic (9.68e-2)" "unprognostic (3.85e-2)" "unprognostic (3.23e-1)" "unprognostic (7.49e-2)" "unprognostic (1.09e-1)" "unprognostic (4.75e-3)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (7.19e-2)" 13.6 10.4 11.5 7.1 12.4 4.2 13.9 10.2 16.5 9.8 9.9 11.8 8.6 8.5 9.8 10.0 10.0 8.4 8.0 11.6 10.3 10.6 13.2 10.6 8.0 9.2 11.4 8.9 9.1 8.5 6.6 18.7 12.6 14.7 7.7 12.2 10.6 8.4 10.3 8.7 7.2 7.7 12.9 12.5 11.5 7.6 14.1 11.7 14.0 10.2 8.9 11.6 11.2 7.8 4.3 12.1 1.4 6.5 3.6 6.3 3.9 6.0 8.9 12.3 13.4 7.6 10.2 7.0 9.0 10.4 12.8 15.0 10.2 9.5 8.2 13.3 10.5 6.1 9.9 13.4 16.3 13.5 5.9 5.7 3.6 12.7 10.5 6.3 5.4 9.2 12.0 10.9 6.1 11.8 7.8 4.7 12.4 9.3 9.0 6.9 6.6 5.5 15.0 13.5 8.1 6.5 7.8 8.5 11.3 9.6 5.7 9.5 10.1 7.6 7.1 5.1 7.9 8.5 14.4 6.3 12.4 10.0 7.4 12.5 13.7 0.0 6.5 1.4 5.1 5.9 5.6 4.3 4.3 6.2 12.1 2.4 5.9 5.9 0.2 3.6 1.7 5.5 6.3 3.9 11.5 12.4 10.2 16.5 10.3 10.6 11.4 8.9 14.7 11.7 FAM120C "CXorf17, FLJ20506, ORF34" ENSG00000184083 "Family with sequence similarity 120C" Q9NX05 X 54068324-54183281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047677 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA047677: " "unprognostic (4.70e-2)" "unprognostic (2.58e-3)" "unprognostic (3.72e-2)" "unprognostic (2.20e-2)" "unprognostic (3.21e-2)" "prognostic favourable (4.48e-4)" "unprognostic (1.86e-2)" "unprognostic (3.53e-3)" "unprognostic (2.74e-2)" "unprognostic (4.90e-2)" "unprognostic (2.71e-3)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (1.76e-3)" "unprognostic (5.21e-2)" "unprognostic (5.28e-2)" "unprognostic (3.28e-2)" 8.7 10.5 15.3 8.1 15.8 9.4 9.3 15.5 18.3 11.9 6.2 16.9 6.2 4.6 10.5 16.3 8.1 9.9 6.9 6.8 14.0 11.6 9.9 8.3 6.2 8.4 16.8 11.5 14.9 9.0 16.0 15.8 7.1 12.5 9.0 5.9 7.9 7.3 10.6 12.4 8.3 5.6 9.2 12.1 8.6 5.6 8.3 16.2 10.9 10.8 5.5 9.4 7.8 7.8 4.9 6.0 0.3 2.7 1.7 3.1 1.6 4.0 7.2 3.8 8.4 8.6 6.3 6.9 3.8 6.3 5.8 6.3 3.4 4.2 5.6 2.6 3.3 10.7 10.7 2.8 5.2 4.3 11.7 2.9 10.4 5.5 3.9 2.7 3.1 4.4 3.5 5.1 6.0 3.6 3.1 4.6 4.6 10.7 4.3 10.6 7.0 16.1 5.2 6.0 5.8 4.8 2.2 5.1 5.1 9.9 7.6 2.6 9.0 2.4 6.5 5.2 6.8 6.8 3.1 5.6 5.4 4.2 5.9 8.1 6.2 0.0 2.7 0.3 2.6 1.4 2.3 4.4 2.5 2.1 4.8 4.9 2.9 3.1 0.0 1.7 0.6 6.0 0.9 1.6 15.3 15.8 15.5 13.6 14.0 11.6 16.8 11.5 12.5 16.2 FAM160B1 "bA106M7.3, KIAA1600" ENSG00000151553 "Family with sequence similarity 160 member B1" Q5W0V3 10 114821744-114899832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043624 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA043624: AB_10797145" "unprognostic (2.61e-1)" "unprognostic (2.47e-2)" "unprognostic (2.62e-1)" "unprognostic (8.45e-3)" "unprognostic (6.43e-2)" "unprognostic (9.87e-3)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (2.29e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-1)" "unprognostic (3.87e-2)" "prognostic unfavourable (4.02e-6)" "unprognostic (3.41e-3)" "unprognostic (3.35e-1)" "unprognostic (2.10e-1)" "unprognostic (1.25e-2)" 15.9 13.3 9.9 12.1 13.1 40.9 31.0 10.2 15.7 11.7 10.8 6.1 11.8 11.2 18.4 10.6 9.8 13.4 11.0 18.1 7.7 5.9 7.4 16.8 13.4 18.7 5.9 8.5 15.1 10.8 13.6 11.4 14.4 7.0 10.0 7.6 8.5 9.6 11.0 42.6 9.4 13.4 18.7 6.7 12.1 10.9 16.0 5.2 17.7 12.9 7.2 8.8 13.6 19.7 3.4 3.2 15.0 2.7 3.9 8.7 2.0 9.2 5.2 5.7 8.5 14.0 16.0 6.6 16.8 17.0 10.1 8.1 1.8 3.7 5.6 5.0 15.8 6.3 2.7 7.0 12.0 18.9 5.3 2.2 9.1 4.1 10.2 5.9 7.7 12.4 6.8 7.5 12.2 13.5 3.0 14.5 18.7 4.4 10.2 5.9 3.7 3.6 8.9 9.4 3.8 6.8 5.7 1.2 5.1 7.4 8.1 8.7 3.2 3.5 13.4 6.2 4.0 18.1 5.9 5.5 1.6 6.5 8.1 15.1 5.8 15.0 2.7 3.9 5.0 2.1 3.7 3.4 6.8 8.5 3.1 3.2 3.8 5.0 13.6 3.9 2.3 3.2 8.7 2.0 9.9 13.1 10.2 15.7 7.7 5.9 5.9 8.5 7.0 5.2 FAM227B "C15orf33, FLJ32800" ENSG00000166262 "Family with sequence similarity 227 member B" Q96M60 15 49326962-49620931 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA049774, HPA061695" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA049774: , HPA061695: " "unprognostic (1.19e-2)" "unprognostic (2.57e-1)" "unprognostic (1.89e-2)" "unprognostic (4.74e-3)" "unprognostic (1.17e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-4)" "unprognostic (3.32e-2)" "unprognostic (9.21e-2)" "unprognostic (6.57e-3)" "unprognostic (6.32e-3)" "unprognostic (6.41e-2)" "unprognostic (7.48e-5)" "unprognostic (2.70e-1)" "unprognostic (9.01e-2)" "unprognostic (7.47e-2)" "unprognostic (1.76e-1)" 1.9 7.6 8.0 6.4 8.4 1.8 9.1 2.4 6.7 10.5 6.5 11.6 10.6 3.8 9.0 10.5 4.8 11.0 5.3 11.5 7.8 7.2 10.9 9.7 4.9 7.6 9.8 7.1 13.9 8.6 9.0 28.4 1.8 6.6 8.1 3.9 6.7 7.2 8.7 10.8 5.2 4.0 11.3 9.5 3.7 4.5 19.0 8.1 12.1 10.1 5.2 5.6 8.6 4.0 5.5 4.7 7.8 0.9 3.3 8.2 2.6 0.9 0.9 5.9 3.2 1.9 3.5 0.7 2.5 3.4 3.7 6.1 0.8 2.8 1.7 5.8 3.9 0.9 2.1 3.5 4.4 3.9 1.7 3.7 1.5 1.8 5.0 1.6 1.6 3.7 4.7 2.2 2.3 3.4 5.8 2.8 8.1 3.8 3.4 1.4 2.6 1.5 3.0 5.0 8.8 5.5 1.1 4.5 6.2 2.3 2.9 6.8 3.5 1.3 2.4 2.6 2.1 3.4 1.4 14.1 11.4 5.3 2.9 4.4 2.7 7.8 0.3 2.4 4.9 0.7 6.4 4.0 4.9 6.4 0.5 5.5 8.2 7.8 0.6 3.3 0.9 4.7 4.2 2.6 8.0 8.4 2.4 6.7 7.8 7.2 9.8 7.1 6.6 8.1 FASTK FAST ENSG00000164896 "Fas activated serine/threonine kinase" Q14296 7 151076593-151080866 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031621, CAB032539" Approved Approved "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "CAB032539: AB_2101115, HPA031621: AB_10611966" "unprognostic (7.67e-2)" "unprognostic (6.41e-3)" "prognostic unfavourable (4.73e-4)" "unprognostic (2.60e-1)" "unprognostic (1.75e-3)" "unprognostic (2.03e-3)" "unprognostic (1.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-2)" "prognostic favourable (3.99e-4)" "unprognostic (3.49e-2)" "unprognostic (2.79e-2)" "unprognostic (4.12e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.17e-2)" 13.8 16.8 18.8 15.7 19.0 6.4 10.2 19.0 26.4 18.0 20.6 13.4 20.3 21.2 12.4 14.6 20.3 16.7 16.8 35.7 17.6 12.9 17.7 25.6 9.5 10.4 12.0 15.0 14.4 20.7 20.2 21.8 18.5 12.0 16.8 10.6 14.0 21.7 17.9 89.5 14.4 25.8 11.3 9.2 14.9 14.8 10.6 10.9 11.2 16.8 28.1 16.9 17.4 11.8 15.4 26.0 19.7 22.3 13.1 19.0 14.5 15.7 18.4 5.9 14.1 22.0 9.9 9.8 12.7 17.3 10.8 13.0 12.7 13.7 3.7 17.3 17.1 10.3 5.6 15.2 2.9 10.8 10.1 4.6 4.6 10.8 27.9 3.2 10.4 13.0 22.3 12.5 9.2 12.7 6.7 7.9 12.5 31.7 7.7 9.2 9.9 21.7 5.1 7.1 11.8 14.7 10.9 7.0 7.3 16.7 26.0 16.9 14.0 12.6 10.4 13.8 3.0 12.9 11.2 21.2 12.9 2.4 27.5 7.2 15.8 10.5 22.3 19.7 16.4 21.7 17.1 13.7 17.3 16.9 19.4 15.4 19.0 16.3 4.8 13.1 20.8 26.0 18.7 14.5 18.8 19.0 19.0 26.4 17.6 12.9 12.0 15.0 12.0 10.9 FBXO34 "Fbx34, FLJ20725" ENSG00000178974 "F-box protein 34" Q9NWN3 14 55271303-55361918 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052592 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA052592: " "unprognostic (6.19e-2)" "unprognostic (1.73e-1)" "unprognostic (5.47e-2)" "unprognostic (6.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (9.87e-3)" "unprognostic (3.07e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.20e-13)" "unprognostic (4.49e-2)" "unprognostic (3.14e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" 9.7 8.2 17.7 15.0 21.1 12.6 20.1 13.5 29.3 11.6 23.9 5.6 9.5 12.6 10.0 14.5 31.3 13.9 11.6 11.4 25.9 10.6 16.4 10.5 15.6 11.3 8.8 18.5 11.9 16.0 10.8 7.9 8.7 9.4 11.9 24.9 10.8 19.5 11.3 36.3 12.7 13.6 11.2 9.1 11.6 15.5 24.1 6.4 12.4 30.6 12.0 13.5 13.6 17.1 8.2 11.8 10.5 13.5 13.6 14.9 9.7 18.5 11.2 8.6 8.0 11.2 9.4 9.4 9.3 16.4 14.5 16.9 9.6 24.1 14.9 7.9 8.4 18.5 11.2 9.9 18.8 9.3 7.4 15.9 6.9 5.9 8.6 18.3 15.6 7.9 14.3 10.1 10.4 11.0 12.1 12.2 9.5 12.1 14.5 12.8 5.0 9.0 15.7 21.3 8.2 13.0 21.6 10.0 10.4 11.4 11.2 8.9 13.6 11.8 8.0 12.4 16.5 6.6 7.2 5.6 4.9 16.9 9.0 10.1 7.0 10.5 12.0 2.8 13.1 7.6 14.9 8.2 12.6 12.9 11.8 8.2 11.3 10.7 6.9 13.6 13.5 5.3 7.8 9.7 17.7 21.1 13.5 29.3 25.9 10.6 8.8 18.5 9.4 6.4 FCHSD2 "KIAA0769, SH3MD3" ENSG00000137478 "FCH and double SH3 domains 2" O94868 11 72836745-73142261 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038545, HPA038546" Uncertain Approved "Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites" "Nuclear speckles, Plasma membrane, Actin filaments" "Focal adhesion sites" "HPA038545: , HPA038546: AB_10673013" "unprognostic (1.80e-2)" "unprognostic (1.50e-2)" "prognostic favourable (1.71e-4)" "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.62e-3)" "unprognostic (1.41e-2)" "unprognostic (2.62e-1)" "unprognostic (1.27e-2)" "unprognostic (2.56e-1)" "unprognostic (3.69e-2)" "unprognostic (6.16e-2)" "unprognostic (2.89e-3)" "unprognostic (2.02e-1)" "unprognostic (4.70e-1)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" 18.5 15.1 28.4 41.5 27.8 19.0 26.5 16.9 25.2 13.2 11.4 17.0 6.8 7.0 12.7 10.2 9.7 11.5 18.1 19.2 24.8 21.4 10.6 13.3 26.2 31.7 19.7 12.1 26.3 9.2 10.2 7.6 24.1 17.6 11.2 11.2 12.5 11.1 11.7 7.4 7.0 14.4 16.4 15.6 30.8 10.1 17.4 26.3 19.2 11.9 4.8 33.0 17.9 11.3 16.8 19.0 11.6 4.8 1.1 2.4 2.0 5.1 4.4 9.1 11.9 3.7 9.3 8.5 9.1 19.5 5.6 4.7 3.4 7.5 27.9 11.2 11.7 7.4 5.3 5.3 7.5 9.6 2.7 22.5 5.0 11.2 9.6 11.0 2.9 5.6 5.8 5.5 6.7 13.4 4.9 18.2 7.2 5.5 13.3 18.9 2.0 5.4 20.3 14.2 53.2 8.8 6.9 4.6 6.5 3.3 6.2 11.9 4.5 8.1 17.2 18.0 6.9 12.5 2.8 17.5 9.7 24.8 3.1 18.3 5.2 11.0 4.8 10.5 1.7 3.1 1.2 13.0 1.8 2.0 4.8 16.8 2.1 2.4 11.6 1.1 1.6 19.0 1.8 2.0 28.4 27.8 16.9 20.2 24.8 21.4 19.7 12.1 17.6 26.3 FNDC1 "bA243O10.1, dJ322A24.1, FNDC2, KIAA1866" ENSG00000164694 "Fibronectin type III domain containing 1" Q4ZHG4 6 159169397-159272109 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell line enhanced" "Detected in some" "EFO-21: 2.8;fHDF/TERT166: 7.6;HEK 293: 1.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.5" "Region enriched" "Detected in single" 6 "hippocampal formation: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA030962, HPA030963" Approved Approved "Nuclear speckles" "Secreted to extracellular matrix" "Nuclear speckles" "HPA030962: AB_10696212, HPA030963: " "unprognostic (4.59e-2)" "unprognostic (9.17e-3)" "unprognostic (7.62e-2)" "prognostic favourable (6.10e-5)" "unprognostic (4.57e-1)" "unprognostic (2.11e-1)" "unprognostic (5.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "unprognostic (4.18e-2)" "unprognostic (1.74e-1)" "prognostic unfavourable (1.93e-6)" "unprognostic (6.49e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.76e-3)" 5.2 0.6 0.5 7.6 0.7 0.0 2.5 0.3 0.7 9.7 12.9 3.2 0.0 2.1 4.8 2.2 2.2 0.9 13.1 3.5 4.8 0.5 1.0 1.5 1.2 2.1 0.7 0.0 4.8 1.2 0.0 0.4 0.7 0.5 0.7 1.6 1.0 2.5 0.6 6.2 1.2 7.0 10.2 1.5 0.7 0.7 2.1 0.1 1.0 36.6 11.8 3.6 1.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.1 2.8 7.6 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.2 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.7 4.8 0.5 0.7 0.0 0.5 0.1 FOXJ3 KIAA1041 ENSG00000198815 "Forkhead box J3" Q9UPW0 1 42176539-42335877 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067284 Approved "Nucleoplasm,Nuclear speckles,Vesicles" "Nucleoplasm, Nuclear speckles" Vesicles "HPA067284: " "unprognostic (5.60e-2)" "unprognostic (2.26e-2)" "unprognostic (4.24e-2)" "unprognostic (5.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.56e-2)" "prognostic unfavourable (5.17e-6)" "unprognostic (3.65e-3)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "prognostic unfavourable (4.51e-7)" "unprognostic (2.10e-1)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (5.43e-2)" 24.8 15.1 21.2 20.1 31.3 31.6 25.6 38.2 30.9 22.3 18.4 22.9 15.4 18.8 24.9 18.9 17.4 19.8 16.2 23.5 21.5 20.2 16.8 17.6 20.4 19.6 22.9 19.2 29.5 22.6 31.6 28.7 33.5 21.2 21.7 22.5 18.4 19.0 23.7 44.3 24.3 20.0 22.0 20.7 19.6 20.8 19.0 22.6 29.0 23.7 15.2 22.2 22.8 21.4 12.3 9.7 10.9 9.4 11.6 13.1 4.3 13.6 11.5 12.7 13.2 13.7 17.0 18.4 10.4 15.4 14.0 15.6 10.6 16.4 21.0 11.1 14.5 13.1 17.7 17.1 23.8 15.7 10.0 23.1 14.7 9.0 11.9 21.2 15.9 12.6 17.0 20.9 26.0 15.2 13.9 15.3 16.7 7.8 21.4 12.2 19.8 10.6 20.1 33.4 14.3 11.9 19.9 17.7 16.7 18.7 21.7 18.8 10.9 31.7 14.1 14.7 19.7 14.8 17.1 15.1 18.6 17.2 13.2 17.7 11.7 6.0 5.7 6.1 9.0 4.8 10.9 8.0 11.0 9.5 4.6 12.3 11.8 13.1 10.9 11.6 9.4 9.7 7.0 4.3 21.2 31.3 38.2 30.9 21.5 20.2 22.9 19.2 21.2 22.6 GAS1 ENSG00000180447 "Growth arrest specific 1" P54826 9 86944363-86947189 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Growth arrest" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 61.8" "Cell line enhanced" "Detected in many" "AN3-CA: 19.3;ASC diff: 13.3;BJ hTERT+: 26.2;HSkMC: 18.7;RH-30: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB024164, HPA036085, HPA066902" Approved Approved "Nuclear speckles" "Nuclear speckles" "CAB024164: AB_2107950, HPA036085: , HPA066902: " "unprognostic (2.78e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (1.55e-4)" "unprognostic (1.97e-2)" "unprognostic (6.15e-2)" "unprognostic (2.84e-2)" "unprognostic (6.46e-2)" "unprognostic (6.91e-2)" "unprognostic (3.32e-1)" "unprognostic (1.28e-3)" "unprognostic (2.25e-3)" "unprognostic (4.30e-2)" "prognostic unfavourable (1.96e-5)" "prognostic unfavourable (8.26e-4)" "unprognostic (6.73e-2)" "prognostic unfavourable (1.13e-5)" "unprognostic (3.59e-2)" 26.5 2.9 0.9 8.3 1.1 0.0 14.0 1.3 1.3 26.4 9.1 2.1 15.0 0.9 61.8 37.1 10.0 20.9 11.8 9.9 1.0 0.5 4.5 0.8 4.1 5.7 1.8 0.8 31.5 4.3 0.8 3.2 50.1 2.0 18.1 1.0 8.7 4.8 8.9 8.1 10.1 3.4 24.5 0.9 1.2 6.3 18.9 0.5 3.6 6.0 3.8 1.6 11.3 15.6 0.0 0.8 0.0 0.0 0.1 0.6 0.0 0.0 0.0 3.3 19.3 13.3 5.0 0.3 3.6 26.2 1.3 1.1 0.0 0.0 0.0 0.2 6.7 0.2 0.0 0.1 0.5 2.1 7.4 0.0 10.8 0.0 6.7 0.0 0.3 18.7 2.8 0.4 2.3 0.0 0.0 0.0 5.5 0.0 0.0 0.1 4.0 0.0 3.8 39.9 0.0 0.2 0.0 0.4 1.7 5.4 0.0 5.7 0.0 0.1 0.0 5.6 1.6 0.4 1.2 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.9 1.1 1.3 1.2 1.0 0.5 1.8 0.8 2.0 0.5 GNAQ "G-ALPHA-q, GAQ" ENSG00000156052 "G protein subunit alpha q" P50148 9 77716087-78031458 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Transducer "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 18.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010036, HPA048886" Uncertain Approved "Nuclear speckles,Plasma membrane,Cytosol" 28000000 "Nuclear speckles" "Plasma membrane, Cytosol" "CAB010036: AB_631536, HPA048886: " "unprognostic (2.10e-1)" "unprognostic (8.53e-2)" "unprognostic (1.45e-1)" "unprognostic (4.37e-2)" "unprognostic (1.87e-1)" "unprognostic (6.83e-3)" "unprognostic (1.05e-1)" "unprognostic (3.84e-2)" "unprognostic (2.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-1)" "prognostic favourable (1.11e-7)" "unprognostic (1.90e-1)" "unprognostic (3.13e-1)" "unprognostic (1.05e-1)" "unprognostic (2.01e-1)" 12.7 12.6 24.3 9.9 20.8 21.8 11.6 12.5 29.6 13.1 16.6 17.1 9.1 7.9 13.7 11.2 13.1 10.0 11.6 5.6 24.2 18.3 12.1 12.3 23.1 11.8 19.1 14.6 13.5 8.5 12.7 7.6 12.1 14.3 13.0 16.0 10.4 9.8 15.9 5.9 5.1 9.0 18.2 23.9 5.8 15.5 6.0 14.8 18.6 13.3 4.0 4.8 14.5 13.1 0.8 2.8 18.4 3.5 3.3 2.0 1.2 12.1 13.9 12.3 13.5 15.6 16.0 17.8 16.5 12.5 7.3 8.8 4.2 10.0 0.0 13.4 15.1 20.0 9.1 10.0 9.1 0.4 5.3 33.3 12.1 8.5 14.1 20.3 12.5 10.9 12.3 14.1 14.4 17.8 5.8 0.1 12.8 15.4 23.4 12.9 10.0 2.0 8.7 15.1 0.1 16.5 26.1 13.8 21.1 11.9 10.1 12.4 9.1 7.6 22.3 12.8 0.8 17.4 9.6 0.1 0.0 0.1 8.8 12.0 13.2 18.4 2.2 4.6 0.8 1.9 1.6 0.8 1.8 1.0 2.4 0.8 2.0 1.6 7.7 3.3 3.5 2.8 1.9 1.2 24.3 20.8 12.5 24.0 24.2 18.3 19.1 14.6 14.3 14.8 GNB5 GB5 ENSG00000069966 "G protein subunit beta 5" O14775 15 52115105-52191369 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032353, HPA041942, HPA044198" Uncertain Approved "Nuclear speckles,Centrosome,Rods & Rings" 11000 "Nuclear speckles" "Centrosome, Rods & Rings" "CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: " "unprognostic (2.38e-2)" "unprognostic (3.58e-1)" "unprognostic (1.97e-3)" "prognostic favourable (1.47e-6)" "unprognostic (6.15e-2)" "unprognostic (1.37e-2)" "unprognostic (2.57e-2)" "unprognostic (2.63e-2)" "unprognostic (1.54e-1)" "unprognostic (2.44e-1)" "unprognostic (1.67e-3)" "unprognostic (2.10e-1)" "prognostic favourable (3.32e-11)" "unprognostic (1.40e-3)" "unprognostic (8.12e-3)" "unprognostic (3.55e-3)" "unprognostic (1.52e-1)" 6.2 11.2 17.7 8.2 25.6 3.7 8.9 42.5 30.7 15.2 9.2 4.0 9.6 4.6 21.2 13.4 9.0 20.4 15.4 17.3 13.0 18.6 26.9 10.3 5.8 14.7 13.6 21.9 38.1 13.7 35.5 14.7 4.4 21.3 12.9 4.5 20.4 6.5 20.3 1.7 4.8 7.0 13.3 5.9 8.3 7.5 11.7 9.2 7.0 16.2 1.9 14.1 14.6 14.0 21.6 9.9 3.6 1.9 10.8 19.7 9.3 8.0 20.8 5.8 10.2 9.9 12.4 5.6 15.8 15.4 14.1 15.4 5.8 6.1 14.1 5.0 12.9 11.9 10.2 15.0 10.7 10.9 7.7 9.4 28.1 6.7 11.8 4.7 34.1 11.4 12.7 11.3 4.2 8.8 0.7 13.3 15.4 14.4 7.4 13.4 5.3 9.2 10.0 20.1 17.1 10.0 24.7 9.3 8.1 15.1 1.4 12.3 4.9 14.7 21.6 12.7 13.9 14.4 15.9 8.5 16.3 15.4 26.7 11.5 20.4 3.6 1.9 0.2 10.7 1.7 8.9 21.0 14.0 12.8 4.8 21.6 13.2 11.3 1.0 10.8 1.4 9.9 19.7 9.3 17.7 25.6 42.5 30.7 13.0 18.6 13.6 21.9 21.3 9.2 GPATCH8 "GPATC8, KIAA0553" ENSG00000186566 "G-patch domain containing 8" Q9UKJ3 17 44395284-44503430 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044380 Approved Approved "Nuclear speckles,Mitochondria" "Nuclear speckles" Mitochondria "HPA044380: AB_10965696" "unprognostic (3.37e-1)" "unprognostic (5.90e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (6.07e-3)" "unprognostic (2.13e-2)" "unprognostic (5.86e-3)" "unprognostic (2.25e-1)" "unprognostic (1.38e-1)" "unprognostic (6.84e-3)" "unprognostic (8.47e-2)" "unprognostic (6.99e-2)" "unprognostic (2.04e-2)" "unprognostic (1.50e-1)" "unprognostic (9.91e-2)" "unprognostic (7.58e-2)" "unprognostic (2.49e-1)" 8.6 8.5 7.1 12.0 9.3 11.9 7.7 22.2 11.7 8.3 6.5 9.9 6.4 6.9 10.2 4.7 8.5 7.4 6.7 8.1 7.8 5.6 6.4 4.8 7.5 10.0 8.7 6.8 11.2 7.7 14.7 18.1 11.0 9.0 7.1 7.5 9.2 9.1 5.8 21.0 8.3 8.6 8.0 8.3 9.3 6.5 7.6 10.1 9.6 7.7 3.8 9.5 11.6 12.8 10.1 9.6 10.3 16.0 12.4 13.2 6.1 10.2 7.3 8.8 8.5 5.7 7.8 8.7 8.5 10.1 10.6 11.2 10.2 6.9 12.9 5.0 10.5 6.8 11.8 8.0 13.0 15.2 7.6 15.2 6.9 5.6 4.1 12.5 10.3 8.0 4.4 11.1 10.5 8.6 10.4 11.0 6.3 3.2 16.0 1.1 5.9 7.3 14.3 11.4 9.1 1.4 7.5 8.2 6.4 9.9 4.3 5.8 6.1 6.9 6.9 6.6 6.0 9.8 10.0 11.3 10.0 14.0 7.3 4.9 6.6 10.3 8.2 6.7 13.2 7.9 12.4 10.1 10.4 9.4 7.9 9.7 9.7 9.7 6.4 12.4 16.0 9.6 5.2 6.1 7.1 9.3 22.2 11.7 7.8 5.6 8.7 6.8 9.0 10.1 GPN3 "ATPBD1C, MGC14560" ENSG00000111231 "GPN-loop GTPase 3" Q9UHW5 12 110452484-110469268 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039764, HPA047793" Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA039764: , HPA047793: " "unprognostic (1.68e-3)" "unprognostic (1.11e-2)" "unprognostic (9.82e-2)" "unprognostic (4.96e-2)" "unprognostic (2.09e-1)" "unprognostic (3.27e-3)" "prognostic unfavourable (3.98e-5)" "unprognostic (5.50e-2)" "unprognostic (4.45e-2)" "unprognostic (2.70e-1)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" "prognostic favourable (2.65e-6)" "unprognostic (5.81e-2)" "unprognostic (2.85e-1)" "unprognostic (1.62e-1)" "unprognostic (2.27e-1)" 17.8 15.1 14.1 11.2 17.3 9.6 26.7 18.4 14.2 13.0 12.5 11.9 10.1 5.9 14.9 11.8 15.6 15.1 10.2 24.8 11.4 10.9 23.3 23.2 13.6 14.8 26.6 11.4 19.4 14.5 19.6 12.2 15.4 18.6 17.0 10.0 11.0 16.6 14.3 35.1 9.6 8.7 17.5 20.0 16.0 13.6 28.3 19.4 11.8 20.1 22.0 12.6 16.5 13.1 20.2 28.0 34.4 31.4 11.8 18.9 16.8 15.2 23.5 16.4 16.0 18.4 11.7 21.7 20.9 12.7 23.6 19.2 21.9 9.1 29.3 14.6 11.4 14.0 20.2 18.8 32.2 16.7 18.8 17.3 12.7 18.0 12.8 27.0 16.0 12.4 11.9 23.1 15.0 17.0 29.1 6.7 16.5 10.3 24.7 51.5 20.0 24.1 8.5 22.6 22.4 14.8 13.7 12.6 13.0 21.4 14.6 17.7 24.9 31.9 9.3 19.7 14.5 19.1 24.1 9.2 23.8 30.5 14.5 25.0 22.4 15.3 24.5 34.4 14.0 31.4 15.5 20.2 15.0 15.8 22.6 19.9 18.9 12.6 12.6 11.8 31.1 28.0 12.3 16.8 14.1 17.3 18.4 14.2 11.4 10.9 26.6 11.4 18.6 19.4 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159807-72197785 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 24.6;placenta: 49.2" "Group enriched" "Detected in some" 12 "BEWO: 58.1;SK-BR-3: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "myeloid DC: 2.3" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.3" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavourable (7.01e-4)" "unprognostic (7.29e-2)" 0.1 0.0 2.0 0.2 4.5 0.0 6.8 1.1 1.0 3.1 0.7 1.2 9.8 0.6 0.4 24.6 1.0 8.2 0.8 0.1 2.9 6.5 1.9 0.1 9.7 0.2 1.1 0.1 1.1 1.0 0.2 0.9 49.2 3.9 1.2 0.5 1.0 1.8 4.0 0.3 1.5 3.6 0.1 1.0 0.1 0.4 0.7 0.9 0.2 7.7 1.3 1.1 0.3 0.6 0.0 2.3 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 26.5 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.5 1.1 1.0 2.9 6.5 1.1 0.1 3.9 0.9 GTF2H2C ENSG00000183474 "GTF2H2 family member C" Q6P1K8 5 69560208-69594723 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA047001 Approved "Nuclear speckles" "Nuclear speckles" "HPA047001: " "unprognostic (3.70e-1)" "unprognostic (3.46e-2)" "unprognostic (2.11e-2)" "unprognostic (1.95e-1)" "unprognostic (5.97e-2)" "unprognostic (4.33e-2)" "unprognostic (8.59e-3)" "unprognostic (5.34e-2)" "unprognostic (7.12e-2)" "unprognostic (6.03e-2)" "unprognostic (6.08e-2)" "unprognostic (1.56e-1)" "unprognostic (1.86e-1)" "unprognostic (7.52e-2)" "unprognostic (2.68e-1)" "unprognostic (2.40e-3)" "unprognostic (2.55e-1)" 3.0 3.4 2.3 6.8 2.3 2.0 3.4 2.8 3.2 4.1 2.9 1.1 4.8 1.2 2.6 4.1 1.9 3.2 2.5 2.5 5.0 5.5 4.0 5.9 2.5 7.2 5.4 6.1 3.0 1.9 3.9 3.6 3.6 4.1 3.0 2.4 3.8 7.7 2.7 3.8 3.5 4.2 8.4 1.1 3.3 3.2 4.5 3.2 8.2 2.9 3.4 4.6 3.0 4.4 2.4 2.9 3.4 1.4 2.0 7.3 10.3 5.0 7.7 9.4 3.8 3.2 8.6 16.0 1.9 1.7 4.0 2.5 13.0 11.3 4.0 13.6 1.6 2.9 1.8 7.8 4.0 1.5 0.8 2.9 1.9 2.7 8.8 5.6 0.3 6.5 8.0 0.5 4.1 1.5 2.9 9.3 13.3 12.0 5.3 2.9 7.6 14.1 1.8 1.7 3.6 7.0 6.2 6.2 5.2 3.1 15.3 2.9 20.8 6.9 3.4 7.9 13.2 6.0 2.9 3.5 2.4 2.9 3.4 3.2 1.9 3.6 3.2 4.5 2.7 4.6 8.2 3.4 2.1 2.6 3.3 3.0 HAS2 ENSG00000170961 "Hyaluronan synthase 2" Q92819 8 121612116-121641390 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 22.8" "Group enriched" "Detected in some" 4 "HBF TERT88: 33.9;hTEC/SVTERT24-B: 32.6;LHCN-M2: 43.3;U-138 MG: 85.2;U-251 MG: 25.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052060 Approved "Nuclear speckles" "Nuclear speckles" "HPA052060: " "unprognostic (7.01e-2)" "unprognostic (1.34e-2)" "unprognostic (4.07e-2)" "unprognostic (4.65e-2)" "unprognostic (1.17e-1)" "unprognostic (2.91e-2)" "unprognostic (5.33e-2)" "unprognostic (2.57e-3)" "unprognostic (3.44e-2)" "unprognostic (1.34e-1)" "unprognostic (8.19e-3)" "unprognostic (1.24e-1)" "unprognostic (1.66e-7)" "unprognostic (1.47e-3)" "unprognostic (3.67e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-3)" 22.8 0.9 1.6 9.1 2.4 0.0 5.5 0.8 1.7 4.0 8.5 2.0 0.0 2.6 1.5 2.5 4.8 3.9 7.7 8.3 1.7 1.7 1.2 2.7 6.5 4.5 1.8 0.6 1.2 1.8 0.3 0.7 2.1 5.7 4.3 5.6 2.7 1.9 0.1 2.7 3.8 9.5 3.7 4.2 0.3 2.3 3.2 2.6 0.4 1.7 5.5 2.1 5.7 1.4 0.0 0.2 0.7 0.2 0.3 0.1 0.0 0.0 0.5 0.0 0.0 1.0 2.5 0.0 4.8 3.6 6.3 11.0 0.0 0.0 0.0 0.0 4.3 0.8 0.0 0.0 33.9 0.0 0.1 0.0 0.1 0.0 4.3 0.0 0.0 6.7 0.0 32.6 3.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.7 0.0 5.6 0.0 0.0 0.4 0.0 0.1 2.0 0.0 1.1 0.0 0.0 0.0 85.2 0.3 7.9 25.2 0.0 0.0 0.0 1.8 0.0 1.7 0.5 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.7 0.3 0.2 0.2 0.1 0.0 1.6 2.4 0.8 1.7 1.7 1.7 1.8 0.6 5.7 2.6 HAUS6 "dgt6, FAM29A, FLJ20060, KIAA1574" ENSG00000147874 "HAUS augmin like complex subunit 6" Q7Z4H7 9 19053143-19103119 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020960, HPA020965" Approved Supported "Nuclear speckles,Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "Nuclear speckles" "HPA020960: AB_1848393, HPA020965: AB_1848394" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (6.04e-3)" "unprognostic (6.51e-3)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (3.84e-4)" "unprognostic (1.21e-1)" "unprognostic (2.15e-1)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (1.48e-2)" "prognostic unfavourable (3.13e-5)" "unprognostic (2.52e-1)" "unprognostic (1.68e-1)" "unprognostic (3.13e-2)" "unprognostic (2.03e-1)" 8.7 9.6 10.9 9.2 13.1 17.5 11.1 10.8 10.3 7.7 7.0 9.9 5.6 4.9 8.9 8.0 7.0 7.4 6.4 7.1 10.5 7.3 5.2 11.0 7.1 12.8 15.0 8.9 11.1 6.3 5.8 8.5 8.4 12.4 7.6 7.9 5.6 7.1 7.4 7.2 9.8 7.2 8.9 13.5 10.0 5.8 27.1 13.6 27.3 6.6 3.8 12.7 7.0 7.1 3.6 2.6 10.9 2.2 7.2 6.1 2.5 10.8 7.4 15.3 11.9 5.9 7.1 8.3 11.7 8.3 10.8 16.7 3.8 5.0 12.7 4.3 6.7 4.5 14.0 6.8 16.8 11.6 6.7 67.7 13.5 8.7 3.9 8.9 15.5 4.4 7.1 10.2 22.3 7.8 9.2 8.4 12.4 3.5 17.4 15.2 16.3 7.5 13.6 10.4 5.2 5.8 6.3 8.9 12.3 5.2 4.8 7.4 3.8 11.3 7.7 9.7 5.9 8.3 13.4 3.3 7.3 12.6 9.1 7.6 4.2 10.9 2.2 2.2 4.5 2.2 6.1 3.5 4.3 5.6 2.2 3.6 5.2 4.6 3.5 7.2 2.0 2.6 5.4 2.5 10.9 13.1 10.8 10.3 10.5 7.3 15.0 8.9 12.4 13.6 HELQ Hel308 ENSG00000163312 "Helicase, POLQ like" Q8TDG4 4 83407343-83455856 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036852, HPA036853" Approved Approved "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA036852: , HPA036853: AB_10672102" "unprognostic (4.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.12e-2)" "unprognostic (1.12e-1)" "unprognostic (4.80e-2)" "unprognostic (5.56e-2)" "unprognostic (1.14e-1)" "unprognostic (5.13e-3)" "unprognostic (7.14e-2)" "unprognostic (8.62e-2)" "prognostic favourable (9.07e-4)" "unprognostic (2.03e-1)" "prognostic favourable (2.76e-4)" "unprognostic (3.54e-2)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.37e-1)" 10.5 20.8 6.3 12.2 7.8 7.2 10.4 12.6 9.2 10.7 9.8 9.3 8.2 5.6 9.9 8.7 8.2 9.1 9.0 10.5 6.2 5.7 11.9 10.0 8.0 15.3 6.8 5.7 17.4 8.1 13.3 20.7 11.7 9.0 11.4 7.2 11.0 10.0 10.4 14.6 8.7 9.8 8.0 8.4 14.4 8.4 10.7 7.4 18.5 14.3 8.3 13.4 10.2 9.2 10.1 4.6 6.8 4.7 5.5 9.7 2.9 4.2 3.2 7.0 4.5 8.5 9.0 3.6 6.3 9.5 8.3 8.2 3.1 4.4 11.9 5.1 5.5 4.3 8.4 4.7 8.7 6.9 3.7 7.1 5.3 4.1 5.5 8.6 17.6 7.0 6.3 6.6 6.8 6.6 9.3 10.5 8.4 5.0 7.8 6.2 3.6 2.4 6.1 8.0 4.2 6.8 2.7 5.7 4.7 6.2 6.8 6.9 4.2 9.3 5.0 6.2 5.5 8.0 4.9 9.6 4.1 10.1 5.2 6.5 6.9 5.4 3.7 6.8 5.7 4.0 5.4 5.8 6.3 6.4 4.6 10.1 9.7 8.7 2.3 5.5 4.7 4.5 7.8 2.9 6.3 7.8 12.6 9.2 6.2 5.7 6.8 5.7 9.0 7.4 HES5 bHLHb38 ENSG00000197921 "Hes family bHLH transcription factor 5" Q5TA89 1 2528745-2530245 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.7" "Cell line enhanced" "Detected in some" "AF22: 2.6;HaCaT: 5.0;HAP1: 1.1;SCLC-21H: 1.0" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065458, HPA076164" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" Nucleoplasm "Nuclear speckles, Cytosol" "HPA065458: , HPA076164: " "unprognostic (2.04e-3)" "unprognostic (2.83e-2)" "unprognostic (4.26e-2)" "unprognostic (2.75e-3)" "unprognostic (5.26e-3)" "unprognostic (1.60e-4)" "unprognostic (1.76e-4)" "unprognostic (1.60e-1)" "unprognostic (5.30e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (4.67e-1)" "unprognostic (9.95e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (3.89e-2)" "unprognostic (1.72e-1)" 1.1 0.9 11.1 1.1 12.7 1.4 2.8 3.5 16.7 1.0 1.9 1.2 0.4 1.2 1.9 2.7 1.6 1.1 1.2 2.3 9.7 11.2 1.0 1.0 1.4 1.1 4.1 15.8 1.0 0.9 1.0 2.4 2.2 1.6 1.3 1.4 6.3 1.2 1.1 1.6 6.2 1.2 0.9 0.9 1.0 1.2 2.0 1.9 0.0 1.1 1.9 1.4 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 12.7 3.5 16.7 9.7 11.2 4.1 15.8 1.6 1.9 HIKESHI "C11orf73, HSPC138, HSPC179, OPI10" ENSG00000149196 "Hikeshi, heat shock protein nuclear import factor" Q53FT3 11 86302211-86345931 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012708, HPA035063, HPA035064" Approved Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA012708: , HPA035063: AB_10601143, HPA035064: " "unprognostic (1.10e-3)" "unprognostic (5.09e-2)" "unprognostic (1.92e-1)" "unprognostic (2.40e-2)" "unprognostic (1.50e-1)" "unprognostic (2.18e-1)" "prognostic unfavourable (8.81e-4)" "unprognostic (9.92e-2)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (8.24e-2)" "unprognostic (3.19e-2)" "prognostic unfavourable (4.01e-12)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.33e-3)" "unprognostic (1.71e-1)" 23.4 24.1 25.7 16.0 23.3 15.5 31.1 19.1 24.0 21.1 23.5 20.1 14.5 10.2 27.4 24.9 24.6 18.2 15.5 36.1 23.9 23.8 11.7 20.0 16.9 22.0 30.2 18.9 26.2 22.6 18.7 32.0 26.6 25.9 18.1 19.2 15.7 15.4 29.2 46.9 20.2 13.0 30.0 25.1 18.1 15.9 15.3 26.6 23.8 20.8 23.6 28.1 21.6 24.0 30.0 33.3 20.6 26.7 25.9 39.5 20.7 9.8 10.6 26.0 14.3 22.0 27.5 13.7 15.2 18.4 15.9 19.0 31.6 27.4 10.0 35.1 20.0 21.1 19.2 33.4 17.0 21.3 16.9 16.1 17.6 23.4 29.7 19.7 13.2 19.3 34.0 19.0 22.6 30.4 17.3 23.0 32.4 26.8 23.5 46.9 21.2 7.2 18.1 12.8 22.4 27.2 18.6 16.1 13.9 18.9 14.2 10.3 22.7 13.3 15.4 18.9 13.3 37.8 11.2 9.9 22.4 19.3 9.6 18.7 18.5 19.6 26.7 20.6 25.2 24.7 27.7 30.0 30.9 27.3 33.3 24.9 27.2 27.6 5.5 25.9 24.3 25.9 39.5 20.7 25.7 23.3 19.1 24.0 23.9 23.8 30.2 18.9 25.9 26.6 HS6ST1 HS6ST ENSG00000136720 "Heparan sulfate 6-O-sulfotransferase 1" O60243 2 128236716-128318577 "Disease related genes, Predicted intracellular proteins" Transferase "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 38.8;HMC-1: 61.6;SCLC-21H: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044586, HPA075890" Approved "Nucleoplasm,Nuclear speckles" "Intracellular and membrane" 27000 Nucleoplasm "Nuclear speckles" "HPA044586: AB_10963057, HPA075890: " "unprognostic (9.94e-2)" "unprognostic (8.93e-3)" "unprognostic (4.94e-3)" "unprognostic (6.69e-3)" "unprognostic (1.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" "unprognostic (1.21e-2)" "unprognostic (2.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" 13.2 32.0 22.4 8.0 16.2 4.1 9.2 17.2 33.2 16.2 9.6 13.5 23.8 8.3 8.8 6.4 19.3 17.1 20.1 8.1 17.3 13.9 22.8 29.5 9.1 7.1 17.8 18.8 16.2 24.2 8.9 7.5 11.5 16.5 13.1 6.9 10.5 12.2 23.9 20.1 14.2 11.3 6.4 14.9 18.2 6.3 14.7 15.6 10.9 7.0 6.7 8.0 19.1 11.1 2.0 5.5 5.8 3.0 0.5 2.6 1.2 3.5 5.1 13.7 7.8 5.3 10.0 7.4 4.3 5.6 4.4 2.4 2.6 2.3 3.4 38.8 5.6 9.4 5.2 8.5 1.6 5.6 5.3 3.0 1.9 25.1 6.5 5.2 61.6 13.5 10.1 3.5 1.1 2.3 1.9 3.6 1.6 7.4 13.8 23.0 16.3 3.1 4.5 3.7 17.7 4.0 10.6 33.8 8.4 3.5 8.9 1.9 3.6 2.0 2.8 3.9 8.7 14.5 3.5 2.1 2.0 0.7 2.4 3.7 2.8 5.8 1.6 1.4 2.6 1.0 0.4 1.9 1.0 1.6 1.1 2.0 1.0 1.0 0.5 0.5 3.0 5.5 0.5 1.2 22.4 16.2 17.2 33.2 17.3 13.9 17.8 18.8 16.5 15.6 HTR7 5-HT7 ENSG00000148680 "5-hydroxytryptamine receptor 7" P34969 10 90740823-90857698 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 30.8;testis: 14.3" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.1;hTCEpi: 7.3;hTERT-HME1: 24.5;LHCN-M2: 9.8;U-87 MG: 7.5;WM-115: 9.3" "Group enriched" "Detected in some" 5 "cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "myeloid DC: 4.6" "Lineage enriched" "Detected in single" 12 "dendritic cells: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022708, HPA073617" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" "Plasma membrane" "Nuclear speckles, Cytosol" "CAB022708: , HPA073617: " "unprognostic (1.17e-1)" "unprognostic (1.24e-2)" "unprognostic (4.72e-2)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (1.71e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (1.15e-1)" "unprognostic (4.58e-3)" "unprognostic (3.32e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-1)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" 1.0 0.5 2.4 1.1 2.5 0.5 0.7 0.3 4.3 0.6 0.8 1.7 1.2 0.8 0.4 0.3 1.0 0.4 1.3 0.6 9.9 5.1 0.3 0.6 0.5 0.7 1.7 1.8 0.4 1.4 30.8 0.2 0.5 3.1 1.0 1.2 0.4 0.6 0.3 1.7 0.9 2.2 3.6 1.5 1.3 1.5 14.3 1.0 0.0 0.3 0.1 0.6 3.5 2.1 0.0 4.6 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.2 0.5 0.7 0.0 0.9 0.0 0.0 0.1 3.3 0.9 8.1 2.0 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.4 5.8 7.3 2.4 24.5 0.0 0.0 0.0 9.8 0.0 0.0 0.1 0.9 1.2 0.7 0.1 0.0 0.0 0.9 0.3 0.0 0.3 0.0 3.8 0.0 0.2 0.2 4.5 0.0 0.0 6.8 0.0 0.0 0.0 7.5 0.0 9.3 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 4.6 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.1 0.1 2.4 2.5 0.3 4.3 9.9 5.1 1.7 1.8 3.1 1.0 IFT57 "ESRRBL1, FLJ10147, HIPPI, MHS4R2" ENSG00000114446 "Intraflagellar transport 57" Q9NWB7 3 108160812-108222570 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" DNA-binding Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 22.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035514, HPA035515" Supported Approved "Nuclear speckles,Mitochondria,Cytosol" "Nuclear speckles" "Mitochondria, Cytosol" "HPA035514: AB_10601757, HPA035515: AB_10696505" "unprognostic (1.35e-2)" "unprognostic (1.37e-2)" "prognostic favourable (6.96e-5)" "unprognostic (2.98e-2)" "unprognostic (5.46e-3)" "unprognostic (1.02e-2)" "unprognostic (3.79e-2)" "unprognostic (3.61e-3)" "unprognostic (3.59e-2)" "prognostic favourable (7.63e-4)" "unprognostic (5.04e-2)" "unprognostic (2.78e-1)" "unprognostic (1.68e-3)" "unprognostic (1.86e-1)" "unprognostic (4.70e-2)" "unprognostic (8.67e-3)" "unprognostic (6.12e-2)" 8.5 13.1 9.4 12.1 11.0 8.8 10.4 5.5 16.4 13.3 10.9 6.3 15.7 5.0 11.8 36.3 11.6 24.8 11.6 12.1 9.2 11.2 19.7 3.7 34.3 12.2 9.1 9.9 21.6 13.4 16.4 30.6 6.2 13.5 21.9 11.6 9.4 8.2 16.0 5.7 7.1 9.4 13.1 6.2 14.3 10.0 38.6 5.6 8.3 31.3 7.4 12.2 14.1 9.1 22.4 5.8 1.8 6.7 3.6 4.7 2.9 18.6 9.7 7.0 12.5 14.7 15.2 3.9 5.7 14.0 8.5 7.6 6.6 3.3 21.1 7.4 9.5 7.5 6.2 9.5 14.5 3.3 6.7 7.2 4.3 1.7 11.0 14.9 16.7 9.2 8.9 10.9 19.0 9.5 3.3 3.8 9.6 10.4 4.9 13.7 7.5 11.5 3.2 6.3 3.6 17.4 6.8 11.6 8.1 8.6 2.8 5.2 6.1 4.6 4.0 10.9 5.6 5.7 6.7 4.5 3.2 11.1 15.8 1.5 4.0 0.1 2.1 1.8 2.2 3.6 3.6 22.4 4.7 2.8 5.8 18.6 4.1 2.3 1.1 3.6 6.7 1.2 2.9 2.9 9.4 11.0 5.5 16.4 9.2 11.2 9.1 9.9 13.5 5.6 IPCEF1 "KIAA0403, PIP3-E" ENSG00000074706 "Interaction protein for cytohesin exchange factors 1" Q8WWN9 6 154154496-154356792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9" "Group enriched" "Detected in some" 5 "HMC-1: 19.3;THP-1: 9.8;U-937: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA028708, HPA028710" Enhanced Approved "Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies" "Nuclear speckles, Plasma membrane" "Nucleoli, Cytoplasmic bodies" "HPA028708: AB_10601916, HPA028710: " "unprognostic (1.23e-2)" "unprognostic (8.93e-3)" "unprognostic (4.18e-2)" "unprognostic (5.63e-3)" "unprognostic (2.05e-1)" "unprognostic (6.55e-3)" "unprognostic (1.30e-3)" "unprognostic (2.57e-2)" "unprognostic (3.87e-1)" "unprognostic (5.84e-2)" "unprognostic (3.27e-2)" "unprognostic (4.87e-2)" "unprognostic (5.01e-2)" "unprognostic (8.64e-2)" "unprognostic (5.45e-2)" "unprognostic (1.42e-2)" "unprognostic (1.51e-4)" 1.3 0.7 5.3 6.9 12.9 15.2 1.9 20.0 26.4 3.4 1.6 5.5 0.0 1.1 1.7 1.8 1.9 2.5 3.2 1.0 3.8 4.6 3.4 2.4 2.0 12.4 3.9 14.1 1.3 1.4 0.4 1.3 2.0 5.5 1.3 1.6 0.0 1.4 0.8 0.7 1.2 2.9 1.3 4.2 6.4 2.6 1.5 4.9 10.0 36.9 0.0 11.7 2.4 1.1 0.0 7.1 30.1 6.3 6.0 13.5 5.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 19.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 1.0 0.4 0.2 0.2 0.5 0.9 2.1 0.3 0.3 0.0 0.1 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.2 0.0 1.4 6.3 30.1 6.1 2.8 13.1 0.0 7.7 5.8 7.1 0.0 13.5 7.9 19.3 6.0 3.4 0.2 9.9 5.3 5.3 12.9 20.0 26.4 3.8 4.6 3.9 14.1 5.5 4.9 IQCK "FLJ36575, MGC35048" ENSG00000174628 "IQ motif containing K" Q8N0W5 16 19716456-19858467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026792, HPA048786" Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA026792: AB_1853889, HPA048786: " "unprognostic (4.21e-2)" "unprognostic (3.19e-1)" "unprognostic (6.29e-3)" "unprognostic (2.04e-2)" "unprognostic (3.70e-1)" "unprognostic (4.07e-2)" "unprognostic (1.69e-1)" "unprognostic (8.51e-2)" "unprognostic (1.58e-1)" "unprognostic (9.68e-3)" "unprognostic (1.17e-1)" "unprognostic (5.13e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" 5.5 4.8 9.3 2.8 11.4 1.1 7.8 3.7 7.1 10.1 3.7 13.9 19.4 5.1 6.3 19.9 2.5 25.2 7.5 4.8 10.4 11.2 11.2 3.0 5.3 2.3 8.3 8.9 8.9 5.7 20.7 14.6 4.4 12.1 5.4 4.2 9.3 8.2 22.4 4.0 3.3 2.7 5.3 8.5 2.6 5.1 27.2 7.9 1.1 21.0 3.2 1.9 5.7 3.5 1.5 1.0 0.0 3.8 0.1 3.0 1.0 2.5 7.1 9.0 6.0 2.7 8.9 0.5 0.0 4.5 4.3 3.3 0.4 4.9 0.3 5.0 2.5 3.0 2.0 3.4 2.9 1.1 1.9 0.1 1.8 3.4 8.9 1.6 0.1 5.0 3.0 5.4 1.3 4.5 2.7 0.8 2.6 8.6 1.6 1.0 2.7 6.6 5.3 0.7 0.4 10.6 1.8 8.3 3.6 3.6 1.2 5.5 3.6 0.9 3.1 0.9 0.9 4.8 0.9 0.2 0.5 0.0 5.5 0.2 1.8 0.0 0.7 0.0 1.4 3.8 2.5 1.5 1.6 2.3 0.4 0.6 3.0 1.5 0.0 0.1 3.5 1.0 1.2 1.0 9.3 11.4 3.7 7.1 10.4 11.2 8.3 8.9 12.1 7.9 IQUB FLJ35834 ENSG00000164675 "IQ motif and ubiquitin domain containing" Q8NA54 7 123452400-123535077 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 20.8;testis: 35.5" "Cell line enhanced" "Detected in some" "K-562: 1.8;RPTEC TERT1: 7.1;T-47d: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049626 Approved "Nuclear speckles,Intermediate filaments,Cytosol" "Nuclear speckles, Intermediate filaments" Cytosol "HPA049626: " "unprognostic (8.71e-2)" "unprognostic (1.25e-2)" "unprognostic (1.98e-1)" "unprognostic (6.42e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (6.23e-2)" "unprognostic (7.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "unprognostic (3.76e-1)" "unprognostic (5.44e-6)" "unprognostic (2.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.14e-1)" "unprognostic (7.30e-2)" 0.6 1.0 1.3 0.3 2.9 0.3 0.9 3.0 3.5 1.2 0.5 1.8 3.2 0.4 1.4 6.9 1.8 5.7 1.6 0.6 2.6 1.2 8.5 0.4 3.2 0.3 0.7 1.2 2.7 0.7 2.7 20.8 0.5 6.4 0.9 0.4 0.3 0.7 4.3 0.6 0.5 0.5 0.6 1.0 0.4 0.6 35.5 2.8 0.0 5.6 0.0 0.3 0.7 0.6 0.8 0.0 0.0 0.3 0.5 0.7 0.0 0.3 0.0 1.3 0.6 0.6 0.6 0.1 0.0 0.1 0.0 0.3 0.0 0.8 0.8 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.7 0.3 0.2 0.3 0.0 1.8 0.2 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.1 1.6 1.1 0.4 0.0 0.0 0.1 2.5 0.0 0.0 0.5 0.3 0.4 0.2 0.4 0.1 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.7 0.3 0.4 0.2 0.2 0.2 0.0 0.8 0.7 0.2 0.0 0.5 0.1 0.0 0.3 0.0 1.3 2.9 3.0 3.5 2.6 1.2 0.7 1.2 6.4 2.8 IRX5 IRX-2a ENSG00000176842 "Iroquois homeobox 5" P78411 16 54930862-54934485 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Vision" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 19.0;heart muscle: 26.5" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.8;T-47d: 24.3;THP-1: 13.0" "Cancer enhanced" "Detected in many" "breast cancer: 20.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "cerebellum: 4.1;hypothalamus: 3.2;midbrain: 7.6;pons and medulla: 5.7;thalamus: 4.7" HPA047130 Approved "Nuclear speckles,Microtubules,Cytosol" "Nuclear speckles" "Microtubules, Cytosol" "HPA047130: AB_10962983" "unprognostic (2.63e-1)" "unprognostic (4.49e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-2)" "unprognostic (1.42e-2)" "unprognostic (3.89e-2)" "unprognostic (5.38e-3)" "prognostic favourable (4.59e-4)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (1.17e-3)" "unprognostic (3.34e-2)" "unprognostic (8.90e-2)" "unprognostic (1.77e-3)" "unprognostic (4.28e-2)" 3.3 0.7 0.2 0.2 1.4 0.2 19.0 5.8 0.3 3.6 0.5 1.7 0.2 0.2 0.4 1.9 7.6 0.3 0.4 26.5 0.9 1.3 4.7 0.2 10.3 0.3 2.6 0.0 0.5 0.3 0.5 0.3 0.2 5.3 4.2 0.2 6.5 13.6 0.5 6.7 13.9 0.2 0.3 4.5 0.2 3.3 0.9 2.2 0.4 0.2 1.0 2.4 0.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 5.7 2.1 2.1 0.4 0.2 2.2 5.4 0.7 0.5 1.2 0.5 0.0 0.5 2.9 5.5 2.0 2.3 0.4 3.8 2.7 0.6 2.3 0.0 0.0 1.3 2.2 0.6 10.1 3.6 1.5 0.0 0.3 0.0 4.1 2.0 6.0 7.8 0.1 1.6 3.2 2.9 0.3 17.8 0.1 2.0 2.0 0.9 4.9 2.4 24.3 13.0 0.3 4.0 0.1 2.8 0.8 2.4 1.4 1.8 6.4 2.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 5.8 0.2 0.9 1.3 2.6 0.0 5.3 2.2 ITGA7 ENSG00000135424 "Integrin subunit alpha 7" Q13683 12 55684568-55716043 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Cell shape" "Integrin, Receptor" "Congenital muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 66.4;skeletal muscle: 81.3" "Cell line enhanced" "Detected in many" "ASC diff: 29.5;hTEC/SVTERT24-B: 27.9;LHCN-M2: 16.9;SK-MEL-30: 20.4;U-87 MG: 25.2" "Cancer enhanced" "Detected in all" "glioma: 35.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008427 Uncertain Approved "Nuclear speckles,Vesicles,Plasma membrane" 770000 "Plasma membrane" "Nuclear speckles, Vesicles" "HPA008427: AB_1851823" "unprognostic (4.71e-2)" "unprognostic (1.55e-1)" "unprognostic (2.00e-3)" "unprognostic (3.02e-3)" "unprognostic (2.50e-1)" "unprognostic (2.36e-1)" "unprognostic (1.66e-2)" "unprognostic (2.20e-1)" "unprognostic (2.20e-2)" "unprognostic (3.57e-1)" "prognostic favourable (1.75e-4)" "unprognostic (2.85e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-1)" "unprognostic (5.10e-1)" "unprognostic (2.98e-2)" "prognostic unfavourable (9.59e-5)" 46.2 3.4 6.1 7.2 6.8 0.9 20.6 3.6 7.6 6.3 22.4 5.7 5.9 6.6 15.1 13.5 11.6 12.9 14.8 66.4 7.8 2.6 3.1 4.1 3.4 2.9 3.9 7.6 5.1 1.9 3.4 3.1 1.0 5.7 8.9 3.7 5.6 3.3 14.6 81.3 3.6 7.2 33.3 4.5 2.4 10.3 2.9 5.3 0.2 6.5 10.6 2.2 13.6 14.1 0.5 1.7 0.0 1.0 0.0 0.8 0.3 0.1 1.7 3.2 5.2 29.5 5.9 0.3 2.2 3.7 5.0 5.2 3.5 2.8 0.9 3.2 1.4 0.4 2.2 0.1 4.5 0.1 1.6 0.3 1.1 1.3 0.2 0.1 1.1 8.3 0.0 27.9 0.1 0.0 0.4 0.6 16.9 2.1 0.1 1.2 9.0 0.2 0.0 12.2 0.2 0.1 0.0 0.4 1.2 0.2 0.0 20.4 0.3 5.7 0.0 0.5 5.5 0.3 3.5 1.3 0.9 0.3 25.2 3.4 0.3 0.0 0.7 0.0 0.4 1.0 0.0 0.1 0.0 0.8 1.7 0.5 0.3 0.4 0.0 0.0 1.0 0.6 0.0 0.3 6.1 6.8 3.6 7.6 7.8 2.6 3.9 7.6 5.7 5.3 JDP2 JUNDM2 ENSG00000140044 "Jun dimerization protein 2" Q8WYK2 14 75427716-75474111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 11.0;granulocytes: 6.9;monocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059511 Supported Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA059511: " "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "prognostic unfavourable (8.58e-5)" "unprognostic (1.64e-2)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.99e-2)" "unprognostic (2.81e-1)" "unprognostic (5.06e-2)" "unprognostic (1.91e-1)" "unprognostic (3.25e-2)" "unprognostic (1.86e-1)" "unprognostic (8.11e-3)" "unprognostic (2.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.13e-1)" "unprognostic (9.30e-3)" 27.0 14.4 11.2 19.3 12.5 46.0 59.6 10.6 15.1 16.3 15.3 13.7 6.5 15.3 12.7 10.5 17.1 14.8 21.3 20.7 13.5 9.0 9.7 14.3 24.8 13.2 14.0 8.7 21.8 15.8 7.4 10.1 12.0 11.2 13.9 8.1 16.6 19.5 11.4 13.3 15.2 22.4 17.8 15.7 39.7 15.8 4.7 11.8 1.4 20.7 18.7 9.7 14.2 60.4 11.0 2.1 6.9 10.5 0.1 0.2 1.1 4.3 3.8 0.7 7.7 24.2 18.0 26.3 13.5 14.7 8.9 11.2 9.3 3.8 3.4 6.9 25.7 17.1 4.8 4.6 3.8 4.6 0.5 4.7 7.1 3.3 49.8 6.6 0.3 31.8 27.7 3.6 8.9 0.4 0.6 6.7 7.9 21.3 0.3 11.0 2.6 2.5 2.4 0.1 9.3 4.2 2.4 0.6 3.0 13.9 20.0 15.5 19.1 14.7 1.7 11.2 17.3 0.7 2.0 5.6 1.6 8.2 3.4 25.3 5.5 0.1 4.1 3.8 0.0 7.0 0.0 11.0 0.2 0.0 2.1 5.1 0.0 0.0 6.9 0.1 10.5 1.8 0.2 1.1 11.2 12.5 10.6 15.1 13.5 9.0 14.0 8.7 11.2 11.8 KAT6A "MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220" ENSG00000083168 "Lysine acetyltransferase 6A" Q92794 8 41929479-42051990 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017023, HPA063266, HPA065052" Supported Approved "Nucleoli,Nuclear speckles,Cytosol" "Nuclear speckles" "Nucleoli, Cytosol" "CAB017023: , HPA063266: , HPA065052: " "unprognostic (3.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (3.23e-2)" "unprognostic (2.28e-1)" "unprognostic (9.27e-3)" "unprognostic (3.61e-1)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.50e-1)" "unprognostic (4.45e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" 20.8 10.9 15.3 19.8 20.3 36.8 22.6 29.9 18.7 19.7 14.6 19.4 14.4 10.7 20.6 12.1 16.9 16.5 14.3 13.0 15.5 11.5 12.3 13.6 26.9 28.2 23.2 10.3 27.2 13.1 26.8 22.3 20.9 15.7 14.1 12.0 12.8 15.1 17.0 21.0 25.5 18.0 25.0 22.9 20.4 14.0 14.1 21.7 30.4 17.9 14.3 20.1 16.9 24.2 4.7 1.8 10.9 1.6 3.1 3.9 1.4 12.9 10.6 17.5 11.1 9.8 11.2 5.9 8.7 11.3 10.8 8.4 6.7 6.2 19.2 8.7 8.5 8.3 13.6 8.2 12.7 9.9 7.9 27.6 6.6 5.0 7.4 14.5 12.7 9.3 9.4 10.0 12.4 10.3 23.1 12.2 9.8 5.7 29.5 4.6 6.7 4.2 23.6 19.6 6.1 5.3 14.9 10.9 9.4 10.1 6.8 7.0 15.6 6.4 12.0 13.3 9.4 11.8 9.3 10.0 16.1 20.8 7.1 6.6 11.5 3.5 1.6 2.8 3.5 1.2 3.9 2.4 2.6 3.3 1.0 4.7 3.6 2.9 10.9 3.1 1.2 1.8 3.5 1.4 15.3 20.3 29.9 18.7 15.5 11.5 23.2 10.3 15.7 21.7 KCNK13 "K2p13.1, THIK-1, THIK1" ENSG00000152315 "Potassium two pore domain channel subfamily K member 13" Q9HB14 14 90061765-90185857 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.3;parathyroid gland: 14.3;testis: 13.2" "Cell line enhanced" "Detected in some" "MCF7: 2.3;RT4: 5.1;SCLC-21H: 2.2;SK-BR-3: 2.2;U-2 OS: 2.5;U-266/84: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 7 "dendritic cells: 3.8;monocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003514 Approved Approved "Nuclear speckles,Cell Junctions" "Nuclear speckles, Cell Junctions" "HPA003514: " "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (6.17e-2)" "unprognostic (6.31e-2)" "unprognostic (2.56e-1)" "unprognostic (5.55e-2)" "unprognostic (3.56e-2)" "unprognostic (3.98e-2)" "unprognostic (2.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-2)" "unprognostic (1.97e-1)" "unprognostic (2.04e-2)" "unprognostic (6.32e-2)" "unprognostic (1.46e-1)" "unprognostic (5.65e-2)" 0.8 1.1 2.9 2.2 3.5 0.1 0.4 0.2 4.2 0.4 0.6 4.0 0.0 0.6 0.3 1.5 0.3 0.4 0.5 2.7 2.9 2.4 4.8 0.7 0.7 1.6 6.3 1.4 0.4 2.7 14.3 0.6 1.2 3.6 0.4 0.7 0.1 1.1 0.7 0.1 0.1 0.7 0.4 8.3 1.1 0.5 13.2 5.4 0.7 2.7 0.0 0.6 0.8 0.1 0.0 3.8 0.0 1.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.9 1.2 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.5 5.1 2.2 0.7 0.0 2.2 1.4 0.0 1.9 0.0 0.0 2.5 0.0 0.8 0.7 2.2 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 2.9 3.5 0.2 4.2 2.9 2.4 6.3 1.4 3.6 5.4 KCTD16 KIAA1317 ENSG00000183775 "Potassium channel tetramerization domain containing 16" Q68DU8 5 144170832-144485686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 25.1" "Cell line enhanced" "Detected in some" "SCLC-21H: 6.9;TIME: 13.1;U-87 MG: 3.0" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Group enriched" "Detected in many" 5 "amygdala: 11.4;basal ganglia: 14.5;cerebral cortex: 25.1;hippocampal formation: 14.5;olfactory region: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044590, HPA050154" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA044590: AB_2679008, HPA050154: AB_2681034" "unprognostic (7.22e-2)" "unprognostic (3.63e-1)" "unprognostic (2.54e-2)" "unprognostic (6.81e-5)" "unprognostic (9.88e-2)" "unprognostic (1.21e-1)" "unprognostic (7.74e-3)" "unprognostic (3.23e-2)" "unprognostic (1.94e-2)" "unprognostic (9.57e-2)" "unprognostic (9.38e-3)" "unprognostic (6.20e-3)" "unprognostic (2.52e-8)" "unprognostic (1.55e-3)" "unprognostic (2.34e-1)" "unprognostic (5.80e-3)" "unprognostic (1.22e-2)" 1.0 2.0 11.4 0.7 14.5 0.6 0.9 0.7 25.1 1.5 0.8 0.4 0.0 1.0 0.9 1.5 0.8 1.2 1.4 0.9 14.5 3.2 2.9 0.8 2.4 0.7 1.7 12.0 1.0 5.2 0.8 1.7 0.9 1.3 0.8 0.7 0.0 0.7 1.1 0.6 0.7 1.2 0.9 1.6 0.7 0.8 4.4 2.4 0.0 2.2 0.0 0.7 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.1 0.6 0.0 1.9 1.6 0.6 0.8 0.4 0.0 0.0 0.6 0.5 0.0 0.0 0.3 0.8 0.2 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.4 0.1 1.1 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 6.9 0.3 0.1 0.0 0.1 0.0 0.0 13.1 1.0 0.7 0.2 0.0 0.2 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 14.5 0.7 25.1 14.5 3.2 1.7 12.0 1.3 2.4 KCTD20 "C6orf69, dJ108K11.3, MGC14254" ENSG00000112078 "Potassium channel tetramerization domain containing 20" Q7Z5Y7 6 36442767-36491143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030092 Approved Approved "Nuclear speckles,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear speckles" "HPA030092: AB_10601437" "unprognostic (2.17e-1)" "unprognostic (2.02e-1)" "unprognostic (5.20e-3)" "unprognostic (2.43e-2)" "unprognostic (1.00e-3)" "unprognostic (5.03e-3)" "prognostic unfavourable (8.32e-4)" "unprognostic (3.63e-1)" "unprognostic (1.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic unfavourable (8.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (9.31e-4)" "unprognostic (2.94e-2)" 34.3 23.1 18.4 22.8 17.6 20.1 39.0 15.7 21.4 22.2 20.7 18.7 22.4 12.0 25.5 23.1 24.6 22.0 25.1 21.0 16.3 17.1 16.2 29.7 20.5 26.2 18.0 14.4 25.6 12.7 15.7 16.1 21.7 16.5 17.5 16.0 17.9 16.2 19.2 20.4 24.6 17.6 30.8 17.3 24.2 16.6 10.2 13.3 31.6 13.6 18.1 24.9 21.5 18.3 6.2 14.0 19.4 14.4 6.4 8.5 10.9 10.9 5.0 14.5 27.7 19.9 12.8 7.0 13.3 18.4 14.5 16.2 12.8 6.2 36.8 12.0 21.6 10.1 18.9 9.6 24.1 26.2 10.4 20.9 7.9 13.5 9.3 20.2 14.6 12.9 10.0 11.1 7.1 14.8 32.3 21.1 13.6 9.6 23.0 7.7 5.4 4.5 22.9 16.5 20.7 7.8 12.3 3.5 20.5 11.6 11.8 35.4 16.3 20.2 16.8 39.3 13.5 11.6 16.5 16.7 38.7 26.7 6.8 28.0 40.1 19.4 14.4 9.2 7.5 13.1 8.5 6.2 5.9 6.2 14.0 5.1 6.2 6.1 10.6 6.4 7.2 7.6 6.9 10.9 18.4 17.6 15.7 21.4 16.3 17.1 18.0 14.4 16.5 13.3 KDM6B "JMJD3, KIAA0346" ENSG00000132510 "Lysine demethylase 6B" O15054 17 7839904-7854796 "Predicted intracellular proteins" "Inflammatory response" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 3.7;neutrophil: 11.6" "Lineage enriched" "Detected in single" 12 "granulocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037988 Supported Approved "Nuclear speckles" "Nuclear speckles" "HPA037988: AB_10672502" "unprognostic (3.43e-1)" "unprognostic (3.43e-1)" "unprognostic (1.09e-1)" "unprognostic (2.13e-3)" "unprognostic (1.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.21e-1)" "unprognostic (2.43e-1)" "unprognostic (9.89e-2)" "unprognostic (8.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.42e-2)" "prognostic favourable (6.07e-4)" "unprognostic (5.73e-2)" "unprognostic (1.56e-1)" "prognostic unfavourable (3.37e-4)" "unprognostic (1.85e-1)" 10.7 6.7 3.1 10.6 5.3 17.5 4.4 9.0 7.6 3.9 5.0 6.7 3.1 7.5 6.3 6.1 4.8 6.7 10.4 6.9 3.1 2.5 6.0 6.2 9.8 12.2 5.6 3.1 12.3 9.6 4.0 8.7 6.6 6.6 5.4 1.7 10.2 4.2 3.3 4.7 5.5 8.0 7.6 8.0 8.4 6.1 7.2 3.1 5.9 6.1 7.1 3.1 5.2 4.3 0.7 0.9 11.6 0.8 0.1 0.6 0.4 4.0 5.6 10.8 15.8 3.9 3.0 13.5 3.2 4.7 2.3 2.4 8.1 2.9 9.3 3.9 2.6 9.9 5.1 4.4 1.4 3.7 3.9 4.3 5.4 5.2 11.4 5.6 13.4 4.6 6.8 5.5 4.6 4.1 7.1 4.0 1.0 6.6 8.6 5.1 5.4 3.2 9.7 2.3 2.5 4.1 6.9 5.7 18.0 4.0 9.4 8.2 5.3 7.2 1.9 3.4 6.2 6.0 4.4 4.8 0.9 3.1 4.7 3.3 6.6 3.7 0.8 1.3 0.4 0.5 0.4 0.4 0.3 0.2 0.5 0.7 0.4 0.6 11.6 0.1 0.3 0.9 0.1 0.4 3.1 5.3 9.0 7.6 3.1 2.5 5.6 3.1 6.6 3.1 KIAA0100 "BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488" ENSG00000007202 KIAA0100 Q14667 17 28614440-28645454 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042781 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted - unknown location" "Nuclear speckles, Cytosol" "HPA042781: AB_10797020" "unprognostic (1.91e-1)" "unprognostic (1.03e-2)" "unprognostic (3.47e-2)" "unprognostic (5.26e-3)" "unprognostic (2.43e-1)" "unprognostic (6.89e-2)" "prognostic unfavourable (3.47e-5)" "unprognostic (4.99e-2)" "unprognostic (3.04e-1)" "unprognostic (3.03e-3)" "unprognostic (2.40e-2)" "unprognostic (2.53e-1)" "unprognostic (4.24e-3)" "unprognostic (7.58e-2)" "unprognostic (5.84e-2)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 27.7 31.2 22.3 21.3 34.7 21.9 26.3 28.1 40.1 20.0 24.0 28.2 20.9 15.5 24.7 21.6 25.4 24.0 20.1 21.4 22.0 22.4 38.1 30.7 24.1 26.3 23.1 19.6 25.6 24.6 48.0 27.0 32.7 35.6 22.7 28.5 22.1 27.0 23.3 40.7 25.0 27.9 28.4 21.4 26.4 22.8 24.8 18.6 26.3 28.6 20.2 26.6 22.7 18.8 2.9 7.2 3.5 3.0 2.0 3.3 1.3 19.3 37.0 18.8 17.8 34.3 20.5 13.7 18.2 24.2 22.2 21.0 25.4 8.8 27.0 21.8 33.1 25.9 27.6 26.9 27.0 29.9 25.8 21.5 29.4 13.9 14.8 37.5 37.3 20.8 20.9 30.0 23.0 31.7 20.2 8.8 20.2 27.7 27.3 17.9 8.2 13.7 21.0 21.0 17.6 13.4 34.9 18.5 14.2 22.9 62.6 15.2 37.4 26.2 29.3 17.0 18.8 22.7 34.2 8.3 9.6 17.4 19.4 24.3 19.8 0.8 3.0 3.5 3.0 2.5 3.3 2.9 1.5 2.7 3.3 1.7 1.8 1.8 1.8 2.0 2.7 7.2 1.7 1.3 22.3 34.7 28.1 40.1 22.0 22.4 23.1 19.6 35.6 18.6 KIAA0556 "JBTS26, KATNIP" ENSG00000047578 KIAA0556 O60303 16 27550133-27780369 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.0" "Group enriched" "Detected in all" 4 "granulocytes: 11.0;NK-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035089, HPA035090" Enhanced Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA035089: AB_10671509, HPA035090: AB_10601129" "unprognostic (1.81e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" "unprognostic (3.65e-3)" "unprognostic (7.76e-2)" "prognostic favourable (3.00e-4)" "unprognostic (2.72e-2)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (2.94e-1)" "unprognostic (2.12e-1)" "unprognostic (1.47e-3)" "unprognostic (2.98e-1)" "unprognostic (2.11e-1)" "unprognostic (1.50e-3)" "unprognostic (1.45e-1)" 6.1 6.2 7.1 8.7 10.9 7.9 6.8 6.3 10.8 8.4 8.2 12.0 13.2 6.5 15.1 13.1 11.2 38.6 7.5 7.0 7.1 6.7 9.7 5.0 8.2 5.6 6.5 7.3 8.2 11.7 14.9 19.0 6.8 8.6 11.9 9.8 11.8 9.8 9.7 4.1 11.0 7.9 8.4 9.3 7.9 12.1 22.8 8.4 8.7 20.9 5.0 11.1 7.6 9.0 1.4 1.5 11.0 2.0 5.5 1.8 0.4 5.3 11.0 6.2 5.8 9.4 8.7 10.4 7.3 7.9 6.5 8.8 9.7 9.0 4.6 10.5 10.4 9.0 7.9 9.4 13.0 21.1 5.5 3.6 11.1 5.6 5.7 4.8 9.2 9.2 8.3 14.3 15.4 12.7 5.8 3.9 9.1 12.3 5.3 6.0 3.8 4.5 7.6 7.6 5.0 11.9 7.5 8.0 5.1 7.3 6.6 4.0 14.7 4.3 11.0 8.3 5.3 6.4 6.3 5.2 4.4 4.9 9.5 4.8 7.4 9.5 2.0 3.8 0.8 1.3 0.8 0.9 0.4 1.4 1.3 1.4 1.8 0.3 11.0 5.5 0.5 1.5 1.5 0.4 7.1 10.9 6.3 10.8 7.1 6.7 6.5 7.3 8.6 8.4 KIAA1328 ENSG00000150477 KIAA1328 Q86T90 18 36829106-37232172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040946 Approved Approved "Nuclear speckles,Vesicles,Lipid droplets" "Nuclear speckles" "Vesicles, Lipid droplets" "HPA040946: AB_10794998" "unprognostic (3.66e-2)" "unprognostic (5.37e-4)" "unprognostic (2.76e-2)" "unprognostic (1.55e-3)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (2.46e-2)" "unprognostic (1.51e-3)" "unprognostic (1.99e-1)" "unprognostic (5.05e-2)" "unprognostic (3.18e-3)" "unprognostic (4.85e-2)" "unprognostic (1.06e-4)" "unprognostic (1.77e-1)" "unprognostic (2.25e-2)" "unprognostic (3.36e-2)" "unprognostic (2.64e-3)" 11.1 8.1 14.0 10.7 14.3 23.1 11.1 27.4 13.0 13.7 7.5 13.0 6.1 9.2 12.6 11.1 7.9 9.4 8.3 9.8 10.7 8.5 9.2 7.7 10.4 8.5 12.3 9.0 18.3 6.9 9.0 18.6 9.7 10.3 11.1 7.4 10.9 10.9 9.5 11.4 15.7 9.7 15.8 13.2 8.9 10.7 19.6 14.4 5.4 11.1 9.7 11.5 10.1 11.0 12.7 5.7 17.1 7.4 7.5 10.4 3.6 14.5 4.4 6.5 7.9 2.3 3.1 6.3 5.6 2.1 2.6 1.9 7.7 9.7 9.5 21.1 2.1 6.5 2.6 2.7 3.4 7.4 2.7 12.4 12.0 4.8 1.8 7.9 6.0 3.2 3.0 3.1 2.7 2.3 9.8 23.7 2.6 14.3 5.5 6.0 14.9 7.7 7.9 6.8 7.0 2.5 14.8 7.1 8.2 7.6 9.2 3.7 14.8 4.5 8.0 13.0 19.0 7.5 6.7 18.8 24.0 7.5 6.6 5.7 8.5 17.1 6.8 9.2 9.0 4.8 10.4 7.5 8.0 7.4 3.1 12.7 10.1 8.4 15.1 7.5 7.4 5.7 8.9 3.6 14.0 14.3 27.4 13.0 10.7 8.5 12.3 9.0 10.3 14.4 KLHDC7A FLJ38753 ENSG00000179023 "Kelch domain containing 7A" Q5VTJ3 1 18480982-18486126 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 36.4" "Cell line enhanced" "Detected in some" "A549: 5.2;CAPAN-2: 10.2;EFO-21: 5.2;NTERA-2: 5.7;RPTEC TERT1: 11.6;RT4: 9.2;T-47d: 10.2" "Cancer enhanced" "Detected in many" "renal cancer: 10.9" "Region enriched" "Detected in single" 4 "pons and medulla: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA056616 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA056616: " "unprognostic (4.63e-1)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (5.25e-2)" "unprognostic (1.68e-3)" "unprognostic (2.02e-1)" "unprognostic (1.31e-2)" "unprognostic (1.80e-3)" "unprognostic (2.94e-2)" "unprognostic (1.91e-1)" "unprognostic (9.01e-2)" "unprognostic (2.79e-1)" "prognostic favourable (7.81e-9)" "unprognostic (4.64e-3)" "unprognostic (1.37e-1)" "unprognostic (3.44e-1)" "prognostic favourable (1.88e-4)" 0.6 0.0 0.0 0.3 0.2 0.0 5.0 0.5 0.5 2.5 0.6 0.7 2.6 0.3 0.0 2.6 1.8 0.8 7.4 0.3 0.0 0.0 36.4 6.9 1.4 0.0 0.1 0.6 0.2 5.7 0.0 0.3 0.3 2.9 0.5 0.7 2.8 2.2 1.2 0.0 0.1 0.4 1.0 0.1 0.0 4.8 0.2 0.0 0.0 1.6 0.3 0.8 5.5 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 5.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.0 10.2 0.0 5.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.2 0.0 0.0 11.6 9.2 2.8 0.0 0.0 0.8 0.0 10.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.5 0.5 0.0 0.0 0.1 0.6 2.9 0.0 KTI12 "MGC20419, SBBI81, TOT4" ENSG00000198841 "KTI12 chromatin associated homolog" Q96EK9 1 52032103-52033816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031203, HPA031204, HPA031205" Approved Approved "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles, Cytoplasmic bodies" "HPA031203: , HPA031204: AB_10600110, HPA031205: AB_10611380" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-3)" "unprognostic (3.36e-3)" "unprognostic (4.18e-1)" "unprognostic (1.83e-2)" "prognostic unfavourable (1.02e-4)" "unprognostic (1.74e-1)" "unprognostic (2.94e-1)" "unprognostic (3.72e-2)" "unprognostic (4.06e-2)" "unprognostic (8.08e-3)" "unprognostic (6.59e-2)" "unprognostic (3.36e-3)" "unprognostic (2.39e-1)" "unprognostic (3.59e-2)" "unprognostic (1.64e-2)" 14.9 14.6 5.9 9.9 7.4 22.1 9.7 8.1 9.3 7.8 8.4 6.7 7.2 7.4 10.5 7.6 8.1 10.6 10.9 8.1 5.6 7.6 14.1 14.1 6.4 11.9 5.4 5.9 16.1 10.7 4.3 11.0 15.5 5.5 9.6 6.3 9.1 6.4 7.7 9.4 7.3 10.0 8.9 3.9 12.2 9.5 10.6 4.8 15.4 14.5 9.2 11.3 9.7 10.5 19.4 27.7 9.7 15.2 13.4 19.9 11.7 9.3 9.3 3.6 8.7 12.7 10.7 11.6 9.5 11.8 14.0 12.0 10.3 4.6 10.8 10.7 9.9 10.7 12.9 11.3 9.8 10.9 14.4 11.1 10.5 10.0 8.8 15.9 11.1 10.0 8.7 11.2 6.0 9.5 16.6 5.8 11.7 7.4 11.6 17.8 7.2 10.5 11.2 10.2 14.4 13.3 6.8 6.7 9.5 9.2 16.3 17.0 3.1 25.1 7.1 11.4 7.1 13.7 17.8 20.1 16.6 16.8 12.6 17.0 8.3 7.8 13.9 9.7 14.8 15.2 16.3 19.4 16.7 17.9 18.4 15.2 19.9 14.0 2.9 13.4 11.4 27.7 16.2 11.7 5.9 7.4 8.1 9.3 5.6 7.6 5.4 5.9 5.5 4.8 LHX4 Gsh4 ENSG00000121454 "LIM homeobox 4" Q969G2 1 180230286-180278982 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 21.0" "Cell line enhanced" "Detected in many" "BEWO: 14.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055705 Approved "Nuclear speckles" "Nuclear speckles" "HPA055705: " "unprognostic (2.83e-2)" "unprognostic (3.23e-2)" "unprognostic (1.94e-1)" "unprognostic (2.86e-2)" "unprognostic (9.38e-2)" "unprognostic (5.76e-5)" "unprognostic (9.39e-4)" "unprognostic (1.47e-1)" "unprognostic (2.39e-3)" "unprognostic (2.95e-1)" "unprognostic (3.77e-3)" "unprognostic (2.72e-3)" "unprognostic (4.07e-8)" "unprognostic (3.63e-1)" "unprognostic (1.43e-1)" "unprognostic (6.44e-3)" "unprognostic (7.83e-3)" 0.8 1.4 0.8 2.3 0.8 1.5 0.9 4.3 1.4 0.9 1.2 0.8 0.8 2.5 1.3 0.8 1.2 1.3 1.2 0.8 0.8 0.4 4.6 0.8 1.0 2.2 0.8 0.8 2.2 2.5 0.0 2.4 2.8 2.1 1.2 1.1 21.0 1.4 0.8 1.3 3.4 2.4 0.8 1.4 2.2 1.4 3.6 0.8 0.8 1.9 0.8 0.8 1.3 1.5 0.6 0.1 0.6 0.7 0.2 0.7 0.0 1.4 6.0 1.5 3.2 0.0 0.0 14.3 1.6 0.4 0.4 0.1 1.1 2.6 1.5 0.4 0.0 2.5 2.8 0.0 0.7 0.8 2.3 1.0 5.7 0.6 0.0 1.6 1.8 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.0 3.0 0.9 3.0 1.3 0.3 1.0 3.8 0.6 0.0 1.2 1.5 1.3 1.7 1.3 0.5 3.4 0.3 1.9 1.4 2.6 1.5 1.0 1.1 0.4 1.3 0.5 1.2 1.5 0.0 0.7 0.0 0.6 0.2 0.4 0.6 0.3 0.4 0.0 0.5 0.6 0.3 0.6 0.2 0.5 0.1 0.7 0.0 0.8 0.8 4.3 0.8 0.8 0.4 0.8 0.8 2.1 0.8 LIFR CD118 ENSG00000113594 "LIF receptor alpha" P42702 5 38474963-38608354 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 39.8;HHSteC: 17.0;SCLC-21H: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004478, CAB010252" Approved "Nuclear speckles,Golgi apparatus" "Intracellular and membrane" 74000 "Nuclear speckles" "Golgi apparatus" "CAB010252: AB_2128043, HPA004478: " "unprognostic (6.00e-3)" "unprognostic (2.53e-1)" "unprognostic (1.05e-1)" "unprognostic (2.81e-3)" "unprognostic (8.80e-2)" "unprognostic (7.13e-2)" "unprognostic (1.11e-1)" "prognostic favourable (1.92e-4)" "unprognostic (1.78e-1)" "unprognostic (9.80e-2)" "unprognostic (2.73e-3)" "unprognostic (1.06e-1)" "prognostic favourable (1.40e-7)" "unprognostic (3.69e-2)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" "unprognostic (1.65e-1)" 35.3 14.7 15.8 8.2 19.2 0.5 33.9 10.1 21.3 27.7 10.4 25.3 22.8 4.9 34.8 14.8 10.4 26.0 10.2 16.3 19.1 11.0 20.3 23.9 21.7 20.2 24.3 11.8 17.9 17.8 13.5 12.5 41.5 23.4 23.6 7.5 17.1 24.9 24.7 24.0 10.5 11.7 26.9 21.4 22.5 18.8 9.3 25.3 4.7 31.4 7.3 8.1 13.6 15.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 2.2 39.8 3.0 11.2 12.4 0.3 3.3 1.9 2.7 1.6 0.4 2.1 0.0 0.5 4.7 0.3 2.6 0.9 4.6 0.0 3.6 0.0 4.2 1.5 17.0 0.0 0.2 10.4 0.7 6.5 0.7 3.7 1.0 6.4 3.3 0.5 0.0 0.1 1.0 7.1 0.0 8.4 0.0 2.6 1.0 26.1 3.2 13.7 0.6 0.0 0.9 0.0 0.7 4.3 8.5 10.1 2.0 0.0 0.0 0.0 7.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 19.2 10.1 21.3 19.1 11.0 24.3 11.8 23.4 25.3 LIN52 C14orf46 ENSG00000205659 "Lin-52 DREAM MuvB core complex component" Q52LA3 14 74084796-74201235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000900, HPA001777" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA000900: AB_2135058, HPA001777: " "unprognostic (2.34e-2)" "unprognostic (6.51e-3)" "unprognostic (1.86e-1)" "unprognostic (1.94e-1)" "unprognostic (7.90e-3)" "prognostic favourable (6.60e-4)" "prognostic unfavourable (6.08e-5)" "unprognostic (2.48e-3)" "unprognostic (9.34e-2)" "unprognostic (8.65e-2)" "unprognostic (1.39e-3)" "unprognostic (3.18e-1)" "unprognostic (1.74e-3)" "unprognostic (1.20e-2)" "unprognostic (8.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.04e-1)" 10.8 11.7 12.8 7.3 13.9 4.8 9.1 19.5 17.8 8.8 12.0 12.2 5.6 8.4 10.6 9.6 6.8 7.5 7.0 13.4 11.3 16.8 26.0 9.9 6.9 8.0 13.3 10.3 12.5 10.6 7.5 15.3 7.1 16.5 9.7 8.0 14.2 6.6 8.6 7.7 5.9 14.2 9.0 8.7 7.0 6.9 10.8 7.9 9.3 7.2 5.1 9.3 8.7 6.1 7.4 6.8 16.1 5.3 8.3 13.8 8.2 5.8 4.4 14.8 7.5 9.4 4.1 6.0 9.0 8.2 11.8 13.2 7.6 5.1 3.2 3.2 4.5 5.0 11.1 3.8 18.2 26.4 4.8 4.4 5.3 11.5 9.5 4.7 6.5 4.3 4.3 7.0 8.9 5.7 5.0 15.8 6.4 8.2 7.7 7.6 4.5 6.4 9.9 12.9 5.8 3.4 3.8 10.7 8.7 8.4 7.0 7.5 9.7 7.4 3.3 6.4 11.7 6.4 7.9 9.8 21.1 6.7 6.9 5.9 10.4 4.8 5.1 16.1 9.2 5.3 13.8 7.1 8.1 9.0 6.8 7.4 11.9 11.2 3.0 8.3 3.5 6.3 11.5 8.2 12.8 13.9 19.5 17.8 11.3 16.8 13.3 10.3 16.5 7.9 LMTK2 "AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100" ENSG00000164715 "Lemur tyrosine kinase 2" Q8IWU2 7 98106885-98209633 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010657, HPA041836" Uncertain Approved "Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol" "Nuclear speckles, Centriolar satellite" "Plasma membrane, Cytosol" "HPA010657: AB_1079259, HPA041836: " "unprognostic (7.36e-2)" "unprognostic (3.16e-1)" "unprognostic (1.59e-1)" "unprognostic (2.60e-3)" "unprognostic (2.47e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-2)" "unprognostic (1.23e-1)" "unprognostic (4.96e-1)" "prognostic unfavourable (8.03e-4)" "unprognostic (1.23e-1)" "unprognostic (4.65e-1)" "prognostic favourable (1.12e-7)" "unprognostic (1.88e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (6.38e-3)" 5.1 10.3 13.7 5.6 21.3 17.3 5.6 16.6 34.3 7.3 13.8 6.1 5.6 12.6 6.1 6.3 12.7 6.4 7.9 16.9 11.0 10.1 10.1 8.5 10.0 5.1 7.5 18.9 8.0 21.0 22.2 10.0 4.8 13.2 7.9 11.8 5.4 10.5 6.5 17.5 11.5 13.8 5.7 5.5 6.8 9.4 8.0 6.9 7.2 8.7 5.7 7.4 8.3 8.1 0.6 0.7 4.8 0.9 0.3 1.6 0.5 9.9 11.7 9.1 9.3 4.9 3.9 8.5 4.1 4.5 4.1 4.9 9.2 9.1 5.2 11.9 5.3 10.9 10.5 6.3 6.4 7.4 7.4 3.5 10.5 9.2 6.0 6.3 6.4 2.7 8.8 8.4 11.4 6.1 9.2 11.1 3.7 13.5 6.6 3.8 11.1 5.7 7.3 6.2 10.3 6.8 17.5 6.5 13.1 8.3 15.2 6.0 4.2 2.6 7.4 8.5 14.0 16.9 9.4 4.9 8.6 10.5 5.7 5.0 10.1 1.2 0.6 0.5 0.8 0.3 0.5 0.6 0.9 0.9 0.3 0.6 1.1 1.6 4.8 0.3 0.9 0.7 0.8 0.5 13.7 21.3 16.6 34.3 11.0 10.1 7.5 18.9 13.2 6.9 LNP1 NP3 ENSG00000206535 "Leukemia NUP98 fusion partner 1" A1A4G5 3 100401193-100456319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 9.4;cerebral cortex: 11.0;hippocampal formation: 10.1;olfactory region: 9.4" HPA047926 Approved "Nuclear speckles,Vesicles,Cytosol" Vesicles "Nuclear speckles, Cytosol" "HPA047926: " "unprognostic (1.78e-1)" "unprognostic (3.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.40e-3)" "unprognostic (6.33e-3)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (1.66e-3)" "unprognostic (1.81e-1)" "unprognostic (1.75e-2)" "unprognostic (1.58e-2)" "unprognostic (1.74e-2)" "unprognostic (8.28e-3)" "unprognostic (1.43e-1)" "unprognostic (7.98e-2)" "unprognostic (2.11e-1)" "unprognostic (6.08e-2)" 3.1 2.8 6.5 1.7 11.4 0.6 2.7 7.9 9.7 3.4 2.3 1.5 3.4 1.2 4.6 8.4 1.9 4.0 2.7 9.5 5.3 7.2 4.8 7.4 3.8 1.4 5.7 5.6 6.3 4.5 3.0 17.0 3.7 7.4 2.8 2.2 9.0 2.4 3.3 4.3 1.0 1.5 4.5 4.2 1.8 1.9 31.9 3.5 1.6 5.3 0.8 1.7 3.1 1.8 0.9 0.2 0.0 0.4 0.2 2.7 0.8 2.8 1.6 8.3 1.2 5.4 2.3 0.7 2.2 5.5 1.8 2.2 0.6 0.7 2.5 1.0 1.6 1.8 2.2 1.9 2.2 2.6 2.3 6.1 0.8 2.8 1.6 3.5 0.7 2.5 0.7 1.0 4.7 0.4 2.3 9.5 1.6 2.1 4.9 3.5 5.7 12.5 3.8 4.6 5.0 1.7 0.3 8.6 4.3 1.6 2.4 3.4 0.6 0.4 0.6 0.9 8.9 0.8 2.0 11.2 11.9 7.3 2.5 3.0 1.5 0.0 0.4 0.0 1.1 0.2 2.5 0.9 1.1 0.6 0.2 0.9 1.0 1.1 0.0 0.2 0.0 0.0 2.7 0.8 6.5 11.4 7.9 9.7 5.3 7.2 5.7 5.6 7.4 3.5 LPAR1 "edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1" ENSG00000198121 "Lysophosphatidic acid receptor 1" Q92633 9 110873263-111038458 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4" "Cell line enhanced" "Detected in many" "ASC diff: 96.2;ASC TERT1: 56.2;BJ hTERT+: 68.0;HSkMC: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.5;eosinophil: 15.6" "Group enriched" "Detected in many" 6 "granulocytes: 15.6;monocytes: 7.5" "Low region specificity" "Detected in all" HPA050667 Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA050667: " "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (4.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.17e-2)" "unprognostic (2.10e-1)" "unprognostic (1.40e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (4.29e-3)" "unprognostic (2.12e-2)" "unprognostic (5.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.97e-3)" "unprognostic (1.65e-1)" 16.3 9.5 55.8 12.0 56.2 0.3 14.8 4.7 30.9 43.7 12.3 71.4 3.4 9.4 12.1 12.3 10.6 10.1 9.8 8.5 55.6 30.6 5.7 1.9 7.3 10.5 59.4 17.0 8.9 4.6 1.1 2.3 25.7 29.1 9.4 12.8 3.5 5.6 17.2 3.3 6.9 10.2 14.0 69.8 9.5 6.5 4.8 49.4 0.1 6.2 3.2 11.3 15.4 17.8 0.0 1.9 15.6 7.5 1.8 0.0 1.6 1.8 3.5 4.9 0.0 96.2 56.2 0.0 24.0 68.0 16.8 7.6 0.4 0.2 0.0 0.0 24.8 7.2 0.0 18.7 13.9 0.0 0.6 0.0 0.2 0.0 26.0 0.0 0.0 40.8 1.1 8.3 15.8 0.3 0.0 0.0 12.9 0.0 0.0 0.0 0.9 19.4 0.0 3.6 0.0 3.8 3.2 0.1 1.1 0.4 0.0 0.0 1.6 0.0 0.0 8.0 0.2 5.7 0.0 0.2 0.0 0.0 1.2 0.0 8.7 0.9 7.5 15.6 0.0 2.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 1.8 1.1 0.1 0.0 1.6 55.8 56.2 4.7 29.5 55.6 30.6 59.4 17.0 29.1 49.4 LRRC8B "KIAA0231, TA-LRRP" ENSG00000197147 "Leucine rich repeat containing 8 VRAC subunit B" Q6P9F7 1 89524836-89597864 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8" "Cell line enhanced" "Detected in many" "HAP1: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017950 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA017950: AB_1853346" "unprognostic (2.50e-2)" "unprognostic (3.93e-2)" "prognostic favourable (7.15e-4)" "prognostic unfavourable (9.99e-4)" "unprognostic (1.22e-1)" "unprognostic (5.24e-2)" "unprognostic (3.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-2)" "unprognostic (1.72e-1)" "unprognostic (8.80e-3)" "unprognostic (2.30e-2)" "unprognostic (1.85e-1)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" 8.1 18.0 13.0 4.4 19.3 3.0 6.6 2.5 27.8 3.8 5.6 15.4 0.5 7.4 2.6 6.9 5.0 4.3 6.2 3.3 15.3 6.5 4.9 4.8 5.8 4.9 8.8 17.1 2.6 8.5 12.4 5.1 2.4 8.3 5.6 6.8 4.4 5.0 1.6 5.9 6.9 4.9 3.6 16.2 4.3 6.4 17.4 8.2 3.1 6.1 2.7 5.9 3.3 3.3 3.0 2.4 1.5 2.2 0.9 3.7 1.6 8.4 3.2 2.4 8.3 12.0 7.2 9.6 0.2 2.4 1.1 1.5 5.1 5.1 0.7 3.4 1.2 4.4 21.9 1.9 1.4 4.1 4.4 16.3 2.2 4.4 1.2 7.8 11.6 4.0 7.0 0.9 3.6 11.7 18.2 5.6 1.3 4.5 3.9 3.7 13.6 4.8 8.6 1.1 3.0 2.7 10.5 6.9 11.0 4.6 11.2 7.9 6.8 3.7 3.8 0.9 5.6 2.6 2.6 4.2 3.3 4.1 1.3 1.9 2.0 1.4 2.2 1.5 1.1 1.1 1.7 3.0 2.1 1.7 2.4 2.3 3.7 2.9 0.7 0.9 1.2 2.1 3.4 1.6 13.0 19.3 2.5 27.5 15.3 6.5 8.8 17.1 8.3 8.2 MAGEA4 "CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336" ENSG00000147381 "MAGE family member A4" P43358 X 151912509-151925170 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "placenta: 12.1;testis: 23.5" "Cell line enhanced" "Detected in some" "A-431: 61.4;AN3-CA: 38.3;HMC-1: 73.1;U-266/84: 113.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021942, CAB040535" Enhanced Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB040535: , HPA021942: AB_1853490" "unprognostic (7.90e-3)" "unprognostic (6.66e-3)" "unprognostic (5.39e-1)" "unprognostic (1.36e-1)" "unprognostic (5.81e-2)" "unprognostic (2.94e-2)" "unprognostic (4.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 73.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 19.6 0.0 0.3 15.6 113.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 MAMDC2 MGC21981 ENSG00000165072 "MAM domain containing 2" Q7Z304 9 70043581-70226970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 22.6;HHSteC: 23.6;LHCN-M2: 29.4;TIME: 28.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 4 "NK-cell: 2.6" "Lineage enriched" "Detected in single" 4 "NK-cells: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021814, HPA022249" Uncertain Approved "Nuclear speckles,Plasma membrane" "Secreted in other tissues" "Nuclear speckles, Plasma membrane" "HPA021814: AB_1853508, HPA022249: AB_2139157" "unprognostic (1.88e-1)" "unprognostic (3.16e-3)" "unprognostic (2.21e-3)" "unprognostic (2.71e-2)" "unprognostic (4.30e-2)" "unprognostic (8.49e-2)" "unprognostic (1.27e-2)" "unprognostic (8.25e-2)" "unprognostic (5.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.92e-1)" "unprognostic (3.67e-1)" "unprognostic (3.03e-2)" "unprognostic (4.23e-3)" "unprognostic (2.35e-1)" "prognostic unfavourable (7.78e-4)" "unprognostic (2.79e-3)" 9.0 4.3 0.6 11.1 0.5 0.0 14.7 0.6 0.8 32.3 27.7 0.3 9.1 4.3 40.7 33.7 31.6 28.7 44.9 13.5 0.6 0.6 2.0 1.0 42.4 2.3 0.7 0.8 35.5 2.4 1.0 0.8 2.6 1.3 13.9 6.6 16.1 5.4 10.8 15.5 5.0 14.2 46.3 2.6 12.0 10.7 20.0 0.0 0.3 6.8 24.6 6.1 36.4 27.5 0.0 0.3 0.0 0.0 2.6 0.6 0.0 0.1 0.0 0.2 0.0 22.6 7.7 0.7 4.4 1.9 1.0 1.8 0.0 0.5 0.0 0.3 0.8 3.6 0.0 0.3 0.9 0.0 0.0 0.0 7.3 0.0 23.6 0.0 0.0 1.4 0.2 0.6 0.4 1.9 0.0 0.2 29.4 0.0 0.0 0.0 3.1 0.0 0.0 3.5 2.7 9.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.6 0.5 0.6 0.8 0.6 0.6 0.7 0.8 1.3 0.0 MAMSTR "FLJ36070, MASTR" ENSG00000176909 "MEF2 activating motif and SAP domain containing transcriptional regulator" Q6ZN01 19 48712742-48719721 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 53.9" "Cell line enhanced" "Detected in many" "Hep G2: 7.5;RH-30: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049765 Approved "Nuclear speckles" "Nuclear speckles" "HPA049765: " "unprognostic (6.00e-2)" "unprognostic (3.20e-2)" "unprognostic (5.98e-2)" "unprognostic (6.07e-2)" "unprognostic (1.65e-1)" "unprognostic (6.50e-3)" "unprognostic (4.34e-4)" "unprognostic (2.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (4.65e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-2)" "unprognostic (2.79e-1)" "unprognostic (4.84e-2)" "unprognostic (1.39e-2)" 2.4 14.7 1.8 1.0 1.9 0.5 0.9 8.0 4.3 7.9 1.0 2.2 1.1 0.7 13.5 3.5 2.7 4.8 1.0 2.7 1.6 1.0 0.7 0.4 0.9 0.7 1.0 4.3 9.5 1.0 2.7 2.7 1.4 0.7 4.7 0.8 3.3 1.5 1.7 53.9 1.7 0.9 3.6 0.8 2.9 0.7 7.7 1.1 0.0 0.9 9.2 1.1 1.4 2.4 4.1 2.9 1.1 0.9 0.7 4.0 0.6 0.6 1.4 1.5 3.8 2.9 5.1 1.5 5.0 4.0 2.5 3.9 1.4 0.9 0.7 0.3 4.7 1.1 0.2 0.9 1.0 0.5 1.7 0.3 0.5 7.5 1.5 0.1 1.0 3.1 1.0 3.5 0.5 0.9 0.3 0.9 1.6 0.6 1.2 0.6 0.1 1.1 1.4 17.9 0.4 0.3 0.3 1.6 3.0 0.8 0.3 0.3 0.5 0.0 0.3 5.1 0.9 4.1 0.7 1.1 0.7 0.5 1.9 0.6 0.9 0.0 0.5 1.1 3.9 0.9 2.5 3.1 4.0 3.8 1.0 4.1 4.0 3.5 0.4 0.7 0.9 2.9 1.7 0.6 1.8 1.9 8.0 4.3 1.6 1.0 1.0 4.3 0.7 1.1 MAPK12 "ERK6, p38gamma, PRKM12, SAPK-3, SAPK3" ENSG00000188130 "Mitogen-activated protein kinase 12" P53778 22 50245450-50261825 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "skeletal muscle: 104.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 31 "NK-cell: 3.0" "Lineage enriched" "Detected in single" 31 "NK-cells: 3.0" "Region enhanced" "Detected in many" "cerebellum: 35.4" "Low region specificity" "Detected in all" "CAB025483, HPA054562" Enhanced Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB025483: , HPA054562: " "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (4.53e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (6.35e-3)" "unprognostic (3.90e-3)" "unprognostic (3.16e-2)" "unprognostic (6.02e-2)" "unprognostic (5.70e-2)" "unprognostic (3.48e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (5.00e-6)" "unprognostic (2.57e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-2)" "unprognostic (4.28e-3)" 3.0 1.6 4.5 2.1 4.5 1.0 1.8 9.0 7.0 2.1 1.4 2.1 1.6 2.0 5.4 5.1 3.3 2.9 2.4 5.1 3.9 3.6 2.5 1.0 2.1 2.0 3.5 5.7 3.0 1.4 1.2 7.0 2.3 2.6 2.9 1.1 2.2 1.4 3.7 104.2 0.9 1.5 4.2 2.6 1.6 1.5 1.6 2.4 0.0 1.3 10.8 1.1 2.4 1.9 0.0 0.0 0.0 0.0 3.0 0.0 0.0 10.3 6.4 2.4 7.4 5.6 6.2 3.5 7.9 6.9 13.3 8.5 9.2 3.2 19.4 10.8 8.7 6.9 11.0 1.6 2.5 5.6 15.4 12.7 19.3 11.4 17.9 11.9 25.2 13.4 2.9 3.0 0.0 15.0 11.2 18.1 6.1 5.7 0.0 15.9 7.5 10.4 18.1 6.7 19.7 7.9 1.4 8.5 2.9 6.1 0.2 9.8 3.3 13.8 7.8 13.7 12.4 2.9 4.9 4.2 3.2 10.4 3.5 11.2 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 4.5 4.5 9.0 7.0 3.9 3.6 3.5 5.7 2.6 2.4 MAPT "DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau" ENSG00000186868 "Microtubule associated protein tau" P10636 17 45894382-46028334 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Alzheimer disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 89.9;skeletal muscle: 43.7" "Cell line enhanced" "Detected in some" "HDLM-2: 27.3;SCLC-21H: 9.8;T-47d: 12.4" "Group enriched" "Detected in many" 11 "breast cancer: 9.5;glioma: 13.3;prostate cancer: 3.0;renal cancer: 4.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000151, HPA048895, HPA069524, HPA069570, CAB072344" Enhanced Supported "Nuclear speckles,Plasma membrane" "Plasma membrane" "Nuclear speckles" "CAB000151: , CAB072344: , HPA048895: , HPA069524: , HPA069570: " "unprognostic (1.78e-3)" "unprognostic (7.51e-2)" "unprognostic (3.71e-2)" "unprognostic (8.40e-5)" "unprognostic (1.40e-1)" "unprognostic (1.31e-2)" "unprognostic (4.06e-5)" "unprognostic (6.04e-2)" "unprognostic (2.19e-2)" "unprognostic (3.49e-2)" "unprognostic (3.88e-3)" "unprognostic (2.65e-1)" "unprognostic (1.72e-3)" "unprognostic (6.53e-2)" "unprognostic (3.43e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" 3.8 7.1 28.9 2.4 31.2 2.1 8.8 40.1 89.9 2.4 2.7 21.4 1.7 2.5 2.6 2.3 6.4 2.5 2.8 6.5 28.7 29.7 15.3 2.2 2.4 2.3 22.6 35.2 2.3 2.8 8.5 8.8 5.2 29.1 5.1 2.5 2.2 8.1 5.3 43.7 4.6 2.8 2.5 13.6 2.2 2.3 6.5 27.7 0.0 2.3 3.1 2.3 3.2 0.8 0.0 0.0 0.3 0.1 0.5 1.7 0.1 0.8 0.3 0.2 2.6 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.1 0.0 27.3 1.4 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.2 1.3 0.0 4.1 0.5 0.1 0.0 1.1 0.0 2.2 2.7 0.0 3.5 9.8 4.6 1.0 0.0 0.9 12.4 0.0 0.0 0.2 0.3 0.6 0.1 0.5 0.1 0.0 0.2 0.5 0.3 0.0 0.1 0.3 0.8 0.0 0.6 0.0 0.4 1.2 0.0 0.0 0.9 0.9 0.0 0.5 0.1 0.0 1.7 0.1 28.9 31.2 40.1 46.3 28.7 29.7 22.6 35.2 29.1 27.7 MAST3 KIAA0561 ENSG00000099308 "Microtubule associated serine/threonine kinase 3" O60307 19 18097793-18151692 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035061, HPA035062" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA035061: AB_10670585, HPA035062: AB_10671508" "unprognostic (5.94e-3)" "unprognostic (4.75e-2)" "unprognostic (1.70e-1)" "unprognostic (1.02e-1)" "unprognostic (3.38e-1)" "prognostic favourable (2.97e-4)" "unprognostic (1.93e-1)" "unprognostic (4.63e-2)" "unprognostic (1.43e-1)" "unprognostic (3.21e-1)" "prognostic favourable (7.01e-4)" "unprognostic (2.58e-1)" "unprognostic (1.64e-3)" "unprognostic (1.02e-2)" "unprognostic (3.61e-1)" "unprognostic (1.58e-3)" "unprognostic (1.26e-3)" 4.6 3.5 20.7 8.3 36.1 12.3 1.8 1.1 72.5 3.8 5.3 19.0 0.2 9.1 3.6 4.9 2.2 4.9 3.1 2.1 19.7 9.3 3.6 6.4 4.6 9.9 13.0 33.6 4.6 14.3 7.1 7.7 2.6 13.0 2.7 4.4 0.7 4.6 4.2 2.6 6.9 8.8 3.0 7.9 11.4 3.9 2.1 12.5 1.8 2.4 0.3 9.4 3.3 2.4 4.4 10.3 23.2 9.7 5.8 8.4 3.1 3.3 4.9 2.3 10.0 6.8 5.5 5.4 3.4 2.2 2.4 3.4 4.9 4.6 8.6 5.1 3.4 1.8 3.3 1.9 1.7 7.3 4.1 3.9 5.2 7.8 5.7 2.1 13.2 6.2 5.7 3.6 1.4 1.0 4.0 5.7 2.7 5.9 4.4 6.9 2.4 6.1 11.9 1.9 6.3 1.8 1.5 3.7 6.1 4.7 2.8 2.0 3.1 4.9 3.9 3.1 3.3 12.9 1.4 6.2 8.3 7.9 6.7 11.1 2.8 0.1 4.5 9.4 8.4 5.6 6.2 4.1 4.7 3.3 2.1 4.4 3.7 6.4 23.2 5.8 9.7 10.3 5.0 3.1 20.7 36.1 1.1 72.5 19.7 9.3 13.0 33.6 13.0 12.5 MED17 "CRSP6, CRSP77, DRIP80, SRB4, TRAP80" ENSG00000042429 "Mediator complex subunit 17" Q9NVC6 11 93784227-93814963 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA046619 Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA046619: " "prognostic unfavourable (4.94e-4)" "unprognostic (2.92e-1)" "unprognostic (2.72e-3)" "unprognostic (1.38e-1)" "unprognostic (6.71e-2)" "unprognostic (1.42e-1)" "prognostic unfavourable (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.48e-3)" "unprognostic (7.73e-2)" "unprognostic (1.41e-1)" "unprognostic (4.59e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-1)" "unprognostic (2.22e-1)" "unprognostic (5.56e-3)" "unprognostic (1.48e-1)" 9.0 7.4 5.8 9.9 8.0 9.5 9.2 13.9 10.7 10.7 10.2 9.0 9.4 4.3 12.1 7.5 7.9 10.4 7.3 11.5 6.3 5.4 6.4 4.6 8.2 8.1 9.5 7.3 13.8 9.9 5.4 13.1 9.5 6.1 8.2 4.9 8.0 9.4 6.6 9.3 10.2 14.0 7.7 7.7 13.9 12.1 7.9 8.8 20.7 7.8 5.5 9.8 11.2 11.6 10.5 6.8 10.8 5.7 10.2 8.5 5.1 3.0 1.0 2.6 5.6 3.2 0.4 5.1 6.7 2.3 4.5 2.8 5.3 6.3 5.0 11.3 0.6 9.4 2.4 1.4 1.2 6.0 2.7 5.6 3.4 1.5 1.7 9.4 9.5 1.3 3.3 3.3 2.2 1.8 5.0 3.0 2.7 0.9 11.2 2.7 4.9 0.8 8.6 7.6 4.1 2.7 2.1 9.2 11.7 5.6 4.7 2.8 7.0 2.3 6.1 7.0 5.6 9.3 5.8 4.7 9.1 3.6 1.8 6.7 8.0 4.9 4.6 10.8 6.4 5.7 7.6 10.5 8.2 8.0 6.0 9.0 8.5 4.8 4.7 10.2 3.3 6.8 8.1 5.1 5.8 8.0 13.9 7.9 6.3 5.4 9.5 7.3 6.1 8.8 MFSD11 "FLJ20226, FLJ22196" ENSG00000092931 "Major facilitator superfamily domain containing 11" O43934 17 76735865-76781449 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022001 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA022001: AB_2297599" "unprognostic (2.84e-2)" "unprognostic (1.22e-1)" "unprognostic (2.43e-2)" "prognostic unfavourable (7.69e-4)" "unprognostic (4.87e-2)" "unprognostic (1.17e-1)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-3)" "unprognostic (1.68e-2)" "unprognostic (2.06e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-1)" "unprognostic (1.18e-2)" "unprognostic (6.98e-2)" "prognostic unfavourable (7.90e-4)" 17.2 20.7 13.9 14.3 21.3 15.6 18.7 20.4 25.0 18.0 20.9 19.6 16.9 17.4 18.8 18.8 24.1 13.4 14.3 23.5 13.3 14.8 13.3 19.2 17.4 22.0 20.1 16.1 14.4 17.4 24.6 27.9 27.4 18.1 14.8 22.8 32.8 21.3 17.3 26.8 20.8 17.7 16.8 17.9 19.0 21.7 28.6 19.7 15.6 18.0 16.8 18.6 16.8 21.6 8.0 14.9 16.7 16.1 6.3 18.3 8.2 13.5 7.7 9.1 8.7 19.6 11.9 10.7 12.1 11.2 11.7 10.4 15.6 24.9 11.1 10.3 12.3 13.4 6.4 6.3 12.2 5.1 12.9 11.1 14.7 10.7 9.4 5.9 11.0 14.2 10.3 15.0 6.8 22.2 13.2 16.5 14.8 10.4 13.3 9.7 3.8 4.5 10.5 11.9 22.9 9.0 10.1 8.9 15.0 11.5 16.5 10.3 28.9 9.1 15.6 21.4 10.5 13.4 10.1 18.4 7.3 16.7 16.5 5.2 14.1 11.2 14.1 11.3 15.2 16.1 6.4 7.5 13.6 15.3 14.9 8.0 8.5 10.6 16.7 6.3 12.5 10.7 18.3 8.2 13.9 21.3 20.4 25.0 13.3 14.8 20.1 16.1 18.1 19.7 MKX "C10orf48, IRXL1, MGC39616" ENSG00000150051 "Mohawk homeobox" Q8IYA7 10 27672875-27746060 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 21.3;prostate: 24.3" "Cell line enhanced" "Detected in some" "BJ: 18.8;BJ hTERT+: 10.8;BJ hTERT+ SV40 Large T+: 12.4;BJ hTERT+ SV40 Large T+ RasG12V: 8.5;fHDF/TERT166: 53.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "myeloid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006927 Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA006927: AB_1853981" "unprognostic (2.04e-1)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.23e-2)" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (8.37e-2)" "unprognostic (2.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (7.62e-2)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (6.38e-3)" 3.7 3.2 1.6 1.4 2.1 0.3 3.0 2.6 5.9 4.9 4.3 1.4 0.9 0.5 1.8 3.4 1.8 7.1 2.7 0.8 1.4 2.5 0.6 1.9 1.2 0.5 2.7 1.4 21.3 1.0 0.3 13.9 0.3 6.7 24.3 1.5 2.9 0.9 7.7 0.5 1.0 0.7 10.6 2.7 0.8 3.4 1.3 0.1 0.0 4.5 0.5 0.3 8.7 1.6 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.8 10.8 12.4 8.5 0.0 0.0 0.0 0.0 53.9 0.0 0.1 0.0 3.3 0.0 1.2 0.0 3.4 0.0 0.5 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.2 1.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.0 1.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 2.6 5.9 1.4 2.5 2.7 1.4 6.7 0.1 MNS1 "FLJ11222, SPATA40" ENSG00000138587 "Meiosis specific nuclear structural 1" Q8NEH6 15 56421544-56465137 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;testis: 36.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039975, HPA040382" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA039975: AB_10793858, HPA040382: AB_10794740" "unprognostic (7.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.19e-1)" "unprognostic (5.07e-2)" "unprognostic (2.25e-1)" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.13e-2)" "unprognostic (2.05e-2)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-3)" "unprognostic (8.20e-3)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.71e-2)" 1.6 1.4 3.2 2.7 4.9 3.2 2.6 35.2 6.7 4.3 2.0 2.1 0.6 2.0 3.2 5.4 2.4 17.6 2.9 2.1 4.1 4.0 7.9 1.8 2.9 1.2 2.1 4.9 4.0 2.1 0.8 10.7 1.4 11.4 3.8 1.9 1.1 1.8 1.7 1.2 1.3 1.8 1.9 3.2 1.3 1.9 36.4 2.4 3.3 2.6 1.4 1.1 1.6 2.2 0.1 0.8 0.0 0.4 0.0 0.0 0.0 19.0 4.5 2.4 7.0 2.0 4.3 0.4 4.6 2.7 5.5 11.8 6.3 9.2 10.7 5.9 1.9 7.5 2.9 2.6 11.3 0.0 1.2 13.7 5.0 1.1 0.7 4.7 1.5 1.7 0.1 11.1 1.6 1.0 3.0 0.0 4.6 2.5 0.1 5.8 0.7 2.6 8.9 14.0 0.1 5.4 3.7 18.4 5.6 7.7 2.3 8.1 5.6 7.2 0.4 7.5 8.6 7.2 11.3 2.2 7.0 0.2 8.4 11.0 8.6 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 3.2 4.9 35.2 6.7 4.1 4.0 2.1 4.9 11.4 2.4 MYADM ENSG00000179820 "Myeloid associated differentiation marker" Q96S97 19 53866223-53876437 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 52.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056301 Approved "Nuclear speckles" 34000 "Nuclear speckles" "HPA056301: " "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (2.94e-1)" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (8.21e-3)" "prognostic unfavourable (8.15e-4)" "unprognostic (3.97e-2)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (4.11e-1)" "prognostic unfavourable (7.71e-7)" "unprognostic (2.28e-3)" "unprognostic (1.29e-1)" "unprognostic (2.37e-2)" "unprognostic (6.14e-3)" 58.2 9.5 9.2 26.4 13.9 53.5 39.2 7.4 17.1 67.9 58.9 18.8 25.1 15.8 105.6 33.0 44.6 66.1 40.8 39.9 9.3 11.7 13.0 15.6 42.4 22.3 8.2 11.4 51.7 31.8 8.7 8.9 46.5 13.3 41.9 13.4 22.2 21.1 45.4 13.2 19.5 26.8 76.8 9.6 22.6 37.6 28.7 9.4 20.3 20.5 32.6 15.3 81.6 30.5 2.0 14.3 52.2 11.6 4.1 5.4 3.9 6.4 54.2 6.9 5.6 23.7 16.4 11.1 34.5 24.8 13.7 14.0 22.3 20.1 0.6 12.3 43.9 13.3 3.5 13.1 11.9 8.1 8.1 8.8 9.0 17.0 54.3 18.2 32.0 17.8 3.1 17.5 2.5 12.3 9.3 16.7 8.7 7.7 4.8 14.2 6.6 15.5 19.1 7.5 3.2 15.4 0.7 0.1 10.8 0.3 10.8 3.4 10.6 15.6 25.1 30.9 11.1 4.1 15.5 10.8 6.7 0.1 18.9 8.8 0.5 14.1 11.6 38.3 5.4 6.7 5.1 1.4 3.5 3.9 14.3 2.0 3.4 2.8 52.2 4.1 5.4 5.5 1.3 3.9 9.2 13.9 7.4 17.1 9.3 11.7 8.2 11.4 13.3 9.4 NAMPT "PBEF, PBEF1" ENSG00000105835 "Nicotinamide phosphoribosyltransferase" P43490 7 106248285-106286326 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Biological rhythms, Pyridine nucleotide biosynthesis" "Cytokine, Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 108.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 18 "neutrophil: 143.5" "Lineage enriched" "Detected in many" 20 "granulocytes: 143.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034349, HPA047776, HPA057722" Approved Approved "Nuclear speckles,Cell Junctions" "Secreted to blood" 2140000 410000 "Nuclear speckles" "Cell Junctions" "CAB034349: AB_2251220, HPA047776: , HPA057722: " "unprognostic (2.87e-1)" "prognostic unfavourable (4.78e-4)" "unprognostic (5.90e-3)" "unprognostic (1.63e-2)" "unprognostic (1.50e-2)" "prognostic unfavourable (8.81e-4)" "unprognostic (2.15e-1)" "unprognostic (2.74e-2)" "unprognostic (2.74e-1)" "unprognostic (3.30e-1)" "prognostic unfavourable (1.51e-4)" "unprognostic (3.02e-1)" "prognostic unfavourable (2.49e-6)" "unprognostic (6.83e-2)" "unprognostic (6.96e-2)" "unprognostic (7.76e-2)" "unprognostic (6.44e-3)" 67.3 22.2 8.1 113.6 18.1 110.4 52.6 7.8 12.9 11.6 18.2 2.9 9.5 9.3 9.9 13.5 53.4 27.8 28.1 84.4 13.4 6.3 13.5 92.9 48.9 117.5 10.3 5.2 27.3 18.3 5.5 10.0 23.9 29.2 17.4 10.5 8.2 32.9 14.3 41.0 12.9 14.1 44.9 59.1 41.1 26.4 11.9 7.1 6.2 13.5 40.7 13.2 48.8 26.4 0.8 2.0 143.5 7.3 1.0 1.5 1.3 18.9 12.6 4.6 7.6 19.4 22.6 7.5 6.0 34.0 12.2 21.6 7.4 11.5 15.9 14.4 6.7 15.0 8.4 18.1 26.8 9.4 9.1 6.4 5.4 5.8 72.5 12.4 11.9 21.6 20.7 21.8 25.5 38.8 13.4 60.9 14.5 9.9 12.3 5.2 8.8 10.2 5.9 6.5 34.9 11.6 17.8 9.3 5.1 8.4 18.5 21.4 5.9 3.6 33.0 18.2 14.1 26.1 11.0 42.0 23.8 22.8 108.1 14.1 26.9 8.1 2.3 3.5 0.4 5.6 0.7 0.8 0.5 0.6 2.0 0.7 0.8 0.4 143.5 1.0 7.3 0.8 1.5 1.3 8.1 18.1 7.8 12.9 13.4 6.3 10.3 5.2 29.2 7.1 NCBP3 "C17orf85, ELG, HSA277841" ENSG00000074356 "Nuclear cap binding subunit 3" Q53F19 17 3802165-3846251 "Predicted intracellular proteins" "Antiviral defense, mRNA capping, mRNA processing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008959, HPA013195" Supported Approved "Nuclear speckles" "Nuclear speckles" "HPA008959: , HPA013195: " "unprognostic (1.39e-1)" "unprognostic (1.42e-1)" "unprognostic (2.11e-1)" "unprognostic (3.49e-3)" "unprognostic (1.97e-2)" "unprognostic (5.47e-2)" "unprognostic (2.53e-1)" "unprognostic (2.06e-2)" "prognostic unfavourable (4.68e-4)" "unprognostic (1.23e-1)" "unprognostic (1.84e-3)" "prognostic unfavourable (4.90e-4)" "unprognostic (2.00e-1)" "unprognostic (1.32e-1)" "unprognostic (3.64e-1)" "unprognostic (5.68e-2)" "unprognostic (5.36e-2)" 14.4 12.8 11.9 20.8 18.4 36.3 14.2 14.3 14.8 17.1 17.8 26.1 17.4 20.5 20.5 18.2 16.9 16.6 15.7 15.9 14.4 11.0 12.3 11.3 13.5 15.1 15.0 13.3 20.5 18.2 17.5 16.4 17.3 15.2 13.8 15.1 12.4 14.4 17.8 20.7 19.6 17.6 16.2 18.9 16.7 15.2 25.4 17.1 29.3 14.7 9.0 17.7 16.6 17.9 3.4 4.4 6.1 3.9 2.9 6.6 2.1 9.1 11.9 11.0 8.1 5.8 4.3 5.5 6.3 4.3 8.9 5.7 4.7 3.6 8.1 5.7 6.7 16.8 8.3 8.3 11.4 10.1 11.4 6.7 5.5 5.2 4.9 4.0 9.8 6.5 3.5 8.5 9.0 7.3 8.1 8.6 6.5 3.1 14.4 7.2 10.1 4.5 25.0 8.8 5.3 4.5 4.7 4.0 8.7 13.2 4.5 8.4 7.0 8.4 7.5 5.1 7.1 8.0 13.6 4.6 4.2 6.5 6.5 7.2 7.9 1.5 3.9 4.8 4.7 2.6 4.1 3.4 4.0 6.6 2.6 2.4 6.5 5.4 6.1 2.9 1.6 4.4 6.0 2.1 11.9 18.4 14.3 14.4 14.4 11.0 15.0 13.3 15.2 17.1 NEFL "CMT1F, CMT2E, NF68, NFL, PPP1R110" ENSG00000277586 "Neurofilament light" P07196 8 24950955-24957110 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.1" "Group enriched" "Detected in some" 5 "HEK 293: 112.2;PC-3: 30.1" "Cancer enhanced" "Detected in many" "renal cancer: 24.0" "Cell type enriched" "Detected in some" 5 "memory CD4 T-cell: 13.7" "Lineage enriched" "Detected in single" 138 "T-cells: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014850, HPA015021" Enhanced Supported Approved "Nuclear speckles,Intermediate filaments" "Nuclear speckles" "Intermediate filaments" "HPA014850: AB_1854397, HPA015021: " "unprognostic (7.63e-2)" "unprognostic (1.36e-2)" "unprognostic (9.53e-2)" "unprognostic (6.81e-2)" "unprognostic (2.82e-2)" "unprognostic (6.69e-2)" "unprognostic (3.69e-2)" "unprognostic (3.78e-3)" "unprognostic (3.06e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (4.91e-4)" "unprognostic (5.76e-3)" "unprognostic (7.88e-2)" "unprognostic (3.97e-3)" "unprognostic (3.17e-3)" 0.7 12.0 10.3 1.4 20.1 0.6 0.6 2.3 92.1 1.8 1.8 3.0 0.0 1.0 0.7 0.8 3.8 0.7 0.6 0.6 14.1 3.5 0.6 0.6 0.7 0.0 23.8 0.7 0.7 0.6 0.0 0.6 95.1 1.6 1.5 5.0 0.6 9.5 0.6 0.7 1.7 1.2 18.0 0.7 1.1 1.6 2.1 0.0 1.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 13.7 2.1 0.0 0.1 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 112.2 0.0 0.0 0.0 4.9 0.0 0.1 1.8 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.8 30.1 0.0 0.0 0.0 6.9 1.0 6.2 6.4 2.6 0.0 0.4 0.0 0.0 0.0 0.6 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 1.5 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.2 2.1 NEUROG3 "Atoh5, bHLHa7, Math4B, ngn3" ENSG00000122859 "Neurogenin 3" Q9Y4Z2 10 69571698-69573238 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.5;intestine: 8.4" "Cell line enriched" "Detected in some" 5 "THP-1: 15.0" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Region enriched" "Detected in single" 20 "hippocampal formation: 7.5" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;memory B-cell: 1.1" "Group enriched" "Detected in many" 7 "B-cells: 1.1;T-cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA039785 Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA039785: AB_10795114" "unprognostic (1.22e-2)" "unprognostic (7.33e-2)" "unprognostic (3.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (5.85e-5)" "unprognostic (4.58e-2)" "unprognostic (4.19e-1)" 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 7.6 0.0 0.0 8.0 0.0 0.0 0.9 0.0 1.8 0.0 7.5 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.1 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.3 7.5 0.1 0.1 0.0 0.0 0.0 OSER1 "C20orf111, dJ1183I21.1, HSPC207, Osr1, Perit1" ENSG00000132823 "Oxidative stress responsive serine rich 1" Q9NX31 20 44196496-44210791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045125 Approved Approved "Nucleoli,Nuclear speckles" "Nucleoli, Nuclear speckles" "HPA045125: AB_10961629" "unprognostic (2.77e-2)" "unprognostic (3.01e-2)" "unprognostic (3.22e-1)" "prognostic unfavourable (2.58e-5)" "unprognostic (1.18e-1)" "unprognostic (6.07e-2)" "unprognostic (8.44e-3)" "unprognostic (3.31e-1)" "unprognostic (1.14e-1)" "unprognostic (8.78e-2)" "unprognostic (8.01e-3)" "unprognostic (9.87e-2)" "unprognostic (3.96e-1)" "unprognostic (2.14e-1)" "unprognostic (2.45e-1)" "unprognostic (8.39e-2)" "unprognostic (1.06e-1)" 18.7 11.8 11.9 18.4 13.3 62.5 20.0 17.8 13.3 19.1 17.2 13.0 13.0 15.1 17.5 17.6 23.5 14.2 13.7 16.9 12.4 10.0 15.0 16.3 17.7 16.9 16.3 10.9 21.4 10.9 19.3 12.5 31.7 13.1 22.6 14.1 12.4 17.0 13.2 46.3 22.3 18.9 23.5 16.9 18.2 14.7 47.4 13.3 15.1 19.0 15.4 17.4 29.6 16.7 28.4 14.6 74.3 21.9 15.1 17.6 19.8 20.5 16.1 11.6 9.2 31.3 22.3 13.6 19.0 28.6 29.9 27.5 38.5 21.3 20.6 18.8 17.3 28.0 13.2 17.4 25.2 6.9 8.7 6.6 34.6 26.1 18.1 11.4 11.1 26.4 29.4 19.6 36.0 13.6 9.8 25.4 16.4 30.7 9.1 13.9 10.6 16.5 12.8 19.8 14.2 14.9 14.1 11.8 11.8 27.1 35.9 24.0 18.3 10.2 11.9 24.7 19.0 14.7 16.3 17.3 18.4 20.0 17.5 8.5 12.8 50.2 16.8 27.7 12.7 15.7 13.7 28.4 14.8 12.5 14.6 26.9 17.6 15.9 74.3 15.1 21.9 9.5 17.1 19.8 11.9 13.3 17.8 13.3 12.4 10.0 16.3 10.9 13.1 13.3 PABPN1 "OPMD, PAB2, PABP2" ENSG00000100836 "Poly(A) binding protein nuclear 1" Q86U42 14 23321289-23326185 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000637 Supported Approved "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553" "unprognostic (5.11e-3)" "unprognostic (2.65e-2)" "unprognostic (7.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (3.55e-4)" "unprognostic (1.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.95e-3)" "prognostic favourable (9.66e-4)" "unprognostic (5.88e-2)" "prognostic unfavourable (2.41e-7)" "unprognostic (1.52e-2)" "unprognostic (1.31e-2)" "unprognostic (1.07e-1)" "unprognostic (8.25e-3)" 41.1 46.0 67.4 39.8 73.7 57.1 34.0 79.5 80.2 36.1 42.2 39.4 51.2 55.1 55.3 67.7 38.3 43.2 43.4 35.3 64.4 44.7 46.6 47.1 33.2 46.4 62.4 45.8 48.6 35.2 44.8 54.0 40.6 60.3 46.2 52.8 39.4 42.3 45.2 46.6 53.7 55.9 50.2 47.4 46.0 41.4 54.1 69.3 53.5 51.0 29.6 54.6 33.3 46.5 11.4 15.6 13.1 9.8 12.0 9.0 2.8 25.3 28.5 63.0 49.7 29.6 33.3 41.0 26.4 26.0 36.1 34.6 34.0 47.7 45.5 14.2 33.3 40.3 70.2 36.4 50.2 38.8 26.8 35.1 40.7 87.9 33.1 54.4 48.3 38.7 36.5 26.8 31.6 39.5 32.8 35.7 34.5 48.3 57.2 66.6 68.9 32.5 57.2 24.4 27.4 40.8 52.7 43.5 34.0 33.8 31.5 26.8 23.8 39.5 33.3 25.2 32.2 24.6 33.4 42.7 29.5 53.9 15.0 44.7 29.3 13.1 9.8 8.9 7.3 7.0 5.9 8.7 7.3 6.3 7.6 11.4 9.0 8.5 11.9 12.0 7.7 15.6 7.9 2.8 67.4 73.7 79.5 80.2 64.4 44.7 62.4 45.8 60.3 69.3 PACSIN2 SDPII ENSG00000100266 "Protein kinase C and casein kinase substrate in neurons 2" Q9UNF0 22 42835412-43015145 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 37.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049854, HPA056520" Enhanced Supported "Nuclear speckles,Vesicles,Plasma membrane,Cytosol" 83000 "Nuclear speckles, Vesicles, Cytosol" "Plasma membrane" "HPA049854: AB_2680915, HPA056520: AB_2683163" "unprognostic (5.62e-3)" "unprognostic (1.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-3)" "unprognostic (1.63e-2)" "unprognostic (3.96e-1)" "prognostic unfavourable (7.33e-4)" "unprognostic (4.48e-2)" "unprognostic (3.40e-2)" "unprognostic (2.82e-3)" "unprognostic (3.09e-2)" "unprognostic (1.00e-1)" "prognostic favourable (1.09e-13)" "unprognostic (2.87e-1)" "unprognostic (1.11e-1)" "unprognostic (6.20e-2)" "unprognostic (2.95e-1)" 20.1 42.0 19.4 19.4 20.7 14.3 22.9 32.3 21.3 18.7 28.4 17.5 21.1 22.5 20.8 18.9 19.3 17.5 33.3 28.0 17.9 19.5 32.5 20.7 25.8 16.9 20.6 15.7 17.4 77.3 14.3 21.5 33.8 32.4 24.6 23.5 26.6 31.7 16.6 23.9 19.4 25.6 25.1 17.8 22.5 27.8 12.6 19.2 13.1 31.0 15.8 18.4 17.7 17.6 4.7 8.3 37.9 12.6 6.7 4.5 5.0 24.7 26.0 21.9 14.0 11.3 12.1 18.0 22.6 13.7 20.5 17.1 27.0 14.6 11.5 19.2 16.7 17.6 14.3 24.0 13.5 11.7 14.2 18.5 13.3 38.4 16.1 13.0 40.4 11.6 23.7 26.9 11.8 16.7 16.0 8.4 17.5 16.2 13.8 20.5 12.0 11.0 17.0 32.8 7.7 23.5 14.7 14.3 6.4 27.0 18.7 50.7 13.5 17.4 24.7 15.3 19.5 16.9 13.3 6.3 8.6 12.6 14.6 11.6 33.2 7.9 7.0 17.4 2.8 12.6 3.0 4.2 3.2 2.4 8.3 4.7 3.2 2.4 37.9 6.7 12.1 3.1 4.5 5.0 19.4 20.7 32.3 21.3 17.9 19.5 20.6 15.7 32.4 19.2 PCDHA5 "CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5" ENSG00000204965 "Protocadherin alpha 5" Q9Y5H7 5 140821604-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 13.6" "Cell line enhanced" "Detected in some" "A549: 2.6;EFO-21: 7.3;T-47d: 7.5;WM-115: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044557 Approved Approved "Nuclear speckles,Plasma membrane,Mitochondria" "Plasma membrane" "Nuclear speckles, Mitochondria" "HPA044557: AB_10970597" "unprognostic (4.95e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-1)" "unprognostic (8.81e-4)" "unprognostic (5.10e-2)" "unprognostic (6.25e-3)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (2.46e-2)" "unprognostic (4.49e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-4)" "unprognostic (9.30e-4)" "unprognostic (1.07e-1)" "unprognostic (1.39e-1)" "unprognostic (8.17e-5)" "unprognostic (2.11e-1)" 0.9 1.2 3.4 0.5 3.6 0.6 0.6 13.6 10.2 0.6 0.6 0.4 0.0 0.5 1.2 0.5 0.4 0.5 1.1 0.3 1.6 2.0 1.1 0.4 0.7 0.4 1.3 5.1 0.6 1.2 0.4 2.5 0.4 2.3 0.6 0.5 0.0 0.4 0.4 0.4 0.5 0.5 0.7 1.1 0.4 0.7 0.9 0.1 0.0 0.5 0.0 0.3 0.5 0.2 0.6 0.6 1.6 0.5 0.3 0.3 0.2 0.0 2.6 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 7.5 0.1 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.5 0.5 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.6 0.3 0.4 0.6 0.2 0.2 3.4 3.6 13.6 7.2 1.6 2.0 1.3 5.1 2.3 0.1 PCLO "ACZ, DKFZp779G1236, KIAA0559" ENSG00000186472 "Piccolo presynaptic cytomatrix protein" Q9Y6V0 7 82754013-83162930 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.3" "Group enriched" "Detected in some" 28 "REH: 61.0;U-2 OS: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015858, HPA029579, CAB079012" Approved Supported Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles, Plasma membrane" "CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044" "unprognostic (1.32e-2)" "unprognostic (1.99e-1)" "unprognostic (9.33e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (4.49e-3)" "unprognostic (6.14e-2)" "unprognostic (4.61e-2)" "unprognostic (1.82e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" "unprognostic (4.79e-6)" "unprognostic (5.15e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-5)" "unprognostic (6.62e-5)" 3.1 7.9 8.8 0.8 26.3 0.4 4.7 50.3 19.4 3.2 3.9 1.6 0.4 2.9 1.0 7.3 2.3 2.0 1.9 2.2 9.8 5.7 8.2 0.6 1.8 0.6 4.6 12.6 1.9 4.0 11.4 19.2 1.0 9.1 4.9 3.5 3.6 2.5 5.0 0.6 2.6 2.4 0.7 5.3 1.1 2.9 4.5 4.4 0.0 8.4 0.0 0.8 1.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.1 1.3 0.5 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.0 2.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 1.1 61.0 1.0 0.0 0.4 0.2 1.1 0.8 0.0 0.6 0.1 0.7 0.1 0.0 0.0 70.0 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.8 26.3 50.3 19.4 9.8 5.7 4.6 12.6 9.1 4.4 PCP2 "GPSM4, MGC41903" ENSG00000174788 "Purkinje cell protein 2" Q8IVA1 19 7631611-7633748 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 45.5;retina: 20.2;testis: 80.7" "Cell line enhanced" "Detected in some" "HMC-1: 8.9;Karpas-707: 4.5;NB-4: 18.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 14 "cerebellum: 45.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in some" 43 "cerebellum: 2422.3" "Region enriched" "Detected in single" 19 "cerebellum: 135.0" HPA057428 Approved "Nuclear speckles,Vesicles" "Nuclear speckles" Vesicles "HPA057428: " "prognostic favourable (7.93e-4)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.43e-2)" "unprognostic (1.49e-1)" "unprognostic (1.79e-4)" "unprognostic (1.19e-1)" "unprognostic (4.88e-5)" "unprognostic (1.11e-1)" "unprognostic (6.23e-2)" "unprognostic (9.15e-3)" "unprognostic (6.01e-2)" "unprognostic (1.36e-2)" "unprognostic (8.17e-2)" "unprognostic (1.18e-1)" "unprognostic (8.70e-2)" "prognostic favourable (2.76e-5)" 0.5 0.4 0.5 0.5 0.5 1.9 3.3 45.5 0.6 1.0 0.5 0.5 0.5 0.6 0.5 2.0 0.5 1.3 1.2 0.5 0.5 0.0 2.5 1.0 1.2 1.4 0.5 0.5 0.5 1.6 0.3 0.5 0.5 3.2 2.0 0.0 20.2 10.6 1.0 0.5 4.2 0.5 0.5 1.9 1.1 0.9 80.7 0.5 0.5 1.9 0.5 0.6 0.5 0.5 1.0 1.7 2.6 0.3 0.7 1.2 5.2 1.8 0.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 1.6 0.7 1.1 0.0 1.3 0.0 0.2 0.0 0.8 0.6 2.7 2.5 0.1 0.0 0.3 8.9 0.0 0.6 0.0 0.0 0.0 0.2 4.5 0.0 0.3 0.3 18.0 0.4 0.0 0.8 0.2 0.7 0.9 0.1 0.1 0.0 1.4 1.5 0.0 3.9 3.3 0.2 0.0 0.6 0.4 0.1 1.6 0.6 0.2 0.0 2.1 0.0 0.0 0.3 0.0 0.9 0.1 1.2 0.4 0.5 0.5 0.5 1.0 0.8 1.0 2.6 0.7 0.0 1.7 0.2 5.2 0.5 0.5 45.5 0.6 0.5 0.0 0.5 0.5 3.2 0.5 PDZK1IP1 "DD96, MAP17, SPAP" ENSG00000162366 "PDZK1 interacting protein 1" Q13113 1 47183593-47191044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 281.3" "Group enriched" "Detected in some" 6 "EFO-21: 30.8;RPTEC TERT1: 102.0" "Cancer enhanced" "Detected in all" "renal cancer: 340.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA014907 Enhanced Approved "Nuclear speckles,Cytosol" Cytosol "Nuclear speckles" "HPA014907: AB_1855166" "unprognostic (2.97e-1)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "prognostic unfavourable (6.92e-4)" "unprognostic (8.14e-3)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.65e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (3.45e-4)" "unprognostic (2.64e-2)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (1.75e-3)" "unprognostic (1.89e-1)" 2.7 1.2 0.6 2.4 0.6 3.9 4.1 0.6 0.6 9.2 9.1 0.6 0.6 2.2 1.3 4.8 30.4 2.9 23.9 0.7 0.5 0.0 281.3 1.6 7.2 0.5 0.6 0.5 2.3 16.8 0.0 0.6 3.2 0.6 2.1 3.4 0.8 33.9 12.4 0.7 19.9 9.5 0.5 0.5 0.7 9.0 1.4 0.6 1.1 1.0 18.3 18.5 4.1 8.3 0.1 0.5 2.1 1.1 0.2 0.3 42.4 10.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.4 0.0 30.8 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 102.0 0.0 0.0 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.1 0.2 0.0 0.5 0.3 42.4 0.6 0.6 0.6 0.6 0.5 0.0 0.6 0.5 0.6 0.6 PHLDB3 FLJ40193 ENSG00000176531 "Pleckstrin homology like domain family B member 3" Q6NSJ2 19 43474954-43504935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA043425 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Nuclear speckles" "Plasma membrane, Cytosol" "HPA043425: AB_10797142" "unprognostic (2.50e-2)" "unprognostic (4.22e-3)" "unprognostic (3.06e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.22e-3)" "unprognostic (4.43e-1)" "unprognostic (1.93e-1)" "unprognostic (2.15e-1)" "unprognostic (3.60e-2)" "prognostic favourable (6.36e-6)" "unprognostic (4.62e-2)" "prognostic unfavourable (4.11e-5)" "prognostic unfavourable (5.77e-4)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (2.37e-1)" 2.7 8.5 6.6 11.7 5.9 3.6 6.0 2.1 5.2 8.7 4.8 1.8 7.1 5.8 8.8 6.5 28.4 7.3 15.9 4.5 5.2 2.9 4.8 9.6 4.0 7.8 3.5 5.8 9.5 7.7 6.8 7.9 6.4 3.2 11.7 2.2 6.7 11.1 7.6 9.0 28.7 9.4 7.5 3.0 6.4 5.4 18.7 3.0 12.2 5.7 15.2 23.2 9.3 14.8 4.4 8.1 0.9 3.3 2.6 5.5 2.3 5.3 5.6 2.4 5.9 2.1 4.4 15.3 3.8 3.4 3.9 2.7 5.7 5.6 3.2 12.2 2.3 6.2 1.7 6.7 0.7 7.5 5.3 3.5 5.4 6.8 5.3 1.3 6.8 3.7 8.6 4.1 2.5 3.4 6.2 4.9 1.9 8.4 5.4 0.3 1.4 4.6 6.4 3.1 2.1 1.8 18.1 0.1 5.1 4.9 10.7 4.6 7.6 4.5 4.3 2.5 6.7 3.0 3.6 12.6 13.7 3.5 2.3 2.6 4.1 0.3 3.3 0.5 4.0 2.3 2.9 3.7 3.7 3.0 6.9 4.4 5.5 4.8 0.9 2.6 0.2 8.1 3.6 2.3 6.6 5.9 2.1 5.2 5.2 2.9 3.5 5.8 3.2 3.0 PHYHD1 MGC16638 ENSG00000175287 "Phytanoyl-CoA dioxygenase domain containing 1" Q5SRE7 9 128920895-128942041 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 20.9;ASC TERT1: 15.0;BEWO: 22.9;HSkMC: 12.8;RPTEC TERT1: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012115 Approved "Nuclear speckles" "Nuclear speckles" "HPA012115: AB_1859448" "unprognostic (1.18e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-3)" "unprognostic (2.16e-1)" "unprognostic (1.17e-2)" "unprognostic (4.49e-2)" "unprognostic (5.37e-3)" "unprognostic (1.35e-1)" "unprognostic (3.18e-1)" "unprognostic (1.86e-2)" "unprognostic (3.70e-2)" "prognostic favourable (6.38e-10)" "unprognostic (1.10e-2)" "unprognostic (3.09e-1)" "unprognostic (2.14e-1)" "unprognostic (9.83e-3)" 14.4 11.4 20.3 3.9 15.7 5.9 20.0 8.5 14.0 31.1 8.3 16.3 31.9 2.3 14.2 29.7 16.3 18.5 12.7 14.9 18.4 13.6 25.0 35.9 14.4 5.6 16.9 11.2 24.3 29.9 12.4 6.3 7.3 16.4 16.9 3.2 29.4 29.4 30.2 17.5 25.4 4.3 13.7 25.8 5.5 11.9 9.0 17.7 3.1 30.2 6.6 8.1 9.9 9.8 3.5 13.9 1.1 0.7 2.6 2.5 0.6 0.1 0.2 0.1 0.4 20.9 15.0 22.9 1.6 0.0 1.5 2.7 0.8 0.2 0.3 0.2 1.3 0.3 0.1 0.1 1.4 0.2 2.3 0.0 3.0 7.5 6.9 0.3 0.3 12.8 0.4 0.2 0.1 0.1 0.2 0.5 10.6 0.4 0.2 1.0 7.5 0.2 8.8 4.2 0.2 34.6 0.3 0.5 0.2 0.2 0.1 0.1 2.0 0.6 0.5 0.3 0.9 0.3 0.2 0.1 0.4 8.7 0.2 0.2 0.3 1.1 0.6 0.5 1.6 0.7 0.6 3.5 0.8 0.7 1.8 1.2 2.3 2.5 1.1 2.6 0.6 13.9 0.4 0.6 20.3 15.7 8.5 14.0 18.4 13.6 16.9 11.2 16.4 17.7 PLA1A ps-PLA1 ENSG00000144837 "Phospholipase A1 member A" Q53H76 3 119597842-119629811 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8" "Cell line enriched" "Detected in some" 18 "SK-MEL-30: 23.4" "Group enriched" "Detected in many" 5 "liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "T-reg: 1.9" "Lineage enriched" "Detected in single" 5 "T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059740 Approved "Nucleoplasm,Nuclear speckles,Cytoplasmic bodies" "Secreted in other tissues" "Nuclear speckles, Cytoplasmic bodies" Nucleoplasm "HPA059740: " "unprognostic (1.35e-1)" "prognostic favourable (2.81e-7)" "unprognostic (2.24e-2)" "unprognostic (3.46e-2)" "unprognostic (3.18e-2)" "unprognostic (1.94e-2)" "unprognostic (1.11e-2)" "unprognostic (2.43e-1)" "unprognostic (3.87e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" "unprognostic (9.09e-2)" "unprognostic (1.55e-3)" "unprognostic (9.53e-3)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" "unprognostic (2.67e-1)" 2.5 0.4 3.8 1.5 4.7 0.2 1.8 1.4 2.5 2.5 1.3 1.7 47.8 0.6 3.2 63.1 0.8 2.7 1.3 5.0 3.6 4.3 9.3 17.2 13.7 6.1 6.0 1.0 0.5 1.8 11.4 1.0 4.4 7.0 6.0 1.2 10.7 1.5 123.8 10.3 0.3 1.9 4.2 7.4 0.5 2.2 2.0 2.5 0.4 5.0 0.4 3.7 2.1 1.3 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.7 0.2 0.5 0.1 0.0 0.2 0.0 0.0 23.4 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 3.8 4.7 1.4 2.5 3.6 4.3 6.0 1.0 7.0 2.5 PLEKHN1 DKFZP434H2010 ENSG00000187583 "Pleckstrin homology domain containing N1" Q494U1 1 966497-975865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.5;lymphoid tissue: 21.2;skin 1: 31.3;tongue: 20.2" "Cell line enhanced" "Detected in many" "A-431: 11.1;HaCaT: 19.5;SK-BR-3: 13.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA031742 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA031742: AB_10670704" "unprognostic (2.72e-3)" "unprognostic (8.05e-3)" "unprognostic (9.03e-2)" "unprognostic (4.47e-2)" "unprognostic (7.50e-4)" "unprognostic (2.93e-2)" "unprognostic (1.38e-2)" "unprognostic (1.78e-1)" "unprognostic (3.24e-1)" "unprognostic (1.01e-2)" "unprognostic (2.58e-3)" "unprognostic (2.08e-2)" "prognostic unfavourable (4.97e-5)" "unprognostic (9.98e-2)" "unprognostic (1.96e-1)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" 0.4 0.6 0.0 1.8 0.2 0.4 1.4 0.0 0.1 7.7 0.9 0.0 0.0 0.8 1.1 2.7 31.5 0.3 5.0 0.5 0.3 0.0 2.3 0.8 1.1 0.3 0.0 0.0 0.1 0.5 0.3 0.0 1.5 0.0 3.7 0.2 0.3 5.3 1.2 1.5 31.3 0.7 0.6 0.6 0.5 1.7 0.8 0.0 0.2 0.7 20.2 21.2 6.0 10.6 0.0 0.3 2.0 0.9 2.3 1.1 0.2 11.1 1.2 0.0 0.7 0.0 0.5 1.9 5.2 1.3 3.4 0.8 1.5 8.6 0.0 2.5 2.1 19.5 0.2 3.2 0.5 3.8 0.8 0.0 3.4 2.2 0.4 0.2 0.1 0.1 2.7 2.2 1.2 0.3 0.2 3.1 0.2 6.5 0.0 0.2 0.3 9.0 0.0 0.0 4.1 3.6 3.4 0.1 0.1 5.8 13.3 0.7 2.5 0.0 2.3 4.2 1.8 0.4 3.4 2.5 0.1 0.1 5.1 1.9 2.4 0.0 0.9 2.0 0.3 0.3 0.0 0.0 0.5 1.1 0.3 0.0 0.2 0.0 0.0 2.3 0.1 0.0 0.8 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 POLR3B "FLJ10388, RPC2" ENSG00000013503 "RNA polymerase III subunit B" Q9NW08 12 106357658-106510198 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Nucleotidyltransferase, Transferase" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036466 Supported Approved "Nuclear speckles" "Nuclear speckles" "HPA036466: AB_10671842" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (4.80e-2)" "unprognostic (1.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.73e-1)" "unprognostic (4.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.33e-1)" "unprognostic (3.36e-2)" "unprognostic (6.11e-2)" "unprognostic (5.09e-2)" "prognostic favourable (1.21e-4)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" 6.4 14.0 7.1 7.9 14.6 6.5 6.9 8.6 13.6 8.6 7.2 8.2 5.7 6.0 10.1 7.2 14.8 7.7 5.8 8.2 8.9 7.1 9.9 17.5 7.1 11.4 6.2 10.4 11.3 11.9 22.5 17.0 22.9 12.3 8.0 8.3 6.2 8.6 9.9 12.1 15.3 5.7 7.8 6.0 6.4 7.5 9.9 4.7 10.3 8.5 10.2 10.0 7.3 10.1 4.3 4.9 9.8 4.1 3.7 6.3 3.1 11.1 5.3 11.8 5.6 10.5 9.6 16.4 15.7 9.5 10.9 8.5 9.7 3.1 14.2 5.6 9.7 10.4 13.6 13.4 13.6 11.5 9.1 11.3 7.1 8.2 6.7 17.9 12.3 8.5 9.6 10.9 12.7 8.1 16.6 4.7 8.3 8.2 13.0 6.0 12.7 19.9 7.9 7.0 9.3 6.2 15.2 12.8 7.0 9.6 12.9 9.2 12.0 5.3 7.7 6.0 7.1 9.7 9.0 5.8 14.8 21.2 2.9 11.1 6.4 9.8 3.9 2.6 4.1 4.1 5.5 4.3 4.5 4.3 4.9 2.6 6.3 3.9 2.6 3.7 4.0 1.8 4.7 3.1 7.1 14.6 8.6 13.6 8.9 7.1 6.2 10.4 12.3 4.7 PRPF18 hPrp18 ENSG00000165630 "Pre-mRNA processing factor 18" Q99633 10 13586927-13630868 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA037599, HPA047950" Supported Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA037599: AB_10795137, HPA047950: " "unprognostic (5.82e-2)" "unprognostic (7.86e-3)" "unprognostic (4.07e-2)" "unprognostic (1.20e-2)" "unprognostic (3.00e-2)" "unprognostic (6.36e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (6.12e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-3)" "unprognostic (2.82e-2)" "unprognostic (2.20e-1)" "unprognostic (8.09e-2)" "unprognostic (1.63e-1)" 21.7 20.4 22.8 21.1 21.3 40.5 22.6 29.3 22.9 18.5 18.5 15.9 25.3 18.3 20.8 32.1 20.7 15.6 17.1 19.5 17.1 14.8 22.8 23.5 17.9 17.9 17.2 21.4 18.4 19.8 20.1 40.8 20.2 21.6 16.4 20.5 9.8 22.3 28.5 34.1 20.9 20.1 20.9 21.9 17.4 18.6 19.4 22.0 25.6 26.2 16.0 20.7 18.0 21.9 20.0 19.9 30.3 25.0 27.0 25.8 11.6 16.5 12.4 11.0 9.5 15.5 15.2 13.9 19.4 9.7 21.3 20.5 11.8 25.5 13.9 10.9 17.7 13.8 14.6 16.0 24.7 20.4 14.6 16.3 10.6 9.2 18.6 12.7 19.5 11.7 26.1 18.5 9.0 20.6 16.7 18.8 19.3 17.1 23.5 8.7 10.4 6.2 16.9 13.5 17.2 14.0 7.1 7.8 19.4 15.2 11.0 16.4 17.0 20.8 17.4 13.3 15.6 21.4 14.5 18.5 19.7 19.9 19.6 16.0 9.0 16.9 20.4 25.9 21.6 18.1 18.6 20.0 19.7 18.5 19.9 18.2 21.0 25.8 30.3 27.0 25.0 17.4 23.6 11.6 22.8 21.3 29.3 22.9 17.1 14.8 17.2 21.4 21.6 22.0 PSMD13 "p40.5, Rpn9" ENSG00000185627 "Proteasome 26S subunit, non-ATPase 13" Q9UNM6 11 236546-252984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038691, HPA038692" Approved Approved "Nuclear speckles,Cytosol" 49000 "Nuclear speckles" Cytosol "HPA038691: AB_2676153, HPA038692: AB_10671749" "unprognostic (1.32e-2)" "unprognostic (7.98e-2)" "unprognostic (9.19e-2)" "prognostic favourable (5.74e-4)" "unprognostic (2.24e-2)" "unprognostic (3.13e-2)" "prognostic unfavourable (4.76e-5)" "unprognostic (7.54e-3)" "unprognostic (2.94e-1)" "unprognostic (1.90e-1)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (1.52e-13)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" 24.2 17.9 18.4 20.9 21.3 29.1 28.6 22.1 25.6 24.0 23.6 19.2 20.0 15.6 25.3 20.3 26.8 20.6 19.1 31.8 19.6 20.4 23.4 34.9 23.0 29.8 17.1 19.1 18.1 26.5 15.1 18.0 31.7 21.8 24.0 19.5 16.8 20.9 21.1 56.5 25.5 20.5 21.3 17.0 26.9 18.8 21.2 12.9 32.8 23.3 30.0 27.0 20.5 17.9 20.8 33.5 25.1 32.6 26.4 26.6 39.0 30.9 18.5 22.1 22.7 22.3 20.3 12.7 21.3 30.2 46.7 34.5 16.3 41.8 29.4 20.7 25.9 29.4 27.8 32.1 37.1 23.7 21.2 13.0 7.2 11.2 24.8 31.7 27.6 17.9 23.0 23.3 20.2 42.3 32.9 23.0 35.7 12.2 26.4 19.5 29.5 26.8 20.5 21.7 20.7 27.4 8.3 17.9 14.1 15.6 16.7 16.5 10.2 19.6 27.8 13.7 13.1 6.9 24.8 20.8 24.1 38.2 24.7 25.4 22.6 22.2 31.4 20.5 23.5 30.6 26.3 20.8 24.1 23.6 33.5 18.5 21.3 23.3 25.1 26.4 32.6 22.7 26.6 39.0 18.4 21.3 22.1 25.6 19.6 20.4 17.1 19.1 21.8 12.9 PSMD8 "HIP6, HYPF, Nin1p, p31, Rpn12, S14" ENSG00000099341 "Proteasome 26S subunit, non-ATPase 8" P48556 19 38374536-38383824 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006702, CAB021101" Supported Approved "Nuclear speckles,Cytosol" Cytosol "Nuclear speckles" "CAB021101: AB_10061018, HPA006702: AB_1079710" "unprognostic (9.50e-2)" "unprognostic (7.02e-2)" "unprognostic (1.70e-2)" "prognostic unfavourable (3.84e-4)" "unprognostic (1.59e-1)" "unprognostic (5.54e-3)" "unprognostic (1.94e-3)" "unprognostic (5.03e-2)" "unprognostic (2.85e-2)" "unprognostic (1.73e-2)" "unprognostic (4.61e-1)" "unprognostic (8.79e-2)" "prognostic unfavourable (4.66e-4)" "unprognostic (2.28e-1)" "unprognostic (2.08e-2)" "unprognostic (2.58e-3)" "unprognostic (4.84e-2)" 53.0 35.1 30.0 23.9 35.6 32.9 43.0 28.1 49.4 26.5 31.8 25.8 30.1 31.5 30.9 40.9 39.1 32.5 28.0 75.3 32.2 29.3 40.9 71.1 28.8 28.8 27.1 37.0 24.4 48.2 30.6 29.2 56.6 30.0 33.6 32.9 24.6 32.6 29.7 157.1 42.2 33.2 34.5 25.0 27.6 28.9 55.8 21.4 38.1 35.4 50.1 33.9 28.3 27.1 40.4 60.8 32.0 68.1 38.8 65.6 68.7 61.1 97.6 38.5 43.9 62.8 50.6 20.2 44.6 60.9 68.7 71.9 66.9 36.9 43.2 46.6 59.3 21.3 64.3 55.4 62.1 71.1 42.4 46.9 32.2 41.2 81.2 47.2 41.7 50.9 55.4 59.1 78.8 53.9 58.4 48.6 75.4 60.9 44.5 26.6 29.9 53.3 46.5 61.9 34.3 48.6 51.0 40.3 41.0 46.2 59.9 43.2 31.3 44.6 39.6 52.6 48.6 55.0 65.2 49.2 56.8 57.6 79.1 48.6 58.3 32.0 55.2 29.2 46.1 59.9 39.1 40.4 40.4 44.2 60.8 37.0 33.6 32.6 20.8 38.8 68.1 42.3 65.6 68.7 30.0 35.6 28.1 49.4 32.2 29.3 27.1 37.0 30.0 21.4 PYROXD1 "DKFZp762G094, FLJ22028" ENSG00000121350 "Pyridine nucleotide-disulphide oxidoreductase domain 1" Q8WU10 12 21437615-21471252 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038319, HPA038320" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA038319: AB_10669522, HPA038320: AB_2675956" "unprognostic (1.48e-1)" "unprognostic (1.68e-1)" "unprognostic (1.15e-2)" "unprognostic (9.89e-2)" "unprognostic (1.51e-1)" "unprognostic (2.64e-3)" "unprognostic (1.50e-1)" "unprognostic (9.31e-2)" "unprognostic (8.94e-3)" "unprognostic (1.17e-2)" "unprognostic (1.57e-1)" "unprognostic (3.32e-2)" "unprognostic (1.06e-2)" "unprognostic (3.78e-2)" "unprognostic (2.30e-2)" "unprognostic (2.00e-1)" "prognostic favourable (1.70e-4)" 12.7 10.8 6.2 8.5 7.6 7.5 10.4 9.4 10.1 12.2 22.2 5.1 11.7 13.6 9.3 11.2 18.1 8.2 9.2 10.3 6.2 7.6 22.7 32.3 8.3 11.2 8.9 7.5 11.2 15.7 8.8 7.9 9.0 10.6 10.2 11.4 7.6 14.3 13.0 18.9 9.7 26.1 17.2 11.5 9.1 12.3 7.5 6.5 6.8 15.8 12.7 8.1 10.2 8.1 3.0 2.6 2.1 5.8 3.8 5.2 2.1 6.5 2.5 3.7 4.1 2.8 5.1 8.8 10.1 4.8 3.8 2.9 3.2 6.2 7.1 4.4 7.7 8.1 4.1 8.1 4.3 8.4 3.6 8.4 6.7 3.9 12.8 12.3 8.8 8.3 9.8 2.4 10.5 5.6 3.9 3.0 7.7 4.1 5.7 16.9 6.4 4.6 1.0 8.2 7.8 11.9 6.6 1.2 9.5 4.8 8.8 18.5 10.5 14.7 7.4 4.6 4.4 9.5 9.3 4.5 3.2 8.9 18.5 9.3 5.4 2.1 2.0 1.3 4.5 3.3 4.8 3.0 5.0 5.2 1.9 2.5 4.2 4.3 0.9 3.8 5.8 2.6 3.8 2.1 6.2 7.6 9.4 10.1 6.2 7.6 8.9 7.5 10.6 6.5 R3HCC1L "C10orf28, GIDRP86, PSORT" ENSG00000166024 "R3H domain and coiled-coil containing 1 like" Q7Z5L2 10 98134624-98244897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037367 Enhanced Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA037367: AB_10696930" "unprognostic (3.00e-1)" "unprognostic (2.55e-2)" "unprognostic (1.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.67e-2)" "unprognostic (7.04e-2)" "unprognostic (1.15e-3)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (6.00e-2)" "unprognostic (1.55e-1)" "unprognostic (1.74e-3)" "unprognostic (7.39e-2)" "unprognostic (3.12e-1)" "unprognostic (1.49e-1)" "unprognostic (1.43e-2)" 14.5 8.2 9.5 14.9 12.9 19.1 13.0 16.4 11.4 11.1 12.9 8.9 10.3 8.0 11.4 13.0 12.0 8.0 7.7 8.1 10.2 6.2 9.6 10.8 10.9 13.8 11.9 5.4 9.3 10.1 15.6 20.7 14.4 11.8 13.7 13.1 12.9 12.0 9.5 10.0 14.1 15.0 10.1 16.7 13.2 9.4 25.2 12.5 17.1 11.0 6.9 15.7 11.5 16.0 10.2 6.0 18.6 12.9 10.2 13.9 5.5 10.5 6.9 10.6 9.3 9.1 9.7 8.8 12.0 16.8 11.8 13.1 9.4 7.6 14.9 6.5 7.1 12.1 10.6 7.2 13.3 11.2 7.2 8.8 5.4 10.5 11.2 12.0 10.8 8.9 8.3 10.3 15.4 7.5 7.6 9.3 9.1 10.1 9.5 12.5 7.6 9.1 9.7 12.1 6.0 8.5 6.3 3.6 7.8 6.2 4.5 23.4 8.2 7.6 8.3 7.9 8.5 8.8 9.0 9.5 10.0 25.6 11.3 12.6 5.8 10.7 6.9 18.6 9.9 9.4 8.8 10.2 10.2 10.0 5.3 9.5 9.0 8.8 8.5 10.2 12.9 6.0 13.9 5.5 9.5 12.9 16.4 11.4 10.2 6.2 11.9 5.4 11.8 12.5 RAD52 ENSG00000002016 "RAD52 homolog, DNA repair protein" P43351 12 912077-990053 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028957 Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA028957: " "unprognostic (4.53e-1)" "unprognostic (8.08e-3)" "unprognostic (4.68e-2)" "unprognostic (5.27e-2)" "unprognostic (7.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.82e-3)" "unprognostic (1.88e-1)" "unprognostic (2.80e-2)" "unprognostic (8.43e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-1)" "prognostic unfavourable (2.22e-6)" "unprognostic (1.54e-1)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (3.74e-2)" 7.4 8.5 12.4 8.1 15.1 5.0 10.0 18.8 15.9 12.6 11.7 14.5 13.6 9.4 12.5 14.2 8.2 11.0 9.0 7.8 14.3 7.3 9.9 10.5 6.9 8.9 15.0 9.6 17.6 11.4 9.6 15.6 8.5 15.0 10.5 11.7 9.5 8.4 11.0 16.5 14.9 10.4 12.8 17.0 10.3 8.8 6.8 20.9 9.4 14.6 4.3 9.7 9.7 13.3 7.0 9.6 7.4 3.8 4.0 6.0 1.4 3.1 12.2 9.6 10.7 10.5 7.9 10.3 6.4 5.9 7.0 7.0 11.7 11.2 10.0 2.0 6.3 9.4 7.3 4.3 6.3 13.5 6.5 11.2 11.8 8.1 5.9 12.0 3.4 4.6 7.5 7.4 22.8 5.9 7.4 5.8 6.8 6.7 8.1 11.9 12.4 8.0 8.3 9.4 3.7 7.3 5.8 3.4 3.9 8.2 8.9 4.5 8.2 5.9 5.8 9.9 11.9 7.7 6.6 2.2 3.5 10.5 5.1 5.1 3.6 7.4 3.4 2.0 4.6 2.9 6.0 4.8 4.9 4.0 4.4 7.0 5.7 5.2 2.8 4.0 3.8 9.6 4.4 1.4 12.4 15.1 18.8 15.9 14.3 7.3 15.0 9.6 15.0 20.9 RAF1 "c-Raf, CRAF, Raf-1" ENSG00000132155 "Raf-1 proto-oncogene, serine/threonine kinase" P04049 3 12583601-12664226 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 53.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 53.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002640, CAB019291" Approved Approved "Nuclear speckles" "Nuclear speckles" "CAB019291: , HPA002640: AB_1856047" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (5.92e-2)" "unprognostic (2.17e-3)" "unprognostic (6.51e-3)" "unprognostic (7.66e-3)" "unprognostic (2.66e-3)" "unprognostic (1.53e-2)" "unprognostic (2.72e-1)" "unprognostic (7.66e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-2)" "unprognostic (2.79e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (2.36e-2)" 19.5 15.6 15.1 14.7 17.1 32.2 17.5 35.2 18.9 19.9 20.3 21.1 19.6 18.4 24.9 15.7 24.6 18.6 20.2 39.3 15.3 11.0 21.7 36.2 19.7 15.7 16.0 13.4 24.9 31.3 30.7 16.9 24.8 14.3 18.8 19.2 25.0 18.3 18.4 79.7 23.9 29.6 23.7 13.8 22.1 23.7 16.7 17.8 27.7 26.9 27.9 26.1 20.5 20.4 6.6 9.3 53.9 9.9 8.5 8.6 7.7 15.1 17.4 26.6 20.5 23.1 18.7 53.5 23.1 39.2 30.6 34.8 13.6 12.5 15.9 11.1 35.8 9.7 28.0 20.5 31.9 27.7 21.9 21.4 21.0 12.6 23.4 20.8 20.3 17.2 20.7 31.5 25.6 21.9 15.5 41.8 29.5 25.9 26.7 15.3 27.0 23.7 21.6 23.4 20.0 18.3 22.9 8.3 17.5 18.9 18.3 12.3 30.4 27.5 15.7 21.1 20.1 17.6 25.7 32.6 51.8 34.2 18.2 24.3 22.4 11.3 9.7 18.4 7.4 9.9 7.5 6.6 7.3 7.2 9.3 6.3 7.5 7.6 53.9 8.5 9.6 4.2 8.6 7.7 15.1 17.1 35.2 18.9 15.3 11.0 16.0 13.4 14.3 17.8 RALGAPB "DKFZp781M2411, KIAA1219, RalGAPbeta" ENSG00000170471 "Ral GTPase activating protein non-catalytic beta subunit" Q86X10 20 38472816-38578861 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051454 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA051454: " "unprognostic (1.06e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-2)" "unprognostic (3.42e-3)" "unprognostic (1.34e-1)" "unprognostic (1.06e-1)" "unprognostic (2.72e-3)" "unprognostic (7.28e-2)" "unprognostic (2.33e-1)" "unprognostic (8.93e-3)" "unprognostic (2.71e-1)" "unprognostic (9.51e-2)" "prognostic favourable (7.25e-4)" "unprognostic (3.03e-1)" "unprognostic (3.95e-1)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" 18.0 19.4 13.9 16.9 22.2 14.3 21.6 28.1 25.4 17.5 16.6 21.2 14.9 15.6 25.3 17.6 18.7 15.3 14.3 15.3 14.3 15.2 19.7 11.6 15.6 14.6 15.5 13.5 17.4 15.5 39.2 34.9 21.5 19.9 19.7 17.8 18.6 17.1 17.9 21.3 19.7 22.3 17.2 13.6 18.5 16.5 25.4 16.2 32.1 24.0 12.3 22.9 22.4 15.5 3.3 3.6 6.1 3.4 5.6 4.8 1.5 13.0 12.3 12.9 9.4 12.4 14.4 13.7 10.7 12.6 13.5 13.3 22.1 9.9 12.3 10.3 12.5 15.5 12.0 16.3 19.1 7.0 5.1 18.8 11.1 12.6 11.8 15.2 10.0 10.2 21.2 15.9 17.5 17.5 13.7 12.3 12.9 8.6 17.4 6.4 9.4 16.1 10.0 18.4 8.2 9.0 24.6 13.6 15.0 23.8 32.2 20.0 18.7 7.8 20.7 27.3 10.9 15.4 10.8 14.4 17.6 11.2 19.8 7.5 12.0 3.1 2.3 6.1 3.3 1.8 4.6 3.3 4.8 4.3 3.6 3.0 4.1 3.5 4.6 5.6 3.4 2.4 1.9 1.5 13.9 22.2 28.1 25.4 14.3 15.2 15.5 13.5 19.9 16.2 RBM26 "ARRS2, C13orf10, FLJ20957, PPP1R132, PRO1777, SE70-2, ZC3H17" ENSG00000139746 "RNA binding motif protein 26" Q5T8P6 13 79311824-79406477 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040252 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA040252: AB_10672895" "unprognostic (5.55e-2)" "unprognostic (4.55e-1)" "unprognostic (2.65e-1)" "unprognostic (3.09e-2)" "unprognostic (3.03e-1)" "unprognostic (2.57e-1)" "unprognostic (3.05e-3)" "unprognostic (2.18e-1)" "unprognostic (8.80e-2)" "unprognostic (1.81e-1)" "unprognostic (2.30e-2)" "prognostic unfavourable (3.46e-4)" "prognostic unfavourable (5.87e-6)" "unprognostic (8.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.47e-2)" "prognostic favourable (8.20e-4)" 18.0 23.7 25.1 23.2 35.2 28.0 22.9 47.3 30.2 22.1 16.4 21.9 18.4 16.0 25.2 25.8 18.2 21.4 15.5 15.6 23.7 17.7 14.7 17.4 18.7 32.4 24.7 18.5 30.5 24.8 20.3 34.4 20.9 25.5 19.5 19.8 16.2 20.0 17.7 20.9 27.9 23.5 18.6 23.4 29.1 20.4 25.1 27.8 37.0 22.9 15.2 28.9 17.6 18.2 9.4 4.3 6.0 3.3 3.7 7.5 1.6 20.3 10.9 26.9 13.7 12.1 12.9 14.7 14.0 11.8 14.6 15.1 14.5 17.3 30.5 11.5 10.3 19.4 20.1 13.7 21.2 18.3 21.5 23.5 24.3 13.1 9.5 43.7 18.8 8.6 11.5 14.9 20.9 15.2 17.8 10.2 16.1 6.8 26.5 23.2 16.6 6.5 26.8 22.4 16.1 13.4 11.7 20.5 13.8 12.0 14.5 8.5 13.1 36.5 14.4 12.4 12.4 9.9 14.1 14.8 12.9 38.0 20.1 24.6 14.7 6.0 2.4 4.4 5.0 3.3 5.2 6.2 5.0 4.7 1.4 9.4 7.5 6.6 3.3 3.7 2.4 4.3 5.2 1.6 25.1 35.2 47.3 30.2 23.7 17.7 24.7 18.5 25.5 27.8 RBM27 "ARRS1, KIAA1311, Psc1, ZC3H20" ENSG00000091009 "RNA binding motif protein 27" Q9P2N5 5 146203600-146289132 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA035944, HPA036422" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA035944: AB_10670672, HPA036422: AB_10669987" "unprognostic (8.18e-2)" "unprognostic (3.17e-1)" "unprognostic (6.04e-2)" "unprognostic (7.03e-2)" "unprognostic (2.75e-2)" "unprognostic (2.04e-3)" "prognostic unfavourable (8.58e-4)" "unprognostic (4.73e-2)" "unprognostic (4.59e-2)" "unprognostic (1.65e-2)" "unprognostic (1.19e-2)" "unprognostic (2.90e-2)" "unprognostic (1.16e-2)" "unprognostic (4.49e-2)" "unprognostic (5.51e-2)" "unprognostic (6.67e-3)" "unprognostic (4.09e-3)" 17.1 11.7 14.4 19.0 18.1 28.8 16.3 21.2 18.3 16.0 17.4 11.3 13.0 12.7 18.0 14.4 15.8 14.8 11.1 14.4 13.6 11.3 14.1 17.8 13.5 18.2 13.2 14.6 20.1 12.7 18.7 15.3 15.5 14.4 15.1 14.6 11.6 15.5 12.1 23.4 15.1 15.9 19.2 13.7 15.1 14.4 16.4 13.9 26.4 18.9 14.3 18.6 18.6 16.3 5.2 4.3 5.1 4.7 6.0 6.6 2.4 10.1 8.3 10.7 17.2 9.4 9.0 12.4 7.5 8.5 11.1 12.2 14.5 13.1 21.5 5.9 8.5 10.6 15.9 17.3 19.7 16.3 7.1 14.8 9.3 9.9 10.3 22.9 17.1 8.3 9.1 11.9 21.1 9.8 16.1 13.0 10.4 9.1 16.5 11.5 14.8 9.4 14.9 16.8 14.7 11.1 11.3 13.5 9.2 15.5 15.1 11.9 17.7 12.6 9.4 11.9 12.6 8.8 12.1 12.5 11.8 25.4 8.9 16.8 11.0 4.9 2.8 5.1 5.0 4.3 5.7 4.5 5.0 5.7 3.6 5.2 6.6 5.2 4.2 6.0 4.7 4.3 4.9 2.4 14.4 18.1 21.2 18.3 13.6 11.3 13.2 14.6 14.4 13.9 RBM41 FLJ11016 ENSG00000089682 "RNA binding motif protein 41" Q96IZ5 X 107064420-107118823 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042881 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA042881: AB_10794536" "unprognostic (1.07e-2)" "unprognostic (1.55e-1)" "unprognostic (4.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.39e-1)" "unprognostic (2.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-2)" "unprognostic (1.98e-2)" "unprognostic (2.19e-3)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.04e-4)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" "unprognostic (2.80e-2)" "unprognostic (1.92e-1)" 10.0 10.3 9.2 9.1 10.8 5.0 9.5 23.7 14.2 13.4 11.9 10.1 8.2 12.7 12.2 11.5 11.1 12.4 7.6 8.8 8.7 6.8 11.8 13.7 8.3 8.9 9.7 9.4 9.7 10.6 21.0 14.1 12.0 11.6 10.8 11.2 9.0 10.7 9.0 14.6 11.6 15.5 11.2 14.2 11.5 8.2 15.6 12.8 12.2 15.7 8.0 9.9 12.4 9.8 6.3 4.8 10.6 7.0 8.6 6.3 3.4 14.1 11.4 7.3 5.9 4.9 8.6 8.5 8.4 8.3 6.2 8.4 7.5 11.9 7.8 15.9 6.1 11.8 10.6 7.8 9.5 9.6 15.7 9.5 20.6 9.2 5.5 9.6 7.5 6.0 15.6 7.5 7.6 9.3 16.3 10.9 7.5 6.8 8.1 5.5 10.8 13.1 6.6 6.1 6.7 9.2 9.0 6.1 9.6 10.5 7.6 6.7 6.9 5.0 9.0 8.7 5.1 10.3 6.6 5.1 9.4 8.7 4.9 4.4 6.5 10.6 7.0 10.6 6.3 3.7 3.9 6.3 5.5 6.3 4.7 6.3 4.1 2.8 1.0 8.6 3.7 4.8 4.9 3.4 9.2 10.8 23.7 14.2 8.7 6.8 9.7 9.4 11.6 12.8 RBM6 "3G2, DEF-3, DEF3, g16, NY-LU-12" ENSG00000004534 "RNA binding motif protein 6" P78332 3 49940007-50100045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026272, HPA027164" Enhanced Approved "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles" "Cytoplasmic bodies" "HPA026272: AB_1847592, HPA027164: AB_1847593" "unprognostic (3.81e-3)" "unprognostic (2.13e-1)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (4.53e-2)" "unprognostic (2.88e-2)" "unprognostic (1.40e-2)" "unprognostic (7.97e-3)" "unprognostic (8.84e-3)" "unprognostic (5.09e-2)" "prognostic favourable (1.41e-4)" "unprognostic (4.31e-2)" "prognostic unfavourable (8.83e-4)" "unprognostic (7.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.45e-1)" "prognostic favourable (5.13e-5)" 24.4 30.2 30.2 51.3 37.1 30.0 25.1 49.4 41.1 31.2 31.0 28.9 38.5 30.3 51.4 34.3 21.8 28.8 32.6 25.3 32.1 19.8 29.2 30.6 26.8 39.8 38.1 26.0 42.6 35.9 41.9 36.9 21.9 30.5 40.1 29.8 25.6 28.1 38.3 25.3 35.9 32.4 36.7 40.9 42.6 28.0 29.7 38.0 24.9 32.6 21.9 35.9 25.1 36.6 12.8 9.9 14.7 8.6 7.3 15.6 5.9 9.6 6.1 25.1 16.7 25.7 14.1 8.9 16.3 14.2 14.4 15.2 10.6 10.9 49.5 9.6 16.2 8.0 21.4 14.4 18.3 19.8 8.0 22.9 14.1 13.7 14.6 24.1 23.8 13.1 17.8 16.3 18.4 18.1 18.8 12.5 13.7 9.1 22.6 35.8 20.1 11.2 8.7 10.8 12.6 14.3 18.8 9.9 17.9 14.9 10.8 10.2 8.4 19.0 16.8 14.4 17.2 11.7 16.5 17.2 40.7 29.8 8.3 20.2 14.1 14.7 8.6 5.0 15.6 4.7 12.1 12.8 10.2 8.5 8.8 11.9 10.5 11.5 6.1 7.3 7.7 9.9 6.7 5.9 30.2 37.1 49.4 41.1 32.1 19.8 38.1 26.0 30.5 38.0 RCAN3 DSCR1L2 ENSG00000117602 "RCAN family member 3" Q9UKA8 1 24502351-24541040 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 37.0" "Group enriched" "Detected in many" 4 "MAIT T-cell: 5.6;memory CD4 T-cell: 14.0;memory CD8 T-cell: 5.0;naive CD4 T-cell: 19.2;naive CD8 T-cell: 9.9;T-reg: 19.2" "Lineage enriched" "Detected in many" 7 "T-cells: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034533, HPA064289" Enhanced Approved "Nucleoli fibrillar center,Nuclear speckles" "Nuclear speckles" "Nucleoli fibrillar center" "HPA034533: AB_10601481, HPA064289: " "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (4.01e-2)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "unprognostic (4.20e-3)" "unprognostic (3.41e-3)" "unprognostic (3.66e-2)" "unprognostic (6.42e-2)" "unprognostic (2.47e-1)" "unprognostic (1.72e-3)" "unprognostic (7.44e-2)" "unprognostic (3.52e-3)" "unprognostic (9.83e-2)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "unprognostic (4.71e-2)" 3.2 1.5 2.7 15.8 4.0 4.7 7.6 37.0 3.7 3.9 5.0 7.6 3.2 5.2 3.2 7.7 12.6 11.2 6.5 3.1 3.3 7.8 5.3 2.1 8.1 27.2 5.5 1.9 2.0 15.0 5.5 15.0 7.0 7.6 27.7 5.2 6.1 17.4 4.8 1.6 10.0 6.7 2.6 7.9 7.9 13.2 2.6 2.9 17.2 11.7 8.6 23.2 6.0 6.3 2.8 1.5 1.4 0.9 1.9 19.2 4.2 10.3 8.1 0.1 2.5 2.2 5.2 9.5 7.0 3.8 5.6 5.3 2.3 13.8 7.7 6.4 11.8 9.8 7.3 8.9 6.1 7.4 4.4 0.8 2.1 7.1 1.4 2.5 6.8 1.8 6.7 1.9 2.9 1.2 1.1 0.3 2.5 3.4 6.7 4.0 10.9 6.0 2.7 0.1 0.2 4.2 8.9 22.2 5.5 5.6 7.3 21.7 7.6 5.3 8.1 6.7 8.0 0.4 4.8 10.5 12.6 9.9 2.8 10.6 7.7 1.4 0.9 1.1 0.7 0.5 5.6 2.6 14.0 5.0 1.5 2.8 19.2 9.9 0.3 1.9 0.2 1.1 19.2 4.2 2.7 4.0 37.0 3.7 3.3 7.8 5.5 1.9 7.6 2.9 RFPL1 RNF78 ENSG00000128250 "Ret finger protein like 1" O75677 22 29438583-29442455 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.4" "Cell line enhanced" "Detected in some" "HDLM-2: 10.9;HMC-1: 4.2;Karpas-707: 4.5;SH-SY5Y: 5.7;SiHa: 2.7;THP-1: 5.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA048320: , HPA072380: " "unprognostic (4.54e-1)" "unprognostic (6.63e-8)" "unprognostic (3.14e-3)" "unprognostic (1.89e-1)" 0.0 3.3 0.2 0.1 0.7 0.0 0.0 0.4 20.4 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 1.9 0.0 0.1 0.4 2.8 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 4.5 0.0 0.0 0.0 0.4 1.6 0.9 0.0 1.8 0.0 1.2 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.9 0.7 0.0 1.0 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 5.7 2.7 0.0 0.0 0.0 5.2 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 1.2 0.8 0.0 0.6 1.0 0.9 1.6 0.1 1.1 0.0 0.0 1.8 0.0 1.2 0.5 RFPL2 RNF79 ENSG00000128253 "Ret finger protein like 2" O75678 22 32190435-32203477 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 7.9;prostate: 10.8" "Cell line enhanced" "Detected in some" "A549: 2.4;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2" "Cancer enriched" "Detected in single" 15 "prostate cancer: 5.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA046608, HPA048320, HPA072380" Approved Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA046608: , HPA048320: , HPA072380: " "unprognostic (3.81e-2)" "unprognostic (4.05e-2)" "unprognostic (8.29e-2)" "unprognostic (9.66e-3)" "unprognostic (2.54e-1)" "unprognostic (9.90e-2)" "unprognostic (2.59e-1)" "unprognostic (6.02e-3)" "unprognostic (2.22e-2)" "unprognostic (3.44e-2)" "unprognostic (8.64e-3)" "prognostic favourable (4.16e-4)" "unprognostic (2.04e-4)" "unprognostic (6.02e-2)" "unprognostic (3.28e-2)" "unprognostic (5.62e-7)" "unprognostic (3.50e-2)" 0.1 0.3 2.3 0.2 3.9 1.1 0.1 2.7 7.9 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 3.1 5.6 0.2 0.5 0.1 0.4 1.9 0.1 0.1 0.1 0.0 0.1 10.8 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.5 0.0 0.8 0.0 1.2 0.2 0.0 2.4 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.2 1.8 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.1 0.8 0.0 1.2 1.2 0.5 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 RFPL3 RNF120 ENSG00000128276 "Ret finger protein like 3" O75679 22 32354885-32361161 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.4" "Cell line enhanced" "Detected in some" "BEWO: 3.7;NB-4: 4.7;U-266/70: 5.5;U-266/84: 5.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA048320: , HPA072380: " "unprognostic (1.63e-1)" "unprognostic (9.90e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.97e-1)" "unprognostic (3.25e-2)" "unprognostic (4.31e-2)" "unprognostic (1.90e-1)" "unprognostic (6.32e-2)" 0.0 0.0 0.3 0.0 0.3 1.0 0.0 0.7 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.4 0.2 0.6 0.5 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.3 1.1 0.2 0.0 0.1 0.5 0.0 23.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.2 0.1 0.8 2.4 0.7 0.0 0.0 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 2.3 1.1 0.1 0.1 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.8 1.3 4.7 0.2 0.1 2.4 0.5 0.6 0.0 0.4 1.7 0.5 0.1 0.4 1.3 0.0 0.4 0.0 0.0 0.9 0.3 0.0 5.5 5.4 0.1 0.1 1.6 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 RFXAP ENSG00000133111 "Regulatory factor X associated protein" O00287 13 36819224-36829104 "Disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding SCID "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032035 Approved "Nuclear speckles" "Nuclear speckles" "HPA032035: " "unprognostic (2.03e-1)" "unprognostic (9.69e-2)" "unprognostic (7.40e-2)" "unprognostic (3.13e-1)" "unprognostic (5.14e-3)" "unprognostic (4.45e-3)" "unprognostic (1.15e-2)" "prognostic favourable (2.26e-5)" "unprognostic (1.45e-1)" "unprognostic (2.94e-1)" "prognostic favourable (4.18e-4)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "prognostic favourable (4.91e-4)" "unprognostic (2.81e-2)" "unprognostic (4.09e-1)" "unprognostic (5.99e-3)" 8.5 6.7 15.0 8.8 14.4 9.2 9.0 31.8 15.6 12.7 9.5 12.3 8.4 5.7 13.1 10.2 5.8 10.9 7.7 6.4 13.0 9.1 6.2 5.0 8.1 11.5 13.3 10.8 13.9 9.3 11.9 14.2 7.0 11.3 10.3 8.1 9.8 8.8 11.3 8.1 6.5 8.7 11.1 10.5 9.1 7.9 11.7 14.5 19.7 11.2 4.6 9.8 8.0 8.1 1.4 1.9 2.4 0.6 0.7 1.3 0.0 4.5 1.1 6.6 9.2 2.5 3.4 4.2 3.6 3.9 6.9 4.3 3.2 3.7 19.8 3.1 3.3 4.2 6.8 2.2 7.9 14.8 11.3 9.5 5.0 6.2 4.5 17.3 7.0 3.1 4.1 3.4 2.6 5.2 5.4 4.0 2.1 2.2 17.3 12.4 7.0 2.0 15.2 12.3 5.9 2.9 2.8 5.4 6.8 3.6 2.4 2.8 2.4 10.4 4.0 1.8 3.9 6.2 3.3 3.8 3.1 15.0 5.1 12.1 2.8 0.0 0.1 2.4 1.0 0.0 0.8 1.4 0.6 1.1 0.1 0.5 0.7 1.3 0.0 0.7 0.6 1.9 1.1 0.0 15.0 14.4 31.8 15.6 13.0 9.1 13.3 10.8 11.3 14.5 RIOK1 "AD034, bA288G3.1, FLJ30006, RRP10" ENSG00000124784 "RIO kinase 1" Q9BRS2 6 7389496-7418037 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017866, HPA051446" Enhanced Approved "Nucleoli,Nuclear speckles,Cytosol" "Nucleoli, Nuclear speckles" Cytosol "HPA017866: , HPA051446: " "unprognostic (2.33e-2)" "unprognostic (1.24e-1)" "unprognostic (2.38e-1)" "unprognostic (1.03e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "prognostic unfavourable (3.41e-5)" "unprognostic (2.23e-1)" "prognostic unfavourable (4.43e-4)" "unprognostic (3.45e-2)" "unprognostic (1.47e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (5.85e-5)" "unprognostic (2.33e-1)" "unprognostic (2.09e-1)" "unprognostic (6.12e-3)" "unprognostic (2.59e-2)" 13.8 10.6 7.7 13.2 13.0 17.5 13.1 12.2 13.5 12.7 11.6 7.3 4.0 7.3 15.4 6.0 15.6 12.3 8.5 11.8 8.0 8.1 8.7 11.7 10.1 14.2 11.6 9.4 13.8 15.3 7.7 17.8 13.9 13.3 10.7 9.6 7.2 10.2 10.3 18.8 12.5 9.9 15.5 9.4 14.4 10.3 21.3 9.2 19.2 10.1 14.7 16.8 10.9 12.6 15.4 14.9 7.7 11.1 18.6 15.0 8.2 7.5 4.4 7.1 16.7 11.1 9.1 10.9 9.5 6.4 8.9 7.4 12.8 3.9 19.7 16.9 7.7 7.7 17.9 7.6 11.4 13.0 19.3 10.5 7.1 13.7 9.4 30.2 13.8 6.7 10.6 9.6 19.8 7.8 26.8 4.6 8.3 9.9 20.5 14.3 15.3 10.4 15.8 9.3 21.4 5.0 7.4 23.7 11.7 8.0 4.8 13.8 7.3 10.0 7.8 9.8 7.4 6.4 14.3 6.4 12.1 29.3 3.0 15.6 14.9 7.7 8.5 5.9 11.5 11.1 13.8 15.2 11.9 12.1 14.9 15.4 13.7 15.0 1.7 18.6 9.7 12.4 11.3 8.2 7.7 13.0 12.2 13.5 8.0 8.1 11.6 9.4 13.3 9.2 RNF112 "BFP, ZNF179" ENSG00000128482 "Ring finger protein 112" Q9ULX5 17 19411125-19417276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;fHDF/TERT166: 4.7;SCLC-21H: 4.7;SH-SY5Y: 8.2;U-87 MG: 26.9" "Cancer enriched" "Detected in some" 8 "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015970 Supported Approved "Nuclear speckles" "Nuclear speckles" "HPA015970: AB_1859103" "unprognostic (1.16e-1)" "unprognostic (3.74e-1)" "unprognostic (8.43e-5)" "unprognostic (3.65e-2)" "unprognostic (2.96e-2)" "unprognostic (6.02e-2)" "unprognostic (1.27e-1)" "unprognostic (2.88e-1)" "unprognostic (4.26e-1)" "unprognostic (5.02e-2)" "unprognostic (3.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.31e-9)" "unprognostic (1.32e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" "unprognostic (4.24e-1)" 2.5 8.1 11.3 2.3 15.9 0.6 1.8 47.5 29.1 1.2 3.6 1.4 0.0 2.9 2.0 6.9 1.1 1.5 4.4 2.3 12.4 8.2 1.2 0.7 1.7 1.4 3.9 14.1 1.3 0.8 0.5 1.9 1.1 3.1 10.2 4.4 1.6 1.3 3.5 2.1 1.9 3.6 3.5 2.9 1.7 2.1 2.0 3.7 0.0 0.9 0.0 0.8 2.8 1.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 4.1 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.0 1.7 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.1 0.1 0.1 0.0 0.0 4.7 8.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 26.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 15.9 47.5 15.9 12.4 8.2 3.9 14.1 3.1 3.7 RPL3L ENSG00000140986 "Ribosomal protein L3 like" Q92901 16 1943974-1957606 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 49.0;skeletal muscle: 148.3;tongue: 36.7" "Cell line enhanced" "Detected in many" "CACO-2: 7.6;Karpas-707: 5.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049136 Enhanced Approved "Nuclear speckles" "Nuclear speckles" "HPA049136: " "unprognostic (2.53e-1)" "unprognostic (2.63e-2)" "unprognostic (9.27e-4)" "unprognostic (6.38e-4)" "unprognostic (4.36e-2)" "unprognostic (3.48e-3)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.19e-2)" "unprognostic (2.00e-1)" "unprognostic (2.46e-2)" "unprognostic (4.53e-3)" "unprognostic (3.32e-1)" "unprognostic (4.24e-1)" "unprognostic (8.32e-3)" "unprognostic (4.60e-2)" 1.1 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 1.4 0.0 0.1 49.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 2.8 0.0 148.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 36.7 2.1 0.0 0.0 1.8 1.7 4.9 1.5 0.9 1.4 0.5 2.1 2.4 0.5 2.3 0.1 0.1 1.4 0.9 0.0 0.1 0.0 7.6 4.1 1.3 1.4 0.0 2.1 0.2 0.2 0.0 1.0 1.2 0.8 1.7 2.6 0.0 0.5 0.9 0.2 0.3 0.2 0.2 0.0 0.8 5.6 0.1 1.2 1.6 1.9 1.3 4.9 0.7 0.7 1.7 0.3 0.8 3.3 1.0 1.0 2.7 1.2 1.4 1.1 1.1 1.1 2.8 1.6 0.8 2.5 1.1 1.1 1.6 0.6 0.4 1.6 1.5 1.3 1.4 1.1 0.9 1.4 1.1 1.2 0.5 1.8 1.2 1.4 4.9 0.9 1.0 1.7 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RSRC1 "BM-011, MGC12197, SFRS21, SRrp53" ENSG00000174891 "Arginine and serine rich coiled-coil 1" Q96IZ7 3 158105855-158545730 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044792 Supported Approved "Nuclear speckles" "Nuclear speckles" "HPA044792: AB_10794502" "unprognostic (1.06e-2)" "unprognostic (8.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavourable (7.40e-5)" "unprognostic (5.18e-1)" "unprognostic (1.17e-1)" "unprognostic (3.60e-3)" "unprognostic (2.91e-2)" "unprognostic (2.86e-2)" "unprognostic (5.71e-2)" "unprognostic (2.53e-3)" "unprognostic (8.84e-2)" "unprognostic (7.98e-3)" "unprognostic (3.48e-2)" "unprognostic (9.71e-2)" "unprognostic (2.71e-1)" "unprognostic (2.15e-1)" 26.2 24.4 23.8 16.6 25.6 18.7 23.0 43.0 32.3 22.6 17.3 17.7 12.2 12.3 19.4 19.2 18.2 14.6 14.7 20.1 23.8 27.0 22.1 23.1 13.2 17.9 26.5 22.5 18.8 21.5 22.8 28.2 16.5 31.9 19.3 20.7 12.5 16.7 21.5 22.8 15.4 14.3 20.7 33.7 19.5 16.4 14.8 23.2 24.0 24.1 13.3 19.9 19.6 16.2 24.5 33.8 17.6 21.6 9.4 15.7 6.6 30.9 14.9 11.8 15.1 27.9 19.5 15.4 15.6 13.6 17.8 19.8 20.6 23.8 29.8 29.1 19.0 13.9 21.8 14.0 26.6 45.1 18.6 30.8 13.1 16.8 4.4 26.1 19.9 14.1 13.5 13.9 12.4 8.3 17.9 22.4 13.5 25.3 20.3 17.5 9.8 14.4 23.9 20.1 36.2 13.1 10.3 20.3 23.1 17.2 11.9 19.2 27.1 22.7 9.2 22.3 13.4 28.8 30.6 18.9 20.2 32.0 22.7 35.6 27.3 17.6 19.8 10.3 14.8 21.6 15.6 24.5 15.7 14.8 11.9 24.1 14.9 15.7 13.7 9.4 19.9 33.8 12.5 6.6 23.8 25.6 43.0 32.3 23.8 27.0 26.5 22.5 31.9 23.2 RSRC2 FLJ11021 ENSG00000111011 "Arginine and serine rich coiled-coil 2" Q7L4I2 12 122503458-122527000 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040070, HPA048183" Uncertain Approved "Nucleoli fibrillar center,Nuclear speckles,Cytosol" "Nuclear speckles" "Nucleoli fibrillar center, Cytosol" "HPA040070: AB_10673430, HPA048183: " "unprognostic (4.76e-2)" "unprognostic (1.41e-1)" "unprognostic (1.32e-2)" "unprognostic (1.44e-1)" "unprognostic (6.42e-3)" "unprognostic (6.90e-2)" "prognostic unfavourable (2.05e-4)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" "unprognostic (2.74e-2)" "unprognostic (3.26e-1)" "unprognostic (3.19e-2)" "unprognostic (1.06e-2)" "unprognostic (2.23e-2)" "unprognostic (8.87e-2)" "unprognostic (4.84e-2)" "unprognostic (1.53e-2)" 18.5 19.4 24.8 20.2 31.9 82.6 20.1 34.9 45.9 19.3 21.0 16.0 19.9 14.3 21.4 21.4 26.9 19.6 21.0 20.2 28.9 21.4 20.6 18.2 19.1 23.0 24.9 24.1 25.2 19.0 11.3 43.2 20.6 28.1 20.0 18.6 10.7 19.1 21.3 36.8 18.7 19.2 20.4 45.1 18.6 16.0 20.7 29.4 21.1 23.5 17.7 15.7 25.0 28.0 24.6 16.3 22.3 18.4 16.4 19.3 9.8 11.7 14.2 13.5 5.7 10.7 7.0 9.7 21.8 7.0 9.4 5.3 19.9 5.0 13.4 18.6 7.6 7.6 14.7 6.1 9.2 12.6 13.6 23.4 17.2 21.2 5.9 20.1 14.3 8.7 7.2 8.0 13.6 6.6 14.9 8.4 8.2 9.4 14.5 15.0 11.1 11.7 11.1 12.2 8.7 12.1 22.1 10.9 9.8 17.0 5.7 12.0 9.2 7.4 9.9 9.6 11.6 10.6 11.9 9.6 22.3 21.6 6.1 11.6 5.4 19.8 16.6 22.3 16.4 13.5 13.9 22.8 15.0 13.3 16.3 24.6 19.3 15.2 17.7 16.4 18.4 15.4 19.0 9.8 24.8 31.9 34.9 45.9 28.9 21.4 24.9 24.1 28.1 29.4 RTEL1 "bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL" ENSG00000258366 "Regulator of telomere elongation helicase 1" Q9NZ71 20 63657810-63696253 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA020622, HPA067329, HPA078328" Approved "Nuclear speckles,Nuclear bodies" "Nuclear speckles, Nuclear bodies" "HPA020622: , HPA067329: , HPA078328: " "unprognostic (3.63e-2)" "unprognostic (8.08e-3)" "unprognostic (4.80e-2)" "unprognostic (1.12e-1)" "unprognostic (4.27e-1)" "unprognostic (9.30e-3)" "unprognostic (2.59e-1)" "unprognostic (3.64e-2)" "unprognostic (3.30e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (9.50e-2)" "unprognostic (8.77e-3)" "unprognostic (1.17e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" "unprognostic (8.84e-2)" 8.4 14.3 9.4 11.5 12.4 14.2 7.9 25.6 11.8 9.1 11.1 11.2 10.9 9.8 15.4 7.4 7.0 9.5 9.3 6.2 8.0 6.9 7.1 7.2 8.9 7.8 7.5 12.1 10.6 17.8 7.2 18.2 9.8 8.2 10.2 4.8 10.2 12.9 10.2 10.2 8.2 10.1 8.8 4.4 11.6 10.4 17.6 8.9 9.1 11.9 4.9 9.5 9.3 9.0 1.7 3.6 0.0 3.3 0.4 3.0 2.4 5.2 7.2 5.2 10.0 1.1 1.2 9.6 10.9 2.9 17.0 4.5 14.4 4.5 7.1 5.7 3.3 9.9 3.5 7.1 4.1 3.5 7.3 8.7 12.5 13.7 3.8 8.5 16.0 1.5 4.0 4.2 5.2 5.8 10.8 6.7 3.8 5.6 13.2 11.0 5.1 15.2 10.6 4.9 7.3 2.7 6.5 10.3 6.2 6.1 17.8 1.3 4.7 9.6 7.7 19.3 6.3 6.6 8.3 6.2 2.6 4.4 4.7 6.0 6.7 0.0 2.7 0.0 3.0 3.3 1.6 0.9 1.7 2.0 3.6 1.7 2.9 1.1 0.0 0.4 2.6 3.2 1.4 2.4 9.4 12.4 25.6 11.8 8.0 6.9 7.5 12.1 8.2 8.9 RTL6 "dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3" ENSG00000188636 "Retrotransposon Gag like 6" Q6ICC9 22 44492572-44498298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005697 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA005697: AB_1079244" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (1.57e-1)" "unprognostic (9.64e-3)" "unprognostic (5.40e-2)" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.57e-2)" "unprognostic (1.65e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" 11.6 14.1 19.3 7.7 17.4 3.2 10.2 16.2 30.0 13.6 12.2 14.7 15.2 9.7 17.8 14.2 9.4 19.1 12.4 16.7 17.1 16.1 10.9 4.9 10.4 6.3 16.9 11.4 22.6 12.1 18.9 9.9 5.9 11.9 11.5 10.4 9.2 7.7 16.3 15.5 3.7 9.2 19.0 16.5 7.9 10.7 12.6 9.5 14.4 11.6 7.2 5.3 11.8 10.2 0.2 1.1 0.1 1.4 0.9 4.5 2.1 6.9 9.7 12.6 16.7 9.9 8.1 3.3 9.2 11.0 13.0 10.3 3.2 4.1 0.0 5.8 17.2 6.1 8.5 9.1 8.1 3.3 16.5 0.0 18.7 0.0 12.2 0.9 4.6 8.7 8.9 11.9 9.2 11.6 3.9 0.0 8.8 12.3 22.1 2.0 7.7 10.4 6.1 6.7 0.0 11.2 8.1 13.6 15.9 15.1 7.3 9.3 7.3 9.8 11.9 10.2 13.9 13.5 7.4 4.4 1.7 0.0 15.2 2.3 15.2 0.0 1.4 0.1 4.3 0.6 4.5 0.0 2.5 3.6 1.1 0.2 1.0 2.5 0.0 0.9 0.8 0.1 0.4 2.1 19.3 17.4 16.2 27.8 17.1 16.1 16.9 11.4 11.9 9.5 RTN2 "NSP2, NSPL1, SPG12" ENSG00000125744 "Reticulon 2" O75298 19 45485289-45497061 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "skeletal muscle: 155.7;tongue: 43.2" "Cell line enhanced" "Detected in many" "RH-30: 23.2;RT4: 23.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 9.1;eosinophil: 3.5;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 11 "dendritic cells: 2.4;granulocytes: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034941, HPA034948" Approved Approved "Nuclear speckles" 16000 "Nuclear speckles" "HPA034941: AB_10671358, HPA034948: " "unprognostic (3.08e-1)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (5.07e-3)" "unprognostic (1.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.89e-2)" "unprognostic (3.09e-1)" "unprognostic (6.44e-2)" "unprognostic (5.10e-3)" "unprognostic (2.96e-2)" "prognostic unfavourable (5.58e-6)" "unprognostic (4.34e-1)" "unprognostic (3.23e-1)" "unprognostic (2.21e-1)" "unprognostic (2.03e-1)" 3.4 3.1 6.9 1.9 9.0 1.3 3.4 5.9 10.4 2.5 4.2 1.0 3.7 1.8 3.4 6.7 5.4 2.0 3.5 5.4 7.4 4.8 1.4 1.7 2.6 2.2 4.8 3.7 1.0 2.5 2.2 1.6 11.4 4.6 5.1 1.6 2.6 6.5 4.8 155.7 2.6 1.8 3.3 1.4 2.6 1.9 1.2 1.0 0.0 1.8 43.2 3.5 4.2 1.5 0.1 2.4 9.1 0.5 0.3 0.0 0.5 1.9 2.6 4.5 3.5 7.8 9.6 8.9 4.4 10.5 2.7 5.3 5.3 1.7 1.7 6.1 4.7 3.7 2.9 2.1 0.8 4.0 4.3 11.6 1.9 3.9 3.4 0.7 13.2 10.5 1.1 1.2 2.2 5.0 6.3 3.2 8.1 1.5 0.0 2.1 3.3 3.4 2.0 23.2 9.3 1.5 23.0 12.7 12.2 0.9 21.4 6.7 16.8 4.6 4.4 7.8 2.4 0.2 0.9 1.8 4.3 3.8 2.1 2.7 3.9 9.1 0.2 3.5 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.3 0.5 2.4 0.0 0.5 6.9 9.0 5.9 10.4 7.4 4.8 4.8 3.7 4.6 1.0 RUFY1 "FLJ22251, RABIP4, ZFYVE12" ENSG00000176783 "RUN and FYVE domain containing 1" Q96T51 5 179550558-179610026 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038804 Approved Supported "Nuclear speckles,Vesicles,Cytosol" 9600 "Vesicles, Cytosol" "Nuclear speckles" "HPA038804: AB_10673290" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.50e-1)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (9.74e-2)" "unprognostic (1.31e-1)" "unprognostic (2.73e-2)" "unprognostic (3.60e-1)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" 20.9 27.9 19.7 24.7 22.4 21.1 36.9 22.4 18.9 18.2 20.2 16.9 27.9 16.9 22.5 16.9 25.9 18.8 20.7 14.8 19.7 14.8 23.9 17.5 20.8 23.1 18.8 17.1 19.4 19.8 22.6 21.5 17.3 19.7 20.9 15.5 16.4 21.2 18.3 26.7 24.2 18.8 17.5 14.7 27.9 18.6 12.2 20.5 20.1 27.3 14.1 20.1 20.7 34.3 3.2 3.4 7.9 4.5 1.2 2.9 21.5 7.1 11.8 6.3 8.3 12.2 10.1 7.2 12.7 9.1 7.5 8.8 11.4 16.7 11.6 7.2 15.4 6.6 11.5 16.6 8.9 36.6 8.7 20.2 9.0 8.2 12.5 11.2 11.1 10.2 9.2 5.1 14.6 8.2 8.2 11.1 6.7 21.6 11.9 7.8 6.7 5.5 10.7 4.5 10.7 12.6 11.7 6.3 9.0 18.6 12.0 6.6 9.6 13.8 9.8 10.0 3.3 5.3 9.9 6.9 10.6 20.8 9.2 20.3 9.1 7.4 3.4 7.9 1.7 3.6 1.0 2.7 2.0 1.7 3.0 3.2 1.4 1.8 5.9 1.2 4.5 3.4 2.9 21.5 19.7 22.4 22.4 18.9 19.7 14.8 18.8 17.1 19.7 20.5 RUNDC1 DKFZp761H0421 ENSG00000198863 "RUN domain containing 1" Q96C34 17 42980565-42993690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023726 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA023726: AB_2184078" "unprognostic (4.24e-2)" "unprognostic (1.26e-1)" "unprognostic (9.39e-2)" "prognostic favourable (6.93e-5)" "unprognostic (9.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.40e-2)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (3.84e-2)" "unprognostic (1.22e-1)" "unprognostic (1.53e-3)" "unprognostic (2.87e-3)" "unprognostic (1.25e-1)" "unprognostic (1.12e-2)" "unprognostic (4.77e-3)" 7.3 11.0 23.4 8.7 23.1 8.4 14.7 18.6 24.6 13.0 12.9 7.9 12.2 9.0 12.3 17.9 9.0 20.9 9.5 8.7 17.2 13.0 12.1 6.6 9.6 9.3 9.2 16.9 7.7 14.2 17.7 17.2 6.7 12.2 17.9 11.0 8.9 11.1 12.9 14.5 9.1 10.0 12.3 7.5 10.7 13.9 11.9 12.5 9.6 14.5 4.4 10.4 12.7 8.1 5.6 7.5 10.0 5.2 1.4 2.6 1.2 11.3 19.8 8.0 10.9 13.8 8.3 8.6 10.9 11.4 15.7 11.8 12.5 6.6 7.6 10.0 10.8 14.2 10.2 11.1 17.6 8.6 16.1 5.1 11.2 11.9 8.9 11.0 10.9 6.2 13.6 13.9 9.3 8.4 9.7 4.9 9.0 8.2 13.5 7.8 9.0 12.6 9.8 11.3 7.6 13.2 15.2 11.8 10.9 8.6 8.3 9.0 15.9 12.3 6.9 14.4 9.0 8.5 13.0 11.6 11.2 6.7 10.2 5.9 8.9 5.0 3.3 10.0 1.9 5.2 2.4 4.6 2.3 1.6 2.5 5.6 2.3 2.5 7.6 1.4 3.6 7.5 2.6 1.2 23.4 23.1 18.6 24.6 17.2 13.0 9.2 16.9 12.2 12.5 SALL1 "Hsal1, TBS, ZNF794" ENSG00000103449 "Spalt like transcription factor 1" Q9NSC2 16 51135975-51151367 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.9;kidney: 26.8;liver: 32.0" "Cell line enhanced" "Detected in some" "AF22: 14.8;BJ hTERT+: 12.7;NTERA-2: 24.1;RPTEC TERT1: 20.4;U-87 MG: 23.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 5 "olfactory region: 64.6" "Low region specificity" "Detected in many" "HPA049829, HPA074673" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol" Nucleoplasm "Nucleoli, Nuclear speckles, Cytosol" "HPA049829: , HPA074673: " "unprognostic (9.91e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-6)" "prognostic favourable (1.28e-4)" "unprognostic (2.55e-1)" "unprognostic (1.17e-1)" "unprognostic (1.96e-2)" "unprognostic (4.41e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.96e-1)" "prognostic favourable (1.91e-7)" "unprognostic (1.86e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-2)" "unprognostic (1.76e-1)" 0.8 0.7 12.2 1.2 14.5 0.7 0.9 1.7 18.9 16.1 3.1 31.9 0.0 1.6 17.8 1.5 0.8 10.4 1.1 1.2 13.6 5.5 26.8 32.0 0.6 0.6 21.8 9.1 5.2 1.6 0.9 4.3 4.3 17.6 1.3 3.2 0.0 0.9 2.3 0.6 0.7 1.4 9.4 19.7 0.7 3.0 2.2 19.4 0.0 23.7 0.0 0.6 2.2 4.8 1.0 1.9 2.3 3.1 0.1 1.1 1.1 0.0 0.8 14.8 0.1 0.4 0.3 0.0 4.9 12.7 0.3 0.7 0.0 0.0 0.0 5.7 6.9 0.0 9.2 0.0 0.4 0.0 5.6 0.0 0.0 8.9 0.3 0.0 4.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 1.8 0.9 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 23.5 0.0 4.9 0.6 3.1 2.3 0.7 2.0 0.7 1.0 1.0 0.9 1.9 0.8 0.6 0.6 1.8 0.1 1.5 1.9 1.1 1.1 12.2 14.5 1.7 10.3 13.6 5.5 21.8 9.1 17.6 19.4 SETD2 "FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A" ENSG00000181555 "SET domain containing 2" Q9BYW2 3 47016429-47163967 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042451 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA042451: AB_10806239" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (6.08e-2)" "unprognostic (1.01e-1)" "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.40e-2)" "unprognostic (1.01e-2)" "prognostic unfavourable (8.19e-4)" "unprognostic (6.19e-2)" "unprognostic (2.45e-1)" "unprognostic (7.84e-2)" "prognostic favourable (7.99e-6)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (8.79e-2)" "unprognostic (5.43e-2)" 13.2 10.5 12.2 15.2 15.4 20.0 11.7 22.4 16.4 13.4 14.0 9.1 12.9 9.5 15.8 7.5 10.8 11.4 8.7 8.8 10.6 6.8 11.4 10.3 10.4 11.8 11.7 9.5 16.0 13.4 21.4 16.3 10.7 11.3 12.4 10.9 7.7 12.7 14.8 27.6 12.5 11.5 11.9 9.8 13.8 10.4 12.8 12.8 23.2 15.8 5.5 12.8 16.1 15.5 4.8 2.6 6.0 2.3 7.1 3.9 1.0 11.4 9.0 15.2 7.8 9.1 10.6 6.4 10.6 10.3 12.4 11.3 9.5 7.5 25.3 6.6 14.5 7.0 16.4 10.1 16.8 14.5 6.5 25.9 15.1 7.3 6.8 19.4 15.0 9.1 9.7 12.2 15.2 11.4 16.6 9.6 10.1 6.0 14.2 2.6 11.5 7.5 9.4 14.7 13.1 6.2 15.1 6.6 10.5 17.8 7.0 6.6 7.4 14.4 14.6 13.6 10.2 11.6 16.8 12.2 13.6 25.5 7.9 11.1 7.9 2.4 2.2 5.2 3.9 2.3 2.4 3.7 2.4 3.0 2.5 4.8 3.5 3.0 6.0 7.1 1.9 2.6 1.0 1.0 12.2 15.4 22.4 16.4 10.6 6.8 11.7 9.5 11.3 12.8 SETD4 "C21orf18, C21orf27" ENSG00000185917 "SET domain containing 4" Q9NVD3 21 36034541-36079389 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024073, HPA035405" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA024073: AB_1856755, HPA035405: " "unprognostic (4.23e-1)" "unprognostic (5.67e-2)" "unprognostic (6.98e-2)" "unprognostic (5.73e-2)" "unprognostic (1.98e-1)" "unprognostic (8.05e-3)" "unprognostic (7.86e-2)" "unprognostic (2.13e-3)" "unprognostic (2.17e-2)" "unprognostic (5.81e-2)" "unprognostic (1.33e-1)" "unprognostic (4.60e-3)" "unprognostic (1.15e-3)" "unprognostic (1.99e-1)" "unprognostic (8.09e-3)" "unprognostic (3.30e-2)" "unprognostic (1.28e-2)" 10.9 12.1 14.4 10.6 19.4 10.2 12.4 19.8 20.8 11.5 12.9 22.0 13.8 15.1 14.7 15.8 14.1 14.9 10.6 13.4 13.6 13.6 12.6 9.1 11.2 10.6 21.0 14.0 13.8 10.5 18.0 17.2 11.9 18.9 13.2 13.0 14.2 12.7 11.3 11.6 18.0 18.0 15.1 14.5 11.1 13.1 28.9 21.7 10.9 13.5 8.6 16.3 12.3 13.4 17.1 17.4 11.9 14.2 10.9 13.4 8.4 9.3 6.6 10.0 12.8 5.0 6.1 16.3 12.5 11.0 12.8 8.7 13.9 8.6 5.1 8.8 5.7 7.0 7.5 7.4 11.2 9.0 9.1 13.7 10.5 8.7 12.1 12.9 7.9 6.3 12.6 8.7 11.2 9.6 17.8 9.4 7.9 9.8 8.6 18.7 21.0 8.5 12.9 7.4 12.4 14.0 6.7 8.3 13.3 12.6 13.7 12.6 12.0 10.9 8.0 11.2 4.2 7.0 11.3 15.0 21.7 7.9 11.8 17.9 9.6 6.7 14.2 11.9 9.8 11.0 10.8 17.1 12.1 10.3 16.2 13.9 8.9 10.3 10.7 10.9 10.5 17.4 13.4 8.4 14.4 19.4 19.8 20.8 13.6 13.6 21.0 14.0 18.9 21.7 SF3B4 "Hsh49, SAP49, SF3b49" ENSG00000143368 "Splicing factor 3b subunit 4" Q15427 1 149923317-149928344 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028578, HPA064660" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA028578: AB_10601601, HPA064660: " "unprognostic (2.43e-1)" "unprognostic (6.58e-2)" "unprognostic (2.49e-2)" "unprognostic (9.26e-3)" "unprognostic (2.74e-1)" "unprognostic (2.30e-2)" "prognostic unfavourable (1.54e-5)" "unprognostic (3.11e-1)" "unprognostic (2.04e-1)" "unprognostic (6.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.54e-1)" "prognostic unfavourable (1.74e-7)" "unprognostic (9.63e-2)" "unprognostic (6.54e-2)" "unprognostic (3.15e-2)" "unprognostic (1.91e-1)" 26.7 26.1 14.0 21.1 26.2 32.8 22.2 18.3 33.5 29.1 31.8 28.6 18.3 21.0 36.7 24.6 31.9 29.2 24.3 15.7 13.8 13.3 28.9 26.3 21.4 22.0 16.1 11.3 45.0 23.2 31.1 20.3 41.1 18.1 27.4 28.0 27.6 24.2 27.0 15.2 30.5 27.5 28.3 13.2 30.6 23.5 43.7 14.8 57.7 30.9 24.6 41.5 27.4 23.3 35.7 36.7 53.9 48.7 43.9 41.9 27.3 31.1 26.1 30.2 22.3 17.7 14.2 33.9 29.5 25.7 39.2 31.7 28.4 24.8 31.3 18.7 31.6 33.2 36.3 31.3 42.7 17.7 20.7 29.9 17.6 22.2 24.7 37.9 36.6 15.9 27.6 38.1 21.9 21.3 22.9 26.2 42.0 82.1 42.2 26.6 43.4 28.3 32.2 27.8 31.4 30.1 30.5 16.9 31.5 26.2 31.9 18.5 47.0 37.7 17.4 33.5 37.1 27.4 46.2 36.5 55.0 37.4 26.8 27.8 30.8 29.0 35.8 53.9 39.0 46.5 40.1 35.7 37.2 41.9 31.1 31.7 35.2 33.1 48.4 43.9 48.7 36.7 41.2 27.3 14.0 26.2 18.3 33.5 13.8 13.3 16.1 11.3 18.1 14.8 SHANK2 "CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3" ENSG00000162105 "SH3 and multiple ankyrin repeat domains 2" Q9UPX8 11 70467856-71252577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Cell line enhanced" "Detected in many" "Karpas-707: 16.6;MCF7: 9.5;RT4: 15.4;T-47d: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008174, HPA017220" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles" "Nuclear speckles" "Nucleoplasm, Vesicles" "HPA008174: AB_1856822, HPA017220: " "unprognostic (3.08e-1)" "unprognostic (1.31e-3)" "unprognostic (1.79e-1)" "unprognostic (1.51e-2)" "unprognostic (1.51e-1)" "unprognostic (7.23e-5)" "unprognostic (1.24e-1)" "unprognostic (6.67e-2)" "unprognostic (1.83e-2)" "unprognostic (8.42e-2)" "unprognostic (4.87e-2)" "unprognostic (4.01e-1)" "prognostic favourable (1.94e-6)" "unprognostic (3.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.03e-2)" "unprognostic (4.80e-2)" 2.1 1.7 16.8 0.8 22.6 0.0 7.3 6.1 24.1 2.8 3.1 2.3 1.9 2.4 1.8 3.1 5.1 7.9 1.1 0.2 12.2 8.1 7.0 4.7 5.5 0.3 3.6 12.9 0.2 11.3 0.0 7.3 2.7 8.7 4.6 2.8 1.4 12.7 3.3 0.1 1.2 2.0 0.6 1.5 1.5 4.7 1.2 3.7 0.0 8.5 0.0 0.5 2.3 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 7.7 4.2 0.0 0.4 0.7 3.1 0.6 0.3 0.0 0.0 8.1 2.9 5.1 1.5 0.0 0.8 0.0 2.9 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 1.7 0.2 1.5 0.0 0.0 0.0 0.0 16.6 1.6 9.5 0.0 0.0 3.3 0.3 0.0 7.6 7.5 3.9 15.4 2.5 1.0 0.0 6.2 0.0 11.8 0.0 0.0 0.1 1.2 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.8 22.6 6.1 24.1 12.2 8.1 3.6 12.9 8.7 3.7 SHPK "CARKL, SHK" ENSG00000197417 Sedoheptulokinase Q9UHJ6 17 3608262-3636322 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA024361, HPA064939" Enhanced Approved "Nucleoplasm,Nuclear speckles" 150000 "Nucleoplasm, Nuclear speckles" "HPA024361: AB_1846030, HPA064939: " "unprognostic (1.75e-2)" "unprognostic (1.51e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (3.57e-3)" "unprognostic (1.54e-2)" "unprognostic (1.95e-2)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" "unprognostic (3.64e-2)" "unprognostic (1.08e-2)" "unprognostic (1.42e-1)" "unprognostic (3.82e-2)" "unprognostic (6.75e-2)" "unprognostic (1.55e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" 8.9 12.9 7.6 6.2 10.6 5.9 8.9 17.3 12.3 8.8 14.1 14.9 8.8 18.5 10.7 6.1 11.6 7.6 5.3 5.9 7.0 5.5 14.3 26.7 6.3 5.3 12.0 4.5 10.2 13.7 11.8 6.2 8.6 9.8 7.4 8.6 12.3 8.9 9.4 7.5 12.1 22.8 5.1 6.7 6.1 9.7 5.2 13.0 7.7 7.7 4.0 7.6 7.5 9.6 5.2 7.1 5.1 4.8 6.4 7.5 5.4 5.2 10.7 11.5 7.3 4.8 4.8 6.4 3.5 3.2 6.9 4.2 18.5 4.9 6.2 7.9 6.8 10.3 15.2 11.5 5.1 10.0 14.8 6.8 9.2 13.2 5.7 5.9 9.7 8.1 5.5 7.6 5.2 13.0 9.0 8.0 6.7 9.4 7.5 4.6 5.8 7.2 10.4 6.0 9.9 9.8 6.8 3.3 8.8 12.9 12.0 3.6 10.7 3.5 9.3 10.6 5.1 10.2 8.5 2.7 3.4 4.1 11.5 5.3 5.4 3.3 4.7 5.1 4.6 4.8 4.7 5.2 4.2 3.7 6.5 4.0 7.5 4.7 0.9 6.4 4.1 7.1 3.6 5.4 7.6 10.6 17.3 12.3 7.0 5.5 12.0 4.5 9.8 13.0 SIM1 bHLHe14 ENSG00000112246 "Single-minded family bHLH transcription factor 1" P81133 6 100385015-100464929 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 7.8;BJ: 12.5;BJ hTERT+: 18.3;RPTEC TERT1: 14.4" "Cancer enhanced" "Detected in single" "renal cancer: 1.8" "Region enriched" "Detected in single" 21 "hypothalamus: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "hypothalamus: 6.1" "Group enriched" "Detected in some" 5 "basal ganglia: 2.6;hypothalamus: 5.2" HPA024385 Approved "Nuclear speckles" "Nuclear speckles" "HPA024385: AB_1856879" "unprognostic (1.04e-1)" "unprognostic (4.34e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-1)" "unprognostic (4.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "unprognostic (4.64e-2)" "unprognostic (3.76e-2)" "prognostic favourable (5.32e-7)" "unprognostic (1.00e-1)" "unprognostic (1.19e-1)" 5.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 13.2 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.0 2.2 21.6 0.5 0.0 0.0 0.1 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 17.5 4.7 0.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.2 7.8 0.0 12.5 18.3 5.6 5.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 4.8 5.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 SLC2A4RG "GEF, HDBP1, Si-1-2, Si-1-2-19" ENSG00000125520 "SLC2A4 regulator" Q9NR83 20 63739861-63743505 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in single" 4 "T-cells: 3.1" "Low region specificity" "Detected in many" HPA063050 Approved "Nuclear speckles" "Nuclear speckles" "HPA063050: " "unprognostic (2.89e-2)" "unprognostic (2.32e-1)" "unprognostic (1.84e-2)" "unprognostic (5.78e-2)" "unprognostic (2.07e-3)" "unprognostic (6.48e-3)" "unprognostic (2.70e-1)" "unprognostic (1.96e-2)" "unprognostic (1.31e-1)" "unprognostic (3.44e-2)" "unprognostic (2.09e-3)" "unprognostic (1.50e-1)" "unprognostic (1.39e-2)" "unprognostic (1.41e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-3)" "unprognostic (3.22e-1)" 30.9 10.5 6.3 7.4 6.1 13.0 16.4 5.4 7.5 19.3 14.2 6.7 18.9 5.2 11.7 17.9 25.1 10.1 19.6 19.3 5.2 4.4 19.3 37.5 10.6 18.6 5.8 4.2 25.1 17.3 5.1 6.9 9.4 6.3 23.4 2.6 16.1 14.7 15.0 71.0 20.2 9.1 29.4 5.0 14.4 11.3 13.2 3.3 6.1 9.3 19.9 16.2 19.3 11.6 0.0 0.7 0.5 0.2 0.6 3.1 0.0 17.6 12.0 5.4 9.0 4.0 10.0 7.2 11.5 9.4 25.4 8.9 21.8 31.0 2.3 19.4 5.7 18.3 1.8 13.5 2.7 10.7 5.8 2.1 9.2 12.7 11.8 7.6 6.3 10.8 18.1 4.9 5.6 7.1 8.5 3.6 8.7 21.3 4.6 16.2 2.7 34.4 21.3 11.6 8.5 8.4 4.8 7.2 13.5 23.7 13.9 3.1 32.5 28.8 6.8 33.4 13.7 20.3 9.3 9.7 14.0 5.4 14.8 6.7 8.7 0.0 0.1 0.5 2.0 0.0 0.8 0.0 3.1 1.8 0.3 0.0 3.0 1.9 0.0 0.6 0.2 0.7 1.8 0.0 6.3 6.1 5.4 7.5 5.2 4.4 5.8 4.2 6.3 3.3 SLC31A2 "COPT2, CTR2, hCTR2" ENSG00000136867 "Solute carrier family 31 member 2" O15432 9 113150942-113164137 "Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.2;salivary gland: 125.5" "Cell line enhanced" "Detected in many" "hTCEpi: 33.0;hTERT-HME1: 22.6;LHCN-M2: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2" "Group enriched" "Detected in many" 36 "dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014861 Approved Approved "Nuclear speckles,Plasma membrane,Intermediate filaments" "Nuclear speckles" "Plasma membrane, Intermediate filaments" "HPA014861: AB_1857098" "unprognostic (2.26e-1)" "unprognostic (7.20e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (5.63e-2)" "unprognostic (3.31e-2)" "unprognostic (2.24e-1)" "unprognostic (3.44e-2)" "unprognostic (1.47e-1)" "unprognostic (1.86e-1)" "unprognostic (6.05e-3)" "unprognostic (1.76e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" "unprognostic (8.89e-2)" 15.7 8.0 10.0 8.1 20.5 7.0 8.5 3.2 15.0 3.0 8.4 45.1 27.1 5.2 2.0 6.0 4.6 3.0 4.5 3.4 18.2 9.4 9.8 11.2 10.0 6.2 34.3 10.5 2.8 7.8 17.9 1.2 10.2 22.3 2.1 4.4 1.0 125.5 21.8 6.7 18.5 9.9 3.8 48.5 14.1 4.5 5.4 26.2 1.2 2.8 2.9 5.8 3.9 4.1 0.3 21.2 54.5 60.2 0.2 1.2 13.4 5.4 2.4 1.3 2.0 21.7 8.9 4.7 4.1 5.3 5.0 4.8 1.8 1.6 0.3 0.8 3.4 20.2 1.9 11.7 4.7 2.7 0.8 0.3 1.2 2.8 8.3 2.1 1.2 10.0 33.0 11.7 22.6 2.6 1.5 3.0 26.1 5.2 2.1 1.2 0.7 2.3 0.4 19.7 0.3 1.7 3.3 1.2 2.1 5.6 17.5 1.6 6.2 1.9 2.4 2.7 1.9 9.0 3.5 1.8 3.8 0.2 8.7 2.9 2.7 0.8 36.6 3.6 0.9 50.5 1.2 0.2 1.0 1.0 21.2 0.3 0.8 0.8 54.5 0.2 60.2 0.5 0.6 13.4 10.0 20.5 3.2 15.0 18.2 9.4 34.3 10.5 22.3 26.2 SLC4A2 "AE2, BND3L, EPB3L1, HKB3, NBND3" ENSG00000164889 "Solute carrier family 4 member 2" P04920 7 151057210-151076527 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.2;retina: 100.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 73.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA019339 Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" "Nuclear speckles, Plasma membrane" Cytosol "HPA019339: AB_1844825" "unprognostic (1.19e-1)" "unprognostic (3.33e-3)" "unprognostic (8.12e-3)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "prognostic unfavourable (9.04e-6)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (3.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favourable (1.26e-4)" "unprognostic (4.67e-3)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.36e-2)" 9.9 13.5 4.7 10.4 7.4 6.7 10.5 3.0 8.6 12.4 18.6 29.0 6.0 12.1 16.2 6.3 7.7 10.8 14.1 11.9 10.1 3.8 35.5 94.2 12.3 7.2 10.4 4.8 12.6 34.1 30.6 5.3 31.4 73.3 10.5 4.0 100.7 11.9 8.3 8.7 9.5 26.0 10.7 10.4 10.1 27.1 6.5 8.5 8.8 9.7 7.0 5.9 11.7 10.6 2.5 5.6 2.1 4.2 0.5 2.7 1.9 15.6 51.8 10.2 21.0 10.2 6.0 23.3 19.0 10.3 15.6 13.5 29.5 25.1 9.4 41.8 9.0 15.4 10.4 9.2 2.9 27.1 15.5 12.3 25.2 15.0 16.7 6.3 39.8 8.7 8.1 17.7 4.5 8.7 38.2 8.0 12.0 30.1 18.2 11.0 24.3 19.3 14.4 5.6 11.0 12.7 11.9 8.4 30.6 17.4 32.9 16.2 13.6 12.6 18.6 21.0 10.7 20.6 28.0 8.6 11.6 5.3 32.1 16.0 42.1 0.0 4.2 2.1 2.7 3.9 1.9 2.5 2.1 1.8 2.4 1.0 2.4 2.4 1.0 0.5 2.5 5.6 1.0 1.9 4.7 7.4 3.0 8.6 10.1 3.8 10.4 4.8 73.3 8.5 SLU7 9G8 ENSG00000164609 "SLU7 homolog, splicing factor" O95391 5 160401641-160421711 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035907, HPA058120" Uncertain Approved "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA035907: AB_10671717, HPA058120: " "unprognostic (3.70e-2)" "unprognostic (7.18e-2)" "unprognostic (1.86e-2)" "unprognostic (9.96e-3)" "unprognostic (8.01e-2)" "unprognostic (3.52e-1)" "unprognostic (3.38e-3)" "unprognostic (3.76e-2)" "unprognostic (2.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (7.69e-2)" "prognostic favourable (1.98e-4)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" 19.4 18.9 25.7 14.1 30.7 32.9 22.0 30.4 32.9 18.0 16.2 14.2 14.2 12.9 18.1 21.4 17.8 14.6 14.8 19.3 23.7 23.6 19.4 19.0 18.1 19.4 25.7 28.1 17.5 15.4 18.4 21.6 18.5 28.4 17.5 16.8 10.3 18.6 16.6 33.8 17.7 17.0 18.6 26.2 20.6 17.8 20.3 25.8 21.4 26.0 20.2 23.5 20.6 17.7 18.4 13.2 33.5 20.1 20.6 17.9 12.2 12.3 15.6 13.4 19.0 17.7 18.8 17.4 17.4 25.4 19.3 23.3 20.7 15.0 20.1 17.8 18.6 13.7 11.7 19.3 24.3 32.3 17.3 14.9 21.3 13.2 17.8 25.1 18.4 20.2 18.1 17.6 20.1 13.2 13.5 18.8 17.2 10.8 12.2 16.1 9.8 14.0 10.5 27.9 19.8 17.0 20.0 16.3 22.5 20.4 18.7 30.7 25.1 23.8 16.7 18.8 9.7 13.6 18.4 21.0 24.0 17.9 27.1 16.7 17.7 24.7 13.2 22.5 17.4 14.8 16.3 18.4 16.3 17.1 12.1 16.6 17.9 17.1 33.5 20.6 20.1 13.2 17.4 12.2 25.7 30.7 30.4 32.9 23.7 23.6 25.7 28.1 28.4 25.8 SMIM19 C8orf40 ENSG00000176209 "Small integral membrane protein 19" Q96E16 8 42541155-42555193 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011145, HPA074830" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA011145: AB_1078360, HPA074830: " "unprognostic (2.12e-2)" "unprognostic (2.33e-3)" "unprognostic (4.01e-2)" "unprognostic (1.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (7.04e-3)" "unprognostic (1.76e-2)" "unprognostic (4.84e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (2.67e-2)" "prognostic favourable (1.74e-6)" "unprognostic (5.10e-2)" "unprognostic (9.70e-3)" "unprognostic (9.64e-2)" "unprognostic (2.93e-3)" 23.7 26.9 20.2 19.2 17.2 12.7 31.2 21.1 23.9 17.5 23.2 12.4 25.2 14.0 16.1 39.3 23.2 27.3 27.9 41.9 18.2 15.6 35.6 61.9 22.1 23.4 17.4 16.5 21.5 40.2 18.0 12.8 16.0 13.6 17.7 16.7 17.7 42.7 20.4 50.6 19.8 31.3 26.6 17.2 18.0 19.5 26.4 9.8 21.4 34.9 30.8 15.8 26.5 13.2 28.1 41.4 25.7 17.0 29.7 29.2 15.2 13.4 10.0 22.0 18.9 13.5 16.2 7.0 10.5 14.5 8.6 10.2 2.4 30.1 14.8 4.4 8.8 9.7 11.4 6.8 8.9 11.8 9.5 12.6 6.8 5.4 27.6 8.8 3.2 13.2 5.9 7.1 23.0 7.7 9.9 34.1 8.5 13.1 6.4 13.4 26.0 6.9 7.3 15.7 25.0 21.6 10.0 4.6 16.9 10.7 11.6 31.5 24.5 16.9 9.6 5.4 4.6 14.8 6.8 32.5 17.9 19.5 22.8 14.4 14.2 25.7 17.0 11.5 19.3 12.4 23.2 28.1 24.9 23.5 25.1 27.5 23.9 22.9 6.0 29.7 10.3 41.4 29.2 15.2 20.2 17.2 21.1 23.9 18.2 15.6 17.4 16.5 13.6 9.8 SOCS6 "CIS4, Cish4, HSPC060, SOCS4, SSI4, STAI4, STATI4" ENSG00000170677 "Suppressor of cytokine signaling 6" O14544 18 70288901-70330200 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 6.0;myeloid DC: 6.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" CAB010189 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB010189: AB_661195" "unprognostic (1.76e-3)" "unprognostic (6.83e-3)" "unprognostic (8.90e-3)" "unprognostic (4.52e-2)" "unprognostic (1.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.07e-1)" "unprognostic (7.93e-2)" "unprognostic (5.83e-2)" "unprognostic (1.75e-1)" "unprognostic (6.90e-2)" "unprognostic (8.19e-2)" "prognostic favourable (1.02e-4)" "unprognostic (1.02e-1)" "unprognostic (1.52e-1)" "unprognostic (4.11e-2)" "unprognostic (1.80e-2)" 9.1 8.8 12.7 5.1 16.3 10.2 12.8 13.8 11.6 15.0 14.6 20.1 9.8 14.1 12.9 6.7 17.7 11.8 12.6 9.8 12.8 7.8 8.9 26.1 8.8 2.8 21.4 10.1 10.6 12.4 18.1 7.2 21.1 14.9 8.7 13.5 14.3 17.3 7.8 17.7 8.4 20.4 13.3 20.3 4.2 12.7 6.1 18.0 2.5 10.8 10.3 7.5 10.6 11.8 0.5 6.3 4.6 6.0 1.5 1.1 1.7 10.1 22.5 9.6 6.6 9.1 10.8 10.8 22.0 13.5 13.4 10.1 8.4 17.3 1.1 2.0 20.4 12.1 7.0 7.1 13.1 0.0 4.2 7.6 8.0 12.9 10.9 4.1 8.7 8.7 8.6 11.6 9.8 6.7 4.5 5.3 9.1 4.9 3.6 3.1 6.2 9.7 4.2 9.3 1.9 8.2 8.4 4.4 11.1 11.3 12.6 10.2 3.7 7.3 8.2 14.8 7.5 3.0 8.8 0.0 0.0 2.8 16.5 0.3 9.9 0.0 6.0 4.6 0.4 1.2 0.2 0.5 0.8 0.1 6.3 0.0 1.1 0.6 0.0 1.5 0.1 0.6 0.0 1.7 12.7 16.3 13.8 11.6 12.8 7.8 21.4 10.1 14.9 18.0 SOHLH1 "bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2" ENSG00000165643 "Spermatogenesis and oogenesis specific basic helix-loop-helix 1" Q5JUK2 9 135693407-135699528 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "brain: 21.1;testis: 21.5" "Group enriched" "Detected in some" 46 "CACO-2: 14.4;U-266/84: 22.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA059439 Approved "Nuclear speckles" "Nuclear speckles" "HPA059439: " "unprognostic (2.93e-1)" "unprognostic (1.23e-3)" "unprognostic (9.85e-3)" "unprognostic (2.84e-2)" "unprognostic (3.55e-1)" "unprognostic (2.59e-3)" "unprognostic (4.98e-3)" "unprognostic (2.17e-1)" "unprognostic (1.63e-1)" 0.2 0.1 4.4 0.2 3.2 0.1 0.2 1.7 21.1 0.2 0.2 0.2 0.2 0.1 0.2 0.6 0.2 0.1 0.2 0.2 9.4 1.4 0.2 0.2 0.2 0.2 2.0 0.2 0.3 0.2 0.3 1.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.7 0.2 0.2 0.4 0.2 0.2 21.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 3.2 1.7 21.1 9.4 1.4 2.0 0.2 0.2 0.2 SOX7 ENSG00000171056 "SRY-box 7" Q9BT81 8 10723768-10730512 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.2" "Cell line enhanced" "Detected in some" "HaCaT: 9.2;hTCEpi: 17.0;HUVEC TERT2: 19.9;TIME: 5.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA009065 Approved Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (1.21e-1)" "unprognostic (1.08e-1)" "unprognostic (1.15e-3)" "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-1)" "unprognostic (8.74e-2)" "unprognostic (7.26e-2)" "unprognostic (7.44e-2)" "unprognostic (1.09e-1)" "unprognostic (7.71e-3)" "unprognostic (2.45e-3)" "unprognostic (2.38e-1)" "unprognostic (5.41e-3)" "unprognostic (4.84e-3)" 17.4 1.8 3.5 3.4 3.3 0.7 7.0 1.7 4.2 16.0 3.4 2.1 1.0 0.8 7.1 6.8 19.7 3.0 6.1 12.5 2.6 2.2 3.0 7.4 37.2 2.9 2.6 1.5 2.6 4.5 2.7 4.2 26.4 3.6 5.8 2.2 7.6 7.1 5.0 12.5 11.7 2.1 4.2 3.0 2.2 2.2 1.9 3.2 0.6 4.7 22.7 14.5 8.8 23.1 1.9 0.3 0.8 0.4 0.2 1.2 0.1 4.4 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.2 9.2 2.7 3.3 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.2 0.1 17.0 0.0 3.5 19.9 0.4 0.2 0.0 0.1 0.1 0.1 1.2 2.6 0.9 0.0 0.0 0.0 1.6 0.5 2.7 1.7 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.5 0.4 0.1 0.2 0.2 1.2 1.9 0.3 0.1 0.1 0.3 0.2 0.4 0.8 0.2 0.1 0.3 0.1 0.1 3.5 3.3 1.7 4.2 2.6 2.2 2.6 1.5 3.6 3.2 SPINDOC "C11orf84, SPIN-DOC" ENSG00000168005 "Spindlin interactor and repressor of chromatin binding" Q9BUA3 11 63813388-63827718 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040128, HPA050313" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA040128: AB_10673027, HPA050313: " "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-2)" "unprognostic (2.82e-3)" "unprognostic (1.13e-1)" "unprognostic (1.75e-2)" "prognostic unfavourable (1.53e-5)" "unprognostic (2.20e-1)" "unprognostic (3.78e-3)" "unprognostic (1.44e-2)" "unprognostic (1.20e-2)" "unprognostic (4.33e-2)" "prognostic unfavourable (5.42e-5)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" 9.2 9.0 9.6 12.3 9.8 5.8 23.3 12.8 15.8 8.8 11.4 6.9 5.8 6.0 13.2 6.0 7.9 8.4 10.1 9.3 9.3 12.2 8.2 3.1 9.9 14.8 9.4 9.1 11.3 8.2 3.3 12.0 28.0 10.8 11.8 4.2 7.8 6.6 12.3 7.7 4.5 6.9 12.9 8.6 10.3 7.4 24.1 6.0 11.8 10.5 3.1 10.5 9.0 39.5 2.0 1.5 2.2 0.1 0.7 1.5 0.2 11.9 16.0 23.5 20.5 4.6 4.5 8.9 9.3 8.0 17.0 11.9 16.9 8.3 20.0 21.8 5.4 15.8 21.4 4.8 6.2 19.0 9.3 22.1 15.0 14.3 7.3 12.3 19.2 5.2 5.0 13.4 4.9 10.0 12.1 9.9 7.2 16.4 25.5 33.6 40.2 15.0 34.4 16.2 6.8 5.8 7.1 18.0 22.7 14.2 9.1 18.8 12.6 14.9 11.2 19.2 22.2 23.0 16.3 14.5 20.5 20.0 9.9 11.0 13.5 2.2 0.1 0.4 1.5 0.1 0.2 1.2 0.3 0.9 0.4 2.0 0.7 0.4 0.0 0.7 0.1 1.5 0.6 0.2 9.6 9.8 12.8 15.8 9.3 12.2 9.4 9.1 10.8 6.0 SPTSSB "ADMP, C3orf57, ssSPTb" ENSG00000196542 "Serine palmitoyltransferase small subunit B" Q8NFR3 3 161344792-161372880 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 68.6;skin 1: 27.5;stomach 1: 42.0" "Group enriched" "Detected in some" 11 "MCF7: 155.3;RT4: 41.2" "Cancer enhanced" "Detected in many" "urothelial cancer: 24.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 12 "NK-cell: 68.6" "Lineage enriched" "Detected in many" 12 "NK-cells: 68.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047712 Approved "Nuclear speckles" "Nuclear speckles" "HPA047712: " "unprognostic (2.09e-1)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "unprognostic (1.34e-2)" "unprognostic (4.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (5.10e-2)" "unprognostic (6.37e-3)" "unprognostic (2.72e-1)" "unprognostic (4.08e-2)" "unprognostic (5.37e-4)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (9.51e-3)" 1.4 0.4 2.0 0.7 3.4 0.5 6.4 8.9 18.5 4.0 0.9 1.6 0.0 0.5 1.0 0.4 5.1 0.6 1.5 0.4 2.2 2.2 0.7 0.6 0.3 1.0 2.0 6.2 0.4 1.5 0.3 0.3 0.3 12.0 12.4 0.8 0.2 8.0 0.4 0.4 27.5 0.5 1.4 1.1 1.1 42.0 0.3 0.4 0.1 0.4 2.1 1.7 23.5 5.4 0.0 0.0 0.2 0.0 68.6 5.6 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 155.3 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 41.2 0.2 1.6 0.0 5.6 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.6 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.2 68.6 0.0 0.0 0.0 0.5 2.0 3.4 8.9 18.5 2.2 2.2 2.0 6.2 12.0 0.4 SSH3 "FLJ10928, FLJ20515" ENSG00000172830 "Slingshot protein phosphatase 3" Q8TE77 11 67303448-67312607 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 23.6;RT4: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.8;eosinophil: 10.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019949, HPA019957" Approved Approved "Nuclear speckles,Plasma membrane,Actin filaments,Cytosol" "Nuclear speckles, Cytosol" "Plasma membrane, Actin filaments" "HPA019949: AB_1857498, HPA019957: AB_1857499" "unprognostic (4.38e-2)" "unprognostic (1.37e-1)" "unprognostic (3.50e-3)" "unprognostic (3.73e-2)" "unprognostic (2.61e-3)" "unprognostic (9.30e-2)" "unprognostic (2.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-2)" "prognostic unfavourable (2.89e-4)" "unprognostic (1.50e-1)" "unprognostic (2.06e-2)" "unprognostic (1.47e-1)" "unprognostic (3.20e-1)" "unprognostic (4.94e-3)" "unprognostic (6.78e-3)" 8.6 5.5 5.6 6.8 9.7 8.1 13.5 17.8 9.4 14.6 15.9 15.4 19.5 12.4 10.1 10.6 27.0 15.2 20.5 7.7 6.0 6.1 10.3 7.5 9.0 3.5 13.6 5.4 17.1 12.0 11.3 7.4 20.0 8.5 19.8 9.2 11.9 19.1 30.5 5.2 18.2 13.6 13.1 9.3 6.9 13.9 4.2 9.7 0.8 12.8 14.0 13.2 33.3 18.6 0.3 1.6 10.8 2.3 1.5 2.2 1.0 6.1 6.7 0.1 0.2 4.7 4.9 7.3 4.0 5.4 2.1 2.0 7.2 16.3 0.3 12.5 3.7 23.6 2.2 17.0 1.1 1.3 2.5 1.5 10.8 2.9 3.3 0.3 6.0 4.3 15.8 3.1 3.2 2.4 0.0 0.6 2.5 20.8 0.2 3.0 1.5 5.4 7.6 0.2 1.1 6.9 35.7 1.4 2.2 9.4 14.0 4.4 19.6 5.2 3.8 1.7 3.7 4.7 1.1 0.6 0.3 0.2 4.8 2.7 1.6 10.8 1.4 10.5 2.2 2.3 1.7 0.3 2.1 1.8 1.6 0.2 0.8 0.9 4.5 1.5 1.1 1.1 1.8 1.0 5.6 9.7 17.8 9.4 6.0 6.1 13.6 5.4 8.5 9.7 STYXL1 "DUSP24, MK-STYX" ENSG00000127952 "Serine/threonine/tyrosine interacting like 1" Q9Y6J8 7 75996338-76048004 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050261 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA050261: " "unprognostic (6.24e-2)" "unprognostic (1.12e-1)" "unprognostic (7.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.88e-3)" "unprognostic (9.33e-2)" "unprognostic (1.50e-3)" "unprognostic (4.77e-2)" "unprognostic (8.01e-2)" "unprognostic (4.02e-2)" "unprognostic (4.47e-3)" "unprognostic (1.47e-1)" "unprognostic (1.87e-1)" "unprognostic (5.45e-2)" "unprognostic (3.17e-2)" "unprognostic (2.28e-1)" "prognostic favourable (8.22e-4)" 9.4 19.2 16.0 10.2 23.1 12.7 17.5 12.8 19.8 15.7 15.1 19.6 13.9 10.5 10.3 21.0 21.1 28.2 9.4 13.2 16.6 12.1 14.8 20.1 11.3 13.7 20.9 13.5 15.4 30.0 15.9 19.9 24.6 16.8 16.6 20.1 12.2 16.0 13.9 12.4 19.3 10.3 14.0 17.0 17.4 14.0 25.0 19.7 20.8 19.9 12.1 19.5 14.8 14.6 19.7 23.0 30.8 29.3 24.7 22.1 17.4 19.7 10.6 8.3 11.1 13.2 14.4 8.7 8.9 12.7 14.5 14.4 12.2 18.0 4.6 4.5 11.8 8.8 13.5 17.9 21.1 14.7 5.9 5.6 5.0 10.9 18.8 7.8 10.3 14.0 21.0 17.4 43.7 14.1 18.1 13.9 12.9 16.0 3.0 33.4 7.0 25.6 11.9 7.0 12.2 18.4 12.9 11.0 11.4 8.3 19.2 22.3 21.1 15.1 7.0 12.5 5.3 13.7 12.6 15.1 9.6 15.7 11.1 14.9 19.4 30.8 29.3 25.8 13.7 25.3 15.2 19.7 13.2 15.2 23.0 15.6 11.7 13.2 24.6 24.7 23.7 15.1 22.1 17.4 16.0 23.1 12.8 19.8 16.6 12.1 20.9 13.5 16.8 19.7 TAB3 MAP3K7IP3 ENSG00000157625 "TGF-beta activated kinase 1 and MAP3K7 binding protein 3" Q8N5C8 X 30827442-30975084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034980, HPA034981" Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA034980: AB_10602708, HPA034981: " "unprognostic (4.39e-1)" "unprognostic (2.22e-1)" "unprognostic (3.04e-2)" "unprognostic (1.73e-1)" "unprognostic (6.35e-2)" "unprognostic (2.95e-3)" "unprognostic (1.49e-2)" "unprognostic (1.73e-2)" "unprognostic (3.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.51e-1)" "prognostic favourable (8.45e-4)" "unprognostic (5.91e-2)" "unprognostic (1.25e-1)" "unprognostic (9.12e-2)" "unprognostic (2.75e-1)" 6.1 8.0 5.9 6.6 6.9 10.1 6.5 9.1 9.2 7.6 6.5 4.2 17.9 5.2 40.3 7.4 13.2 9.2 10.6 6.9 6.1 5.3 16.9 23.3 8.0 8.1 6.7 6.6 11.3 17.3 25.0 9.4 39.3 9.1 12.9 6.7 9.3 11.5 15.0 8.8 8.1 7.4 9.6 5.2 7.1 8.4 26.7 3.6 8.3 7.7 14.5 15.6 6.6 7.9 1.0 0.6 0.8 1.1 3.9 1.0 0.4 22.8 5.5 5.7 5.8 4.4 6.7 6.0 7.0 8.9 4.8 5.4 6.2 19.6 10.4 4.3 8.2 11.9 8.7 18.1 7.0 17.7 8.4 9.7 6.4 15.1 3.9 10.1 7.5 4.8 10.9 8.2 21.0 7.9 11.0 8.5 6.2 11.0 8.0 5.1 6.8 9.3 5.2 10.0 7.7 8.0 6.7 4.7 6.7 7.9 12.0 15.3 10.3 4.1 7.6 5.3 7.8 26.6 6.5 11.1 8.4 10.3 8.3 4.8 7.4 0.2 0.5 0.8 0.7 1.1 0.9 0.8 1.0 0.4 0.6 1.0 1.0 1.0 0.8 3.9 0.8 0.3 0.6 0.4 5.9 6.9 9.1 9.2 6.1 5.3 6.7 6.6 9.1 3.6 TADA2A "ADA2, ADA2A, hADA2, TADA2L" ENSG00000276234 "Transcriptional adaptor 2A" 17 37406874-37479730 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076497 Approved "Nuclear speckles" "Nuclear speckles" "HPA076497: " "unprognostic (3.49e-1)" "unprognostic (5.12e-2)" "unprognostic (7.32e-2)" "unprognostic (7.86e-2)" "unprognostic (4.80e-1)" "unprognostic (1.23e-3)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (6.13e-3)" "unprognostic (8.18e-2)" "unprognostic (1.10e-3)" "unprognostic (7.81e-2)" "prognostic unfavourable (2.25e-5)" "unprognostic (4.38e-2)" "unprognostic (1.06e-1)" "unprognostic (2.56e-2)" "unprognostic (4.41e-2)" 3.9 1.7 2.5 5.1 7.0 3.8 3.2 6.6 11.1 4.8 4.2 5.7 3.0 3.3 5.9 5.5 3.7 4.2 3.5 3.4 4.0 2.7 2.4 4.2 4.2 2.8 5.0 3.8 5.7 4.5 5.7 3.6 6.5 3.9 5.9 6.1 4.4 3.4 7.3 6.7 4.4 6.5 3.0 4.5 3.0 12.4 3.6 5.8 4.6 2.0 5.5 3.4 1.7 10.2 11.4 5.6 7.4 3.9 8.4 3.5 0.8 5.8 6.4 4.5 3.6 3.9 6.3 3.6 3.7 6.6 4.5 7.1 0.0 11.7 5.6 1.9 8.9 7.9 4.7 8.7 7.6 6.7 6.0 7.2 3.6 4.8 9.1 3.6 3.2 4.4 6.9 3.7 6.2 9.4 3.4 8.0 2.8 16.3 7.6 4.3 4.0 11.3 17.9 8.8 4.0 5.6 7.2 6.5 4.6 2.4 4.3 7.8 3.3 4.9 7.2 6.1 5.0 5.5 5.2 5.3 13.9 6.9 4.2 5.9 3.2 5.6 5.6 8.4 5.9 5.9 5.9 5.3 6.3 6.3 10.2 8.0 7.3 0.5 3.9 7.4 11.4 4.2 3.5 TADA2B MGC21874 ENSG00000173011 "Transcriptional adaptor 2B" Q86TJ2 4 7041899-7057952 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035770 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA035770: AB_10603993" "unprognostic (1.52e-1)" "unprognostic (1.50e-1)" "unprognostic (6.61e-2)" "unprognostic (2.77e-3)" "unprognostic (1.14e-2)" "unprognostic (1.70e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (2.99e-1)" "unprognostic (6.03e-2)" "unprognostic (8.91e-3)" "unprognostic (1.72e-1)" "prognostic favourable (7.17e-11)" "unprognostic (5.00e-2)" "unprognostic (1.58e-1)" "unprognostic (2.59e-2)" "prognostic favourable (1.59e-4)" 8.7 15.0 10.9 12.9 15.3 24.0 13.9 12.5 16.0 10.5 10.6 7.5 12.4 10.2 11.5 8.8 11.4 11.0 11.0 15.6 10.9 7.0 12.9 13.6 8.9 12.4 8.3 9.8 15.8 26.2 10.8 9.0 12.6 9.9 10.2 8.0 17.0 20.5 10.8 42.8 10.6 11.3 10.4 6.6 12.4 11.9 13.0 8.9 9.8 12.8 12.7 10.4 10.6 12.8 3.7 2.1 10.3 3.0 2.1 4.4 1.8 8.7 13.4 9.4 11.0 10.5 11.9 9.0 12.9 13.3 16.7 10.3 13.1 13.1 11.6 7.7 14.2 7.2 12.8 6.8 10.8 6.9 9.8 11.8 8.3 9.8 12.8 13.5 19.5 8.6 14.5 11.1 12.9 7.7 13.2 18.9 12.5 8.3 16.3 11.7 11.1 20.8 10.7 19.2 6.1 15.3 12.3 15.4 11.0 11.1 10.0 13.2 15.0 20.5 11.9 10.6 8.2 12.8 17.5 17.2 14.4 15.3 8.7 7.4 10.7 1.1 2.2 10.3 4.4 2.6 3.2 3.7 2.9 4.4 1.9 2.7 3.9 2.9 7.1 2.1 3.0 2.1 3.0 1.8 10.9 15.3 12.5 16.0 10.9 7.0 8.3 9.8 9.9 8.9 TARBP1 "TRM3, TRMT3, TRP-185" ENSG00000059588 "TAR (HIV-1) RNA binding protein 1" Q13395 1 234391313-234479103 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020810, HPA024632" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "CAB020810: , HPA024632: AB_1857770" "unprognostic (3.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.75e-1)" "unprognostic (3.47e-1)" "unprognostic (8.26e-2)" "unprognostic (2.44e-3)" "unprognostic (8.45e-3)" "unprognostic (5.22e-3)" "unprognostic (3.72e-2)" "unprognostic (5.52e-2)" "unprognostic (2.56e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (5.14e-10)" "unprognostic (5.72e-2)" "unprognostic (1.82e-1)" "unprognostic (4.38e-2)" "unprognostic (4.27e-2)" 7.2 6.7 10.3 10.5 19.4 12.0 11.4 22.5 22.9 6.5 7.3 10.5 3.0 7.8 7.2 9.8 10.7 10.0 11.3 6.6 7.1 6.8 7.0 4.7 7.6 11.9 6.6 18.2 5.7 12.7 12.9 12.1 10.1 13.0 9.5 11.4 8.7 12.8 5.8 11.0 10.1 8.9 5.7 8.0 8.7 10.2 5.6 6.4 8.7 10.1 6.2 13.6 5.5 7.7 1.2 4.0 0.0 0.3 0.9 1.9 0.2 11.4 8.0 5.3 6.1 8.8 12.2 11.0 4.9 3.7 6.4 4.8 3.8 7.5 10.0 5.3 3.7 7.6 6.1 6.2 6.2 9.7 9.4 5.5 8.4 5.6 2.8 24.0 4.9 5.0 5.7 4.7 2.6 6.6 6.9 6.4 4.5 2.4 9.9 11.8 11.3 3.3 17.5 3.1 9.8 4.4 6.7 5.7 6.8 6.8 8.9 7.4 5.7 24.6 4.4 6.0 0.7 6.6 9.8 17.3 11.4 4.4 3.9 11.3 8.8 0.0 0.3 0.0 0.6 0.3 0.9 1.2 0.4 0.4 0.4 0.3 1.9 1.1 0.0 0.9 0.1 4.0 0.0 0.2 10.3 19.4 22.5 22.9 7.1 6.8 6.6 18.2 13.0 6.4 TATDN2 KIAA0218 ENSG00000157014 "TatD DNase domain containing 2" Q93075 3 10248023-10281218 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA036822 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA036822: AB_10671972" "unprognostic (4.51e-2)" "unprognostic (2.66e-3)" "unprognostic (2.75e-1)" "unprognostic (4.23e-2)" "unprognostic (9.88e-2)" "unprognostic (1.58e-2)" "unprognostic (2.57e-3)" "unprognostic (8.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.63e-1)" "prognostic favourable (4.66e-4)" "unprognostic (3.25e-1)" "unprognostic (1.87e-1)" "unprognostic (2.55e-2)" "unprognostic (1.70e-1)" "unprognostic (3.33e-1)" "unprognostic (2.48e-2)" 12.0 13.1 20.4 16.2 22.8 32.8 14.3 17.5 31.6 15.5 13.8 15.8 17.5 14.2 17.2 17.9 16.4 12.6 14.5 13.8 18.3 14.0 14.3 12.2 14.3 21.6 13.7 19.2 22.4 20.8 25.8 16.9 11.1 13.8 17.6 17.2 16.2 20.4 15.3 12.0 19.5 15.2 15.8 13.0 20.6 13.7 10.1 13.5 37.5 18.8 8.6 25.2 12.5 15.2 3.3 3.5 2.5 2.5 2.2 6.0 2.3 9.3 15.8 8.8 7.4 11.3 12.5 37.5 11.3 11.9 15.1 9.9 11.5 8.4 22.8 8.6 16.7 6.8 15.3 10.8 12.2 14.4 17.5 12.1 15.4 12.1 7.5 16.8 12.7 9.5 12.1 21.3 7.1 12.3 13.3 20.7 13.8 18.0 22.1 14.0 12.1 15.8 12.1 9.5 13.1 9.6 13.7 9.7 11.5 9.6 11.5 5.2 11.2 15.8 9.9 17.6 11.3 14.3 20.4 12.7 20.8 40.7 15.4 17.2 11.8 2.5 1.6 1.2 4.6 2.5 4.5 2.5 3.9 3.7 1.5 3.3 4.0 6.0 1.3 2.2 1.3 3.5 4.4 2.3 20.4 22.8 17.5 31.6 18.3 14.0 13.7 19.2 13.8 13.5 TBC1D12 KIAA0608 ENSG00000108239 "TBC1 domain family member 12" O60347 10 94402504-94535930 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.2" "Group enriched" "Detected in many" 13 "B-cells: 1.4;dendritic cells: 2.2;monocytes: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038277, HPA038645" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA038277: AB_10672584, HPA038645: AB_10672650" "unprognostic (7.23e-3)" "unprognostic (1.58e-2)" "prognostic favourable (1.79e-5)" "unprognostic (7.83e-2)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" "unprognostic (1.21e-2)" "unprognostic (7.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-1)" "unprognostic (2.27e-2)" "unprognostic (9.43e-2)" "unprognostic (3.71e-1)" "unprognostic (1.29e-1)" "unprognostic (1.12e-1)" 6.9 4.9 8.9 4.0 18.1 1.2 8.1 7.5 14.8 5.3 8.4 39.2 7.1 6.2 5.6 4.0 4.7 4.3 5.1 4.4 12.4 8.5 5.8 4.1 5.2 3.0 25.5 8.7 5.8 7.1 16.8 3.2 7.8 23.1 6.0 9.7 5.9 3.6 6.5 4.3 5.7 6.9 6.0 41.6 5.6 4.2 10.9 21.3 0.2 4.3 1.5 3.5 5.7 4.9 1.4 2.2 0.0 1.1 0.0 0.1 0.2 7.6 3.4 4.5 6.7 6.3 7.7 5.9 5.0 10.3 5.6 5.3 13.6 3.4 0.0 3.0 7.3 4.3 5.4 3.7 7.2 0.0 6.1 2.4 3.1 4.3 4.8 0.0 1.9 5.2 4.7 5.9 7.6 6.0 3.5 8.0 9.0 4.2 0.0 0.0 1.4 3.6 0.0 5.8 4.0 5.0 3.4 1.9 4.5 5.0 4.3 4.0 9.4 4.6 5.9 3.9 5.4 6.3 3.9 5.7 5.4 0.0 3.9 0.0 2.1 0.0 1.1 0.0 0.0 0.7 0.0 0.5 0.0 0.0 2.2 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 8.9 18.1 7.5 13.4 12.4 8.5 25.5 8.7 23.1 21.3 TBX19 "dj747L4.1, TPIT" ENSG00000143178 "T-box 19" O60806 1 168281040-168314426 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "pituitary gland: 50.4" "Cell line enhanced" "Detected in many" "HaCaT: 9.5;HDLM-2: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005800, HPA072686" Enhanced Approved "Nuclear speckles" "Nuclear speckles" "HPA005800: AB_1080219, HPA072686: " "unprognostic (2.47e-1)" "unprognostic (1.20e-2)" "unprognostic (8.76e-4)" "unprognostic (1.43e-2)" "unprognostic (3.09e-2)" "unprognostic (8.36e-2)" "unprognostic (7.14e-7)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (5.58e-2)" "unprognostic (9.78e-3)" "unprognostic (1.28e-1)" "prognostic unfavourable (4.55e-9)" "unprognostic (8.57e-2)" "unprognostic (6.63e-2)" "unprognostic (9.06e-2)" "unprognostic (1.05e-2)" 1.0 0.4 1.0 1.0 1.0 0.5 2.5 1.0 1.0 1.5 1.3 1.0 1.0 0.8 5.3 1.0 1.1 2.0 1.4 1.0 1.0 0.8 1.0 1.0 2.2 2.1 1.0 1.0 2.9 1.0 0.2 50.4 1.0 1.0 1.2 1.1 1.0 2.2 1.4 1.0 1.9 1.0 3.6 1.0 2.1 0.6 1.0 1.0 1.0 1.0 1.0 1.3 1.3 1.2 1.6 6.3 2.7 2.4 2.6 3.1 1.3 1.6 0.1 1.4 5.3 2.5 1.2 1.7 2.9 1.5 1.0 1.6 2.4 1.7 1.5 2.9 1.1 9.5 0.8 0.7 1.4 8.1 1.4 0.3 1.7 0.7 2.9 2.6 3.6 2.2 2.6 0.3 1.5 1.2 1.8 2.4 1.3 0.3 1.4 2.4 0.4 1.0 2.2 0.7 0.5 2.3 0.7 1.9 2.8 1.6 1.2 1.6 0.4 2.2 2.1 1.0 2.4 2.0 2.9 1.6 1.3 1.2 0.2 0.8 2.8 0.5 1.8 0.8 3.1 1.3 1.4 1.2 2.2 2.0 1.8 1.6 1.5 1.3 2.7 2.6 2.4 6.3 2.0 1.3 1.0 1.0 1.0 1.0 1.0 0.8 1.0 1.0 1.0 1.0 TBXA2R ENSG00000006638 "Thromboxane A2 receptor" P21731 19 3594506-3606840 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 11.7;U-2197: 8.4;U-937: 7.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 12.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA077366 Supported "Nuclear speckles,Plasma membrane" "Plasma membrane" "Nuclear speckles" "HPA077366: " "unprognostic (1.59e-1)" "unprognostic (3.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (8.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.52e-2)" "unprognostic (2.17e-3)" "unprognostic (8.41e-2)" "unprognostic (6.25e-2)" "prognostic favourable (7.17e-4)" "unprognostic (3.89e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (4.32e-2)" "unprognostic (9.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.02e-1)" 8.7 11.8 1.4 3.9 1.6 2.1 3.9 0.5 1.6 13.5 3.8 1.7 3.9 2.6 7.4 4.8 8.0 4.7 6.0 6.8 2.4 1.5 10.1 18.4 6.7 7.3 1.4 1.9 8.3 2.2 2.5 1.7 10.6 2.7 3.6 1.4 5.0 1.7 4.2 3.1 1.8 4.4 6.5 2.1 14.9 3.7 3.4 1.9 2.2 3.9 3.2 1.8 6.8 9.6 12.6 0.3 3.2 0.4 3.1 9.6 3.9 0.1 0.2 0.2 4.1 0.9 2.2 0.7 2.9 0.7 2.3 1.8 0.1 0.3 0.1 4.3 1.2 0.1 0.8 0.0 0.8 0.2 1.0 2.8 11.7 0.3 1.2 0.0 5.2 1.1 0.0 3.0 0.0 0.9 4.4 0.4 0.4 0.2 0.2 1.5 0.1 2.5 0.1 0.0 0.2 0.0 0.1 0.2 1.7 0.2 0.4 0.1 1.8 5.0 2.5 4.7 1.0 8.4 2.8 0.2 0.3 0.2 3.9 7.2 1.1 2.9 0.4 0.2 2.6 0.2 0.3 1.8 0.8 2.3 0.0 12.6 4.6 9.6 3.2 3.1 0.2 0.3 0.2 3.9 1.4 1.6 0.5 1.6 2.4 1.5 1.4 1.9 2.7 1.9 TCEAL2 "my048, MY0876G05, WEX1" ENSG00000184905 "Transcription elongation factor A like 2" Q9H3H9 X 102125688-102127711 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 84.0;ovary: 46.5" "Group enriched" "Detected in some" 4 "HAP1: 7.2;SCLC-21H: 7.9;U-2 OS: 14.2" "Cancer enhanced" "Detected in many" "glioma: 22.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.1" HPA076317 Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA076317: " "unprognostic (2.34e-3)" "unprognostic (1.35e-2)" "unprognostic (7.59e-3)" "unprognostic (3.84e-3)" "unprognostic (2.07e-1)" "unprognostic (4.57e-2)" "unprognostic (4.27e-2)" "unprognostic (2.80e-2)" "unprognostic (3.47e-1)" "unprognostic (3.26e-1)" "unprognostic (7.07e-3)" "unprognostic (1.43e-1)" "unprognostic (1.56e-2)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.04e-1)" "unprognostic (4.11e-3)" 2.4 19.6 34.1 2.6 44.6 1.1 2.4 40.9 84.0 5.8 7.0 8.5 1.8 3.1 19.5 8.6 5.3 7.3 6.4 5.1 30.0 37.9 8.2 1.3 4.4 1.6 25.4 26.5 46.5 3.7 2.8 38.3 1.1 30.1 19.4 3.8 6.6 16.4 21.6 1.2 1.7 3.2 14.0 16.1 2.9 4.2 19.7 9.6 0.0 25.6 0.0 2.1 4.3 2.6 0.1 0.1 0.0 0.1 0.0 2.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.0 7.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.8 0.1 1.7 0.0 0.1 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.1 0.4 34.1 44.6 40.9 41.8 30.0 37.9 25.4 26.5 30.1 9.6 TCEANC MGC17403 ENSG00000176896 "Transcription elongation factor A N-terminal and central domain containing" Q8N8B7 X 13653189-13681964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000337, HPA001013" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA000337: , HPA001013: AB_1079371" "unprognostic (1.44e-1)" "unprognostic (2.21e-3)" "unprognostic (1.74e-2)" "unprognostic (4.45e-2)" "unprognostic (2.21e-3)" "unprognostic (2.29e-3)" "unprognostic (4.03e-2)" "unprognostic (4.29e-6)" "unprognostic (3.82e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-5)" "unprognostic (1.68e-1)" "unprognostic (1.25e-3)" "unprognostic (1.19e-1)" "unprognostic (1.38e-1)" "unprognostic (5.10e-3)" "unprognostic (1.11e-4)" 2.2 2.4 2.1 1.1 2.1 6.3 3.9 3.3 1.8 2.1 1.6 1.3 2.3 5.0 1.1 2.8 1.2 2.0 1.9 2.3 2.1 2.8 2.5 3.6 2.1 4.1 2.7 1.6 2.3 1.5 2.1 2.1 2.3 1.7 2.6 2.0 2.5 2.1 2.4 4.4 1.9 1.0 3.1 2.8 1.9 1.6 5.6 3.7 9.9 2.7 2.4 6.1 3.1 0.7 2.1 2.4 4.1 5.1 6.0 0.9 0.7 1.9 2.0 0.9 0.7 1.7 2.5 2.3 1.6 1.2 2.0 1.1 0.5 2.6 3.0 1.3 1.2 1.1 2.8 2.0 2.5 5.1 2.0 1.1 8.4 0.6 2.5 4.3 2.8 1.8 3.2 2.0 3.2 0.6 2.6 2.2 5.1 1.1 1.3 2.5 2.3 2.1 2.3 3.0 2.4 1.9 1.1 1.7 0.9 1.6 0.3 3.4 2.0 1.7 2.4 1.2 0.9 9.9 2.7 6.8 4.7 2.2 5.1 5.6 5.1 6.1 2.2 5.2 6.1 5.6 3.4 2.4 2.4 3.7 5.8 3.1 TCF23 "bHLHa24, OUT" ENSG00000163792 "Transcription factor 23" Q7RTU1 2 27149004-27156974 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 28.0;endometrium 1: 56.4;ovary: 49.9" "Cell line enriched" "Detected in single" 10 "THP-1: 8.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044596 Approved "Nuclear speckles" "Nuclear speckles" "HPA044596: AB_10797258" "unprognostic (1.04e-1)" "unprognostic (2.47e-3)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (3.65e-2)" "unprognostic (2.68e-2)" "unprognostic (1.70e-2)" "unprognostic (4.07e-2)" "unprognostic (3.21e-1)" "unprognostic (1.74e-2)" "unprognostic (4.08e-2)" "unprognostic (8.58e-2)" "unprognostic (2.41e-5)" "unprognostic (7.58e-3)" "unprognostic (3.01e-1)" "unprognostic (8.58e-4)" "unprognostic (2.64e-2)" 0.3 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.1 28.0 0.5 0.0 0.5 0.0 56.4 7.2 0.1 14.0 0.4 0.6 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 49.9 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 16.7 0.1 6.2 0.1 7.5 0.0 0.0 0.1 0.0 0.0 0.7 1.5 1.8 1.4 4.4 1.0 1.3 1.2 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.3 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.5 0.1 0.6 0.3 0.1 0.8 0.1 0.7 0.0 0.3 0.2 0.1 0.2 0.3 0.0 0.3 8.6 0.0 0.2 0.2 0.3 0.2 0.1 0.0 0.2 0.1 0.3 0.0 4.4 1.0 0.9 1.0 0.5 0.8 1.1 1.1 0.8 0.2 1.8 1.2 1.0 3.9 1.3 0.5 1.4 0.6 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 TEPSIN "C17orf56, ENTHD2, FLJ31528" ENSG00000167302 "TEPSIN, adaptor related protein complex 4 accessory protein" Q96N21 17 81228277-81239091 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063410 Supported "Nuclear membrane,Nuclear speckles,Golgi apparatus" "Nuclear membrane, Nuclear speckles, Golgi apparatus" "HPA063410: " "unprognostic (6.90e-3)" "unprognostic (1.03e-2)" "unprognostic (4.26e-2)" "unprognostic (3.64e-2)" "unprognostic (1.00e-1)" "prognostic favourable (9.96e-4)" "unprognostic (1.16e-2)" "unprognostic (4.85e-2)" "unprognostic (8.52e-2)" "unprognostic (2.29e-1)" "prognostic favourable (6.95e-4)" "unprognostic (4.99e-2)" "prognostic unfavourable (7.31e-8)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (3.58e-1)" "unprognostic (3.16e-3)" 8.5 6.7 8.0 11.9 8.5 17.3 21.3 11.9 9.8 6.0 9.9 9.0 7.3 14.9 7.9 8.6 8.8 8.0 6.6 4.9 8.8 4.7 9.8 13.3 12.5 13.5 12.5 6.3 6.8 11.1 5.3 9.2 7.7 9.8 10.1 6.5 4.8 9.1 9.3 12.4 15.8 12.4 9.8 8.5 17.0 9.7 9.1 9.8 12.2 12.6 7.5 9.0 7.2 7.0 3.0 2.7 7.6 2.9 0.7 1.8 1.2 8.7 12.9 5.0 8.1 3.5 5.8 10.0 7.8 4.4 7.8 7.2 8.3 6.2 6.3 4.4 5.2 11.4 5.2 6.6 3.8 3.8 17.1 5.2 7.2 11.9 5.2 5.6 10.9 3.0 8.6 3.6 4.1 12.4 6.4 6.2 5.0 7.6 10.5 13.0 5.5 11.1 6.6 6.6 6.9 3.0 5.6 6.7 7.8 9.3 10.2 10.7 6.9 10.1 7.9 10.6 6.1 8.1 7.4 8.4 5.8 4.7 7.8 4.8 5.2 4.2 2.4 7.6 1.8 2.9 1.1 2.5 1.2 1.4 2.7 3.0 0.8 0.8 4.3 0.7 1.9 2.7 1.6 1.2 8.0 8.5 11.9 9.8 8.8 4.7 12.5 6.3 9.8 9.8 THAP4 CGI-36 ENSG00000176946 "THAP domain containing 4" Q8WY91 2 241584405-241637449 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044982, HPA053448" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA044982: AB_10959786, HPA053448: " "unprognostic (3.17e-2)" "unprognostic (1.70e-2)" "unprognostic (6.56e-2)" "unprognostic (1.36e-2)" "unprognostic (8.35e-2)" "unprognostic (7.23e-2)" "unprognostic (1.16e-3)" "unprognostic (3.61e-2)" "unprognostic (7.56e-2)" "unprognostic (2.18e-1)" "unprognostic (3.24e-1)" "unprognostic (2.21e-1)" "prognostic favourable (1.46e-4)" "unprognostic (2.57e-1)" "unprognostic (1.78e-1)" "unprognostic (5.06e-1)" "unprognostic (1.07e-1)" 11.9 11.5 19.3 13.0 22.5 13.3 26.3 13.8 27.5 12.8 21.3 13.5 10.8 23.7 12.7 19.1 23.6 15.3 16.9 52.4 15.4 18.1 38.2 25.1 13.6 11.9 18.3 11.7 16.7 25.0 30.9 15.0 11.2 15.6 17.1 15.4 12.5 19.7 17.4 55.8 18.5 20.4 13.7 11.3 10.3 18.5 22.7 11.4 16.0 19.0 26.1 15.7 19.4 18.3 14.3 13.9 22.9 12.7 12.5 30.2 9.8 15.1 19.1 11.5 21.3 15.5 16.2 18.1 10.0 15.4 17.2 15.3 17.3 14.2 13.6 5.9 17.8 17.6 23.1 25.5 6.5 10.2 27.1 13.9 13.1 49.2 20.7 16.5 9.8 16.7 20.2 18.4 25.5 15.8 23.8 4.7 13.2 29.7 16.8 40.2 19.8 16.2 19.3 16.1 18.2 35.7 20.2 27.4 18.0 8.4 27.5 22.8 13.7 19.4 13.8 18.4 12.8 17.4 20.3 11.1 6.5 14.0 14.1 14.1 14.0 15.4 9.3 22.9 17.5 10.8 18.5 13.8 19.4 16.2 9.7 14.3 18.7 14.9 6.5 12.5 12.7 13.9 30.2 9.8 19.3 22.5 13.8 27.5 15.4 18.1 18.3 11.7 15.6 11.4 THBS2 TSP2 ENSG00000186340 "Thrombospondin 2" P35442 6 169215780-169254044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 84.6;urinary bladder: 67.4" "Cell line enhanced" "Detected in some" "ASC diff: 81.9;ASC TERT1: 56.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.2;HSkMC: 30.3;hTEC/SVTERT24-B: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017716, HPA044304" Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to extracellular matrix" 22000000 "Plasma membrane" "Nuclear speckles, Cytosol" "CAB017716: , HPA044304: " "unprognostic (2.85e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (8.90e-2)" "unprognostic (3.64e-2)" "unprognostic (8.73e-2)" "unprognostic (2.93e-1)" "unprognostic (5.10e-3)" "unprognostic (1.39e-1)" "unprognostic (4.71e-2)" "unprognostic (4.00e-2)" "unprognostic (2.56e-1)" "prognostic unfavourable (3.77e-6)" "unprognostic (2.19e-3)" "unprognostic (4.38e-2)" "unprognostic (4.16e-2)" "unprognostic (2.48e-3)" 43.5 4.0 4.3 10.1 7.8 0.4 84.6 1.1 9.0 24.3 17.0 6.3 3.3 1.9 26.1 16.1 9.8 14.8 43.0 21.9 5.5 3.6 4.6 5.9 8.4 3.8 8.1 1.4 26.2 5.9 1.5 4.4 2.0 14.8 10.5 3.4 0.7 3.9 2.8 14.6 22.7 3.8 22.0 16.0 2.8 2.6 12.5 5.2 0.0 13.2 10.6 4.8 67.4 29.4 0.4 0.7 0.2 0.8 0.1 0.3 0.0 0.0 0.0 0.5 0.3 81.9 56.2 0.0 15.6 21.4 21.6 27.2 0.1 0.0 0.0 0.0 18.6 0.0 0.6 0.8 12.4 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 30.3 0.0 29.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 3.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 0.1 22.0 1.8 0.0 0.3 0.0 6.1 0.1 0.5 0.0 0.8 0.2 0.2 0.5 0.0 0.4 0.1 0.0 0.2 0.3 0.1 0.3 0.0 0.1 0.5 0.7 0.2 0.0 4.3 7.8 1.1 3.1 5.5 3.6 8.1 1.4 14.8 5.2 THEM6 "C8orf55, DSCD75" ENSG00000130193 "Thioesterase superfamily member 6" Q8WUY1 8 142727203-142736927 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 28.6;RT4: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023255 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted - unknown location" "Nuclear speckles, Cytosol" "HPA023255: AB_1845782" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (9.10e-2)" "unprognostic (5.33e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-2)" "unprognostic (1.74e-2)" "unprognostic (6.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.44e-1)" "unprognostic (4.91e-2)" "unprognostic (6.76e-2)" "prognostic favourable (6.66e-7)" "unprognostic (7.02e-3)" "unprognostic (3.55e-2)" "unprognostic (2.39e-2)" "prognostic favourable (4.49e-4)" 11.9 13.9 9.4 5.6 13.4 6.0 21.6 9.0 20.7 10.8 11.8 12.8 16.6 14.4 5.6 7.1 14.9 12.5 15.0 12.6 10.7 11.5 16.7 35.2 11.0 7.4 8.8 11.7 4.5 30.7 13.4 10.0 10.7 11.6 9.8 6.7 10.0 18.5 15.3 11.3 11.7 14.3 4.8 9.3 8.7 15.1 3.0 7.5 10.3 14.4 15.6 10.6 19.7 7.9 6.5 3.8 4.5 7.4 8.4 14.6 7.5 9.8 8.2 1.2 8.6 4.0 1.4 6.1 5.1 4.2 7.8 5.4 5.0 14.8 4.1 11.6 1.9 23.0 3.6 11.0 1.3 3.4 10.1 3.1 4.6 10.0 4.4 1.8 3.3 2.0 3.9 1.5 2.2 6.6 1.4 2.1 1.3 28.6 7.4 0.4 1.9 26.9 8.7 0.8 9.5 9.3 40.4 19.4 7.6 7.8 23.4 6.5 11.5 1.5 3.8 3.4 2.5 9.7 0.8 1.4 1.9 1.8 3.5 9.0 4.1 4.5 4.0 2.0 9.7 7.4 14.6 4.6 10.3 12.5 3.8 6.5 12.5 11.5 0.5 8.4 7.1 2.9 9.1 7.5 9.4 13.4 9.0 20.7 10.7 11.5 8.8 11.7 11.6 7.5 TMEM209 "FLJ14803, NET31" ENSG00000146842 "Transmembrane protein 209" Q96SK2 7 130164715-130207770 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031678 Uncertain Approved "Nuclear membrane,Nuclear speckles,Vesicles" "Nuclear membrane, Nuclear speckles, Vesicles" "HPA031678: AB_10603135" "unprognostic (3.03e-1)" "unprognostic (5.06e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (5.98e-2)" "unprognostic (1.25e-1)" "unprognostic (1.66e-1)" "unprognostic (3.19e-1)" "unprognostic (6.00e-2)" "unprognostic (2.34e-3)" "unprognostic (1.11e-1)" "unprognostic (3.48e-1)" "unprognostic (1.68e-2)" "unprognostic (3.24e-1)" 12.0 33.5 9.9 9.1 12.1 9.4 12.2 12.7 13.3 9.4 12.2 23.8 9.5 10.4 16.4 11.8 8.8 11.2 8.1 7.9 9.9 10.9 11.6 16.9 10.3 12.2 11.6 12.0 13.7 19.8 19.0 18.7 18.6 16.4 10.3 12.9 19.0 16.5 10.3 10.1 11.1 19.0 10.5 19.1 13.3 8.8 17.8 11.3 24.9 18.6 8.0 13.1 11.1 8.9 14.1 10.8 10.0 13.4 13.8 20.5 10.4 9.4 9.1 12.4 15.3 7.2 7.4 9.2 8.6 8.7 7.9 10.6 10.1 17.2 14.0 6.5 5.5 14.2 14.5 10.0 14.1 17.3 8.3 7.3 15.4 6.7 12.8 15.3 7.4 8.2 10.3 15.7 15.7 6.0 23.5 16.5 9.5 12.3 29.1 9.3 18.5 8.1 15.7 13.9 23.2 7.9 12.1 11.1 17.1 19.7 31.7 12.5 10.2 10.3 4.7 14.4 5.6 15.0 20.7 22.0 32.2 29.2 23.4 17.7 22.1 10.0 8.9 9.5 17.0 13.4 17.7 14.1 17.4 15.4 8.6 14.0 20.5 17.3 1.3 13.8 11.3 10.8 17.3 10.4 9.9 12.1 12.7 13.3 9.9 10.9 11.6 12.0 16.4 11.3 TMEM259 "ASBABP1, C19orf6, MBRL, MGC4022" ENSG00000182087 "Transmembrane protein 259" Q4ZIN3 19 1009648-1021179 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042669, HPA054801" Approved Approved "Nuclear speckles,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear speckles" "HPA042669: AB_10794916, HPA054801: " "unprognostic (1.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "prognostic favourable (1.01e-4)" "unprognostic (4.12e-2)" "unprognostic (6.87e-3)" "unprognostic (2.77e-2)" "unprognostic (1.23e-1)" "unprognostic (2.20e-1)" "unprognostic (2.74e-1)" "unprognostic (4.85e-3)" "unprognostic (4.07e-2)" "unprognostic (4.81e-2)" "prognostic favourable (8.92e-6)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (4.10e-3)" 39.5 39.2 35.7 42.3 39.2 46.4 36.9 54.8 44.3 35.4 41.0 46.1 33.9 43.7 39.6 27.4 37.0 34.8 38.6 43.9 34.8 26.1 37.1 59.2 40.5 44.6 44.1 30.0 38.4 59.0 43.5 55.7 47.9 40.1 41.1 23.3 47.8 49.0 36.2 39.3 62.3 42.9 30.1 27.5 61.8 48.5 36.0 40.2 38.0 47.6 24.9 45.4 37.9 37.0 3.8 6.7 2.5 5.2 2.5 5.5 3.0 35.9 23.2 16.1 18.3 19.9 19.3 28.5 30.6 26.7 25.3 27.4 21.3 20.3 24.9 30.2 23.1 41.2 16.2 30.1 11.2 31.9 27.4 14.6 28.7 23.4 35.3 28.0 37.2 25.8 30.8 20.3 25.5 22.0 24.6 50.5 16.8 15.7 30.7 25.8 23.9 19.1 35.1 12.3 31.5 20.0 33.9 22.4 23.4 19.4 24.6 20.9 24.2 36.5 25.5 25.3 14.6 35.4 31.8 71.7 26.9 27.7 29.9 23.1 25.1 0.9 3.9 2.2 5.5 3.5 4.1 3.8 3.2 5.5 6.0 3.4 3.5 3.9 2.5 2.5 5.2 6.7 3.2 3.0 35.7 39.2 54.8 44.3 34.8 26.1 44.1 30.0 40.1 40.2 TMEM56 FLJ31842 ENSG00000152078 "Transmembrane protein 56" Q96MV1 1 95117338-95197607 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.2" "Cell line enhanced" "Detected in many" "A-431: 13.9;RH-30: 23.2" "Cancer enhanced" "Detected in many" "liver cancer: 13.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 3.3;naive B-cell: 1.6;neutrophil: 1.0" "Group enriched" "Detected in many" 6 "B-cells: 3.3;granulocytes: 1.0" HPA046762 Approved "Nuclear speckles" "Nuclear speckles" "HPA046762: " "unprognostic (1.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.98e-3)" "unprognostic (2.79e-1)" "unprognostic (3.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.82e-3)" "unprognostic (3.63e-2)" "unprognostic (4.42e-3)" "unprognostic (2.69e-2)" "unprognostic (4.99e-2)" "unprognostic (4.40e-2)" "unprognostic (1.16e-3)" "unprognostic (1.10e-1)" "unprognostic (9.46e-2)" "unprognostic (1.59e-1)" "unprognostic (3.15e-2)" 3.3 6.6 6.1 1.6 6.5 10.4 2.0 10.9 10.6 2.0 8.2 3.8 2.8 3.6 2.5 2.1 1.9 2.2 4.5 15.1 4.2 3.2 3.9 74.2 2.6 0.7 3.5 5.7 1.5 6.5 5.4 6.8 3.1 4.7 3.8 6.6 28.1 4.8 2.7 7.2 1.7 6.6 8.1 4.1 1.0 3.9 3.2 3.2 0.0 4.8 1.7 0.8 4.8 3.1 3.3 0.1 1.0 0.1 0.0 0.3 0.1 13.9 8.0 1.1 1.7 0.5 0.0 1.9 0.5 0.3 1.8 4.3 5.8 6.7 0.0 7.0 0.2 0.1 4.7 0.7 3.2 9.7 2.6 0.3 6.8 1.2 0.5 0.2 0.4 0.8 0.2 1.4 0.0 0.0 12.2 0.7 0.4 1.1 0.8 0.0 1.1 4.4 0.0 23.2 0.3 7.8 9.1 2.9 2.3 9.9 7.0 4.1 7.6 0.2 0.1 0.2 6.0 0.7 4.9 2.5 4.8 0.0 1.0 0.0 1.4 0.3 0.1 0.1 0.1 0.0 0.0 3.3 0.2 0.2 0.0 1.6 0.3 0.1 1.0 0.0 0.0 0.1 0.1 0.1 6.1 6.5 10.9 10.6 4.2 3.2 3.5 5.7 4.7 3.2 TOR1B "DQ1, MGC4386" ENSG00000136816 "Torsin family 1 member B" O14657 9 129803153-129811281 "Predicted intracellular proteins" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013403, HPA013697, CAB022709" Approved Approved "Nuclear speckles,Cytosol" "Intracellular and membrane" "Nuclear speckles" Cytosol "CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196" "unprognostic (2.91e-3)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-2)" "unprognostic (1.75e-1)" "unprognostic (5.73e-3)" "unprognostic (1.95e-1)" "unprognostic (7.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.13e-2)" "unprognostic (2.07e-3)" "unprognostic (4.09e-2)" "unprognostic (1.23e-1)" "unprognostic (5.40e-3)" "unprognostic (1.69e-3)" 14.2 14.4 9.7 13.8 12.2 14.0 18.4 23.6 11.9 11.3 22.5 10.5 11.6 12.3 14.0 8.2 13.5 10.5 15.0 13.3 11.7 11.5 11.8 35.3 13.0 10.8 9.4 9.0 10.8 21.1 13.3 13.6 20.0 10.6 12.9 25.8 10.8 12.8 13.7 13.5 13.0 18.1 14.2 8.9 12.4 14.9 19.5 8.3 16.8 16.4 10.0 11.9 14.9 18.0 4.6 6.2 17.2 14.6 7.3 12.3 8.4 5.3 12.3 5.2 13.8 26.0 19.5 12.0 19.3 12.6 13.2 13.2 10.2 12.3 3.8 12.3 18.9 22.0 5.6 7.9 13.6 14.0 5.9 3.4 10.5 7.2 11.2 6.3 15.0 11.0 14.0 18.9 9.4 11.7 11.6 8.9 12.3 15.0 8.6 10.0 10.9 9.8 3.6 9.1 11.6 10.2 5.6 7.2 8.3 12.4 14.4 7.6 20.7 6.2 10.7 25.1 12.0 29.8 16.5 6.5 24.3 3.2 13.8 8.3 17.0 6.3 11.5 17.2 12.2 14.6 12.3 3.9 9.5 10.5 6.2 4.6 7.1 7.1 14.2 7.3 8.5 3.8 9.1 8.4 9.7 12.2 23.6 11.9 11.7 11.5 9.4 9.0 10.6 8.3 TRIP12 KIAA0045 ENSG00000153827 "Thyroid hormone receptor interactor 12" Q14669 2 229763838-229923239 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036835, HPA045893" Enhanced Approved "Nuclear speckles" "Nuclear speckles" "HPA036835: , HPA045893: " "unprognostic (1.22e-1)" "unprognostic (4.87e-2)" "unprognostic (2.61e-1)" "unprognostic (3.33e-2)" "unprognostic (6.81e-2)" "unprognostic (1.88e-1)" "prognostic unfavourable (3.60e-4)" "unprognostic (3.37e-3)" "unprognostic (3.49e-3)" "unprognostic (4.87e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (1.62e-1)" "unprognostic (6.83e-2)" "unprognostic (8.80e-2)" "unprognostic (2.01e-2)" 29.6 28.1 23.6 25.4 26.9 26.9 23.1 20.5 26.2 24.0 23.1 26.2 24.3 14.3 25.3 26.3 30.6 19.9 20.7 35.9 19.0 19.3 26.2 24.9 26.2 26.5 23.1 20.5 24.3 18.8 32.4 33.1 27.2 24.8 25.8 21.3 22.3 25.5 22.0 62.7 23.6 22.0 26.2 23.3 32.5 23.4 77.1 24.0 42.2 28.0 21.5 31.5 26.5 27.4 7.0 9.1 25.8 12.0 9.1 12.7 6.1 23.8 26.9 24.7 20.7 23.6 28.7 23.0 36.8 25.0 26.7 29.8 21.5 19.2 9.3 27.0 32.8 18.7 36.0 26.2 39.2 38.2 13.1 64.8 22.6 19.0 20.4 48.7 42.4 24.8 20.2 44.4 28.5 34.8 47.8 10.0 30.5 18.1 27.2 16.8 19.3 12.3 24.8 48.8 8.2 19.8 41.0 25.1 17.9 0.5 12.4 25.3 12.5 29.8 48.3 34.6 24.6 22.5 28.4 17.4 19.9 30.5 26.4 19.2 29.0 18.8 9.9 15.7 9.5 11.3 9.7 7.0 8.8 9.2 9.1 6.8 7.3 7.0 25.8 9.1 12.0 9.0 12.7 6.1 23.6 26.9 20.5 26.2 19.0 19.3 23.1 20.5 24.8 24.0 TSC22D3 "DIP, DSIPI, GILZ, hDIP, TSC-22R" ENSG00000157514 "TSC22 domain family member 3" Q99576 X 107713221-107777342 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 57.8;ASC TERT1: 39.8;HHSteC: 95.7;hTCEpi: 85.2;Karpas-707: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001916, CAB034364" Approved Approved "Nuclear speckles,Golgi apparatus,Cytosol" Cytosol "Nuclear speckles, Golgi apparatus" "CAB034364: AB_2272198, HPA001916: " "unprognostic (3.67e-2)" "unprognostic (3.90e-3)" "unprognostic (5.99e-2)" "prognostic unfavourable (2.43e-4)" "unprognostic (3.49e-2)" "unprognostic (3.21e-2)" "unprognostic (3.73e-3)" "unprognostic (4.40e-2)" "unprognostic (9.42e-2)" "unprognostic (5.32e-2)" "unprognostic (3.25e-1)" "unprognostic (7.47e-2)" "unprognostic (6.38e-2)" "unprognostic (1.37e-3)" "unprognostic (6.41e-2)" "unprognostic (4.14e-1)" "unprognostic (9.64e-2)" 69.1 48.4 18.2 72.7 21.0 72.4 142.4 31.8 32.7 53.3 49.0 10.6 36.7 16.7 37.2 26.6 58.7 45.4 47.8 42.6 18.8 12.2 33.8 20.9 83.3 98.8 22.0 16.2 54.6 20.0 7.1 18.8 31.3 20.8 51.8 37.2 39.8 172.4 40.7 163.5 65.2 54.6 45.4 22.9 55.7 49.3 20.3 19.2 29.7 59.8 36.1 62.7 75.3 89.6 47.9 31.7 191.5 62.4 69.0 82.4 105.1 1.5 2.6 1.3 3.7 57.8 39.8 0.5 2.4 2.0 1.1 1.2 0.0 5.2 3.3 6.0 1.9 7.8 2.8 7.8 0.5 1.0 1.3 1.6 11.0 0.1 95.7 0.3 5.6 36.2 85.2 0.9 23.8 4.3 0.5 53.8 9.8 5.3 0.1 5.7 2.4 1.7 0.1 3.4 7.0 3.8 1.0 0.3 3.0 2.4 13.2 18.1 2.5 7.5 6.4 3.5 1.0 0.7 0.4 11.8 5.1 1.5 1.8 6.7 0.9 42.7 34.0 126.9 55.2 40.4 40.6 47.9 63.4 53.6 31.7 45.5 59.6 55.4 191.5 69.0 62.4 6.4 82.4 105.1 18.2 21.0 31.8 32.7 18.8 12.2 22.0 16.2 20.8 19.2 TTC26 "dyf-13, DYF13, FLJ12571, IFT56" ENSG00000105948 "Tetratricopeptide repeat domain 26" A0AVF1 7 139133744-139191986 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036338, HPA036339" Enhanced Approved "Nuclear speckles,Intermediate filaments,Cytosol" "Nuclear speckles, Intermediate filaments, Cytosol" "HPA036338: AB_10673351, HPA036339: AB_10673386" "unprognostic (3.40e-2)" "unprognostic (8.88e-2)" "unprognostic (5.01e-2)" "unprognostic (6.72e-2)" "unprognostic (8.34e-3)" "unprognostic (1.45e-1)" "unprognostic (2.46e-7)" "unprognostic (1.72e-1)" "unprognostic (4.96e-2)" "unprognostic (5.27e-2)" "unprognostic (7.12e-2)" "unprognostic (2.75e-1)" "unprognostic (5.18e-2)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.56e-1)" 3.5 6.5 6.9 2.5 8.1 3.3 5.6 6.9 8.3 6.1 3.1 4.4 7.4 1.3 6.6 7.6 3.1 20.9 4.5 3.5 5.7 5.1 8.3 1.9 5.1 2.8 2.7 4.8 8.8 3.2 13.0 20.1 3.8 8.4 5.6 2.8 5.4 3.6 5.5 2.3 3.2 2.2 4.6 2.7 2.6 3.1 17.4 3.9 3.8 7.3 2.8 3.1 3.7 3.9 3.6 2.5 5.3 1.5 1.6 2.3 0.9 11.3 8.6 7.6 9.0 9.5 11.1 3.8 5.5 5.8 9.1 9.3 5.5 8.2 2.5 9.3 4.3 5.7 8.5 6.5 13.3 7.1 7.3 3.1 6.9 4.7 4.7 8.8 2.1 6.3 5.9 13.6 6.2 6.7 6.8 1.6 7.2 10.7 14.9 10.3 7.6 7.6 5.2 9.0 4.0 7.9 3.4 11.2 8.0 13.7 5.8 7.8 7.0 4.7 4.6 8.5 7.4 7.7 10.2 3.7 4.6 1.9 14.9 4.3 9.9 1.2 0.5 1.2 2.1 0.5 1.1 3.6 1.5 1.4 1.1 2.4 2.3 1.7 5.3 1.6 1.5 2.5 1.0 0.9 6.9 8.1 6.9 8.3 5.7 5.1 2.7 4.8 8.4 3.9 UBAP2L "KIAA0144, NICE-4" ENSG00000143569 "Ubiquitin associated protein 2 like" Q14157 1 154220179-154271510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035068 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA035068: AB_10696366" "unprognostic (3.14e-2)" "unprognostic (1.50e-1)" "unprognostic (8.82e-2)" "unprognostic (2.93e-3)" "unprognostic (3.98e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (4.65e-5)" "unprognostic (1.97e-2)" "unprognostic (5.10e-3)" "unprognostic (9.01e-2)" "unprognostic (1.67e-1)" "unprognostic (6.96e-2)" "prognostic unfavourable (2.89e-5)" "unprognostic (7.40e-3)" "unprognostic (9.14e-2)" "unprognostic (2.69e-1)" "unprognostic (3.72e-1)" 33.8 33.0 39.1 34.8 47.5 32.7 32.3 34.3 46.6 31.2 31.3 32.9 25.5 20.6 40.6 30.3 36.1 34.8 28.3 36.9 38.3 25.2 26.7 23.9 35.1 34.1 26.5 39.5 42.7 25.0 42.1 40.6 43.9 30.5 29.2 25.8 31.2 31.8 32.8 53.2 36.8 25.3 36.6 30.2 30.5 27.4 37.5 30.2 34.6 33.8 26.6 38.5 37.9 32.4 18.3 24.3 17.6 26.5 24.6 20.6 18.3 42.7 41.3 40.5 31.9 28.9 33.1 34.8 49.3 35.7 44.8 31.2 44.3 33.3 53.5 51.3 41.3 37.2 53.0 36.3 39.5 47.1 45.4 57.9 42.8 36.9 27.2 60.3 34.3 31.4 15.9 40.5 25.9 35.4 52.6 26.0 35.2 46.6 47.0 22.6 75.3 39.2 33.8 32.0 47.2 28.0 50.1 41.3 50.0 56.7 53.4 21.5 53.6 41.8 56.8 27.8 29.5 34.1 46.8 57.0 61.3 72.8 29.9 33.1 41.5 8.8 19.2 13.2 17.5 25.1 19.1 15.6 16.4 15.7 24.3 18.3 19.1 20.6 17.6 24.6 26.5 11.4 14.7 18.3 39.1 47.5 34.3 46.6 38.3 25.2 26.5 39.5 30.5 30.2 UBE3B ENSG00000151148 "Ubiquitin protein ligase E3B" Q7Z3V4 12 109477402-109536705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041012 Approved Approved "Nuclear speckles,Mitochondria" "Nuclear speckles" Mitochondria "HPA041012: AB_10964435" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (7.12e-2)" "unprognostic (7.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.19e-2)" "unprognostic (2.93e-1)" "unprognostic (4.46e-3)" "unprognostic (9.39e-2)" "unprognostic (1.23e-1)" "prognostic favourable (2.49e-5)" "unprognostic (3.35e-1)" "unprognostic (3.35e-2)" "unprognostic (2.87e-1)" "unprognostic (1.26e-1)" 14.5 19.3 17.2 12.9 21.2 9.2 15.3 19.7 27.8 14.4 17.3 23.3 14.0 14.6 17.4 16.2 20.1 19.3 13.9 28.6 14.6 11.6 19.8 16.4 15.5 13.1 18.6 13.9 18.4 20.3 25.5 15.1 16.8 15.8 17.5 21.2 20.7 15.7 17.4 34.0 21.6 16.3 18.6 15.2 17.0 17.3 24.5 18.3 18.2 21.1 17.6 15.9 19.5 19.6 15.9 14.5 22.4 16.7 14.3 18.2 11.4 10.4 16.6 13.0 9.4 22.2 17.9 11.4 13.8 15.9 16.8 11.3 17.3 10.8 6.5 10.3 22.6 13.5 13.2 17.7 16.3 14.3 9.3 12.5 10.8 15.6 14.3 10.1 10.5 20.3 16.6 16.3 19.6 18.1 13.6 6.2 19.1 16.4 6.9 14.8 13.3 20.0 11.5 12.3 12.8 14.4 18.9 12.1 22.4 16.1 22.0 10.8 22.4 10.8 16.5 20.9 6.0 10.6 9.8 13.9 11.5 11.5 20.8 8.5 17.3 22.4 15.3 14.3 15.9 16.7 15.7 15.9 15.3 11.2 14.5 12.9 12.9 17.1 19.5 14.3 13.6 13.5 18.2 11.4 17.2 21.2 19.7 27.8 14.6 11.6 18.6 13.9 15.8 18.3 UFC1 HSPC155 ENSG00000143222 "Ubiquitin-fold modifier conjugating enzyme 1" Q9Y3C8 1 161152776-161158856 "Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027481, HPA028722" Enhanced Approved "Nuclear speckles,Cytosol" 180000 "Nuclear speckles" Cytosol "HPA027481: AB_10599850, HPA028722: AB_10601674" "unprognostic (2.16e-1)" "unprognostic (6.17e-2)" "unprognostic (1.83e-1)" "unprognostic (8.25e-3)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-3)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (3.40e-2)" "unprognostic (5.04e-2)" "unprognostic (1.86e-1)" "prognostic unfavourable (2.62e-6)" "unprognostic (3.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.13e-1)" "unprognostic (6.22e-2)" 34.2 38.6 52.6 25.4 54.7 35.1 45.6 21.1 41.8 35.4 37.3 27.8 47.7 36.9 31.5 57.2 40.6 69.9 40.8 36.0 42.5 45.9 56.1 55.2 32.0 29.8 46.3 35.6 48.7 85.5 39.3 40.6 54.2 34.4 44.0 46.8 29.2 63.6 40.3 34.3 36.1 48.6 35.8 34.4 39.1 39.1 22.2 33.9 38.9 50.2 38.9 38.9 37.9 33.4 41.1 43.6 22.4 33.0 40.9 54.1 48.0 22.8 21.2 18.7 23.5 25.1 40.4 39.5 23.3 27.5 22.3 19.8 27.7 46.9 31.8 39.2 32.4 11.9 15.6 22.4 16.6 27.0 43.0 19.4 31.5 33.2 24.9 42.6 49.4 34.4 36.3 27.8 19.2 38.8 32.1 23.3 28.4 27.6 19.7 39.0 34.4 23.3 24.2 13.6 44.2 43.2 27.9 21.6 34.3 20.3 67.5 26.8 25.8 79.4 29.0 16.6 16.2 15.9 34.0 40.6 51.9 28.7 26.3 27.2 21.0 22.4 32.8 20.4 39.0 33.0 47.2 41.1 41.8 41.5 40.4 31.0 36.7 39.5 6.0 40.9 24.0 43.6 54.1 48.0 52.6 54.7 21.1 41.8 42.5 45.9 46.3 35.6 34.4 33.9 USP22 "KIAA1063, USP3L" ENSG00000124422 "Ubiquitin specific peptidase 22" Q9UPT9 17 20999593-21043760 "Enzymes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044980 Supported Approved "Nuclear speckles" "Nuclear speckles" "HPA044980: AB_10794503" "unprognostic (7.24e-2)" "unprognostic (5.38e-2)" "unprognostic (7.67e-2)" "unprognostic (6.19e-2)" "unprognostic (4.72e-1)" "unprognostic (1.11e-2)" "prognostic unfavourable (9.66e-4)" "unprognostic (2.17e-2)" "unprognostic (7.81e-2)" "unprognostic (6.37e-2)" "unprognostic (1.07e-3)" "unprognostic (5.68e-2)" "prognostic favourable (1.53e-7)" "unprognostic (8.95e-2)" "unprognostic (1.93e-1)" "unprognostic (2.91e-1)" "unprognostic (1.79e-2)" 22.5 33.0 40.7 21.5 49.5 25.9 24.6 66.1 66.4 26.8 23.6 31.9 25.1 18.9 36.7 29.3 21.9 33.9 23.0 44.1 38.7 47.6 27.7 22.9 26.1 25.1 31.0 40.7 45.6 24.5 47.4 32.2 22.4 35.1 27.5 20.5 28.7 20.0 29.5 47.6 22.1 21.1 31.2 24.8 23.7 22.7 20.2 23.7 41.2 32.8 24.8 27.3 25.1 23.2 13.7 12.1 13.4 13.3 8.9 15.5 6.9 21.6 39.4 38.3 32.9 22.4 23.3 18.3 25.0 19.3 22.6 19.2 45.4 9.8 29.8 24.1 38.4 23.4 37.1 29.8 33.8 14.2 25.7 24.7 26.2 22.0 26.5 27.1 21.6 25.6 17.9 25.5 26.9 28.1 28.0 10.8 31.9 22.3 37.9 12.9 19.7 13.0 42.0 60.6 20.3 20.8 31.9 18.5 38.1 32.3 13.4 26.3 22.5 16.1 35.6 23.1 30.7 23.6 33.8 11.7 15.6 99.0 23.5 14.5 35.6 6.8 13.3 12.6 11.0 9.8 11.1 10.9 11.7 10.9 12.1 13.7 15.5 14.6 13.4 8.9 12.2 10.2 7.8 6.9 40.7 49.5 66.1 66.4 38.7 47.6 31.0 40.7 35.1 23.7 VAX2 DRES93 ENSG00000116035 "Ventral anterior homeobox 2" Q9UIW0 2 70900590-70965373 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.4;retina: 21.2" "Cell line enhanced" "Detected in many" "AN3-CA: 6.5;MCF7: 7.4;RH-30: 6.4;SCLC-21H: 6.4;SH-SY5Y: 7.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basal ganglia: 2.1;hypothalamus: 4.7" HPA009708 Approved "Nuclear speckles" "Nuclear speckles" "HPA009708: " "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.96e-2)" "unprognostic (3.16e-2)" "unprognostic (1.63e-2)" "unprognostic (2.17e-1)" "unprognostic (3.52e-2)" "unprognostic (7.23e-3)" "unprognostic (2.42e-1)" "unprognostic (1.98e-1)" "unprognostic (3.81e-1)" "unprognostic (2.16e-1)" "unprognostic (7.74e-3)" "unprognostic (6.63e-3)" "unprognostic (4.65e-1)" "unprognostic (6.67e-3)" "unprognostic (2.18e-2)" 2.7 2.6 4.4 1.4 1.9 0.4 2.1 16.4 7.9 1.9 0.8 1.1 0.0 0.5 3.6 0.8 1.8 1.1 0.6 1.5 2.5 4.1 0.6 0.3 0.9 0.6 1.4 1.1 2.3 6.9 0.9 2.2 1.2 0.8 2.3 0.6 21.2 4.5 0.6 2.0 1.5 0.5 1.9 1.6 0.4 0.4 0.8 1.0 0.0 0.7 1.2 0.4 1.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 4.9 1.2 6.5 1.8 1.0 3.6 1.2 0.5 0.1 0.0 0.1 0.0 0.0 0.0 2.9 0.3 2.5 0.0 0.2 0.0 4.0 0.0 0.1 2.7 0.8 0.0 0.0 1.8 0.0 0.3 0.0 0.6 0.0 0.0 2.4 7.4 0.0 0.1 2.8 0.1 0.0 6.4 0.0 2.0 1.6 6.4 7.7 5.0 0.0 2.7 2.8 0.2 1.2 3.1 0.7 1.5 1.3 0.0 0.0 0.0 1.5 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.9 16.4 2.7 2.5 4.1 1.4 1.1 0.8 1.0 VPS72 "Swc2, TCFL1, YL-1, YL1" ENSG00000163159 "Vacuolar protein sorting 72 homolog" Q15906 1 151169987-151195321 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065709 Approved "Nuclear speckles" "Nuclear speckles" "HPA065709: " "unprognostic (2.55e-1)" "unprognostic (3.79e-1)" "unprognostic (3.10e-1)" "unprognostic (4.50e-2)" "unprognostic (2.16e-2)" "unprognostic (7.00e-2)" "prognostic unfavourable (4.41e-6)" "unprognostic (4.10e-2)" "unprognostic (2.25e-1)" "unprognostic (1.10e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (7.92e-2)" "unprognostic (4.52e-2)" "unprognostic (4.92e-2)" "unprognostic (4.49e-2)" "unprognostic (1.30e-1)" 23.7 19.7 28.2 20.9 26.3 11.8 19.2 30.2 30.2 21.0 19.2 20.6 20.5 17.8 26.1 21.6 24.6 26.5 19.2 22.0 25.7 26.2 20.1 14.9 18.2 19.6 26.5 25.1 27.3 18.5 19.8 16.4 23.7 21.8 23.8 17.7 19.2 23.8 24.6 66.6 22.5 16.3 32.8 27.0 19.3 19.6 17.3 21.9 21.4 22.2 20.2 26.4 29.0 21.3 35.4 28.8 41.4 25.8 38.2 33.8 27.9 20.2 13.9 32.5 23.3 14.3 12.7 27.9 22.1 11.8 17.8 12.9 14.9 17.0 20.5 27.2 16.6 19.1 23.9 14.2 13.4 24.2 25.2 17.5 10.9 10.1 20.1 25.7 15.8 10.1 19.8 20.2 16.9 23.2 33.2 15.2 14.0 33.9 22.1 17.5 37.8 23.0 24.4 18.6 32.0 16.5 10.3 23.0 41.0 15.2 23.6 26.5 26.5 38.2 21.8 9.3 15.6 14.8 27.9 28.6 40.4 32.9 15.4 17.9 17.1 25.9 25.8 41.4 32.1 24.5 31.0 35.4 28.9 27.2 28.8 27.4 28.9 26.2 18.9 38.2 19.6 18.3 33.8 27.9 28.2 26.3 30.2 27.3 25.7 26.2 26.5 25.1 21.8 21.9 WDR17 ENSG00000150627 "WD repeat domain 17" Q8IZU2 4 176065834-176182818 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9;parathyroid gland: 19.0;pituitary gland: 22.5" "Cell line enhanced" "Detected in many" "AF22: 8.9;SCLC-21H: 10.3;SH-SY5Y: 7.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042766, HPA054501" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA042766: AB_10806372, HPA054501: " "unprognostic (3.41e-4)" "unprognostic (1.72e-1)" "unprognostic (1.20e-1)" "unprognostic (6.43e-7)" "unprognostic (3.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (8.62e-2)" "unprognostic (1.42e-1)" "unprognostic (1.39e-3)" "unprognostic (6.04e-4)" "unprognostic (3.66e-4)" "unprognostic (9.25e-3)" "unprognostic (4.63e-2)" "unprognostic (7.32e-3)" "unprognostic (8.24e-3)" 2.1 5.8 12.4 2.2 22.1 1.5 3.3 12.2 23.9 2.0 2.9 3.4 0.0 1.6 4.5 6.2 1.9 3.5 3.0 1.3 9.7 7.1 6.2 1.0 3.6 1.8 4.4 16.3 4.0 3.0 19.0 22.5 0.7 7.9 2.3 3.1 6.0 1.7 2.2 0.7 1.2 1.8 2.8 4.0 2.9 3.1 4.1 6.9 0.1 10.2 0.0 1.6 1.9 1.5 1.1 0.7 2.6 1.6 1.3 0.8 0.2 0.0 3.7 8.9 0.1 0.2 0.6 0.3 0.2 0.0 0.8 3.1 0.2 0.1 6.1 0.0 0.1 0.1 3.9 2.0 0.8 0.0 3.2 0.0 0.7 0.0 0.3 3.3 4.8 1.4 1.2 0.1 0.5 0.0 0.0 0.3 0.6 1.6 3.4 0.1 2.0 1.9 0.0 3.8 0.0 0.5 0.0 10.3 7.4 0.0 2.4 6.2 0.4 0.0 0.0 1.2 1.7 0.1 5.8 4.4 2.9 3.5 7.0 0.0 2.4 2.6 0.6 0.3 0.6 1.6 0.3 1.1 0.6 0.4 0.2 0.8 0.7 0.8 1.7 1.3 0.3 0.7 0.3 0.2 12.4 22.1 12.2 21.8 9.7 7.1 4.4 16.3 7.9 6.9 WDR90 "C16orf15, C16orf16, C16orf17, C16orf18, C16orf19, FLJ36483, KIAA1924" ENSG00000161996 "WD repeat domain 90" Q96KV7 16 649311-667833 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA049362, HPA061785" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA049362: , HPA061785: " "unprognostic (1.97e-2)" "unprognostic (1.50e-2)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.89e-2)" "prognostic favourable (2.70e-4)" "unprognostic (2.67e-2)" "unprognostic (8.28e-2)" "unprognostic (5.23e-2)" "unprognostic (1.02e-1)" "unprognostic (9.55e-2)" "unprognostic (9.96e-3)" "unprognostic (2.84e-3)" "unprognostic (8.26e-2)" "unprognostic (3.08e-1)" "unprognostic (4.25e-2)" "unprognostic (4.48e-2)" 4.5 10.5 5.9 8.7 8.0 14.2 6.5 11.1 6.6 11.2 6.5 7.7 11.5 8.5 15.6 12.5 5.9 13.8 10.3 4.2 5.1 4.1 8.9 5.5 6.1 5.4 4.3 3.8 13.4 10.3 7.0 16.7 6.9 6.8 8.5 3.5 11.4 7.9 8.9 3.2 13.5 7.4 6.8 4.6 4.3 8.4 34.3 6.2 9.8 13.4 9.1 7.9 5.0 6.1 3.3 1.9 0.0 0.8 0.0 1.7 0.8 5.6 7.9 4.4 10.7 1.7 1.1 0.3 4.1 1.6 3.1 3.6 10.2 7.9 4.9 3.3 1.3 12.4 2.2 3.3 0.7 8.2 7.7 1.6 28.1 9.2 0.5 8.7 7.7 2.2 2.7 6.2 1.4 2.2 0.5 12.5 1.3 4.1 6.7 8.2 4.3 2.6 19.1 1.7 8.1 3.4 5.2 8.4 8.9 3.8 7.9 0.8 16.3 7.1 2.4 7.6 7.6 8.2 5.4 12.7 5.4 5.1 2.2 4.7 4.9 0.0 0.1 0.0 0.3 0.8 0.0 3.3 0.5 1.7 0.2 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.8 5.9 8.0 11.1 6.6 5.1 4.1 4.3 3.8 6.8 6.2 XYLB "FLJ10343, FLJ12539" ENSG00000093217 Xylulokinase O75191 3 38346760-38421348 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Xylose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 34.0" "Cell line enhanced" "Detected in many" "Hep G2: 21.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 6.4;monocytes: 3.6;T-cells: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037863, HPA038415" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA037863: AB_10672729, HPA038415: AB_10672592" "unprognostic (2.48e-1)" "unprognostic (9.72e-2)" "unprognostic (3.42e-2)" "unprognostic (6.25e-2)" "unprognostic (7.52e-2)" "unprognostic (5.19e-2)" "unprognostic (5.82e-2)" "unprognostic (1.26e-3)" "unprognostic (6.55e-2)" "unprognostic (2.22e-1)" "unprognostic (6.91e-3)" "unprognostic (4.63e-2)" "prognostic favourable (8.57e-4)" "unprognostic (3.26e-1)" "unprognostic (2.06e-1)" "unprognostic (5.78e-2)" "unprognostic (3.37e-2)" 2.3 3.2 2.7 1.9 3.4 2.5 3.0 10.3 4.7 2.7 5.9 2.3 1.6 5.8 3.7 3.6 3.1 1.9 2.5 1.5 1.8 1.8 11.3 34.0 1.8 1.3 1.9 3.3 2.8 6.1 1.2 3.1 1.4 4.1 2.1 5.1 3.0 7.1 1.8 1.3 1.9 9.8 3.6 2.0 1.6 3.7 2.1 1.6 2.3 1.5 1.8 1.3 2.7 2.9 0.4 6.4 1.1 3.6 0.9 3.9 1.1 3.0 5.7 2.1 4.6 2.9 3.2 5.1 4.3 1.6 3.9 3.8 7.7 3.2 2.7 1.1 5.4 2.1 6.2 2.5 4.2 3.8 4.8 5.3 4.4 21.0 1.8 7.5 5.7 2.1 4.3 5.2 2.1 3.5 14.3 5.2 3.7 1.6 6.4 1.0 3.0 6.9 3.2 4.2 3.8 0.4 4.7 2.6 2.4 2.5 11.5 9.3 5.5 4.3 1.3 7.3 5.7 11.1 1.8 2.8 4.5 7.3 3.9 6.3 5.3 0.5 2.2 0.7 1.5 3.6 1.0 0.3 1.2 0.8 6.4 0.4 1.5 1.5 1.1 0.9 2.9 1.3 3.9 1.1 2.7 3.4 10.3 4.7 1.8 1.8 1.9 3.3 4.1 1.6 YTHDF3 FLJ31657 ENSG00000185728 "YTH N6-methyladenosine RNA binding protein 3" Q7Z739 8 63168553-63212786 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048703 Approved "Nuclear membrane,Nuclear speckles,Cytosol" "Nuclear speckles" "Nuclear membrane, Cytosol" "HPA048703: " "unprognostic (1.06e-2)" "unprognostic (9.89e-3)" "unprognostic (6.65e-3)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "unprognostic (7.87e-2)" "unprognostic (9.57e-2)" "unprognostic (2.07e-1)" "unprognostic (6.14e-2)" "unprognostic (2.24e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "unprognostic (1.51e-1)" "unprognostic (1.35e-3)" "unprognostic (1.11e-1)" 21.7 17.5 12.2 12.8 15.2 53.2 16.0 16.7 17.3 19.4 20.2 14.3 16.8 14.2 24.3 13.6 17.7 17.6 17.6 26.9 11.9 11.4 18.8 26.8 16.8 12.4 14.2 10.6 25.1 15.6 16.6 19.3 29.0 16.8 21.2 15.6 12.9 18.1 18.8 28.0 12.7 24.7 19.4 14.4 18.1 15.9 13.3 14.2 20.1 17.2 15.9 14.1 21.0 15.9 8.2 16.9 21.2 24.9 9.7 11.0 10.1 16.0 21.8 21.0 15.8 28.1 24.2 14.4 29.3 24.6 18.6 22.1 18.5 16.1 17.0 6.4 28.5 15.4 27.6 19.5 27.7 13.8 13.1 31.6 16.5 12.5 25.6 9.0 15.6 32.0 15.0 19.9 27.9 15.7 18.5 15.6 27.9 11.1 17.2 8.4 29.2 16.1 13.1 16.1 8.4 17.5 28.5 8.6 15.4 20.8 18.8 21.2 25.2 11.4 28.2 17.4 16.8 15.5 15.7 18.8 17.0 25.5 17.7 12.7 20.9 20.6 16.6 17.4 8.9 19.4 9.8 7.4 9.0 10.5 16.9 8.2 11.0 10.5 21.2 9.7 24.9 5.1 9.4 10.1 12.2 15.2 16.7 17.3 11.9 11.4 14.2 10.6 16.8 14.2 ZBTB8A "BOZF1, FLJ90065, ZBTB8, ZNF916A" ENSG00000160062 "Zinc finger and BTB domain containing 8A" Q96BR9 1 32539427-32605939 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031768, HPA031769, HPA031770" Approved Approved "Nuclear speckles,Focal adhesion sites" "Nuclear speckles, Focal adhesion sites" "HPA031768: AB_10610568, HPA031769: , HPA031770: " "unprognostic (1.71e-1)" "unprognostic (1.98e-1)" "unprognostic (1.01e-1)" "unprognostic (7.40e-2)" "unprognostic (7.21e-2)" "unprognostic (2.85e-2)" "unprognostic (9.45e-5)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (7.83e-3)" "unprognostic (4.23e-3)" "unprognostic (1.78e-1)" "unprognostic (8.10e-2)" "unprognostic (2.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.47e-1)" "unprognostic (3.15e-2)" 8.8 4.9 4.4 3.2 5.0 2.3 19.1 11.1 5.9 13.6 6.2 4.8 12.2 3.8 12.7 8.6 7.2 7.8 5.7 6.9 4.4 3.4 5.7 4.4 14.0 1.9 3.3 4.5 8.6 10.9 10.7 8.9 5.5 7.9 7.8 6.2 6.9 9.9 11.4 10.3 4.8 4.2 15.4 5.2 2.7 6.4 6.2 3.5 1.8 11.2 6.6 3.0 9.1 7.6 1.6 2.1 4.1 1.0 2.6 1.0 0.5 6.5 1.8 7.7 8.3 5.5 7.4 5.8 6.5 5.2 6.2 6.3 0.8 5.3 5.3 4.5 7.0 5.2 7.6 5.2 5.5 1.4 5.1 0.3 6.5 2.8 7.1 1.2 0.4 5.0 7.5 4.5 11.9 6.9 1.1 3.8 6.2 6.7 3.6 0.6 7.0 2.7 6.5 11.2 4.2 3.8 6.8 6.5 5.9 9.2 4.6 8.7 6.0 3.0 7.1 8.3 6.8 11.3 4.7 7.0 3.3 4.1 5.7 1.3 3.4 4.1 1.0 0.8 0.8 0.6 1.0 0.8 0.7 0.7 0.7 1.6 0.8 0.9 3.8 2.6 0.8 2.1 0.6 0.5 4.4 5.0 11.1 5.9 4.4 3.4 3.3 4.5 7.9 3.5 ZC2HC1C "C14orf140, FAM164C" ENSG00000119703 "Zinc finger C2HC-type containing 1C" Q53FD0 14 75064170-75079987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 75.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA050928, HPA065062" Enhanced Approved "Nuclear speckles,Mitochondria" "Nuclear speckles" Mitochondria "HPA050928: , HPA065062: " "unprognostic (8.01e-2)" "unprognostic (2.01e-2)" "unprognostic (9.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.97e-3)" "unprognostic (6.00e-2)" "unprognostic (8.94e-2)" "unprognostic (1.20e-2)" "unprognostic (3.71e-3)" "unprognostic (3.22e-2)" "unprognostic (1.09e-3)" "unprognostic (2.26e-1)" "prognostic favourable (4.63e-13)" "unprognostic (4.69e-3)" "unprognostic (7.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.81e-1)" 0.7 2.1 2.3 0.5 5.3 0.2 1.3 1.8 3.4 1.5 2.0 2.3 4.6 2.5 1.0 18.2 1.3 8.2 1.5 2.9 3.0 3.0 4.3 6.8 2.2 0.1 2.3 2.3 0.8 3.6 5.2 10.9 3.3 4.7 1.0 1.8 1.2 2.3 5.7 3.0 1.1 1.9 1.0 1.9 0.6 1.2 75.7 2.3 0.6 5.9 0.5 0.4 1.2 0.4 1.6 0.6 0.8 0.3 3.8 3.8 0.8 5.9 4.7 1.0 5.2 0.3 0.3 2.7 0.5 2.0 2.6 1.1 7.5 10.9 5.5 4.2 0.5 2.3 0.0 0.1 1.8 5.8 0.6 1.4 1.6 2.6 3.6 0.1 3.6 1.0 0.6 3.4 0.1 1.5 7.8 2.4 1.3 1.3 0.6 0.7 1.7 3.2 0.1 0.3 2.7 5.9 0.3 9.5 2.3 3.4 3.0 2.7 4.3 1.7 0.8 1.6 1.9 2.8 1.1 5.5 8.2 2.8 2.4 1.0 0.8 0.8 0.3 0.8 1.9 0.0 0.5 1.6 1.6 0.5 0.3 0.8 0.7 0.8 0.4 3.8 0.2 0.6 3.8 0.8 2.3 5.3 1.8 3.4 3.0 3.0 2.3 2.3 4.7 2.3 ZC3H11A "KIAA0663, ZC3HDC11A" ENSG00000058673 "Zinc finger CCCH-type containing 11A" O75152 1 203795654-203854999 "Predicted intracellular proteins" "mRNA transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA026439, HPA028490, HPA028526" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533" "unprognostic (8.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.45e-2)" "unprognostic (3.35e-1)" "unprognostic (1.51e-1)" "unprognostic (3.67e-2)" "unprognostic (2.87e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-2)" "unprognostic (2.38e-1)" "unprognostic (1.13e-1)" "unprognostic (4.71e-2)" "prognostic unfavourable (5.58e-4)" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-2)" "unprognostic (1.41e-1)" 21.7 18.1 19.0 17.7 15.9 23.2 49.0 27.7 17.9 16.8 20.4 16.9 15.7 18.4 21.9 12.5 18.8 15.2 13.7 15.5 20.7 12.8 16.2 23.9 20.8 22.4 22.9 11.0 19.0 17.2 23.0 42.7 30.8 18.8 16.9 16.8 11.0 19.5 15.6 23.0 23.4 25.4 15.5 20.5 23.9 18.5 42.1 18.7 23.1 21.0 14.1 22.8 21.5 44.7 6.7 5.1 15.1 6.3 5.9 9.5 4.9 13.8 11.1 21.9 14.3 13.6 10.5 24.0 16.0 11.1 13.1 14.8 15.6 17.6 17.7 9.8 16.2 19.8 17.3 9.4 18.0 25.8 12.5 17.0 18.4 7.7 7.5 23.6 30.7 9.0 11.5 13.9 13.7 11.7 33.7 24.3 10.6 11.4 26.1 9.6 21.1 9.3 19.2 25.7 11.7 9.4 24.2 16.4 15.4 15.9 13.1 14.6 14.1 17.7 18.6 19.3 17.1 16.4 14.9 18.0 17.0 28.3 12.3 13.8 14.6 15.1 4.4 6.5 6.9 4.3 9.5 6.7 6.3 6.2 5.1 5.0 8.0 5.8 9.2 5.9 6.3 2.8 5.8 4.9 19.0 15.9 27.7 17.9 20.7 12.8 22.9 11.0 18.8 18.7 ZC3H11B ZC3HDC11B ENSG00000215817 "Zinc finger CCCH-type containing 11B" 1 219608347-219613145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 8.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA026439, HPA028490, HPA028526" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533" "unprognostic (1.75e-1)" "unprognostic (5.54e-2)" "unprognostic (2.21e-1)" "unprognostic (2.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.92e-1)" "unprognostic (5.07e-1)" "unprognostic (1.15e-1)" "unprognostic (1.02e-1)" "unprognostic (2.44e-1)" "unprognostic (1.30e-1)" "unprognostic (8.19e-2)" "unprognostic (2.28e-2)" "unprognostic (7.87e-2)" "unprognostic (9.15e-2)" "unprognostic (2.56e-2)" "unprognostic (1.87e-2)" 0.1 0.1 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.8 0.1 0.0 0.1 0.0 8.9 0.0 0.0 0.0 0.5 0.7 2.1 0.9 0.6 0.9 0.6 0.9 0.8 2.1 1.3 0.4 0.3 1.9 1.9 0.2 0.3 0.4 0.9 0.8 0.7 0.5 0.2 1.5 0.2 0.2 0.3 3.1 0.8 0.5 1.1 0.7 0.1 0.8 1.8 0.2 0.1 0.4 0.5 0.0 2.2 2.3 0.2 0.4 1.6 1.1 1.2 0.6 0.7 1.5 0.7 0.2 0.9 0.9 1.4 1.1 1.7 1.3 1.4 3.2 1.1 1.0 1.3 1.0 2.0 1.3 1.2 1.1 2.2 1.3 2.0 1.0 0.9 0.7 0.7 0.4 0.8 0.5 0.6 0.7 0.7 0.5 0.7 0.6 2.1 0.6 0.3 0.3 0.9 0.6 ZCCHC4 "FLJ23024, HSPC052, ZGRF4" ENSG00000168228 "Zinc finger CCHC-type containing 4" Q9H5U6 4 25312785-25370383 "Predicted intracellular proteins" "Acyltransferase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035575, HPA035576" Uncertain Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles, Golgi apparatus" "HPA035575: , HPA035576: AB_10671516" "unprognostic (5.52e-1)" "unprognostic (1.54e-1)" "unprognostic (2.94e-2)" "unprognostic (3.06e-2)" "unprognostic (1.87e-2)" "unprognostic (5.84e-2)" "unprognostic (2.80e-3)" "unprognostic (1.71e-1)" "unprognostic (3.00e-1)" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (1.85e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.59e-2)" "unprognostic (1.07e-2)" 11.5 10.3 9.7 14.6 12.8 8.1 12.4 13.1 12.4 11.3 9.5 12.8 12.5 8.9 14.6 10.4 9.1 11.7 8.0 10.6 9.0 6.5 9.3 8.8 8.7 11.5 13.7 7.0 15.4 9.4 12.7 11.6 10.7 9.8 10.9 10.0 11.6 10.0 10.3 16.6 10.4 10.4 13.5 10.0 12.4 9.1 11.2 10.9 15.0 11.3 7.6 11.1 11.0 12.7 6.5 4.4 2.4 3.8 6.5 7.5 3.9 3.8 2.4 8.0 3.6 6.3 8.0 7.1 9.9 10.5 11.6 13.5 3.7 10.3 6.4 2.8 6.0 3.1 7.7 7.2 16.3 1.5 4.2 5.9 5.3 6.3 8.0 9.6 4.4 6.2 8.1 11.1 8.7 5.5 10.5 3.3 9.8 2.8 9.9 12.7 11.0 5.2 6.7 12.2 3.9 6.2 4.0 7.5 5.2 4.3 3.6 6.3 5.2 5.9 4.4 9.8 4.0 6.3 13.1 6.4 8.0 9.3 10.5 9.4 9.3 2.4 3.2 1.0 5.3 3.8 7.5 6.0 6.8 6.4 4.4 6.5 6.7 7.3 1.8 6.5 3.6 3.5 6.5 3.9 9.7 12.8 13.1 12.4 9.0 6.5 13.7 7.0 9.8 10.9 ZCWPW2 ZCW2 ENSG00000206559 "Zinc finger CW-type and PWWP domain containing 2" Q504Y3 3 28349146-28538122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035035, HPA039839" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA035035: AB_10602256, HPA039839: " "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (4.59e-3)" "unprognostic (6.53e-2)" "unprognostic (6.09e-4)" "unprognostic (3.21e-1)" "unprognostic (2.70e-2)" "unprognostic (1.73e-3)" "unprognostic (1.12e-1)" "unprognostic (1.10e-4)" "unprognostic (1.06e-2)" "unprognostic (7.88e-2)" "unprognostic (1.40e-2)" "unprognostic (2.38e-2)" 2.6 3.1 3.9 2.8 5.3 1.3 3.4 4.8 4.2 3.3 2.9 3.1 5.2 2.1 6.2 4.1 2.8 2.6 4.1 5.1 3.5 2.7 3.2 2.7 4.4 1.9 3.9 2.3 5.0 3.5 3.7 10.5 2.5 3.9 4.2 2.0 2.9 4.8 2.6 9.6 3.6 2.4 5.7 5.4 2.4 2.8 16.1 5.1 2.8 5.2 0.4 2.6 2.7 2.6 0.9 1.4 3.6 2.4 0.6 2.4 0.7 0.7 0.4 1.8 0.8 2.5 5.9 3.0 2.4 2.0 0.9 0.8 0.6 1.9 1.8 1.2 1.4 1.1 0.5 0.6 1.1 0.9 0.8 0.6 2.1 0.6 1.8 0.7 1.2 3.5 1.6 0.7 1.1 2.0 0.8 2.1 3.8 1.0 0.5 1.4 0.8 2.5 0.6 0.7 1.3 2.8 0.3 0.8 2.8 0.2 1.2 1.6 1.0 5.6 1.9 2.2 1.1 1.6 1.3 0.9 0.6 0.5 6.5 1.1 2.4 2.7 2.4 3.1 0.8 2.1 0.5 0.4 0.8 0.6 1.0 0.9 1.8 2.4 3.6 0.6 0.5 1.4 0.8 0.7 3.9 5.3 4.8 4.2 3.5 2.7 3.9 2.3 3.9 5.1 ZDHHC15 "DHHC15, FLJ31812, MRX91" ENSG00000102383 "Zinc finger DHHC-type containing 15" Q96MV8 X 75368427-75523502 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 5.6;K-562: 3.5;LHCN-M2: 3.9;MOLT-4: 4.1;NTERA-2: 3.7;RH-30: 5.7;RPTEC TERT1: 3.1;SH-SY5Y: 4.7" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003618 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA003618: AB_2217686" "unprognostic (8.28e-2)" "unprognostic (1.73e-1)" "unprognostic (8.05e-2)" "unprognostic (1.62e-5)" "unprognostic (1.64e-2)" "unprognostic (1.00e-1)" "unprognostic (4.00e-4)" "unprognostic (1.96e-2)" "unprognostic (3.19e-1)" "unprognostic (8.70e-2)" "unprognostic (3.77e-3)" "unprognostic (1.40e-1)" "unprognostic (4.78e-13)" "unprognostic (2.60e-3)" "unprognostic (1.17e-2)" "unprognostic (1.09e-1)" "unprognostic (9.67e-4)" 3.0 5.4 4.9 1.5 6.8 1.1 5.3 6.2 9.9 5.8 3.4 3.9 2.4 1.3 6.5 3.7 3.2 4.5 3.3 5.4 5.9 8.7 5.3 1.2 4.1 1.6 4.8 5.3 8.5 4.7 5.0 8.7 0.7 7.0 4.0 2.3 5.4 12.7 6.9 1.6 2.8 1.8 5.2 6.4 2.9 2.1 2.6 3.1 2.0 6.6 2.1 1.5 2.6 3.1 0.3 0.4 0.7 0.2 0.5 1.6 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 3.9 0.0 4.1 0.1 3.7 0.0 0.0 5.7 0.0 3.1 0.0 1.6 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.0 0.0 0.7 2.8 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.1 0.3 0.6 0.0 0.0 0.2 1.6 1.1 0.7 0.5 0.1 0.4 0.0 0.3 4.9 6.8 6.2 9.6 5.9 8.7 4.8 5.3 7.0 3.1 ZFP14 "KIAA1559, ZNF531" ENSG00000142065 "ZFP14 zinc finger protein" Q9HCL3 19 36334453-36379199 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030637 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA030637: AB_10602353" "unprognostic (1.89e-1)" "unprognostic (3.80e-2)" "unprognostic (9.61e-2)" "unprognostic (3.53e-1)" "unprognostic (2.20e-2)" "unprognostic (3.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.23e-2)" "unprognostic (1.96e-2)" "unprognostic (1.17e-1)" "unprognostic (3.18e-3)" "unprognostic (1.91e-1)" "unprognostic (5.51e-2)" "unprognostic (1.86e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "prognostic favourable (2.75e-5)" 4.8 6.7 9.1 6.0 11.7 2.7 10.0 13.8 11.5 7.5 5.1 10.3 5.6 6.7 11.4 13.1 5.6 8.0 4.8 4.6 9.6 7.8 8.2 5.0 5.0 8.3 14.6 9.8 10.7 5.1 12.9 14.9 5.1 10.6 7.8 5.2 6.5 6.0 8.0 3.5 7.9 6.5 7.6 11.6 8.3 6.1 2.8 12.8 9.2 10.9 3.1 8.3 6.2 7.0 10.4 5.7 5.7 4.4 5.8 9.5 1.7 2.1 3.8 7.7 7.1 6.7 3.4 1.8 1.0 3.3 2.1 3.3 2.5 1.7 6.1 2.8 1.5 0.8 3.2 0.5 2.3 2.3 2.4 5.4 3.8 2.1 2.2 4.4 5.8 1.5 1.4 0.9 0.2 2.9 1.6 0.1 3.3 1.5 6.8 1.8 5.8 1.7 5.7 4.4 1.8 2.2 4.2 4.3 6.5 3.8 1.2 2.2 2.4 3.5 2.0 2.2 4.9 2.3 1.1 1.7 2.7 3.2 0.4 0.6 3.8 5.7 4.0 5.3 6.2 4.4 6.3 10.4 6.8 7.8 3.8 9.4 9.5 9.5 2.5 5.8 3.9 5.7 6.3 1.7 9.1 11.7 13.8 11.5 9.6 7.8 14.6 9.8 10.6 12.8 ZIM2 ZNF656 ENSG00000269699 "Zinc finger imprinted 2" Q9NZV7 19 56774552-56840729 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;ovary: 35.4" "Cell line enhanced" "Detected in some" "BEWO: 8.2;Hep G2: 9.6;NTERA-2: 2.8;RH-30: 2.9;U-2 OS: 2.0;U-266/84: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA071856 Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA071856: " "unprognostic (9.01e-4)" "unprognostic (8.77e-2)" "unprognostic (5.09e-2)" "unprognostic (4.60e-2)" "unprognostic (2.45e-2)" "unprognostic (3.01e-1)" "unprognostic (2.33e-1)" "unprognostic (8.68e-3)" "unprognostic (4.12e-1)" "unprognostic (1.00e-1)" 1.6 13.1 8.5 1.6 44.0 1.4 2.5 8.2 19.1 2.2 1.7 4.8 0.0 1.6 3.2 1.2 1.7 2.8 1.4 2.6 8.1 6.5 2.0 1.7 1.4 1.5 3.0 13.7 35.4 1.5 1.8 21.1 18.3 18.2 2.0 1.5 0.1 3.7 2.0 1.3 1.4 1.8 2.2 3.9 1.7 1.5 11.4 6.1 0.0 2.2 0.0 2.0 1.9 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.9 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 44.0 8.2 19.1 8.1 6.5 3.0 13.7 18.2 6.1 ZKSCAN7 "FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39" ENSG00000196345 "Zinc finger with KRAB and SCAN domains 7" Q9P0L1 3 44555193-44594173 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 6.6;NTERA-2: 5.1;SH-SY5Y: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048312, HPA049906, HPA071850" Uncertain Supported "Nuclear speckles,Cytosol" Cytosol "Nuclear speckles" "HPA048312: , HPA049906: , HPA071850: " "unprognostic (3.31e-2)" "unprognostic (4.49e-2)" "unprognostic (7.25e-2)" "unprognostic (5.78e-3)" "unprognostic (3.41e-2)" "unprognostic (1.21e-3)" "unprognostic (2.18e-1)" "unprognostic (2.31e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (4.22e-4)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-1)" "unprognostic (7.17e-3)" 3.4 6.0 5.7 6.3 3.9 1.9 5.3 9.9 6.1 6.1 3.9 6.0 6.1 2.0 6.9 9.5 2.9 6.4 5.3 4.8 5.6 3.9 4.5 4.6 5.1 5.1 4.4 3.4 13.0 6.7 6.8 18.2 3.4 4.1 6.6 3.5 7.2 3.7 5.8 4.3 2.2 3.8 7.2 3.9 4.8 3.7 18.6 4.4 12.1 6.0 1.9 4.8 5.5 5.9 3.7 2.5 2.0 1.2 2.4 3.4 1.2 0.0 0.0 4.6 6.6 1.3 0.7 0.0 2.2 1.9 2.3 2.7 0.0 0.1 0.1 0.8 1.5 0.0 0.0 1.4 2.9 0.0 0.0 0.2 1.4 1.7 4.1 0.0 0.0 3.2 1.5 1.3 0.0 0.6 0.0 0.1 3.5 0.0 0.0 0.0 5.1 0.0 0.0 2.1 0.0 1.3 0.6 3.1 8.1 0.1 0.2 0.0 0.0 3.1 0.7 1.4 0.5 1.8 0.0 0.2 0.1 0.0 0.3 0.0 1.1 2.0 1.2 1.6 3.4 0.5 1.0 1.3 2.1 2.6 1.0 3.7 1.6 3.2 1.6 2.4 1.1 2.5 2.1 1.2 5.7 3.9 9.9 6.1 5.6 3.9 4.4 3.4 4.1 4.4 ZNF160 "F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18" ENSG00000170949 "Zinc finger protein 160" Q9HCG1 19 53066606-53103436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA023599 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA023599: AB_2218442" "unprognostic (1.18e-2)" "unprognostic (4.75e-2)" "unprognostic (1.16e-2)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (8.31e-3)" "unprognostic (2.65e-5)" "unprognostic (5.20e-2)" "unprognostic (4.11e-3)" "unprognostic (2.03e-1)" "unprognostic (3.12e-2)" "unprognostic (6.03e-3)" "unprognostic (2.71e-3)" "unprognostic (2.87e-1)" "unprognostic (4.63e-1)" "unprognostic (1.71e-1)" "prognostic favourable (2.67e-5)" 17.7 28.0 15.7 18.5 19.9 8.1 17.2 26.4 20.0 16.3 15.5 21.6 14.1 9.6 22.7 17.2 11.0 15.5 16.8 13.8 14.5 8.9 19.7 13.2 17.3 12.8 22.5 15.2 25.9 12.7 20.9 18.2 16.1 18.8 15.1 13.3 9.9 14.3 19.3 10.2 13.1 12.1 17.4 19.6 31.5 13.2 15.2 22.4 19.0 29.5 7.5 12.5 18.0 15.0 9.1 4.3 10.7 5.9 17.5 11.2 5.4 5.9 5.3 7.4 11.3 12.5 8.8 12.6 6.5 8.7 5.3 8.5 4.6 3.8 6.8 5.6 6.0 4.4 6.9 6.7 10.6 5.0 8.4 10.5 4.0 2.5 6.8 0.0 7.2 10.9 6.9 5.7 8.0 5.6 5.3 0.0 9.9 4.1 8.6 6.4 6.9 8.6 5.5 7.8 5.2 8.3 30.2 6.3 8.1 0.0 5.2 1.0 5.5 6.1 10.7 14.8 5.3 4.3 4.7 3.9 16.1 9.7 2.6 2.6 7.0 9.0 3.1 10.7 7.1 4.2 10.3 8.4 7.3 9.5 4.3 9.1 11.2 8.7 6.5 17.5 5.9 4.1 7.3 5.4 15.7 19.9 26.4 20.0 14.5 8.9 22.5 15.2 18.8 22.4 ZNF165 "CT53, ZSCAN7" ENSG00000197279 "Zinc finger protein 165" P49910 6 28080975-28089563 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.9" "Cell line enhanced" "Detected in many" "A-431: 10.9;BEWO: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 8.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007247 Approved "Nuclear speckles,Microtubules" "Nuclear speckles, Microtubules" "HPA007247: " "unprognostic (1.85e-1)" "unprognostic (2.01e-3)" "unprognostic (1.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.45e-1)" "unprognostic (4.32e-3)" "unprognostic (3.42e-1)" "unprognostic (2.09e-1)" "unprognostic (1.93e-2)" "prognostic favourable (2.10e-4)" "unprognostic (1.18e-3)" "unprognostic (1.29e-2)" "prognostic favourable (1.19e-5)" "unprognostic (1.10e-1)" "unprognostic (2.40e-1)" "unprognostic (2.18e-1)" "prognostic favourable (9.82e-5)" 0.4 0.8 1.2 2.1 1.7 0.7 2.2 1.3 2.4 1.5 2.6 0.9 7.9 2.0 1.1 6.3 2.5 1.8 0.6 0.8 1.7 1.1 3.5 2.7 2.6 0.9 0.8 0.3 0.7 5.4 3.1 7.7 6.2 4.0 1.2 3.6 0.6 2.5 1.3 0.4 1.0 3.4 0.4 0.5 1.0 2.2 23.9 0.5 1.2 3.1 1.4 2.5 1.2 1.2 8.6 4.2 1.6 0.6 0.2 1.7 0.5 10.9 0.7 0.7 0.6 0.3 0.5 19.4 0.4 0.5 0.8 0.7 7.6 8.2 1.0 3.2 0.2 4.2 1.8 5.4 0.6 0.2 3.0 0.3 1.2 8.2 0.3 1.8 1.5 0.3 3.0 0.6 8.0 0.2 1.8 0.3 0.5 3.2 0.4 2.1 1.6 0.9 1.3 0.6 6.3 4.4 5.4 8.0 0.6 0.8 9.6 0.8 4.4 0.3 0.1 0.6 0.9 0.3 0.7 2.7 7.2 2.8 0.3 2.1 0.3 0.0 0.3 1.6 0.7 0.6 1.5 6.0 0.9 0.5 1.2 8.6 1.7 1.3 1.1 0.2 0.2 4.2 0.4 0.5 1.2 1.7 1.3 2.4 1.7 1.1 0.8 0.3 4.0 0.5 ZNF169 MGC51961 ENSG00000175787 "Zinc finger protein 169" Q14929 9 94259311-94301454 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041769 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA041769: " "unprognostic (1.07e-1)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (3.27e-2)" "unprognostic (9.08e-3)" "unprognostic (1.18e-3)" "unprognostic (7.33e-2)" "unprognostic (2.27e-1)" "unprognostic (7.45e-2)" "unprognostic (6.79e-2)" "unprognostic (1.69e-2)" "unprognostic (1.49e-4)" "unprognostic (6.32e-2)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (2.15e-4)" 4.5 4.2 6.5 8.5 10.9 5.9 7.8 12.7 13.5 7.4 6.7 8.3 4.4 5.6 7.7 8.7 4.1 7.5 5.7 4.6 8.6 5.7 5.5 3.2 5.0 11.0 9.8 8.5 9.4 5.2 5.9 4.9 4.3 8.2 6.6 11.1 5.8 7.2 5.6 8.6 10.0 8.6 6.6 7.1 10.6 8.1 4.3 9.5 10.5 8.0 5.0 10.0 6.9 6.5 9.5 4.5 6.1 6.9 6.7 9.1 3.4 4.0 3.5 4.0 7.0 1.9 5.0 4.5 1.4 2.8 3.1 3.3 2.4 6.0 9.7 2.0 2.3 8.0 8.2 3.7 4.2 5.5 8.8 6.8 8.0 4.5 2.9 10.3 7.0 4.3 4.1 2.6 4.2 3.9 6.1 3.0 3.9 3.9 4.7 5.7 6.5 4.3 4.2 2.8 3.2 2.8 3.6 4.1 4.9 2.8 4.9 2.0 3.1 4.5 4.2 2.9 3.7 3.6 3.1 5.2 1.9 2.0 2.7 6.8 2.7 3.2 6.5 6.1 5.5 6.9 6.9 6.3 6.2 3.9 4.5 9.5 6.7 9.1 5.6 6.7 5.0 4.2 6.5 3.4 6.5 10.9 12.7 13.5 8.6 5.7 9.8 8.5 8.2 9.5 ZNF286B "ZNF286C, ZNF286L, ZNF590" ENSG00000249459 "Zinc finger protein 286B" P0CG31 17 18658429-18682262 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA068125 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA068125: " "unprognostic (3.15e-1)" "unprognostic (1.23e-1)" "unprognostic (3.81e-1)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.78e-2)" "unprognostic (1.47e-3)" "unprognostic (3.20e-1)" "unprognostic (5.52e-3)" "unprognostic (1.97e-1)" "unprognostic (1.05e-4)" "unprognostic (1.50e-1)" "unprognostic (9.20e-4)" "unprognostic (1.16e-1)" "unprognostic (3.82e-1)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" 0.7 0.9 1.4 1.2 1.4 0.8 1.5 6.5 2.8 2.0 1.2 0.3 3.4 1.8 2.3 1.9 1.1 0.8 1.5 1.8 1.6 0.2 0.7 1.2 1.4 5.4 0.6 1.3 1.4 1.0 1.4 1.4 0.8 1.4 2.9 1.4 0.9 1.9 1.5 1.3 1.2 1.1 1.0 1.6 1.4 1.7 3.0 0.9 1.1 1.7 3.2 4.2 1.0 3.1 2.7 5.4 5.3 2.1 3.4 4.2 2.8 0.8 1.3 1.1 6.4 0.4 4.4 1.7 2.3 3.6 5.8 2.2 2.8 1.9 6.1 2.9 2.1 1.1 2.6 0.0 2.5 3.8 2.1 6.2 3.1 3.2 1.9 0.4 2.9 1.1 6.6 2.0 2.2 0.9 3.1 8.1 0.1 1.0 1.0 3.1 9.6 4.3 1.4 2.5 3.9 1.3 3.1 1.7 6.4 4.6 4.4 2.1 2.6 0.2 1.6 1.3 3.9 1.1 0.8 0.5 3.4 0.9 3.0 2.1 3.2 3.8 0.7 3.0 3.9 4.2 0.9 3.2 1.7 0.9 3.5 1.0 ZNF304 ENSG00000131845 "Zinc finger protein 304" Q9HCX3 19 57351307-57359898 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050531 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA050531: " "unprognostic (4.44e-1)" "unprognostic (1.73e-3)" "unprognostic (5.63e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (9.72e-2)" "unprognostic (2.86e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (4.95e-4)" "unprognostic (1.54e-1)" "unprognostic (1.28e-3)" "unprognostic (5.97e-2)" "prognostic favourable (1.52e-7)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (4.31e-1)" "unprognostic (9.00e-3)" 8.5 11.3 8.5 7.8 13.5 6.0 10.8 20.1 12.0 7.7 8.5 7.7 7.2 4.2 9.3 12.6 8.8 8.9 7.1 10.6 7.1 7.0 7.6 5.6 8.7 11.8 8.8 11.0 11.7 5.2 16.4 9.6 9.0 8.6 9.7 5.2 7.4 8.1 10.9 8.5 9.9 7.1 8.8 6.7 11.0 6.8 6.9 8.6 11.1 11.7 9.9 11.4 9.2 6.1 5.5 3.9 5.7 5.6 5.9 6.1 3.8 5.6 2.8 6.9 8.7 5.7 5.4 4.3 5.6 8.7 6.5 14.8 0.0 2.6 4.6 3.6 6.5 2.0 3.9 7.5 9.6 1.5 18.4 7.3 7.3 3.9 4.1 4.0 4.6 6.6 10.0 6.2 8.8 4.1 2.2 0.0 6.8 1.5 8.5 2.3 4.6 8.9 5.5 11.1 5.9 4.6 12.1 5.5 5.9 5.9 4.6 4.0 5.6 5.9 4.6 9.3 5.5 2.8 6.0 7.5 6.4 6.9 5.7 0.1 4.7 5.7 2.8 2.3 3.3 2.3 6.1 5.5 5.6 4.6 3.9 4.6 4.7 4.8 0.2 5.9 5.6 2.1 4.4 3.8 8.5 13.5 20.1 12.0 7.1 7.0 8.8 11.0 8.6 8.6 ZNF337 dJ694B14.1 ENSG00000130684 "Zinc finger protein 337" Q9Y3M9 20 25674215-25696841 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA044303, HPA064219" Approved Approved "Nuclear speckles,Plasma membrane" "Plasma membrane" "Nuclear speckles" "HPA044303: , HPA064219: " "unprognostic (2.14e-1)" "unprognostic (2.19e-2)" "unprognostic (1.65e-2)" "unprognostic (1.80e-1)" "unprognostic (1.30e-1)" "unprognostic (5.81e-3)" "unprognostic (4.54e-3)" "unprognostic (6.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.34e-2)" "unprognostic (3.15e-2)" "unprognostic (9.36e-4)" "prognostic unfavourable (2.87e-6)" "unprognostic (1.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.93e-2)" "unprognostic (8.82e-3)" 10.4 9.8 11.7 9.0 14.3 10.8 13.6 49.5 14.8 17.9 14.6 16.1 13.3 7.0 19.8 19.4 9.6 18.0 9.0 8.4 10.9 9.8 9.4 6.9 13.5 12.3 15.1 14.2 23.1 8.4 20.3 19.0 9.3 11.2 16.6 10.9 11.0 8.6 17.2 11.9 12.9 11.1 15.4 9.4 13.4 8.7 7.0 14.9 19.0 12.2 6.0 11.0 14.3 26.1 3.8 3.9 4.8 3.9 5.3 9.6 3.8 7.8 14.5 11.6 8.1 9.4 12.0 9.7 6.9 6.1 5.4 6.7 2.9 7.4 10.0 6.6 6.2 12.9 7.8 22.3 7.4 3.6 6.1 6.2 9.4 12.6 8.3 5.5 6.7 11.1 20.0 6.2 18.5 8.3 5.4 8.9 10.3 8.9 15.0 10.2 3.1 10.3 9.4 10.9 4.9 5.5 8.7 9.5 10.1 7.0 11.1 9.3 6.5 7.7 11.0 11.5 6.1 7.6 8.9 12.5 6.7 3.6 5.5 4.7 9.2 0.0 2.4 4.8 7.2 3.9 7.9 3.8 6.0 6.8 3.9 3.2 8.4 9.6 0.1 5.3 2.2 3.9 3.9 3.8 11.7 14.3 49.5 14.8 10.9 9.8 15.1 14.2 11.2 14.9 ZNF382 "FLJ14686, KS1" ENSG00000161298 "Zinc finger protein 382" Q96SR6 19 36604817-36634113 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.6" "Cell line enhanced" "Detected in many" "HDLM-2: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049259 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA049259: " "unprognostic (5.43e-3)" "unprognostic (5.16e-2)" "unprognostic (1.17e-1)" "unprognostic (2.68e-3)" "unprognostic (6.13e-2)" "unprognostic (1.85e-3)" "unprognostic (5.63e-2)" "unprognostic (6.64e-2)" "unprognostic (1.12e-2)" "unprognostic (5.76e-2)" "unprognostic (4.43e-3)" "unprognostic (3.07e-3)" "unprognostic (1.76e-5)" "unprognostic (8.71e-2)" "unprognostic (2.06e-2)" "unprognostic (2.53e-1)" "unprognostic (6.22e-2)" 3.3 5.9 6.7 3.5 10.5 1.9 3.3 27.6 13.8 4.2 3.9 4.9 2.3 1.3 4.8 4.2 3.1 5.8 3.0 7.5 6.2 6.2 3.8 1.5 2.7 5.1 5.6 11.2 4.7 2.6 4.8 11.0 4.6 9.4 3.6 1.9 4.4 3.3 3.1 1.7 1.4 2.8 4.3 5.5 5.5 2.2 6.7 5.3 3.6 5.7 2.0 6.3 4.0 2.0 9.0 2.4 3.5 0.7 4.5 9.0 2.7 0.2 0.1 4.6 6.4 1.9 2.6 1.5 2.0 0.6 5.9 6.1 0.2 0.4 3.9 4.3 2.4 0.1 5.8 0.1 3.8 10.9 2.7 6.4 0.3 1.6 5.2 0.9 7.7 3.6 0.2 3.3 0.2 0.7 0.1 0.2 3.9 0.6 8.8 2.1 3.0 2.2 0.4 1.9 1.7 1.6 0.2 0.6 8.7 0.3 0.3 3.6 2.7 0.7 0.2 1.4 0.3 0.3 5.8 10.1 0.7 0.4 0.1 0.1 3.5 2.1 0.6 3.5 5.6 0.7 9.0 9.0 8.8 6.2 2.3 6.6 7.6 8.4 1.2 4.5 0.7 2.4 5.0 2.7 6.7 10.5 27.6 13.8 6.2 6.2 5.6 11.2 9.4 5.3 ZNF441 FLJ38637 ENSG00000197044 "Zinc finger protein 441" Q8N8Z8 19 11767000-11784078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA063338 Approved "Nuclear speckles" "Nuclear speckles" "HPA063338: " "unprognostic (1.97e-1)" "unprognostic (1.96e-1)" "unprognostic (2.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (6.42e-4)" "unprognostic (2.60e-2)" "unprognostic (1.92e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-2)" "unprognostic (1.33e-3)" "unprognostic (1.80e-1)" "unprognostic (1.75e-1)" "unprognostic (1.68e-2)" "unprognostic (2.70e-3)" 7.6 5.7 7.5 10.6 15.5 1.6 11.3 18.4 11.1 9.6 6.0 4.4 9.4 4.4 8.9 12.1 5.4 7.7 6.9 7.0 7.0 6.7 12.4 8.1 6.6 9.5 5.4 7.1 16.4 6.6 12.1 13.3 8.1 11.6 11.1 6.3 6.6 6.7 9.9 13.9 6.1 7.9 10.8 4.9 8.2 5.9 5.0 5.5 7.2 13.5 3.8 8.1 11.1 7.0 4.5 1.5 2.1 3.6 2.1 4.2 1.7 2.6 0.0 3.3 2.8 4.0 4.3 3.4 6.4 3.6 4.7 4.6 2.9 0.9 5.4 3.4 4.2 2.0 2.1 3.9 5.6 0.0 2.3 2.6 2.1 4.7 3.6 0.1 4.6 5.2 4.4 3.4 2.7 2.7 4.0 0.1 7.4 0.0 5.7 1.6 0.6 4.5 2.2 6.5 1.7 3.9 4.4 2.4 3.9 4.2 1.5 2.3 4.2 5.7 1.3 10.4 2.4 9.1 4.2 5.7 8.2 2.4 0.6 0.1 4.1 0.0 1.0 2.1 2.9 0.9 2.2 3.6 2.9 3.9 1.5 4.5 3.8 4.2 1.3 2.1 3.6 1.0 2.1 1.7 7.5 15.5 18.4 11.1 7.0 6.7 5.4 7.1 11.6 5.5 ZNF446 "FLJ20626, ZKSCAN20, ZSCAN52" ENSG00000083838 "Zinc finger protein 446" Q9NWS9 19 58474017-58481230 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052786, HPA078262" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA052786: , HPA078262: " "unprognostic (1.52e-2)" "unprognostic (8.71e-3)" "unprognostic (2.72e-1)" "unprognostic (5.04e-3)" "unprognostic (3.28e-2)" "unprognostic (1.78e-2)" "unprognostic (5.15e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-1)" "unprognostic (3.94e-1)" "prognostic favourable (1.32e-4)" "unprognostic (3.94e-1)" "unprognostic (9.24e-2)" "unprognostic (2.43e-1)" "unprognostic (9.96e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-3)" 3.6 4.6 5.2 5.1 6.7 4.0 5.0 8.9 8.8 6.7 4.9 5.3 15.1 3.7 7.2 6.2 3.4 11.0 10.0 5.5 5.3 4.8 6.2 6.5 4.3 8.6 5.5 5.9 11.9 13.6 9.7 8.8 2.9 6.7 7.2 3.0 4.4 9.4 7.5 3.5 5.6 4.2 8.5 4.9 4.3 4.8 7.8 3.7 17.1 6.8 3.2 6.4 5.7 10.1 6.8 6.0 5.6 9.8 3.0 7.5 3.6 3.5 7.4 5.1 4.6 5.1 9.6 4.9 2.2 6.7 1.8 2.6 3.5 3.1 3.5 3.0 2.9 5.5 2.0 2.8 0.9 5.0 22.6 4.3 5.5 3.0 7.6 2.2 6.5 7.9 5.2 3.1 3.3 4.4 2.5 2.4 2.8 4.2 5.9 2.6 1.7 4.5 5.2 3.6 4.5 3.8 6.6 6.0 5.7 4.2 5.8 3.7 4.0 2.8 3.4 8.9 3.2 2.0 4.8 8.0 10.7 2.2 4.6 1.3 3.2 5.2 4.4 4.6 6.4 5.9 3.9 4.9 7.5 4.1 6.0 6.8 5.1 6.3 5.6 3.0 9.8 3.9 6.0 3.6 5.2 6.7 8.9 8.8 5.3 4.8 5.5 5.9 6.7 3.7 ZNF527 KIAA1829 ENSG00000189164 "Zinc finger protein 527" Q8NB42 19 37371061-37393066 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037740, HPA037741" Uncertain Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA037740: AB_10672284, HPA037741: " "unprognostic (4.36e-2)" "unprognostic (5.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-2)" "unprognostic (1.30e-2)" "unprognostic (9.26e-2)" "unprognostic (8.70e-3)" "unprognostic (6.47e-3)" "unprognostic (1.91e-1)" "unprognostic (6.05e-4)" "unprognostic (8.34e-3)" "unprognostic (8.92e-2)" "unprognostic (6.83e-2)" "unprognostic (1.44e-2)" "unprognostic (1.52e-3)" "unprognostic (3.17e-4)" 6.0 6.3 6.7 4.7 10.2 6.6 8.5 10.2 13.0 7.8 6.8 9.3 2.7 3.4 9.6 6.0 5.5 6.1 4.3 7.1 8.0 5.7 7.3 5.9 5.2 7.2 6.8 9.1 10.8 6.4 10.2 13.5 5.4 9.8 6.9 7.4 8.2 5.8 7.6 10.1 5.0 5.0 9.5 5.8 6.7 5.1 7.2 7.5 6.7 7.6 4.8 7.3 6.9 7.2 6.3 2.6 6.8 2.5 4.7 6.8 3.9 3.9 4.3 3.9 4.7 4.0 6.8 2.3 4.0 3.5 4.0 5.1 3.5 0.9 3.5 4.9 3.8 1.1 6.7 3.6 4.9 6.7 2.7 4.3 4.6 0.9 4.7 7.1 4.7 4.8 3.9 4.6 8.0 3.5 1.8 2.5 4.3 1.4 5.5 1.6 2.2 1.5 4.5 6.0 4.8 2.6 3.8 5.0 2.7 6.2 2.0 2.0 4.6 4.8 5.0 5.0 4.4 3.7 4.5 7.1 9.1 10.2 0.0 4.9 3.2 2.7 1.6 6.8 6.5 2.5 5.5 6.3 4.0 5.9 2.6 5.4 6.4 6.8 0.8 4.7 1.4 2.4 4.2 3.9 6.7 10.2 10.2 13.0 8.0 5.7 6.8 9.1 9.8 7.5 ZNF528 KIAA1827 ENSG00000167555 "Zinc finger protein 528" Q3MIS6 19 52397849-52418412 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 24.3;U-266/84: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA065435 Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA065435: " "unprognostic (1.90e-2)" "unprognostic (1.69e-1)" "unprognostic (1.59e-1)" "unprognostic (3.73e-1)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "unprognostic (9.60e-2)" "unprognostic (4.81e-3)" "unprognostic (1.26e-2)" "unprognostic (2.45e-1)" "unprognostic (1.42e-2)" "unprognostic (2.98e-3)" "unprognostic (3.26e-3)" "unprognostic (2.78e-2)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" 9.8 11.7 16.6 8.9 20.2 5.8 12.2 21.1 21.4 12.4 9.1 15.7 7.9 5.5 15.3 21.7 10.0 15.6 11.4 11.4 15.3 11.2 11.1 5.2 9.3 9.3 17.5 11.4 21.3 6.4 12.7 21.0 10.9 15.3 13.4 10.0 13.3 12.8 12.1 7.6 12.6 7.5 9.8 15.6 11.8 10.0 13.8 22.0 8.2 19.9 5.1 11.5 12.6 10.8 10.5 8.4 10.6 5.0 16.5 12.7 3.4 0.1 0.0 2.9 17.5 6.8 8.4 7.4 6.5 10.8 4.0 9.0 0.2 3.2 0.1 1.6 8.0 2.0 0.0 4.3 5.1 0.0 4.8 2.7 1.0 1.6 10.0 0.1 7.4 8.5 7.5 4.4 0.0 9.5 1.7 0.3 5.8 0.1 9.8 1.4 7.6 4.6 0.1 11.8 3.1 4.9 24.3 12.2 10.1 0.0 0.5 4.1 11.7 1.5 10.9 7.0 8.1 2.7 8.8 0.3 30.6 5.9 3.5 0.1 10.8 7.1 5.0 10.6 6.7 4.7 12.7 7.3 8.1 10.0 5.0 10.5 8.0 7.1 1.4 16.5 5.0 8.4 8.9 3.4 16.6 20.2 21.1 21.4 15.3 11.2 17.5 11.4 15.3 22.0 ZNF551 DKFZp686H1038 ENSG00000204519 "Zinc finger protein 551" Q7Z340 19 57681969-57717301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038187 Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA038187: " "unprognostic (1.96e-1)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (6.24e-3)" "unprognostic (1.30e-1)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (7.68e-5)" "unprognostic (2.92e-1)" "unprognostic (5.89e-2)" "unprognostic (4.83e-3)" "prognostic favourable (1.32e-4)" "unprognostic (4.70e-2)" "unprognostic (2.73e-1)" "unprognostic (1.26e-2)" "unprognostic (1.54e-1)" 6.6 5.6 4.4 8.3 6.9 12.8 7.9 17.3 5.2 5.2 5.1 6.8 8.6 4.2 6.3 5.9 5.3 5.9 6.1 4.9 4.9 4.6 5.1 3.2 3.8 10.8 3.8 3.3 6.8 10.7 6.1 11.3 5.3 4.9 6.0 5.1 6.4 6.0 5.8 8.8 7.3 5.6 6.8 4.0 8.2 5.1 18.1 5.7 13.0 11.1 5.2 10.3 6.4 6.0 6.6 4.7 2.1 3.1 4.7 8.1 3.8 2.6 5.8 7.2 5.2 1.4 1.7 7.6 3.1 2.2 4.4 2.0 4.9 2.6 4.7 2.0 2.3 3.0 4.8 7.2 6.9 0.0 21.0 8.4 0.2 2.1 1.3 5.9 7.6 3.0 2.7 4.5 4.1 1.8 5.7 0.0 3.9 2.5 12.1 2.3 15.1 9.4 7.7 12.5 6.3 1.7 15.0 7.0 5.8 4.7 3.0 2.5 3.8 7.8 2.2 5.1 5.3 1.7 5.8 5.2 11.1 10.8 0.9 2.9 4.8 1.9 2.1 2.1 3.3 3.1 6.2 6.6 4.9 5.2 4.7 5.5 8.1 7.3 1.1 4.7 1.6 3.8 3.9 3.8 4.4 6.9 17.3 5.2 4.9 4.6 3.8 3.3 4.9 5.7 ZNF560 FLJ31986 ENSG00000198028 "Zinc finger protein 560" Q96MR9 19 9466507-9498607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 21.1" "Group enriched" "Detected in some" 5 "HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.9" "Cancer enriched" "Detected in some" 7 "testis cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045439, HPA074438" Enhanced "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA045439: , HPA074438: " "unprognostic (4.43e-3)" "unprognostic (8.91e-2)" "unprognostic (9.85e-3)" "unprognostic (2.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.29e-1)" "unprognostic (1.04e-1)" "unprognostic (1.39e-1)" "unprognostic (6.57e-3)" "unprognostic (6.33e-5)" "unprognostic (5.60e-2)" "unprognostic (2.32e-1)" "unprognostic (9.15e-3)" "unprognostic (1.65e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.8 2.4 0.0 1.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 1.0 17.9 0.0 0.0 1.3 0.0 4.4 2.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 ZNF572 FLJ38002 ENSG00000180938 "Zinc finger protein 572" Q7Z3I7 8 124973298-124979389 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066838 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA066838: " "unprognostic (8.65e-2)" "unprognostic (3.11e-1)" "unprognostic (5.59e-2)" "unprognostic (2.33e-2)" "unprognostic (1.49e-3)" "unprognostic (8.37e-2)" "unprognostic (4.11e-2)" "unprognostic (1.81e-2)" "unprognostic (3.36e-1)" "unprognostic (8.88e-2)" "unprognostic (8.67e-2)" "unprognostic (2.42e-2)" "unprognostic (1.43e-1)" "unprognostic (8.95e-3)" "unprognostic (2.89e-1)" "unprognostic (2.82e-1)" "unprognostic (6.17e-2)" 2.7 1.6 4.5 5.1 4.5 0.5 6.1 2.7 3.5 3.8 3.2 6.4 3.1 2.6 4.6 6.7 2.6 4.6 2.1 2.8 4.0 2.7 5.1 3.5 3.0 7.1 6.0 2.7 6.8 4.4 2.3 2.3 4.3 3.9 4.4 3.9 4.7 3.7 4.9 1.2 2.5 3.6 2.8 4.4 4.4 4.0 9.8 4.6 11.0 5.4 0.7 5.3 5.1 5.3 2.4 0.6 1.1 1.0 2.3 3.3 0.6 1.7 0.8 1.9 0.0 2.7 3.1 0.0 0.6 0.2 2.3 1.3 2.5 1.2 4.3 2.9 0.7 3.4 1.1 0.1 2.1 0.0 0.9 0.0 1.2 2.9 2.2 0.0 2.3 2.3 2.9 2.4 0.0 1.4 2.5 0.0 3.0 7.0 0.0 0.0 0.0 0.0 2.8 5.0 0.5 1.4 1.2 4.4 4.3 2.7 4.3 4.5 1.9 2.9 1.0 2.7 3.2 0.8 0.0 0.0 2.4 1.9 0.6 0.0 0.3 0.0 0.4 1.1 1.0 1.0 1.4 2.4 1.0 0.5 0.6 2.4 3.3 2.0 0.0 2.3 0.7 0.2 0.0 0.6 4.5 4.5 2.7 3.5 4.0 2.7 6.0 2.7 3.9 4.6 ZNF584 FLJ39899 ENSG00000171574 "Zinc finger protein 584" Q8IVC4 19 58401504-58418327 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043408, HPA048075" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA043408: , HPA048075: " "unprognostic (6.06e-2)" "unprognostic (3.27e-3)" "unprognostic (3.76e-3)" "unprognostic (8.15e-3)" "unprognostic (5.50e-2)" "unprognostic (1.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.04e-2)" "unprognostic (6.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.01e-3)" "unprognostic (1.90e-3)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.80e-1)" "unprognostic (3.27e-1)" "unprognostic (1.36e-2)" 10.4 9.3 7.3 7.4 11.7 3.3 11.7 16.6 12.1 10.6 8.6 9.5 6.4 7.4 10.5 8.2 9.2 13.8 10.5 13.3 7.6 9.6 10.4 13.4 7.9 6.7 7.2 5.0 11.9 13.1 13.6 11.6 5.8 7.9 8.6 5.5 10.8 7.6 13.0 13.3 11.7 4.6 10.9 6.2 6.4 8.1 6.3 7.8 6.6 11.5 10.3 6.7 8.7 16.6 4.4 5.0 1.2 4.5 4.1 8.4 3.9 6.9 10.2 7.0 9.1 6.8 6.9 2.8 5.5 9.7 3.4 4.1 1.6 2.0 3.4 4.4 8.8 3.9 7.5 8.9 3.9 4.5 30.8 9.3 5.8 1.9 11.7 10.2 2.6 7.0 6.4 10.3 14.4 6.7 9.3 3.1 5.5 4.9 8.5 3.1 1.7 14.3 6.2 5.2 5.3 4.8 8.2 5.6 5.9 11.9 3.3 4.6 2.1 5.1 4.1 13.4 4.1 5.5 8.6 3.1 5.5 0.7 9.6 3.5 4.3 0.0 3.2 1.2 5.0 3.1 8.4 3.3 6.8 7.2 5.0 4.4 3.8 5.7 1.0 4.1 4.5 4.4 7.2 3.9 7.3 11.7 16.6 12.1 7.6 9.6 7.2 5.0 7.9 7.8 ZNF695 SBZF3 ENSG00000197472 "Zinc finger protein 695" Q8IW36 1 246945547-247008093 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 8.3;testis: 8.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 5.1" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.2" HPA024743 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA024743: AB_1859419" "unprognostic (8.46e-3)" "unprognostic (6.28e-2)" "unprognostic (1.82e-1)" "unprognostic (2.57e-4)" "unprognostic (4.51e-2)" "unprognostic (1.72e-1)" "unprognostic (1.10e-2)" "unprognostic (1.16e-1)" "unprognostic (5.71e-5)" "unprognostic (7.42e-4)" "unprognostic (2.81e-3)" "unprognostic (2.21e-2)" "unprognostic (1.05e-9)" "unprognostic (2.22e-1)" "unprognostic (2.07e-1)" "unprognostic (2.72e-1)" "unprognostic (3.87e-1)" 0.3 0.3 0.6 3.2 2.1 3.3 1.5 1.6 1.0 0.6 1.0 0.0 0.0 0.4 0.6 0.0 1.3 0.3 0.2 0.3 5.1 0.4 0.7 0.2 0.9 1.1 0.5 0.9 0.6 1.7 0.0 0.6 2.5 0.3 0.4 1.5 0.1 1.1 0.1 0.2 0.5 2.3 1.4 0.7 0.4 0.6 8.3 0.0 8.3 0.3 0.0 2.2 0.4 0.7 0.1 0.1 3.2 0.2 0.2 0.2 0.0 6.5 0.8 4.1 10.3 0.1 0.1 10.7 2.2 0.1 3.1 4.2 6.9 0.4 5.4 4.3 1.2 2.0 11.5 0.6 3.6 0.0 4.0 3.5 1.5 4.2 0.0 0.0 1.3 0.2 0.0 3.5 2.9 1.2 4.7 0.0 3.2 2.6 7.4 3.8 7.6 4.2 4.1 9.4 0.0 0.7 3.6 3.6 6.3 3.3 2.6 1.2 2.9 4.9 0.5 0.5 5.9 3.1 0.0 0.7 1.8 0.1 0.0 0.0 2.2 0.7 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 3.2 0.2 0.1 0.1 0.0 0.0 0.6 2.1 1.6 1.0 5.1 0.4 0.5 0.9 0.3 0.0 ZNF786 DKFZp762I137 ENSG00000197362 "Zinc finger protein 786" Q8N393 7 149069643-149090782 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021518, HPA053459" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA021518: , HPA053459: " "unprognostic (3.13e-2)" "unprognostic (2.72e-1)" "unprognostic (5.61e-2)" "unprognostic (5.39e-2)" "unprognostic (1.87e-1)" "unprognostic (2.84e-2)" "prognostic unfavourable (1.09e-4)" "unprognostic (5.62e-2)" "unprognostic (1.09e-3)" "unprognostic (8.85e-2)" "prognostic favourable (2.01e-4)" "unprognostic (3.97e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (3.44e-1)" "unprognostic (1.47e-2)" 3.9 4.3 8.7 6.1 9.6 3.3 5.1 10.4 15.2 6.0 5.1 4.2 6.4 4.6 6.9 6.1 6.8 6.7 4.8 3.2 6.4 6.1 4.5 5.4 7.3 8.2 4.8 5.8 8.3 6.0 7.6 8.5 3.8 4.0 6.8 3.4 5.4 5.3 5.8 4.1 13.0 5.1 6.6 3.4 7.7 5.1 2.9 4.2 8.4 6.1 5.8 6.5 6.2 6.1 7.2 4.5 2.9 5.0 8.4 12.1 5.3 4.4 8.0 6.4 10.8 3.9 1.6 9.2 2.7 2.9 3.1 2.4 4.2 4.2 6.3 6.6 1.9 5.1 3.9 3.7 2.0 6.8 6.0 3.1 4.7 5.3 3.3 6.1 4.2 2.3 4.2 3.8 2.7 2.8 5.5 3.6 2.8 13.8 10.3 10.4 11.8 6.1 7.7 3.2 4.1 2.5 6.2 7.7 12.1 6.7 6.4 5.0 4.1 2.9 3.6 3.6 2.1 6.2 3.9 13.2 9.7 3.5 6.0 3.9 4.0 1.7 3.7 2.9 12.1 5.0 9.8 7.2 8.5 10.7 4.5 7.1 11.3 9.5 1.1 8.4 3.9 3.9 5.1 5.3 8.7 9.6 10.4 15.2 6.4 6.1 4.8 5.8 4.0 4.2 ZNHIT6 "BCD1, C1orf181, FLJ20729, NY-BR-75" ENSG00000117174 "Zinc finger HIT-type containing 6" Q9NWK9 1 85649423-85708433 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018132 Uncertain Approved "Nuclear speckles,Vesicles" "Nuclear speckles, Vesicles" "HPA018132: AB_1848789" "unprognostic (1.37e-1)" "unprognostic (4.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.27e-3)" "unprognostic (1.61e-2)" "unprognostic (1.11e-1)" "prognostic unfavourable (6.08e-6)" "unprognostic (1.11e-1)" "unprognostic (3.89e-2)" "unprognostic (8.48e-2)" "unprognostic (9.91e-3)" "unprognostic (2.92e-2)" "unprognostic (1.27e-3)" "unprognostic (5.91e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (7.37e-2)" 18.5 12.6 20.7 15.9 28.0 15.5 21.5 19.2 25.6 23.5 13.8 21.4 14.2 9.0 20.4 14.9 19.9 14.6 12.0 12.4 22.5 18.8 12.9 10.3 12.9 19.4 21.5 20.5 21.9 11.5 17.4 20.3 15.1 19.5 17.4 14.0 8.1 15.3 15.1 15.7 17.1 12.0 19.8 26.1 14.5 11.0 11.0 26.6 14.8 17.4 13.8 18.9 19.5 25.7 7.6 6.0 1.3 2.3 5.7 6.4 2.5 12.9 9.5 9.0 8.2 19.5 18.4 11.5 17.4 16.9 11.9 11.6 9.4 6.9 10.2 20.9 10.6 11.1 15.4 10.7 19.4 14.4 13.4 20.9 10.7 10.7 17.2 33.8 8.4 17.7 9.9 16.0 14.0 13.9 19.7 13.8 17.9 5.3 19.5 8.3 12.9 16.7 16.1 19.7 11.6 17.9 25.8 8.6 5.6 13.7 18.7 18.5 9.0 8.7 15.9 15.2 10.3 12.9 24.6 8.9 9.1 29.3 3.3 20.9 13.5 1.3 2.1 0.2 5.7 2.3 6.4 5.6 5.1 6.4 3.6 7.6 6.4 6.3 0.3 5.7 1.9 6.0 5.4 2.5 20.7 28.0 19.2 25.6 22.5 18.8 21.5 20.5 19.5 26.6 ZSWIM5 KIAA1511 ENSG00000162415 "Zinc finger SWIM-type containing 5" Q9P217 1 45016399-45306209 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 7.0;Hep G2: 7.8;SCLC-21H: 9.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018211 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA018211: AB_1859502" "unprognostic (1.86e-1)" "unprognostic (2.58e-1)" "unprognostic (3.06e-1)" "unprognostic (1.49e-3)" "unprognostic (3.19e-1)" "unprognostic (3.72e-2)" "unprognostic (1.72e-3)" "unprognostic (2.65e-2)" "unprognostic (1.57e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-3)" "unprognostic (2.55e-1)" "unprognostic (4.12e-3)" "unprognostic (7.12e-2)" "unprognostic (3.09e-2)" "unprognostic (2.88e-2)" "unprognostic (1.16e-1)" 1.8 18.5 5.9 4.4 6.5 0.7 3.2 17.3 6.6 3.8 7.2 6.6 3.8 7.5 5.2 4.5 2.2 4.5 5.4 2.5 6.4 4.6 5.2 1.3 3.8 2.0 4.9 4.0 14.0 5.4 16.9 16.0 1.8 6.1 5.6 8.5 6.2 6.3 4.4 2.0 2.7 11.7 5.4 3.2 2.9 3.2 6.6 7.1 0.0 7.1 1.3 1.9 4.4 3.7 0.1 0.5 0.0 0.0 0.7 2.4 0.3 0.5 1.8 4.1 7.0 0.6 0.2 1.0 0.2 5.6 1.0 0.9 0.5 0.7 0.4 0.1 0.1 0.2 2.9 0.1 1.3 2.9 5.2 0.3 5.7 7.8 0.0 0.8 0.9 0.1 0.2 0.3 0.0 1.2 0.3 0.3 0.1 2.3 0.5 0.3 3.8 2.0 1.8 0.1 0.2 0.1 1.3 9.7 5.0 2.7 1.0 0.5 2.0 0.2 0.3 1.0 0.5 0.3 1.1 1.9 0.3 0.1 3.9 0.2 0.8 0.0 0.0 0.0 0.9 0.0 0.5 0.1 0.5 0.8 0.0 0.0 2.4 0.3 0.0 0.7 0.0 0.5 0.9 0.3 5.9 6.5 17.3 6.6 6.4 4.6 4.9 4.0 6.1 7.1